
<html lang="en"     class="pb-page"  data-request-id="a47ee7da-7089-4171-bfbf-9c150cbfabac"  
><head data-pb-dropzone="head"><meta name="pbContext" content=";requestedJournal:journal:jmcmar;journal:journal:jmcmar;page:string:Article/Chapter View;ctype:string:Journal Content;wgroup:string:ACHS website Group;issue:issue:10.1021/jmcmar.2012.55.issue-21;website:website:acspubs;pageGroup:string:Publication Pages;article:article:10.1021/jm3009635;subPage:string:Full Text"/></meta>




        <link rel="schema.DC" href="http://purl.org/DC/elements/1.0/" /></link><meta name="dc.Title" content="Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors" /></meta><meta name="dc.Creator" content="Michelle M.  Claffey" /></meta><meta name="dc.Creator" content="Christopher J.  Helal" /></meta><meta name="dc.Creator" content="Patrick R.  Verhoest" /></meta><meta name="dc.Creator" content="Zhijun  Kang" /></meta><meta name="dc.Creator" content="Kristina S.  Fors" /></meta><meta name="dc.Creator" content="Stanley  Jung" /></meta><meta name="dc.Creator" content="Jiaying   Zhong" /></meta><meta name="dc.Creator" content="Mark W.  Bundesmann" /></meta><meta name="dc.Creator" content="Xinjun  Hou" /></meta><meta name="dc.Creator" content="Shenping  Lui" /></meta><meta name="dc.Creator" content="Robin J.  Kleiman" /></meta><meta name="dc.Creator" content="Michelle  Vanase-Frawley" /></meta><meta name="dc.Creator" content="Anne W.  Schmidt" /></meta><meta name="dc.Creator" content="Frank  Menniti" /></meta><meta name="dc.Creator" content="Christopher J.  Schmidt" /></meta><meta name="dc.Creator" content="William E.  Hoffman" /></meta><meta name="dc.Creator" content="Mihaly  Hajos" /></meta><meta name="dc.Creator" content="Laura  McDowell" /></meta><meta name="dc.Creator" content="Rebecca E.  O’Connor" /></meta><meta name="dc.Creator" content="Mary  MacDougall-Murphy" /></meta><meta name="dc.Creator" content="Kari R.  Fonseca" /></meta><meta name="dc.Creator" content="Stacey L.  Becker" /></meta><meta name="dc.Creator" content="Frederick R.  Nelson" /></meta><meta name="dc.Creator" content="Spiros  Liras" /></meta><meta name="dc.Description" content="Phosphodiesterase 9A inhibitors have shown activity in preclinical models of cognition with potential application as novel therapies for treating Alzheimer’s disease. Our clinical candidate, PF-044..." /></meta><meta name="Description" content="Phosphodiesterase 9A inhibitors have shown activity in preclinical models of cognition with potential application as novel therapies for treating Alzheimer’s disease. Our clinical candidate, PF-044..." /></meta><meta name="dc.Publisher" content="American Chemical Society" /></meta><meta name="dc.Date" scheme="WTN8601" content="October 12, 2012" /></meta><meta name="dc.Type" content="research-article" /></meta><meta name="dc.Format" content="text/HTML" /></meta><meta name="dc.Identifier" scheme="doi" content="10.1021/jm3009635" /></meta><meta name="dc.Language" content="EN" /></meta><meta name="dc.Coverage" content="world" /></meta><meta name="dc.Rights" content="© 2012 American Chemical Society" /></meta>
        
        

        
            <link rel="meta" type="application/atom+xml" href="https://doi.org/10.1021%2Fjm3009635" /></link>
            <link rel="meta" type="application/rdf+json" href="https://doi.org/10.1021%2Fjm3009635" /></link>
            <link rel="meta" type="application/unixref+xml" href="https://doi.org/10.1021%2Fjm3009635" /></link>
        
    
    

<title>Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors | Journal of Medicinal Chemistry</title>












<meta charset="UTF-8">




<meta name="robots" content="noarchive"/></meta>
<meta name="pb-robots-disabled">









        <meta property="og:url" content="https://pubs.acs.org/doi/full/10.1021/jm3009635" /></meta><meta property="og:title" content="Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors" /></meta><meta property="og:image" content="https://pubs.acs.org/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0022.jpeg" /></meta><meta property="og:description" content="Phosphodiesterase 9A inhibitors have shown activity in preclinical models of cognition with potential application as novel therapies for treating Alzheimer’s disease. Our clinical candidate, PF-04447943 (2), demonstrated acceptable CNS permeability in rats with modest asymmetry between central and peripheral compartments (free brain/free plasma = 0.32; CSF/free plasma = 0.19) yet had physicochemical properties outside the range associated with traditional CNS drugs. To address the potential risk of restricted CNS penetration with 2 in human clinical trials, we sought to identify a preclinical candidate with no asymmetry in rat brain penetration and that could advance into development. Merging the medicinal chemistry strategies of structure-based design with parallel chemistry, a novel series of PDE9A inhibitors was identified that showed improved selectivity over PDE1C. Optimization afforded preclinical candidate 19 that demonstrated free brain/free plasma ≥1 in rat and reduced microsomal clearance along with the ability to increase cyclic guanosine monophosphosphate levels in rat CSF." /></meta><meta property="og:type" content="Article" /></meta><meta property="og:site_name" content="ACS Publications" /></meta><meta name="twitter:card" content="summary_large_image" /></meta><meta name="twitter:site" content="@ACSPublications" /></meta>
    


    <meta name="viewport" content="width=device-width,initial-scale=1,maximum-scale=10, user-scalable=0"/></meta>















    

    <meta name="dc.identifier" content="10.1021/jm3009635"/></meta>



<meta name="format-detection" content="telephone=no">













<link rel="stylesheet" type="text/css" href="/wro/kfa7~product.css">


    <link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-roboto/font-roboto.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/css/build-f32cfd249ff7cb4cf9c7.css"/></link><link rel="stylesheet" href="/products/achs/releasedAssets/fonts/achs-fonts/font-lato/font-lato.css"/></link>




<meta http-equiv="X-UA-Compatible" content="IE=edge">
<meta http-equiv="content-type" content="text/html; charset=UTF-8">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/achs-1625058702970.css">
<link rel="stylesheet" type="text/css" href="/pb-assets/styles/acs-1622125181777.css">
<script type="text/javascript" src="/templates/jsp/js/jquery-3.1.1.min.js"></script>
<script type="text/javascript" src="/pb-assets/javascript/eloqua-1619549134767.js"></script>
<script async="" type="text/javascript" src="https://www.googletagservices.com/tag/js/gpt.js" rel="preconnect"></script>

<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"5200035e6e4d5180","startTime":1570117212010}'></script>






    








    
        
            <script type="text/javascript">
                (function (i, s, o, g, r, a, m) {
                    i['GoogleAnalyticsObject'] = r;
                    i[r] = i[r] || function () {
                        (i[r].q = i[r].q || []).push(arguments)
                    }, i[r].l = 1 * new Date();
                    a = s.createElement(o), m = s.getElementsByTagName(o)[0];
                    a.async = 1;
                    a.src = g;
                    m.parentNode.insertBefore(a, m)
                })(window, document, 'script', '//www.google-analytics.com/analytics.js', 'ga');
                ga('create', 'UA-7663985-4'
                    
                    
                    , 'auto'
                    
                    );
                
                
                ga('send', 'pageview');
            </script>
            
        
    















    
    
            
                
                

                <link rel="canonical" href="https://pubs.acs.org/doi/10.1021/jm3009635">
            
        




























    
    

    
    
    
    
    <script src="//unpkg.com/@theidentityselector/thiss-ds"></script>

    <script type="text/javascript">

        var SeamlessAccessService = {
            spUrl: "/action/ssostart",
            returnURL: window.location.href,
            my_context: 'seamlessaccess.org',
            timeout: 5000,

            getWAYFLessUrl: function (entityId) {
                return this.spUrl + "?idp=" + encodeURIComponent(entityId)
                    + "&redirectUri=" + encodeURIComponent(this.returnURL);
            },
            retrieveEntity: function (ms) {
                var self = this;
                var persistService = new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                if(ms == undefined || ms === ''){
                    ms = this.timeout;
                }

                return new Promise(function (resolve, reject) {
                    persistService.entities(self.my_context)
                        .then(function (res) {
                            // get the results
                            var results = res.data;
                            return resolve(results);
                        }, function (err) {
                            // failed
                            reject('retrieve entity error: ' + err);
                        });
                        // Set up the timeout
                        setTimeout(function() {
                            reject('Promise timed out ' + ms + ' ms');
                        }, ms);
                });
            },
            updateEntity: function (entitydata) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                var jsonObj = {};
                try {
                    //try to parse it, if it is a json string
                    jsonObj = JSON.parse(entitydata.val());
                } catch (e) {
                    jsonObj = entitydata;
                }
                return new Promise(function (resolve, reject) {
                    persistService.update(self.my_context, jsonObj)
                        .then(function (res) {
                            // Process the results
                            var ssoInstitutions = res.data;
                            return resolve(ssoInstitutions);
                        }, function (err) {
                            // failed
                            console.log('failed to update the local storage duo to: ' + err);
                            reject(err);
                        });
                })
            },
            removeEntity: function (entityId) {
                var self = this;
                var persistService =  new thiss.PersistenceService('https://service.seamlessaccess.org/ps/');

                return new Promise(function (resolve) {
                    persistService.remove(self.my_context, entityId)
                        .then(function (res) {
                            return resolve(res);
                        }, function (err) {
                            // failed
                            console.log('failed to remove from local storage duo to: ' + err);
                        });
                })
            },
            getAccessibleEntityStatus: function (doi, entityId) {
                return new Promise(function (resolve) {
                    $.ajax({
                        type: 'POST',
                        url: '/action/seamlessAccess',
                        accept: {
                            text: "application/json"
                        },
                        data: {doi: doi, entityid: entityId}

                    }).done(function (status) {
                        return resolve(status);
                    });
                });
            },
            getEntitiesWithAllInfo: function (doi) {
                let self = this,
                    arrayOfPromises = [];
                return new Promise(function (resolve, reject) {
                    self.retrieveEntity().then(function (res) {
                        let allSsoInstitutions = res;
                        for (i = 0; i < allSsoInstitutions.length; i++) {
                            let ssoInstitution = allSsoInstitutions[i];
                            arrayOfPromises.push(new Promise(function (resolve) {
                                self.getAccessibleEntityStatus(doi, ssoInstitution.entity.entityID)
                                    .then(function (entityStatus) {
                                        resolve({
                                            entityID: ssoInstitution.entity.entityID,
                                            entityTitle: ssoInstitution.entity.title,
                                            entityStatusObj: entityStatus,
                                            entitySsoUrl: self.getWAYFLessUrl(ssoInstitution.entity.entityID)
                                        });
                                    }, function (err) {
                                        console.log('failed to get the entity status: ' + err);
                                    });
                            }));
                        }
                        Promise.all(arrayOfPromises)
                            .then(function (finalResponse) {
                                resolve(finalResponse);
                            });

                    }).catch(function (err) {
                        reject(err);
                    })
                });
            }
        };

        window.addEventListener('load', function () {
            document.querySelectorAll(".sso-institution").forEach(function (institution) {
                var entityId = institution.getAttribute('data-entityid');
                var entityName = institution.getAttribute('data-name');
                var entitydata = {
                    entityID: entityId,
                    title: entityName
                };
                institution.addEventListener("click", function (e) {
                    e.preventDefault();
                    var self = this;
                    SeamlessAccessService.updateEntity(entitydata).then(function (res) {
                        console.log(res);
                        window.location.href = self.href;
                    }).catch(function (err){
                        window.location.href = self.href;
                    });
                });
            });
        });

    </script>




























    






    <meta name="google-site-verification" content="uBHpu2M2kL7VihPCSRXWyBSxooDf7L_BGgfHA3cjSfY" /></meta>


<link rel="prefetch" href="https://tpc.googlesyndication.com/safeframe/1-0-29/html/container.html"></head>
<body class="pb-ui">


























<script type="text/javascript">

    if(false) {
        document.getElementById("skipNavigationLink").onclick =function skipElement () {
            var element = document.getElementById('');
            if(element == null || element == undefined) {
                element = document.getElementsByClassName('').item(0);
            }
            element.setAttribute('tabindex','0');
            element.focus();

        }

    }

</script>











    <div id="pb-page-content" data-ng-non-bindable>
        <div data-pb-dropzone="main" data-pb-dropzone-name="Main">










        <div data-widget-def="UX3HTMLWidget" data-widget-id="ed6ae788-7707-48f4-b02c-3187c75e10db" class="hide">
        



        
        

        </div>
    




        
        




        
        



        <div class="pb-ad">
            <script type="text/javascript">
	var dartInstitutionType = 'none';
	var dartMember = 'false';
</script>
        </div>
    





        
        <script type="text/javascript">
$(document).ready(function() {
	setTimeout(function() {
		// var journalTitle = 'medicinal_chemistry';
		var taxonomyKeywords = $('.article_header-taxonomy');
		var articleKeyword = $('meta[name="keywords"]');
		var articleTitle = $('meta[name="dc.Title"]');
		var articleDescription = $('meta[name="dc.Description"]');
		var abstractKeyword = $('p.articleBody_abstractText:contains("Keywords: ")');
		var searchTerms = [];

		if (taxonomyKeywords.length > 0) {
			$(taxonomyKeywords).children(".rlist--inline").children("li").each(function() {
				searchTerms.push($(this).text());
			});
		}
		else if (articleKeyword.length > 0) { 
			searchTerms = searchTerms.concat(articleKeyword.prop('content').split(', '));
		}
		else if (abstractKeyword.length > 0) {
			searchTerms = searchTerms.concat(abstractKeyword.text().split("Keywords: ")[1].split('; '));
		}
		else if (articleDescription.length > 0) {
			$(articleDescription).each(function() {
				articleDescriptionKeywords = $(this).prop('content');
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/.,/g,"");
				articleDescriptionKeywords = articleDescriptionKeywords.replace(/\s{2,}/g," ");
				searchTerms = searchTerms.concat(articleDescriptionKeywords.split(' '));
			});
		}

		if (articleTitle.length > 0) {
			searchTerms = searchTerms.concat(articleTitle.prop('content').split(' '));
		}

		googletag.cmd.push(function() {
			var mappingLeader = googletag.sizeMapping().
			addSize([320, 400], [320, 50]).
			addSize([320, 700], [320, 50]).
			addSize([750, 200], [728, 90]). 
			addSize([980, 690], [728, 90]).
			addSize([1024, 768], [728, 90]).
			build();
			//leaderboard
			googletag.defineSlot('/8868/journal/medicinal_chemistry/article', [728, 90], 'dfp-journal-article-leaderboard').defineSizeMapping(mappingLeader).setTargeting('location', 'leaderboard1').setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//recommend
			googletag.defineSlot("/8868/journal/medicinal_chemistry/article", [1, 1], "dfp-journal-article-recommend").setTargeting("ntvPlacement", ["1100167"]).setTargeting("location", "recommend").setTargeting('Keyword', searchTerms).addService(googletag.pubads());
			//googletag.pubads().enableSingleRequest();
			googletag.pubads().collapseEmptyDivs();
			googletag.pubads().setTargeting('inst',dartInstitutionType).setTargeting('memb',dartMember);
			googletag.pubads().addEventListener("slotRenderEnded", function(event) {
				if((event.isEmpty === false) && (event.slot.getSlotElementId() != "dfp-journal-article-recommend")) {
					$("#" + event.slot.getSlotElementId()).parents(".advertisement").slideDown();
				}
			});
			googletag.enableServices();
		});
	}, 1000);
});
</script>





        
        <script src="https://common.ccdc.cam.ac.uk/ccdc-widget/1.0.0.76/Widget.min.js"></script>




        
        <header class="header header_article_inactive">



        
        <div class="header_topbar hidden-sm hidden-xs">



        
        <div class="container"><div class="row"><div class="col-lg-3 col-md-4 col-sm-5 header_topbar_left">









        <div data-widget-def="UX3HTMLWidget" data-widget-id="0be92cec-36a8-4b4d-9a08-a28c790ce306" class="header_mainmenu">
        



        
        <ul>
	<li>
		<a href="http://www.acs.org">ACS</a>
	</li>
	<li class="header_mainmenu_current">
		<a href="/">ACS Publications</a>
	</li>
	<li>
		<a href="https://cen.acs.org">C&EN</a>
	</li>
	<li>
		<a href="https://www.cas.org">CAS</a>
	</li>
</ul>

        </div>
    
</div><div class="col-lg-9 col-md-8 col-sm-7 header_topbar_right">



        
        <div class="institution"><span class="institution-info-wrapper"><span class="institution__intro">Access provided by</span><span class="institution__name">Hong Kong University of Science and Technology Library</span></span></div>




        
        <div class="user-login-bar"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" name="heartBeatReloadInterval" value="1740000" class="heartBeatReloadInterval"/></input><input type="hidden" name="logoutUrl" value="https://pubs.acs.org/action/doLogout?logoutRedirectUrl=https%3A%2F%2Fsso.acs.org%2Fidp%2Fglogout%3Fappid%3Datypon-live%26returnURL%3Dhttps%253A%252F%252Fpubs.acs.org%252F" class="logoutUrl"/></input><img src="https://sso.acs.org/idp/heartbeat?appid=atypon-lives&amp;max_auth_age=2592000" alt="Blank image" class="ssoHeartBeatImg"/></img><span class="user-login-bar__value"><a href="https://pubs.acs.org/action/ssoRequestForLoginPage" class="user-login-bar__Login">Log In</a></span><input type="hidden" name="isUserLoggedIn" value="false" class="user-login-bar_is-loggedin"/></input><input type="hidden" name="isPaired" value="false" class="pair-device-is-paired"/></input><input type="hidden" name="isStronglyAuthenticated" value="false" class="isStronglyAuthenticated"/></input></div>
</div></div></div>
</div>




        
        <div class="header_content">



        
        <div class="container"><div class="row"><div class="header_content_main">



        
        <div class="header_content_row">



        
        <div class="header_content_left pull-left">



        
        <a href="/" title="ACS Publications. Most Trusted. Most Cited. Most Read"><img id="" alt="ACS Publications. Most Trusted. Most Cited. Most Read" src="/pb-assets/ux3/pubs-logo-481x82-1523435513963.png"/></img></a>




        
        <div class="pj-badge"></div><a href="/journal/jmcmar" title="journal logo" class="header_article-logo"><img src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo"></a><div class="header_article-separator"></div>
</div><div class="header_content_center">



        
        <div class="header_contnav">
    <div class="header_contnav-row">
         <a href="#" title="Previous" class="header_contnav-pre">
                <i class="icon-angle-left"></i>
        </a>
       <div class="header_contnav-title">
            <span>
                <a href="#" title=""></a>
            </span>
        </div>
         <a href="#" title="Next" class="header_contnav-next">
                <i class="icon-angle-right"></i>
            </a>
    </div>
</div>
</div><div class="header_content_right pull-right">



        
        <div class="header_qv-link"><a href="#" title="Quick View" data-slide-target=".article_qv-xs-container" class="w-slide__btn slide-active icon-quickview">Quick View</a></div>




        
        <div class="header_article-share">



        
        <script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="527d28d6-3414-4cb2-9560-99e677e62c0d" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone1" title="ShareDropzone1"></div><div class="pb-dropzone" data-pb-dropzone="ShareDropzone2" title="ShareDropzone2"></div><div data-db-target-of="527d28d6-3414-4cb2-9560-99e677e62c0d" id="527d28d6-3414-4cb2-9560-99e677e62c0d_Pop" class="share__block dropBlock__holder fixed"><div class="pb-dropzone" data-pb-dropzone="shareBlock" title="shareBlock"></div><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>WeChat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li><li><a role="link" class="addthis_button_email"><i aria-hidden="true" class="at-icon-wrapper icon-envelope-o"></i>Email</a></li></ul></div></div>
</div>




        
        <div class="header_article-separator"></div>




        
        <div class="quick-search"><a href="#" aria-label="quick search" class="quick-search_icon icon-search"></a><div class="quick-search_content"><form action="/action/checkIsValidDoi" name="defaultQuickSearch" method="get" title="Quick Search" autocomplete="off" class="quick-search_default"><input type="search" name="AllField" placeholder="Search text, DOI, authors, etc." aria-label="Search text, DOI, authors, etc." data-auto-complete-max-words="7" data-auto-complete-max-chars="32" data-contributors-conf="3" data-topics-conf="3" data-publication-titles-conf="3" data-history-items-conf="3" value="" required="true" class="quick-search_all-field autocomplete"/></input><button type="submit" title="Search" class="icon-search"></button><div role="radiogroup" aria-labelledby="journal filter" class="quick-search_journal-filter"><label for="thisJournalRadio" tabindex="0" aria-checked="true" role="radio" class="radio--primary"><input id="thisJournalRadio" type="radio" value="jmcmar" name="SeriesKey" checked="checked" class="all-content"/></input><span>J. Med. Chem.</span></label><label for="allPubRadio" tabindex="0" aria-checked="false" role="radio" class="radio--primary"><input id="allPubRadio" type="radio" value="" name="SeriesKey" class="all-content"/></input><span>All Publications/Website</span></label></div></form><p>OR SEARCH CITATIONS</p><form action="/action/quickLink" name="citationQuickSearch" method="get" title="Quick Search" class="quick-search_citation"><input type="hidden" name="quickLink" value="true"/></input><select name="quickLinkJournal" class="quick-search_journals-select"><option value="jmcmar">Journal of Medicinal Chemistry</option><option value="achre4">Accounts of Chemical Research</option><option value="amrcda">Accounts of Materials Research</option><option value="aastgj">ACS Agricultural Science & Technology</option><option value="aabmcb">ACS Applied Bio Materials</option><option value="aaembp">ACS Applied Electronic Materials</option><option value="aaemcq">ACS Applied Energy Materials</option><option value="aamick">ACS Applied Materials & Interfaces</option><option value="aanmf6">ACS Applied Nano Materials</option><option value="aapmcd">ACS Applied Polymer Materials</option><option value="abmcb8">ACS Bio & Med Chem Au</option><option value="abseba">ACS Biomaterials Science & Engineering</option><option value="accacs">ACS Catalysis</option><option value="acscii">ACS Central Science</option><option value="acbcct">ACS Chemical Biology</option><option value="achsc5">ACS Chemical Health & Safety</option><option value="acncdm">ACS Chemical Neuroscience</option><option value="acsccc">ACS Combinatorial Science</option><option value="aesccq">ACS Earth and Space Chemistry</option><option value="aelccp">ACS Energy Letters</option><option value="aeacb3">ACS Engineering Au</option><option value="aeacc4">ACS Environmental Au</option><option value="aeecco">ACS ES&T Engineering</option><option value="aewcaa">ACS ES&T Water</option><option value="afsthl">ACS Food Science & Technology</option><option value="aidcbc">ACS Infectious Diseases</option><option value="amlccd">ACS Macro Letters</option><option value="amacgu">ACS Materials Au</option><option value="amlcef">ACS Materials Letters</option><option value="amachv">ACS Measurement Science Au</option><option value="amclct">ACS Medicinal Chemistry Letters</option><option value="ancac3">ACS Nano</option><option value="anaccx">ACS Nanoscience Au</option><option value="acsodf">ACS Omega</option><option value="aoiab5">ACS Organic & Inorganic Au</option><option value="aptsfn">ACS Pharmacology & Translational Science</option><option value="apchd5">ACS Photonics</option><option value="apcach">ACS Physical Chemistry Au</option><option value="apaccd">ACS Polymers Au</option><option value="ascefj">ACS Sensors</option><option value="ascecg">ACS Sustainable Chemistry & Engineering</option><option value="asbcd6">ACS Synthetic Biology</option><option value="ancham">Analytical Chemistry</option><option value="bichaw">Biochemistry</option><option value="bcches">Bioconjugate Chemistry</option><option value="bomaf6">Biomacromolecules</option><option value="bipret">Biotechnology Progress</option><option value="cgeabj">C&EN Global Enterprise</option><option value="cenear">Chemical & Engineering News Archive</option><option value="chlseg">Chemical Health & Safety</option><option value="chlseg0">Chemical Health & Safety</option><option value="crtoec">Chemical Research in Toxicology</option><option value="chreay">Chemical Reviews</option><option value="cmatex">Chemistry of Materials</option><option value="cgdefu">Crystal Growth & Design</option><option value="enfuem">Energy & Fuels</option><option value="esthag">Environmental Science & Technology</option><option value="estlcu">Environmental Science & Technology Letters</option><option value="iepra6.2">I&EC Product Research and Development</option><option value="iechad">Industrial & Engineering Chemistry</option><option value="iecac0">Industrial & Engineering Chemistry Analytical Edition</option><option value="iecjc0">Industrial & Engineering Chemistry Chemical & Engineering Data Series</option><option value="iecfa7">Industrial & Engineering Chemistry Fundamentals</option><option value="iepdaw">Industrial & Engineering Chemistry Process Design and Development</option><option value="iepra6">Industrial & Engineering Chemistry Product Research and Development</option><option value="iecred">Industrial & Engineering Chemistry Research</option><option value="iecnav">Industrial and Engineering Chemistry, News Edition</option><option value="inocaj">Inorganic Chemistry</option><option value="jaaucr">JACS Au</option><option value="jacsat">Journal of the American Chemical Society</option><option value="jafcau">Journal of Agricultural and Food Chemistry</option><option value="jceaax">Journal of Chemical & Engineering Data</option><option value="jci001">Journal of Chemical Documentation</option><option value="jceda8">Journal of Chemical Education</option><option value="jchsc2">Journal of Chemical Health & Safety</option><option value="jchsc20">Journal of Chemical Health & Safety</option><option value="jcics1">Journal of Chemical Information and Computer Sciences</option><option value="jcisd8">Journal of Chemical Information and Modeling</option><option value="jctcce">Journal of Chemical Theory and Computation</option><option value="jcchff">Journal of Combinatorial Chemistry</option><option value="iechad.1">Journal of Industrial & Engineering Chemistry</option><option value="jmcmar.1">Journal of Medicinal and Pharmaceutical Chemistry</option><option value="jnprdf">Journal of Natural Products</option><option value="joceah">The Journal of Organic Chemistry</option><option value="jpchax">The Journal of Physical Chemistry</option><option value="jpchax.2">The Journal of Physical Chemistry</option><option value="jpcafh">The Journal of Physical Chemistry A</option><option value="jpcbfk">The Journal of Physical Chemistry B</option><option value="jpccck">The Journal of Physical Chemistry C</option><option value="jpclcd">The Journal of Physical Chemistry Letters</option><option value="jprobs">Journal of Proteome Research</option><option value="jamsef">Journal of the American Society for Mass Spectrometry</option><option value="jamsef1">Journal of the American Society for Mass Spectrometry</option><option value="jamsef0">Journal of the American Society for Mass Spectrometry</option><option value="langd5">Langmuir</option><option value="mamobx">Macromolecules</option><option value="mpohbp">Molecular Pharmaceutics</option><option value="nalefd">Nano Letters</option><option value="neaca9">News Edition, American Chemical Society</option><option value="orlef7">Organic Letters</option><option value="oprdfk">Organic Process Research & Development</option><option value="orgnd7">Organometallics</option><option value="iepra6.1">Product R&D</option><option value="scimts">SciMeetings</option><option value="jpchax.1">The Journal of Physical and Colloid Chemistry</option></select><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkVolume" autoComplete="false" placeholder="Vol" required="required" class="quick-search_volume-input"/></input><input type="search" inputmode="numeric" pattern="[0-9]*" name="quickLinkPage" autoComplete="false" placeholder="Page" required="required" class="quick-search_page-input"/></input><button type="submit" title="Search" class="icon-search"></button></form></div></div>




        
        <div class="header_my-activity">



        
        <a href="#"><i class="icon-id-badge" aria-hidden=”true”></i><span>My Activity</span></a>
<div class="header_my-activity-content">
    <div class="header_my-activity-single">
        <i aria-hidden="true" aria-label="close" class="icon-close"></i>
        <div class="" data-name="recentlyViewedDropzone">



        
        <div class="show-recently"><div class="show-recently-header">Recently Viewed</div><h6 class="show-recently-empty">You have not visited any articles yet, Please visit some articles to see contents here. </h6></div>
</div>
    </div>
</div>
</div>




        
        <div class="header_publications">



        
        <a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>Publications</span></a>

</div>




        
        <div class="header_burger-menu">



        
        <a href="#?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuIcon&amp;utm_campaign=Pubs_Refere" class="header_burger-menu_button" title="menu button" aria-label="menu button"><i class="icon-navicon"></i><i
        class="icon-close"></i></a>
<div class="header_burger-menu_content">
    <ul class="hidden-lg">
        <li><a href="#" class="pubModal_button"><i class="icon-book" aria-hidden=”true”></i><span>publications</span></a></li>
        <li class="myActivityMobile"><a href="#" class="openTabletActivity"><i class="icon-id-badge" aria-hidden=”true”></i><span>my Activity</span></a>
            <ul>
                <li><a href="javascript:void(0)" class="recentlyViewed--open">Recently Viewed</a></li>
            </ul>
        </li>
    </ul>
    <ul>
        <li><a href="#">user resources</a>
            <ul>
                <li><a href="/page/remoteaccess"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Access Options');">Access Options</a></li>
                <li><a href="https://publish.acs.org/publish/"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Authors & Reviewers');">Authors &
                        Reviewers</a></li>
                <li><a href="http://www.acs.org/content/acs/en/membership-and-networks/acs/benefits/professional/publications-benefits.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS Members');">ACS Members</a></li>
                <li><a href="https://preferences.acspubs.org/journals"
                        onclick="ga('send', 'event', 'Home_MainMenu', 'Click', 'eAlert');">eAlerts</a></li>
                <li><a href="/page/follow.html?widget=follow-pane-mobile"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'RSS & Mobile');">RSS & Mobile</a></li>
            </ul>
        </li>
		<li><a href="#">for organizations</a>
			<ul>
			    <li><a href="https://solutions.acs.org/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Products & Services');">Products & Services</a></li>
				<li><a href="https://solutions.acs.org/access-options/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Get Access');">Get Access</a></li>
				<li><a href="https://solutions.acs.org/resources/manage-my-account/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Manage My Account');">Manage My Account</a></li>
			</ul>
		</li>
        <li><a href="#">support</a>
            <ul>
                <li><a href="/page/demo/index.html">Website Demos & Tutorials</a></li>
                <li><a href="https://acs.service-now.com/acs"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Support FAQs');">Support FAQs </a></li>
                <li><a href="#"
                        onClick="SnapEngage.startLink();return false; ga('send', 'event', 'Top Nav', 'Menu', 'Live Chat with Agent');"
                        class="help help-chat">Live Chat with Agent</a></li>
                <li><a href="https://acsmediakit.org/digital/acs-pubs/?utm_source=Nav&amp;utm_medium=Pubs&amp;utm_campaign=CEN"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Advertisers');">For Advertisers</a></li>
                <li><a href="https://solutions.acs.org/help/?utm_source=Pubs_Solutions_Referer&amp;utm_medium=Pubs_MenuBotton&amp;utm_campaign=Pubs_Referer"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'For Librarians & Account Managers');">For
                        Librarians & Account Managers</a></li>
            </ul>
        </li>
        <li class="hidden-sm hidden-xs"><a href="#">pairing</a>
            <ul>
                <li><a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a></li>
                <li><a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Pair this device');">Pair this device</a></li>
                <li><a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
                </li>
            </ul>
        </li>
        <li class="hidden-lg hidden-md">
            <a class="header_burger-menu_my-profile-link" href="/action/showPreferences">My Profile</a>
            <a class="header_burger-menu_login-link" href="/action/ssoRequestForLoginPage">Login</a>
            <a class="header_burger-menu_logout-link" href="#">Logout</a>
            <a class="header_burger-menu_pairadevice-link" href="/pairdevice">Pair a device</a>
            <a class="header_burger-menu_pairthisdevice-link" href="/action/devicePairingSubmitCode">Pair this
                device</a>
            <a class="header_burger-menu_pairedstatus" href="/action/devicePairingSubmitCode">Paired status</a>
        </li>
        <li><a href="#">about us</a>
            <ul>
                <li><a href="/page/about-us.html"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Overview');">Overview</a></li>
                <li><a href="http://acsopenscience.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'ACS & Open Access');">ACS & Open Access</a>
                </li>
                <li><a href="/#partners" onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Partners');">Partners</a></li>
                <li><a href="http://acsoncampus.acs.org"
                        onclick="ga('send', 'event', 'Top Nav', 'Menu', 'Events');">Events</a></li>
            </ul>
        </li>
    </ul>
</div>
<div class="activity-container-tablet"><i aria-hidden="true" class="icon-close"></i></div>


<script type="text/javascript">
  (function() {
    var se = document.createElement('script'); se.type = 'text/javascript'; se.async = true;
    se.src = 'https://storage.googleapis.com/code.snapengage.com/js/921a4ec7-cecf-43a6-afa5-6cd1346520b1.js';
    var done = false;
    se.onload = se.onreadystatechange = function() {
      if (!done&&(!this.readyState||this.readyState==='loaded'||this.readyState==='complete')) {
        done = true;
        /* Place your SnapEngage JS API code below */
        /* SnapEngage.allowChatSound(true); Example JS API: Enable sounds for Visitors. */
      }
    };
    var s = document.getElementsByTagName('script')[0]; s.parentNode.insertBefore(se, s);
  })();
</script>

<style>
    #SnapABug_Button,
    #designstudio-button {
        display: none;
    }
</style>

</div>
</div>
</div>
</div></div></div>
</div>




        
        <div class="pub"><div aria-live="polite" aria-atomic="true" class="pub-modal"><div class="pub-modal_content loop-trap"><a href="#" aria-label="close" tabindex="0" class="pub-modal_close icon-close pull-right"></a><div class="pub-modal_row"><div class="pub-modal_left"><div class="pub-modal_left-content"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_types"><h6>CONTENT TYPES</h6><ul class="pub-modal_types-list"><li data-type="all" id="allID" class="pub-modal_types-active"><a href="#"><h4>All Types</h4></a></li></ul></div><div class="pub-modal_subjects hidden-sm hidden-xs"><h6>SUBJECTS</h6><ul class="pub-modal_subjects-list"></ul></div></div></div><div class="pub-modal_right"><div class="pub-modal_control hidden-lg hidden-md"><span class="pub-modal_control-text">Publications: All Types</span><a href="#" title="Back button" class="pub-modal_back"><i class="icon-angle-left"></i></a></div><div class="pub-modal_right--inner"><div class="pub-content"></div></div></div></div></div><input type="hidden" name="pubModalData" value="{&quot;types&quot;:[{&quot;code&quot;:&quot;journals&quot;,&quot;label&quot;:&quot;Journals&quot;},{&quot;code&quot;:&quot;books&quot;,&quot;label&quot;:&quot;Books and Reference&quot;},{&quot;code&quot;:&quot;news&quot;,&quot;label&quot;:&quot;News&quot;}],&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;,&quot;label&quot;:&quot;Analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;,&quot;label&quot;:&quot;Applied&quot;},{&quot;code&quot;:&quot;cat_biological&quot;,&quot;label&quot;:&quot;Biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;,&quot;label&quot;:&quot;Materials Science &amp; Engineering&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;,&quot;label&quot;:&quot;Organic-Inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;,&quot;label&quot;:&quot;Physical&quot;}],&quot;publications&quot;:[{&quot;char&quot;:&quot;A&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achre4/2021/achre4.2021.54.issue-15/achre4.2021.54.issue-15/20210803/achre4.2021.54.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;achre4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Chemical Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achre4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amrcda/2021/amrcda.2021.2.issue-7/amrcda.2021.2.issue-7/20210723/amrcda.2021.2.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amrcda&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Accounts of Materials Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amrcda&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aastgj/2021/aastgj.2021.1.issue-3/aastgj.2021.1.issue-3/20210621/aastgj.2021.1.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aastgj&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS Agricultural Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aastgj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aabmcb/2021/aabmcb.2021.4.issue-7/aabmcb.2021.4.issue-7/20210719/aabmcb.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aabmcb&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Bio Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aabmcb&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaembp/2021/aaembp.2021.3.issue-7/aaembp.2021.3.issue-7/20210727/aaembp.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaembp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Electronic Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaembp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aaemcq/2021/aaemcq.2021.4.issue-7/aaemcq.2021.4.issue-7/20210726/aaemcq.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aaemcq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Energy Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aaemcq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aamick/2021/aamick.2021.13.issue-30/aamick.2021.13.issue-30/20210804/aamick.2021.13.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;aamick&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Materials &amp; Interfaces&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aamick&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aanmf6/2021/aanmf6.2021.4.issue-7/aanmf6.2021.4.issue-7/20210723/aanmf6.2021.4.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aanmf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Nano Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aanmf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aapmcd/2021/aapmcd.2021.3.issue-7/aapmcd.2021.3.issue-7/20210709/aapmcd.2021.3.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aapmcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Applied Polymer Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aapmcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/abmcb8/largecover.png&quot;,&quot;code&quot;:&quot;abmcb8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;}],&quot;name&quot;:&quot;ACS Bio &amp; Med Chem Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abmcb8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/abseba/2021/abseba.2021.7.issue-7/abseba.2021.7.issue-7/20210712/abseba.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;abseba&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Biomaterials Science &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/abseba&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/accacs/2021/accacs.2021.11.issue-14/accacs.2021.11.issue-14/20210716/accacs.2021.11.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;accacs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Catalysis&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/accacs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acscii/2021/acscii.2021.7.issue-7/acscii.2021.7.issue-7/20210728/acscii.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acscii&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Central Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acscii&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acbcct/2021/acbcct.2021.16.issue-7/acbcct.2021.16.issue-7/20210716/acbcct.2021.16.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;acbcct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acbcct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/achsc5/2021/achsc5.2021.28.issue-4/achsc5.2021.28.issue-4/20210726/achsc5.2021.28.issue-4.largecover.jpg&quot;,&quot;code&quot;:&quot;achsc5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Health &amp; Safety&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/achsc5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acncdm/2021/acncdm.2021.12.issue-15/acncdm.2021.12.issue-15/20210804/acncdm.2021.12.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;acncdm&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Chemical Neuroscience&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acncdm&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsccc/2020/acsccc.2020.22.issue-12/acsccc.2020.22.issue-12/20201214/acsccc.2020.22.issue-12.largecover.jpg&quot;,&quot;code&quot;:&quot;acsccc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Combinatorial Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsccc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aesccq/2021/aesccq.2021.5.issue-7/aesccq.2021.5.issue-7/20210715/aesccq.2021.5.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aesccq&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Earth and Space Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aesccq&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aelccp/2021/aelccp.2021.6.issue-7/aelccp.2021.6.issue-7/20210709/aelccp.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aelccp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Energy Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aelccp&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacb3/largecover.png&quot;,&quot;code&quot;:&quot;aeacb3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Engineering Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacb3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aeacc4/largecover.png&quot;,&quot;code&quot;:&quot;aeacc4&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;}],&quot;name&quot;:&quot;ACS Environmental Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeacc4&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aeecco/2021/aeecco.2021.1.issue-7/aeecco.2021.1.issue-7/20210709/aeecco.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aeecco&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;ACS ES&amp;T Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aeecco&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aewcaa/2021/aewcaa.2021.1.issue-7/aewcaa.2021.1.issue-7/20210709/aewcaa.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aewcaa&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS ES&amp;T Water&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aewcaa&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/afsthl/2021/afsthl.2021.1.issue-6/afsthl.2021.1.issue-6/20210716/afsthl.2021.1.issue-6.largecover.jpg&quot;,&quot;code&quot;:&quot;afsthl&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Food Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/afsthl&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;styleguide&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;}],&quot;name&quot;:&quot;ACS Guide to Scholarly Communication&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/styleguide&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;infocus&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS In Focus&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/infocus&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aidcbc/2021/aidcbc.2021.7.issue-7/aidcbc.2021.7.issue-7/20210709/aidcbc.2021.7.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;aidcbc&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Infectious Diseases&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aidcbc&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlccd/2021/amlccd.2021.10.issue-7/amlccd.2021.10.issue-7/20210720/amlccd.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amlccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Macro Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amacgu/largecover.png&quot;,&quot;code&quot;:&quot;amacgu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Materials Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amacgu&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amlcef/2021/amlcef.2021.3.issue-8/amlcef.2021.3.issue-8/20210802/amlcef.2021.3.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;amlcef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Materials Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amlcef&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/amachv/largecover.png&quot;,&quot;code&quot;:&quot;amachv&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;}],&quot;name&quot;:&quot;ACS Measurement Science Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amachv&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/amclct/2021/amclct.2021.12.issue-7/amclct.2021.12.issue-7/20210708/amclct.2021.12.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;amclct&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Medicinal Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/amclct&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancac3/2021/ancac3.2021.15.issue-7/ancac3.2021.15.issue-7/20210727/ancac3.2021.15.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ancac3&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Nano&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancac3&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/anaccx/largecover.png&quot;,&quot;code&quot;:&quot;anaccx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Nanoscience Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/anaccx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/acsodf/2021/acsodf.2021.6.issue-30/acsodf.2021.6.issue-30/20210803/acsodf.2021.6.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;acsodf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Omega&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/acsodf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/aoiab5/largecover.png&quot;,&quot;code&quot;:&quot;aoiab5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;}],&quot;name&quot;:&quot;ACS Organic &amp; Inorganic Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aoiab5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/aptsfn/2021/aptsfn.2021.4.issue-3/aptsfn.2021.4.issue-3/20210611/aptsfn.2021.4.issue-3.largecover.jpg&quot;,&quot;code&quot;:&quot;aptsfn&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Pharmacology &amp; Translational Science&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/aptsfn&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/apchd5/2021/apchd5.2021.8.issue-7/apchd5.2021.8.issue-7/20210721/apchd5.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;apchd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Photonics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apchd5&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apcach/largecover.png&quot;,&quot;code&quot;:&quot;apcach&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;}],&quot;name&quot;:&quot;ACS Physical Chemistry Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apcach&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/apaccd/largecover.png&quot;,&quot;code&quot;:&quot;apaccd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;}],&quot;name&quot;:&quot;ACS Polymers Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/apaccd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/reagents/2017/acsreagents/acsreagents/20170228/acsreagents.largecover.png&quot;,&quot;code&quot;:&quot;reagents&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;ACS Reagent Chemicals&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/reagents&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascefj/2021/ascefj.2021.6.issue-7/ascefj.2021.6.issue-7/20210723/ascefj.2021.6.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;ascefj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sensors&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascefj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ascecg/2021/ascecg.2021.9.issue-30/ascecg.2021.9.issue-30/20210802/ascecg.2021.9.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ascecg&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Sustainable Chemistry &amp; Engineering&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ascecg&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/books/content/symposium/2021/bk-2021-1379/bk-2021-1379/20210430-01/bk-2021-1379.largecover.jpg&quot;,&quot;code&quot;:&quot;symposium&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;ACS Symposium Series&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/symposium&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/asbcd6/2021/asbcd6.2021.10.issue-7/asbcd6.2021.10.issue-7/20210716/asbcd6.2021.10.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;asbcd6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;ACS Synthetic Biology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/asbcd6&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;advances&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;category.books&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;383784032&quot;}],&quot;name&quot;:&quot;Advances in Chemistry&quot;,&quot;type&quot;:&quot;books&quot;,&quot;url&quot;:&quot;/series/advances&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/ancham/2021/ancham.2021.93.issue-30/ancham.2021.93.issue-30/20210803/ancham.2021.93.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;ancham&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Analytical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/ancham&quot;}]},{&quot;char&quot;:&quot;B&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bichaw/2021/bichaw.2021.60.issue-30/bichaw.2021.60.issue-30/20210803/bichaw.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;bichaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biochemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bichaw&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bcches/2021/bcches.2021.32.issue-7/bcches.2021.32.issue-7/20210721/bcches.2021.32.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bcches&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Bioconjugate Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bcches&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/bomaf6/2021/bomaf6.2021.22.issue-7/bomaf6.2021.22.issue-7/20210712/bomaf6.2021.22.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;bomaf6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Biomacromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bomaf6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/covergifs/bipret/largecover.jpg&quot;,&quot;code&quot;:&quot;bipret&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;Biotechnology Progress&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/bipret&quot;}]},{&quot;char&quot;:&quot;C&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgeabj/2021/cgeabj.2021.99.issue-28/cgeabj.2021.99.issue-28/20210802/cgeabj.2021.99.issue-28.largecover.jpg&quot;,&quot;code&quot;:&quot;cgeabj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;}],&quot;name&quot;:&quot;C&amp;EN Global Enterprise&quot;,&quot;type&quot;:&quot;news&quot;,&quot;url&quot;:&quot;/journal/cgeabj&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/crtoec/2021/crtoec.2021.34.issue-7/crtoec.2021.34.issue-7/20210719/crtoec.2021.34.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;crtoec&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Research in Toxicology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/crtoec&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/chreay/2021/chreay.2021.121.issue-14/chreay.2021.121.issue-14/20210728/chreay.2021.121.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;chreay&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;articletoc&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemical Reviews&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/chreay&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cmatex/2021/cmatex.2021.33.issue-14/cmatex.2021.33.issue-14/20210727/cmatex.2021.33.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;cmatex&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Chemistry of Materials&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cmatex&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/cgdefu/2021/cgdefu.2021.21.issue-8/cgdefu.2021.21.issue-8/20210804/cgdefu.2021.21.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;cgdefu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Crystal Growth &amp; Design&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/cgdefu&quot;}]},{&quot;char&quot;:&quot;E&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/enfuem/2021/enfuem.2021.35.issue-14/enfuem.2021.35.issue-14/20210715/enfuem.2021.35.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;enfuem&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Energy &amp; Fuels&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/enfuem&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/esthag/2021/esthag.2021.55.issue-15/esthag.2021.55.issue-15/20210803/esthag.2021.55.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;esthag&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/esthag&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/estlcu/2021/estlcu.2021.8.issue-7/estlcu.2021.8.issue-7/20210713/estlcu.2021.8.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;estlcu&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Environmental Science &amp; Technology Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/estlcu&quot;}]},{&quot;char&quot;:&quot;I&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.2&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;I&amp;EC Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.2&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecac0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Analytical Edition&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecac0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecjc0&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Chemical &amp; Engineering Data Series&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecjc0&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iecfa7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Fundamentals&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecfa7&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepdaw&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Process Design and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepdaw&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Product Research and Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/iecred/2021/iecred.2021.60.issue-30/iecred.2021.60.issue-30/20210804/iecred.2021.60.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;iecred&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Industrial &amp; Engineering Chemistry Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iecred&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/inocaj/2021/inocaj.2021.60.issue-15/inocaj.2021.60.issue-15/20210802/inocaj.2021.60.issue-15.largecover.jpg&quot;,&quot;code&quot;:&quot;inocaj&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Inorganic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/inocaj&quot;}]},{&quot;char&quot;:&quot;J&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jaaucr/2021/jaaucr.2021.1.issue-7/jaaucr.2021.1.issue-7/20210726/jaaucr.2021.1.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jaaucr&quot;,&quot;subjects&quot;:[],&quot;name&quot;:&quot;JACS Au&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jaaucr&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jafcau/2021/jafcau.2021.69.issue-30/jafcau.2021.69.issue-30/20210804/jafcau.2021.69.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jafcau&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Agricultural and Food Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jafcau&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceaax/2021/jceaax.2021.66.issue-7/jceaax.2021.66.issue-7/20210708/jceaax.2021.66.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceaax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical &amp; Engineering Data&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceaax&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jci001&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Documentation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jci001&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jceda8/2021/jceda8.2021.98.issue-7/jceda8.2021.98.issue-7/20210713/jceda8.2021.98.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jceda8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;divched&quot;}],&quot;name&quot;:&quot;Journal of Chemical Education&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jceda8&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jcics1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Computer Sciences&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcics1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jcisd8/2021/jcisd8.2021.61.issue-7/jcisd8.2021.61.issue-7/20210726/jcisd8.2021.61.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jcisd8&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Information and Modeling&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jcisd8&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jctcce/2021/jctcce.2021.17.issue-7/jctcce.2021.17.issue-7/20210713/jctcce.2021.17.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jctcce&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Chemical Theory and Computation&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jctcce&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iechad.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Industrial &amp; Engineering Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iechad.1&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jmcmar.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal and Pharmaceutical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar.1&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jmcmar/2021/jmcmar.2021.64.issue-14/jmcmar.2021.64.issue-14/20210722/jmcmar.2021.64.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;jmcmar&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jmcmar&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jnprdf/2021/jnprdf.2021.84.issue-7/jnprdf.2021.84.issue-7/20210723/jnprdf.2021.84.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jnprdf&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Natural Products&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jnprdf&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/joceah/2021/joceah.2021.86.issue-14/joceah.2021.86.issue-14/20210716/joceah.2021.86.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;joceah&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Organic Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/joceah&quot;},{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;jpchax&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpchax&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcafh/2021/jpcafh.2021.125.issue-29/jpcafh.2021.125.issue-29/20210729/jpcafh.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcafh&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry A&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcafh&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpcbfk/2021/jpcbfk.2021.125.issue-29/jpcbfk.2021.125.issue-29/20210729/jpcbfk.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpcbfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry B&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpcbfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpccck/2021/jpccck.2021.125.issue-29/jpccck.2021.125.issue-29/20210729/jpccck.2021.125.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpccck&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry C&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpccck&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jpclcd/2021/jpclcd.2021.12.issue-29/jpclcd.2021.12.issue-29/20210729/jpclcd.2021.12.issue-29.largecover.jpg&quot;,&quot;code&quot;:&quot;jpclcd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;The Journal of Physical Chemistry Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jpclcd&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jprobs/2021/jprobs.2021.20.issue-7/jprobs.2021.20.issue-7/20210702/jprobs.2021.20.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;jprobs&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of Proteome Research&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jprobs&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jacsat/2021/jacsat.2021.143.issue-30/jacsat.2021.143.issue-30/20210804/jacsat.2021.143.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;jacsat&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_analytical&quot;},{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Chemical Society&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jacsat&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/jamsef/2021/jamsef.2021.32.issue-8/jamsef.2021.32.issue-8/20210804/jamsef.2021.32.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;jamsef&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;1&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Journal of the American Society for Mass Spectrometry&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/jamsef&quot;}]},{&quot;char&quot;:&quot;L&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/langd5/2021/langd5.2021.37.issue-30/langd5.2021.37.issue-30/20210803/langd5.2021.37.issue-30.largecover.jpg&quot;,&quot;code&quot;:&quot;langd5&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_physical&quot;},{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Langmuir&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/langd5&quot;}]},{&quot;char&quot;:&quot;M&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mamobx/2021/mamobx.2021.54.issue-14/mamobx.2021.54.issue-14/20210727/mamobx.2021.54.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;mamobx&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Macromolecules&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mamobx&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/mpohbp/2021/mpohbp.2021.18.issue-8/mpohbp.2021.18.issue-8/20210802/mpohbp.2021.18.issue-8.largecover.jpg&quot;,&quot;code&quot;:&quot;mpohbp&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_biological&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Molecular Pharmaceutics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/mpohbp&quot;}]},{&quot;char&quot;:&quot;N&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/nalefd/2021/nalefd.2021.21.issue-14/nalefd.2021.21.issue-14/20210728/nalefd.2021.21.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;nalefd&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_matscieng&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Nano Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/nalefd&quot;}]},{&quot;char&quot;:&quot;O&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orlef7/2021/orlef7.2021.23.issue-14/orlef7.2021.23.issue-14/20210716/orlef7.2021.23.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orlef7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Letters&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orlef7&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/oprdfk/2021/oprdfk.2021.25.issue-7/oprdfk.2021.25.issue-7/20210716/oprdfk.2021.25.issue-7.largecover.jpg&quot;,&quot;code&quot;:&quot;oprdfk&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;cat_app&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organic Process Research &amp; Development&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/oprdfk&quot;},{&quot;imgUrl&quot;:&quot;/na101/home/literatum/publisher/achs/journals/content/orgnd7/2021/orgnd7.2021.40.issue-14/orgnd7.2021.40.issue-14/20210726/orgnd7.2021.40.issue-14.largecover.jpg&quot;,&quot;code&quot;:&quot;orgnd7&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;cat_organic_inorganic&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Organometallics&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/orgnd7&quot;}]},{&quot;char&quot;:&quot;P&quot;,&quot;publications&quot;:[{&quot;imgUrl&quot;:&quot;&quot;,&quot;code&quot;:&quot;iepra6.1&quot;,&quot;subjects&quot;:[{&quot;code&quot;:&quot;journals&quot;},{&quot;code&quot;:&quot;all journals less jce&quot;}],&quot;name&quot;:&quot;Product R&amp;D&quot;,&quot;type&quot;:&quot;journals&quot;,&quot;url&quot;:&quot;/journal/iepra6.1&quot;}]}]}"/></input></div></div>
</header>




        
        <main data-widget-id="28284a6d-730d-4a56-93ad-909787c5ac1b" id="" class="content article"><article data-figures="https://pubs.acs.org/action/ajaxShowFigures?doi=10.1021%2Fjm3009635&amp;ajax=true" data-references="https://pubs.acs.org/action/ajaxShowEnhancedAbstract?doi=10.1021%2Fjm3009635&amp;ajax=true" data-enable-mathjax="true"><div class="figure-viewer"><div class="figure-viewer_row"><div class="figure-viewer_col loop-trap"><div aria-live="polite" aria-atomic="true" class="figure-viewer_modal"><a href="#" title="Close" aria-label="close" tabindex="0" class="figure-viewer_close icon-close"></a><h2 class="figure-viewer_label"><span class="figure-viewer_current"></span></h2><div class="figure-viewer_image"><a href="#" title="Next" class="figure-viewer_next icon-angle-right"></a><a href="#" title="Previous" class="figure-viewer_prev icon-angle-left"></a><div class="figure-viewer_image-content"><img src="" alt="Figure 1" class="fv-img"/></img><img src="/pb-assets/ux3/loading-1525090748317.gif" alt="Loading Img" class="loading-img"/></img></div></div><div class="figure-viewer_links"><a href="#" title="Download Hi-Res Image" target="_blank" class="figure-viewer_hi-res-link"><i class="icon-file-image-o"></i><span>Download Hi-Res Image</span></a><span class="fv-separator"></span><a href="#" title="Download to MS-PowerPoint" class="figure-viewer_ms-p-link"><i class="icon-file-powerpoint-o"></i><span>Download to MS-PowerPoint</span></a><span class="cit-this-container"><a href="/action/showCitFormats?doi=10.1021/jm3009635&amp;href=/doi/10.1021/jm3009635" title="Cite This" class="figure-viewer-cite-this-link"><i class="icon-check-circle"></i><span><strong>Cite This:</strong></span></a><span class="article_header-cite-this figure-viewer-cite-this"><span class="cit-fg-title"><i>J. Med. Chem.</i></span><span class="cit-fg-year"> 2012</span><span class="cit-fg-volume">, 55</span><span class="cit-fg-issue">, 21</span><span class="cit-fg-pageRange">, 9055-9068</span></span></span></div></div></div></div></div><div class="article_fullPage"><div class="article_header"><div class="articleHeaderDropzone5" data-pb-dropzone="articleHeaderDropzone5"><div class="advertisement">
	<div class="advertisement-link">
		<a href="http://acsmediakit.org">ADVERTISEMENT</a>
	</div>
	<div id="dfp-journal-article-leaderboard">
		<script type="text/javascript">
			$(document).ready(function() {
				setTimeout(function() {
					googletag.cmd.push(function() { googletag.display("dfp-journal-article-leaderboard"); });
				}, 1400);
			});
		</script>
	</div>
</div></div><div class="container container_scaled-down"><div class="row"><div class="col-xs-12.clearfix"><div class="article_header-left pull-left"><div class="article_header-dropzone-1"><div class="articleHeaderDropzone1" data-pb-dropzone="articleHeaderDropzone1"><div class="content-navigation clearfix"><a href="/toc/jmcmar/55/21" title="Return to Issue" id="returnToIssues" class="content-navigation__btn--return"><span>RETURN TO ISSUE</span></a><a href="/doi/10.1021/jm3007799" title="Previous" id="prevID" class="content-navigation__btn--pre"><i class="icon-angle-left"></i><span>PREV</span></a><span class="content-navigation__contentType">Article</span><a href="/doi/10.1021/jm201715d" title="Next" id="nextID" class="content-navigation__btn--next"><span>NEXT</span><i class="icon-angle-right"></i></a></div></div></div><div class="headerLogo_e-alertsMobile_container"><div class="article_header-logo hidden-lg"><div class="pj-badge"></div><a href="/journal/jmcmar" title="Journal Logo"><img src="/specs/ux3/releasedAssets/images/loader.gif" data-src="/na101/home/literatum/publisher/achs/journals/covergifs/jmcmar/title.png" alt="Journal Logo" /></img></a></div><div class="e-alertsMobile_container hidden-md hidden-lg"></div></div><h1 class="article_header-title"><span class="hlFld-Title">Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors</span></h1><ul class="loa non-jats-loa"><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle+M.++Claffey">Michelle M. Claffey</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Helal">Christopher J. Helal</a></span><span class="author-xref-symbol "><sup>*</sup></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Patrick+R.++Verhoest">Patrick R. Verhoest</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Zhijun++Kang">Zhijun Kang</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kristina+S.++Fors">Kristina S. Fors</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stanley++Jung">Stanley Jung</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Jiaying+++Zhong">Jiaying Zhong</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mark+W.++Bundesmann">Mark W. Bundesmann</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Xinjun++Hou">Xinjun Hou</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Shenping++Lui">Shenping Lui</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Robin+J.++Kleiman">Robin J. Kleiman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Michelle++Vanase-Frawley">Michelle Vanase-Frawley</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Anne+W.++Schmidt">Anne W. Schmidt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frank++Menniti">Frank Menniti</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Christopher+J.++Schmidt">Christopher J. Schmidt</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=William+E.++Hoffman">William E. Hoffman</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mihaly++Hajos">Mihaly Hajos</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Laura++McDowell">Laura McDowell</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Rebecca+E.++O%E2%80%99Connor">Rebecca E. O’Connor</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Mary++MacDougall-Murphy">Mary MacDougall-Murphy</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Kari+R.++Fonseca">Kari R. Fonseca</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Stacey+L.++Becker">Stacey L. Becker</a></span></span></li><span class="comma-separator">, </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Frederick+R.++Nelson">Frederick R. Nelson</a></span></span></li><span class="comma-separator">, and </span><li><span><span class="hlFld-ContribAuthor"><a href="/action/doSearch?field1=Contrib&amp;text1=Spiros++Liras">Spiros Liras</a></span></span></li><span class="comma-separator"></span></ul><div class="affiliations"><div class="view-affs"><span class="title">View Author Information</span><i class="caret-icon icon-angle-down"></i></div><div class="all-aff-infos hlFld-Affiliation"><div class="aff-info" id="aff1"><span class="aff-text">Pfizer Worldwide Research and Development, Eastern Point Road, Groton, Connecticut 06340, United States</span></div><div class="corresp-info"><strong>*</strong>: <a href="/cdn-cgi/l/email-protection#cba6a2a8a3aea7a7aee5a6e5a8a7aaadadaeb28bbbada2b1aeb9e5a8a4a6"><span class="__cf_email__" data-cfemail="0b666268636e67676e25662568676a6d6d6e724b7b6d62716e7925686466">[email protected]</span></a>, 860-715-3416; <a href="/cdn-cgi/l/email-protection#8cefe4fee5ffa2e6a2e4e9e0ede0ccfceae5f6e9fea2efe3e1"><span class="__cf_email__" data-cfemail="9bf8f3e9f2e8b5f1b5f3fef7faf7dbebfdf2e1fee9b5f8f4f6">[email protected]</span></a>, 860-715-5064.</div></div></div><div class="article_header-meta clearfix"><div class="article_header-meta-left pull-left"><input type="hidden" name="journalCodeForjhpLink" value="jmcmar" /></input><input type="hidden" name="journalNameForjhpLink" value="Journal of Medicinal Chemistry" /></input><div class="article_header-cite-this"><a href="/action/showCitFormats?doi=10.1021%2Fjm3009635&amp;href=/doi/10.1021%2Fjm3009635" title="Cite This"><i class="icon-check-circle"></i><strong>Cite this: </strong></a><span class="cit-title"><i>J. Med. Chem.</i></span> <span class="cit-year-info"><span>2012</span></span><span class="cit-volume">, 55</span><span class="cit-issue">, 21</span><span class="cit-pageRange">, 9055–9068</span></div><div class="article_header-epubdate"><span class="pub-date epub-date">Publication Date</span><span class="web-text"> (Web)</span><span class="date-separator">:</span><span class="pub-date-value">October 1, 2012</span><div class="article_header-history base dropBlock"><a href="#" data-db-target-for="article_header-history" title="History" target="_self" class="" aria-expanded="false"><i class="icon-angle-down"></i><i class="icon-angle-up"></i></a><div data-db-target-of="article_header-history" class="dropBlock__holder" aria-hidden="true"><div class="articleHeaderHistoryDropzone" data-pb-dropzone="articleHeaderHistoryDropzone"><h4>Publication History</h4>




        
        <ul class="rlist article-chapter-history-list"><li><span class="item_label"><b>Received</b></span>5 July 2012</li><li><span class="item_label"><b>Published</b> online</span>12 October 2012</li><li><span class="item_label"><b>Published</b> in</span><span class="item_label-issue">issue</span> 8 November 2012</li></ul></div></div></div></div><div class="article_header-doiurl"><a href="https://doi.org/10.1021/jm3009635" title="DOI URL">https://doi.org/10.1021/jm3009635</a></div><div class="article_header-article-copyright"><strong>Copyright © 2012 American Chemical Society</strong></div><div class="article_rightPermissionsLink"><div class="articleHeaderDropzone4" data-pb-dropzone="articleHeaderDropzone4"><div class="articleRightsPermissionsLink"><a href="/servlet/linkout?type=rightslink&amp;url=startPage%3D9055%26pageCount%3D14%26copyright%3DAmerican%2BChemical%2BSociety%26author%3DMichelle%2BM.%2BClaffey%252C%2BChristopher%2BJ.%2BHelal%252C%2BPatrick%2BR.%2BVerhoest%252C%2Bet%2Bal%26orderBeanReset%3Dtrue%26imprint%3DAmerican%2BChemical%2BSociety%26volumeNum%3D55%26issueNum%3D21%26contentID%3Djm3009635%26title%3DApplication%2Bof%2BStructure-Based%2BDrug%2BDesign%2Band%2BParallel%2BChemistry%2Bto%2BIdentify%2BSelective%252C%2BBrain%2BPenetrant%252C%2BIn%2BVivo%2BActive%2BPhosphodiesterase%2B9A%2BInhibitors%26numPages%3D14%26pa%3D%26issn%3D0022-2623%26publisherName%3Dacs%26publication%3Djmcmar%26rpt%3Dn%26endPage%3D9068%26publicationDate%3DNovember%2B2012">RIGHTS & PERMISSIONS</a></div></div></div><div class="article_header-access-block"><div class="article_header-open-access"></div><div class="article_header-access-icon"><img src="/products/achs/releasedAssets/images/subscribed.svg" alt="Subscribed Access" /></img></div></div></div><div class="article_header-meta-center pull-left"><div class="articleHeaderDropzone3" data-pb-dropzone="articleHeaderDropzone3"><div class="articleMetrics"><div class="articleMetrics_table"><div class="articleMetrics_row"><input type="hidden" name="articleMetricsDoi" value="10.1021/jm3009635"/></input><div class="articleMetrics_metric"><h6>Article Views</h6><div class="articleMetrics-val">3624</div></div><div class="articleMetrics_altmetric"><h6>Altmetric</h6><div class="articleMetrics-val articleMetrics_score">-</div><div class="altmetric-donut hidden"><div data-badge-details="right" data-badge-type="donut" data-hide-no-mentions="false" data-condensed="true" class="altmetric-embed"></div></div></div><div class="articleMetrics_count"><h6>Citations</h6><div class="articleMetrics-val"><a href="#citeThis" class="internalNav">43</a></div></div></div></div><div class="articleMetrics_about"><div class="base dropBlock"><a href="#" data-db-target-for="aboutArticleMetrics" class="article_aboutLink">LEARN ABOUT THESE METRICS</a><div data-db-target-of="aboutArticleMetrics" aria-live="polite" aria-atomic="true" role="alert" class="dropBlock__holder"><i aria-hidden="true" class="icon-close_thin"></i><p>Article Views are the COUNTER-compliant sum of full text article downloads since November 2008 (both PDF and HTML) across all institutions and individuals. These metrics are regularly updated to reflect usage leading up to the last few days.</p><p>Citations are the number of other articles citing this article, calculated by Crossref and updated daily.<a href="https://www.crossref.org/services/cited-by/" title="Find more information about Crossref citation counts"> Find more information about Crossref citation counts.</a></p><p>The Altmetric Attention Score is a quantitative measure of the attention that a research article has received online. Clicking on the donut icon will load a page at altmetric.com with additional details about the score and the social media presence for the given article. Find more information on<a href="https://help.altmetric.com/support/solutions/articles/6000233311-how-is-the-altmetric-attention-score-calculated" title="The Altmetric Attention Score and how the score is calculated"> the Altmetric Attention Score and how the score is calculated.</a></p></div></div></div></div></div></div><div class="article_header-meta-right"><div class="articleHeaderDropzone6" data-pb-dropzone="articleHeaderDropzone6"><div data-widget-def="UX3share" data-widget-id="787b5b92-0445-40f4-bdd2-9591d56f4a67" class="article_header-share share_label_visible">
        



        
        <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript" async="async" src="//s7.addthis.com/js/300/addthis_widget.js#pubid=xa-4faab26f2cff13a7"></script><div class="share"><div class="share_button"><span class="share__label">Share</span><a href="#" data-db-target-for="787b5b92-0445-40f4-bdd2-9591d56f4a67" data-db-switch="icon-close_thin" aria-label="share button" class="share__ctrl"><i aria-hidden="true" class="icon-Icon_Share"></i></a></div>



        
        <div class="achs-addto-mendeley"><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><input type="hidden" class="doi" value="10.1021/jm3009635" /></input><span class="achs-addto-mendeley_label achs-addto-mendeley_addToLabel">Add to</span><span class="achs-addto-mendeley_label achs-addto-mendeley_viewInLabel">View In</span><a title="Add to mendeley button" class="achs-addto-mendeley_button" tabindex="0"><i class="achs-addto-mendeley_icon icon-mendeley"></i><i class="achs-addto-mendeley_close icon-close"></i></a><div data-db-target-of="5423a74c-bbd8-47b1-9f43-99423ee72e5c" class="achs-addto-mendeley_list dropBlock__holder"><ul><li><a href="#" title="Add Full Text with Reference" class="achs-addto-mendeley_disabled-button add-full-document"><i class="icon-bookmark-o"></i><span>Add Full Text with Reference</span></a></li><li><a href="#" title="Add Description" class="achs-mendeley_button add-metadata-description"><i class="icon-mendeley"></i><span>Add Description</span></a></li></ul></div><a href="#" title="View in mendeley button" class="achs-addto-mendeley_viewin-button"><i class="icon-mendeley"></i></a><div class="achs_loader"><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div><div class="achs_loader_dot"></div></div><input type="hidden" name="meta-data" value="{&quot;title&quot;:&quot;Application of Structure-Based Drug Design and Parallel Chemistry to Identify Selective, Brain Penetrant, In Vivo Active Phosphodiesterase 9A Inhibitors&quot;,&quot;type&quot;:&quot;journal&quot;,&quot;authors&quot;:[{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;M. Claffey&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Helal&quot;},{&quot;first_name&quot;:&quot;Patrick&quot;,&quot;last_name&quot;:&quot;R. Verhoest&quot;},{&quot;first_name&quot;:&quot;Zhijun&quot;,&quot;last_name&quot;:&quot;Kang&quot;},{&quot;first_name&quot;:&quot;Mark&quot;,&quot;last_name&quot;:&quot;W. Bundesmann&quot;},{&quot;first_name&quot;:&quot;Xinjun&quot;,&quot;last_name&quot;:&quot;Hou&quot;},{&quot;first_name&quot;:&quot;Shenping&quot;,&quot;last_name&quot;:&quot;Lui&quot;},{&quot;first_name&quot;:&quot;Robin&quot;,&quot;last_name&quot;:&quot;J. Kleiman&quot;},{&quot;first_name&quot;:&quot;Michelle&quot;,&quot;last_name&quot;:&quot;Vanase-Frawley&quot;},{&quot;first_name&quot;:&quot;Anne&quot;,&quot;last_name&quot;:&quot;W. Schmidt&quot;},{&quot;first_name&quot;:&quot;Frank&quot;,&quot;last_name&quot;:&quot;Menniti&quot;},{&quot;first_name&quot;:&quot;Christopher&quot;,&quot;last_name&quot;:&quot;J. Schmidt&quot;},{&quot;first_name&quot;:&quot;William&quot;,&quot;last_name&quot;:&quot;E. Hoffman&quot;},{&quot;first_name&quot;:&quot;Mihaly&quot;,&quot;last_name&quot;:&quot;Hajos&quot;},{&quot;first_name&quot;:&quot;Laura&quot;,&quot;last_name&quot;:&quot;McDowell&quot;},{&quot;first_name&quot;:&quot;Rebecca&quot;,&quot;last_name&quot;:&quot;E. O’Connor&quot;},{&quot;first_name&quot;:&quot;Mary&quot;,&quot;last_name&quot;:&quot;MacDougall-Murphy&quot;},{&quot;first_name&quot;:&quot;Kari&quot;,&quot;last_name&quot;:&quot;R. Fonseca&quot;},{&quot;first_name&quot;:&quot;Stacey&quot;,&quot;last_name&quot;:&quot;L. Becker&quot;},{&quot;first_name&quot;:&quot;Frederick&quot;,&quot;last_name&quot;:&quot;R. Nelson&quot;},{&quot;first_name&quot;:&quot;Spiros&quot;,&quot;last_name&quot;:&quot;Liras&quot;}],&quot;source&quot;:&quot;Journal of Medicinal Chemistry&quot;,&quot;year&quot;:&quot;2012&quot;,&quot;month&quot;:&quot;10&quot;,&quot;day&quot;:&quot;12&quot;,&quot;issue&quot;:&quot;21&quot;,&quot;volume&quot;:&quot;55&quot;,&quot;pages&quot;:&quot;9055-9068&quot;,&quot;identifiers&quot;:{&quot;doi&quot;:&quot;10.1021/jm3009635&quot;},&quot;abstract&quot;:&quot;Phosphodiesterase 9A inhibitors have shown activity in preclinical models of cognition with potential application as novel therapies for treating Alzheimer’s disease. Our clinical candidate, PF-04447943 (2), demonstrated acceptable CNS permeability in rats with modest asymmetry between central and peripheral compartments (free brain/free plasma = 0.32; CSF/free plasma = 0.19) yet had physicochemical properties outside the range associated with traditional CNS drugs. To address the potential risk of restricted CNS penetration with 2 in human clinical trials, we sought to identify a preclinical candidate with no asymmetry in rat brain penetration and that could advance into development. Merging the medicinal chemistry strategies of structure-based design with parallel chemistry, a novel series of PDE9A inhibitors was identified that showed improved selectivity over PDE1C. Optimization afforded preclinical candidate 19 that demonstrated free brain/free plasma ≥1 in rat and reduced microsomal clearance along with&quot;}" class="meta-data"/></input><input type="hidden" name="mendeley-api-endpoint" value="https://api.mendeley.com/documents" class="mendeley-api-endpoint"/></input><input type="hidden" name="pub-access" value="full" class="pub-access"/></input><input type="hidden" name="library-url" value="https://www.mendeley.com/library/" class="library-url"/></input><input type="hidden" name="selected-share-option" class="selected-share-option"/></input></div>




        
        <div class="cit-download-dropdown"><span class="cit-download-dropdown_label">Export</span><a href="#" data-db-target-for="cit-download-dropdown_content" title="Download citation button" class="cit-download-dropdown_button"><span>RIS</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div data-db-target-of="cit-download-dropdown_content" class="cit-download-dropdown_content"><ul><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009635&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009635" title="Citation"><span>Citation</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009635&amp;include=abs&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009635" title="Citation and abstract"><span>Citation and abstract</span></a></li><li><a href="/action/downloadCitation?doi=10.1021%2Fjm3009635&amp;include=ref&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009635" title="Citation and references"><span>Citation and references</span></a></li><li><a href="/action/showCitFormats?doi=10.1021%2Fjm3009635&amp;include=cit&amp;format=ris&amp;direct=true&amp;downloadFileName=jm3009635&amp;href=/doi/10.1021/jm3009635" title="Cite This"><i class="icon-plus-square"></i><span>More Options</span></a></li></ul></div></div>
<div data-db-target-of="787b5b92-0445-40f4-bdd2-9591d56f4a67" id="787b5b92-0445-40f4-bdd2-9591d56f4a67_Pop" class="share__block dropBlock__holder fixed"><span class="sr-only">Share on</span><ul class="rlist w-slide--list addthis addthis_toolbox addthis_default_style addthis_32x32_style"><li><a role="link" class="addthis_button_facebook"><i aria-hidden="true" class="at-icon-wrapper icon-facebook"></i>Facebook</a></li><li><a role="link" class="addthis_button_twitter"><i aria-hidden="true" class="at-icon-wrapper icon-twitter"></i>Twitter</a></li><li><a role="link" class="addthis_button_wechat"><i aria-hidden="true" class="at-icon-wrapper icon-wechat"></i>Wechat</a></li><li><a role="link" class="addthis_button_linkedin"><i aria-hidden="true" class="at-icon-wrapper icon-linkedin"></i>Linked In</a></li><li><a role="link" class="addthis_button_reddit"><i aria-hidden="true" class="at-icon-wrapper icon-reddit"></i>Reddit</a></li></ul></div></div>

        </div></div></div></div><div class="article_header-footer"><div class="article_header-footer-left pull-left clearfix"><div class="article_header-links pull-left"><input class="pub-doi" type="hidden" name="pub-doi" value="10.1021/jm3009635" /></input><a href="/doi/pdf/10.1021/jm3009635" title="PDF" target="_blank" class="button_primary pdf-button"><i class="icon-file-pdf-o"></i><span>PDF (1 MB)
                            </span></a><a href="/servlet/linkout?suffix=s0&amp;dbid=16384&amp;doi=10.1021/jm3009635&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fid%3Ddoi%3A10.1021%252Fjm3009635%26sid%3Dliteratum%253Aachs%26pmid%3D23025719%26genre%3Darticle%26aulast%3DClaffey%26date%3D2012%26atitle%3DApplication%2Bof%2BStructure-Based%2BDrug%2BDesign%2Band%2BParallel%2BChemistry%2Bto%2BIdentify%2BSelective%252C%2BBrain%2BPenetrant%252C%2BIn%2BVivo%2BActive%2BPhosphodiesterase%2B9A%2BInhibitors%26jtitle%3DJournal%2Bof%2BMedicinal%2BChemistry%26title%3DJournal%2Bof%2BMedicinal%2BChemistry%26volume%3D55%26issue%3D21%26spage%3D9055%26epage%3D9068%26issn%3D0022-2623" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a><div class="articleHeaderDropzone8" data-pb-dropzone="articleHeaderDropzone8"><div class="external-alerts-management"><input type="hidden" name="pub-type" value="article" class="pub-type"/></input><input type="hidden" name="is-enabled" value="true" class="is-enabled"/></input><input type="hidden" name="is-authenticated" value="false" class="is-authenticated"/></input><input type="hidden" name="pub-code" value="jmcmar" class="pub-code"/></input><input type="hidden" name="linkout-url" value="https://preferences.acspubs.org/journals" class="linkout-url"/></input><button data-toggle="modal" data-target="#ealertsModal" class="ealerts-toggle-btn hidden"></button><a class="button_primary_2 niHeader_getEAlerts jhHeader_sub_info"><i class="icon-send"></i><i class="icon-envelope"></i><i class="icon-check"></i><span class="ealerts-btn-text">Get e-Alerts</span><i aria-hidden="true" aria-label="close" class="icon-close"></i></a><div class="ux-modal-container"><div id="ealertsModal" style="display: none;" aria-live="polite" aria-atomic="true" class="modal"><div class="modal__dialog"><div class="modal__body"><iframe src="" class="ealerts-frame"></iframe></div></div></div></div><input type="hidden" id="ealertsModalSrc" value="https://preferences.acspubs.org/jmcmar?ifr=1"/></input></div></div></div><div class="article_header-suppInfo pull-left"><i class="icon-supporting-info"></i><span class="article_header-suppInfo-text">Supporting Info (1)</span><span class="article_header-suppInfo-arrow">»</span><a href="#" data-slide-target=".tab__pane-suppInfo" title="Supporting Information" class="article_header-suppInfo-link-mobile hidden-sm hidden-md hidden-lg w-slide__btn">Supporting Information
                </a><a href="#article_content-right" title="Supporting Information" data-scrollDuration="1000" class="article_header-suppInfo-link internalNav hidden-xs">Supporting Information
                </a></div></div><div class="article_header-footer-right"><div class="articleHeaderDropzone7" data-pb-dropzone="articleHeaderDropzone7"><div class="article_header-footer-right"><div class="article_header-taxonomy"><span>SUBJECTS:</span><ul class="rlist--inline loa"><li><a href="/action/doSearch?ConceptID=291181" title="Amines">Amines</a>,</li><li><a href="/action/doSearch?ConceptID=292462" title="Central nervous system">Central nervous system</a>,</li><li><a href="/action/doSearch?ConceptID=292464" title="Rodent models">Rodent models</a>,</li><li><a href="/action/doSearch?ConceptID=292528" title="Inhibitors">Inhibitors</a>,</li><li><a href="/action/doSearch?ConceptID=291711" title="Selectivity">Selectivity</a></li></ul></div></div></div></div></div></div><div class="article_header-right pull-left hidden-md hidden-sm hidden-xs"><div class="articleHeaderDropzone2" data-pb-dropzone="articleHeaderDropzone2"><div class="cover-image"><div class="cover-image__image"><a href="/toc/jmcmar/55/21" title="Go to Journal of Medicinal Chemistry "><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jmcmar.2012.55.issue-21/production/jmcmar.2012.55.issue-21.largecover.jpg" alt="Go to Journal of Medicinal Chemistry "/></img></a></div></div>




        
        
<script>
 $(document).ready(function() {
   $('.article_header .external-alerts-management .niHeader_getEAlerts').each(function(){
	 var Tab = $(this).attr("href");
	   if(typeof Tab != undefined && Tab != false){
		 console.log("Testing Tab");
		 $(this).attr('href','#');
	   }
   });
 });
 $(document).on('click', '.article_header .external-alerts-management .niHeader_getEAlerts', function (e) {
	 //do something
	 if($(this).hasClass('registered')){
	  //send data to analytics for registered users
	      ga('send','event','Registered e-Alert','Article Page Click','jmcmar');
	  }else{
	     //send data to analytics for non-registered users
	      ga('send','event','Get e-Alert','Article Page Click','jmcmar');
	  }
  });
</script>





        
        <div class="pj-badge"></div>




        
        <div class="aJhp_link"></div>
<a href="/action/doUpdateAlertSettings?action=addJournal&amp;journalCode=jmcmar" class="button_primary_2"><i class="icon-send"></i><span>Get e-Alerts</span></a></div></div></div></div></div></div></div><div class="article_abstract"><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><h2 class="article_abstract-title" id="Abstract">Abstract</h2><div class="article_abstract-content hlFld-Abstract" id="abstractBox"><figure id="f_tgr1" data-index="0" class="article__inlineFigure article_abstract-img"><img class="inline-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><p class="articleBody_abstractText">Phosphodiesterase 9A inhibitors have shown activity in preclinical models of cognition with potential application as novel therapies for treating Alzheimer’s disease. Our clinical candidate, PF-04447943 (<b>2</b>), demonstrated acceptable CNS permeability in rats with modest asymmetry between central and peripheral compartments (free brain/free plasma = 0.32; CSF/free plasma = 0.19) yet had physicochemical properties outside the range associated with traditional CNS drugs. To address the potential risk of restricted CNS penetration with <b>2</b> in human clinical trials, we sought to identify a preclinical candidate with no asymmetry in rat brain penetration and that could advance into development. Merging the medicinal chemistry strategies of structure-based design with parallel chemistry, a novel series of PDE9A inhibitors was identified that showed improved selectivity over PDE1C. Optimization afforded preclinical candidate <b>19</b> that demonstrated free brain/free plasma ≥1 in rat and reduced microsomal clearance along with the ability to increase cyclic guanosine monophosphosphate levels in rat CSF.</p></div></div></div></div></div><div class="article_content"><ul class="tab-nav-shortcut"><li><i class="icon-image"></i></li><li><i class="icon-link"></i></li><li><i class="icon-supporting-info"></i></li></ul><div class="container container_scaled-down"><div class="row"><div class="col-xs-12"><div class="article_content-table hlFld-FullText"><div class="article_content-row"><div class="article_content-left"><div id="specialIssueNotice" class="extra-info-sec articleNote"><h4>SPECIAL ISSUE</h4><p class="last">This article is part of the <a href="/toc/jmcmar/55/21"><issue-title>Alzheimer's Disease</issue-title></a> special issue.</p></div><div class="extra-info-sec articleNote withdrawn"><h4><span></span> Accession Codes</h4><p class="last">All coordinates have been deposited and will be released upon publication.</p></div><div id="sec1" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i2">Introduction</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_41033" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_41033" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div class="NLM_p">Phosphodiesterases (PDEs), enzymes that catalyze the hydrolysis of the key second messenger molecules cyclic guanosine monophosphate (cGMP) and cyclic adenosine monophosphate (cAMP), have been shown to have extensive distribution in brain. On the basis of the critical nature of cyclic nucleotides in neuronal signaling, we sought to identify highly PDE subtype selective inhibitors to allow for the elucidation of the role of specific phosphodiesterates in potentially treating human neurological disease.</div><div class="NLM_p">The identification of PDE10A, a striatal-entriched PDE that hydrolyzes both cGMP and cAMP, as a possible target for the treatment of schizophrenia, has led to a number of reports of selective and brain penetrant PDE10A inhibitors that increase cGMP levels in vivo. There exists one example of a PDE10A inhibitor that is currently in phase II clinical trials.<a onclick="showRef(event, 'ref1'); return false;" href="javascript:void(0);" class="ref ref1">(1)</a></div><div class="NLM_p">We have more recently gained interest in other PDEs as targets, in particular PDE9A, a cGMP-specific phosphodiesterase with wide distribution throughout the brain.<a onclick="showRef(event, 'ref2'); return false;" href="javascript:void(0);" class="ref ref2">(2)</a> Interestingly, the affinity of PDE9A for cGMP (<i>K</i><sub>m</sub> = ca. 170 nM) is significantly higher than that observed for other PDEs for the appropriate cyclic nucleotide. Additionally, preclinical research has shown that PDE9A inhibition can enhance cognition, thus suggesting treatment for Alzheimer’s disease as well as cognitive deficits associated with schizophrenia.<a onclick="showRef(event, 'ref3'); return false;" href="javascript:void(0);" class="ref ref3">(3)</a> We thus set out with the goal of identifying PDE9A inhibitors that are potent and selective to allow for a greater understanding of the biology and potential medical indications as well as to identify compounds with the appropriate alignment of potency, selectivity, permeability, clearance, and safety to consider for nomination as preclinical development candidates.</div><div class="NLM_p">Initial efforts at identifying lead compounds utilized a combination of high-throughput screening (HTS) and corporate database searching which led to the identification of compound <b>1</b>.<a onclick="showRef(event, 'ref4'); return false;" href="javascript:void(0);" class="ref ref4">(4)</a></div><div class="NLM_p">In addition to excellent PDE9A potency (IC<sub>50</sub> = 2 nM) and ligand efficiency (LE = 0.54),<a onclick="showRef(event, 'ref5'); return false;" href="javascript:void(0);" class="ref ref5">(5)</a><b>1</b> showed no efflux in a P-gp-overexpressing cell line (MDR BA/AB = 1.3), which is supportive of brain penetration, as were physicochemical properties such as molecular weight (MW = 294 AMU) and topological polar surface area (TPSA = 64 Å<sup>2</sup>) (Figure <a data-tab="pane-pcw-Figures" href="#fig1" id="" class=" internalNav">1</a>).<a onclick="showRef(event, 'ref6'); return false;" href="javascript:void(0);" class="ref ref6">(6)</a> A number of significant liabilities, however, also existed, such as high human liver microsomal clearance (HLM Cl) and no selectivity for PDE1C (IC<sub>50</sub> = 2 nM).</div><figure id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0001.jpeg" id="gr1" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and profile of starting PDE9A inhibitor <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To efficiently address the issues with this lead, we sought to apply a number of methods simultaneously: (a) X-ray crystallographic structure-based drug design to identify critical small molecule-protein interactions, (b) parallel-enabled chemical synthesis aimed toward optimizing the key small molecule-protein interactions, and (c) prospective tracking of physicochemical properties to increase the probability of alignment of potency, selectivity, clearance, permeability, and safety.<a onclick="showRef(event, 'ref7'); return false;" href="javascript:void(0);" class="ref ref7">(7)</a> We targeted HLM Cl < 20 mL/min/kg, MDR BA/AB < 2.5, and PDE9A IC<sub>50</sub> < 50 nM while maintaining clogP < 3 and TPSA > 75 Å<sup>2</sup>.<a onclick="showRef(event, 'ref8'); return false;" href="javascript:void(0);" class="ref ref8">(8)</a></div><div class="NLM_p">Examination of the X-ray crystal structure of <b>1</b> bound to PDE9A (Figure <a data-tab="pane-pcw-Figures" href="#fig2" id="" class=" internalNav">2</a>) showed a number of key interactions: (a) the pyrimidinone N–H and C═O groups of <b>1</b> formed a bidentate hydrogen bonding interaction with glutamine (Gln-453), a conserved amino acid in all PDEs that plays a critical role in cyclic nucleotide binding, (b) the bicyclic pyrazolopyrimidinone formed a π-interaction with Phe-456, (c) the benzyl substituent fit into a hydrophobic pocket comprised of Val-417, Leu-421, Phe-441, and Ala-452.</div><figure id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0002.jpeg" id="gr2" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <b>1</b> bound to PDE9A (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JS1">3JS1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">An avenue for selectivity for PDE9A over PDE1C is present in Tyr-424 (PDE9A), which is in close proximity to the inhibitor and was shown to be a Phe residue in a PDE1C homology model. Targeting this residue has successfully improved selectivity in previous work with compounds such as <b>2</b> (PF-04447943),<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> wherein the pyrrolidine nitrogen forms a hydrogen bond with a bridging water molecule to Tyr 424 while the 4-methyl group simultaneously fills the lipophilic pocket occupied by the benzyl (Figure <a data-tab="pane-pcw-Figures" href="#fig3" id="" class=" internalNav">3</a>). <b>2</b> has reached phase II clinical trials.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Key attributes of <b>2</b> are good PDE9A potency, high PDE selectivity, low human microsomal clearance, high in vivo oral bioavailability, and no efflux in an MDR cell line, which is predictive of acceptable CNS penetration. Measures of in vivo CNS penetration in dog reveal good central access with cerebrospinal fluid (CSF)/unbound plasma concentrations (<i>C</i><sub>pu</sub>) ratio = 0.9. Studies in rat demonstrated modest impairment between central and peripheral compartments with unbound brain concentration <i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub> = 0.32 and CSF/<i>C</i><sub>pu</sub> = 0.19. While the aggregate in vitro and in vivo CNS penetration data indicates a high probability of brain access, the physicochemical properties of <b>2</b> are outside of the traditional range for CNS drugs with a low cLogP (−1.5) and a high topological polar surface area (TPSA = 101.8 Å<sup>2</sup>).<a onclick="showRef(event, 'cit6b'); return false;" href="javascript:void(0);" class="ref cit6b">(6b)</a> We thus sought to identify alternative compounds that maintained many of the positive attributes of <b>2</b> but that showed no in vivo asymmetry in rat <i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub> and CSF/<i>C</i><sub>pu</sub> to derisk possible poor human clinical CSF drug exposure. The medicinal chemistry strategy toward this ends follows.</div><figure id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0004.jpeg" id="gr3" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (top) Pyrrolidine PDE9 inhibitor PF-04447943 (<b>2</b>). (bottom) X-ray crystal structure of <b>2</b> bound to PDE9A with a water-mediated hydrogen bond to Tyr-424 via the pyrrolidine nitrogen (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW">3JSW</a>). Note an interaction with the N–CH<sub>2</sub> pyrimidine nitrogen in this case to the same bridging water.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of molecular modeling, an alternative structure that would target both hydrogen bonding with Tyr-424 and the lipophilic pocket was devised in structure <b>3</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig4" id="" class=" internalNav">4</a>). The basic nitrogen α to the pyrimidinone was in position to interact directly with the −OH of Tyr-424, and the methyl group fit into the desired lipophilic pocket. Other key design criteria that made this approach attractive were:<table class="listgroup" border="0" width="95%" list-type="label"><tr class="li1"><td valign="top">1.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Relative to <b>1</b>, replacement of the phenyl with the methyl in <b>3</b> would reduce molecular weight and lipophilicity and could thus lead to reduced human liver microsomal clearance (HLM Cl).</p></td></tr><tr class="li1"><td valign="top">2.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Solubility could be improved due to low lipophilicity as well as the presence of the ionizable amine function.</p></td></tr><tr class="li1"><td valign="top">3.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Placement of the amine α to the electron-withdrawing pyrimidinone core would reduce the p<i>K</i><sub>a</sub>, which has shown to be advantageous in minimizing HERG ion channel affinity,<a onclick="showRef(event, 'ref10'); return false;" href="javascript:void(0);" class="ref ref10">(10)</a> improving permeability, and reducing P-gp-mediated efflux.</p></td></tr><tr class="li1"><td valign="top">4.</td><td colspan="5" valign="top" class="paragraph"><p class="last">Placement of the amine α to the pyrimidinone core introduces 1,3-allylic strain that would restrict the α-amino function to a major low energy conformer, thus improving the potential potency.<a onclick="showRef(event, 'ref11'); return false;" href="javascript:void(0);" class="ref ref11">(11)</a></p></td></tr><tr class="li1"><td valign="top">5.</td><td colspan="5" valign="top" class="paragraph"><p class="last">A final and critical aspect was the ability to readily introduce amines at the α-position. Amines are a large and diverse monomer set which could allow for the rapid identification of optimal SAR.</p></td></tr></table></div><figure id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0005.jpeg" id="gr4" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design idea to address liabilities of hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Our initial goal was to prepare a chemical library of α-amine analogues <b>3</b> via S<sub>N</sub>2 displacement of the bromide <b>6</b> (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). This intermediate was prepared via condensation of a hydrazine with 2-(methoxymethylene)malononitrile to afford <b>4</b>. Hydrolysis of the nitrile to the primary amide under acidic conditions gave <b>5</b>. The formation of <b>6</b> was achieved via a one-pot acylation/condensation of 2-bromopropanoyl bromide with <b>5</b>. Selection of amine monomers started with the available compounds from Pfizer’s in-house monomer store. A virtual library was generated with 3700 secondary amines available internally. The product library was filtered to 1658 molecules by MW < 480 and TPSA < 120 Å<sup>2</sup> to generate a subset with a higher probability of brain permeability. The 3-D conformation of the library was generated by Corina,<a onclick="showRef(event, 'ref12'); return false;" href="javascript:void(0);" class="ref ref12">(12)</a> and multiple stereoisomers were generated for unspecified stereocenters in the amine monomers. The resulting 3-D conformers were docked into the binding site of PDE9A with the pyrimidinone core partially constrained to the crystal structure of <b>1</b> using an in-house AGDOCK program.<a onclick="showRef(event, 'ref13'); return false;" href="javascript:void(0);" class="ref ref13">(13)</a> All docked poses were rank-ordered by an in-house scoring function<a onclick="showRef(event, 'ref14'); return false;" href="javascript:void(0);" class="ref ref14">(14)</a> and were followed by visual inspection. A final set of 300 compounds was selected for synthesis.</div><figure id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0006.jpeg" id="gr13" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sup>1</sup>-NHNH<sub>2</sub>, EtOH, NaOEt, rt to reflux; (b) H<sub>2</sub>O<sub>2</sub>, NH<sub>4</sub>OH, EtOH, rt or H<sub>2</sub>SO<sub>4</sub>, 0 °C to rt (60–65% over two steps); (c) (i) BrC(═O)CH(Me)Br, TEA, DMF; (ii) <i>p</i>-TsOH, toluene, reflux (22%); (d) HNRR′, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux.</p></p></figure><div class="NLM_p">Some key SAR points from successfully synthesized library compounds are shown (Table <a class="ref showTableEvent internalNav" data-ID="tbl1" href="#tbl1">1</a>). In the case of minimally substituted cyclic amines, piperidine (<b>3a</b>) had little activity, 3-fluoropyrrolidine (<b>3b</b>) had PDE9A IC<sub>50</sub> approaching 1000 nM, and azetidine (<b>3c</b>) was most active with PDE9A IC<sub>50</sub> = 593 nM. The potency trend of azetidine > pyrrolidine > piperidine was replicated in the case of aryl substituted variants. For example, piperidines with an aryl group fused (<b>3d</b>) or directly attached (<b>3e</b>) showed little activity. Pyrrolidines with an aryl group attached directly (<b>3f</b>) or via an oxygen linker (<b>3g</b>) were significantly more active with PDE9A IC<sub>50</sub> values of 230 and 148 nM, respectively. The azetidine with an oxygen linker (<b>3h</b>) gained an order of magnitude in potency relative to the pyrrolidines (PDE9A IC<sub>50</sub> = 14 nM).</div><div class="NLM_table-wrap" id="tbl1"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 1. SAR of Initial α-Amine Library</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0007.gif" alt="" id="fx1" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0008.gif" alt="" id="fx2" /></img><div></div></div><div class="NLM_p">To verify the result with <b>3h</b>, this compound was resynthesized, isolated as a solid, and was characterized (Figure <a data-tab="pane-pcw-Figures" href="#fig5" id="" class=" internalNav">5</a>). The retest data with <b>3h</b> (racemic) afforded a slight reduction in potency compared to the original library sample (PDE9A IC<sub>50</sub> = 45 nM). Encouragingly, improved PDE1C selectivity (6.6-fold) was observed as compared to the <b>1</b> (no selectivity).</div><figure id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0009.jpeg" id="gr5" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Calculated and in vitro data for resynthesized library hit <b>3h</b> and the single enantiomer <b>3h</b>-(<i>R</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Separation of the racemic mixture and testing of the enantiomers showed PDE9A inhibition resided with one compound (enantiomer PDE9A IC<sub>50</sub> = 11 and 986 nM, respectively). The X-ray crystal structure of the more active enantiomer bound to PDE9A indicated that the (<i>R</i>)-stereochemistry was present (Figure <a data-tab="pane-pcw-Figures" href="#fig6" id="" class=" internalNav">6</a>). A number of interesting features were observed in that: (1) The α-methyl amine function resided in the conformation to minimize 1,3-allylic strain. (2) The α-methyl group of <b>3h</b>-(<i>R</i>) fit into the lipophilic pocket occupied by the benzyl in <b>1</b>. (3) The azetidine nitrogen formed a direct hydrogen bond with the −OH of Tyr-424 and explained the increased selectivity over PDE1C; this is in contrast to the water-bridged hydrogen bond displayed by <b>2</b>. (4) The OPh group was aligned to make an edge–face π-interaction with Phe-456.</div><figure id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0010.jpeg" id="gr6" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure of <b>3h</b>-(<i>R</i>) bound to PDE9A (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2J">4G2J</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">This single enantiomer <b>3h</b>-(<i>R</i>) displayed improved potency as compared to the racemic compound <b>3h</b> (PDE9A IC<sub>50</sub> = 11 and 45 nM, respectively). In addition to improved potency, selectivity over PDE1C improved (11-fold), no efflux was noted in an MDR cell line,<a onclick="showRef(event, 'ref15'); return false;" href="javascript:void(0);" class="ref ref15">(15)</a> and HLM Cl was high. Application of a recently developed multiparametric optimization (MPO) physicochemical analysis for neuroscience drugs suggested that the compound had excellent alignment of physical properties with an MPO score = 5.6 out of 6.<a onclick="showRef(event, 'ref16'); return false;" href="javascript:void(0);" class="ref ref16">(16)</a></div><div class="NLM_p">To improve HLM Cl, SAR from <b>2</b> was applied wherein the cyclopentyl group in <b>3h</b>-(<i>R</i>) was changed to a 4-tetrahydropyran, which decreased cLogP and increased topological polar surface area (<b>7</b>, Figure <a data-tab="pane-pcw-Figures" href="#fig7" id="" class=" internalNav">7</a>). Potency against PDE9A was maintained (IC<sub>50</sub> = 22 nM), PDE1C selectivity was improved (>50-fold), HLM Cl decreased significantly, and excellent permeability with no sign of P-gp-efflux was seen. Additionally, with a CNS MPO of 5.6/6, the physicochemical properties remained in excellent space. In vivo mouse brain penetration studies showed <b>7</b> to be highly brain permeable with <i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub> ratio equal to 0.6 with only moderate plasma protein binding (human fu<sub>p</sub> = 23%).<a onclick="showRef(event, 'ref17'); return false;" href="javascript:void(0);" class="ref ref17">(17)</a></div><figure id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0011.jpeg" id="gr7" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Merging SAR of <b>3h</b>-(<i>R</i>) and <b>2</b> yielded <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">In vivo, <b>7</b> was evaluated for its ability to increase rat CSF cGMP levels (Figure <a data-tab="pane-pcw-Figures" href="#fig8" id="" class=" internalNav">8</a>). Cyclic nucleotide levels increased with increasing dose levels, demonstrating biochemical efficacy.</div><figure id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0012.jpeg" id="gr8" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo increases in cGMP in rat CSF with increasing doses of <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of favorable potency, PDE1C selectivity, and ADME properties, <b>7</b> was evaluated in a selectivity panel against a broad range of enzymes, ion channels, transporters, etc. Besides PDE1 activity, <30% inhibition against PDE2–8, -10, and -11 was observed at a concentration of 1 μM. Significant potency against the human dopamine transporter (DAT <i>K</i><sub>i</sub> = 293 nM) was observed. However, in vivo studies in rodents showed none of the hyperactivity generally associated with dopamine transporter blockade, suggesting that <b>7</b> may be functionally inactive.</div><div class="NLM_p">Nonetheless, on the basis of the potential liabilities associated with DAT inhibition, we sought to design away from DAT activity in our series. Our hypothesis was that the 3-phenoxyazetidine overlapped with an established pharmacophore for DAT inhibition, 4-phenylpiperidine.<a onclick="showRef(event, 'ref18'); return false;" href="javascript:void(0);" class="ref ref18">(18)</a> Pharmacophore disruption was pursued by taking advantage of the highly synthetically enabled nature of 3-phenoxyazetidines.</div><div class="NLM_p">To vary the azetidine 3-substituent effectively, <b>6b</b> could be directly aminated with a 3-aryloxy-azetidine (Scheme <a class="ref internalNav" href="#sch1" aria-label="1">1</a>). Alternatively, <b>6b</b> could be reacted with 3-hydroxy azetidine to afford <b>8</b>, followed by activation of the hydroxyl with methanesulfonyl chloride (<b>9</b>) and displacement of the methanesulfonate with phenols to afford compounds of general formula <b>10</b> (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>). Alternatively, the hydroxyl group of <b>8</b> could be directly functionalized under standard ether forming conditions.</div><figure id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0013.jpeg" id="gr14" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) amine, TEA, acetonitrile, 85–90 °C (54–70%); (b) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub> (67%); (c) R<sup>2</sup>-OH, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux, (33–85%); (d) R<sup>2</sup>-Cl or R<sup>2</sup>-Br, KO<i>t</i>-Bu, 70 °C (40–70%).</p></p></figure><div class="NLM_p">To make analogues in an enantiospecific manner, a variation of the existing synthetic route was devised wherein the use of commercially available (<i>S</i>)-1-chloro-1-oxopropan-2-yl acetate (ca. 90% ee) afforded key α-hydroxy intermediate <b>11</b> in 88% ee (Scheme <a class="ref internalNav" href="#sch3" aria-label="3">3</a>). Activation of the hydroxyl with methanesulfonyl chloride afforded <b>12</b>, which was subsequently treated with a free-based amine in the absence of nucleophilic counterions (e.g., chloride) to allow for highly stereoselective S<sub>N</sub>2 displacement, thus affording final compounds <b>10</b> or key intermediates such as <b>13</b>. If an amine hydrochloride salt was utilized in the displacement, significant racemization was observed due to competing S<sub>N</sub>2 attack with chloride, generating the (<i>R</i>)-α-chloro intermediate that could subsequently be displaced with the amine to afford the undesired (<i>S</i>)-amino enantiomer (see <a class="ref internalNav" href="#notes-1" aria-label="Supporting Information">Supporting Information</a>). As in the racemic synthesis (Scheme <a class="ref internalNav" href="#sch2" aria-label="2">2</a>), the hydroxyl group in <b>13</b> could be directly functionalized to afford final analogues <b>10</b>. In the case of <b>14b</b>, displacement of the mesylate resulted in epimerization under the conditions used (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>).</div><figure id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0014.jpeg" id="gr15" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (<i>S</i>)-1-Chloro-1-oxopropan-2-yl acetate, dioxane, reflux; H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, 45 °C (84–90%); (b) MsCl, triethylamine or <i>N</i>-methylmorpholine, 0 °C to rt (41–74%); (c) amine, TEA, acetonitrile, 85–90 °C (54–70%); (d) R<sup>2</sup>-Cl or R<sup>2</sup>-Br, KO<i>t</i>-Bu, 70 °C (40–70%); (e) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub> (67%); (f) R<sup>2</sup>-OH, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux, (33–85%).</p></p></figure><div class="NLM_table-wrap" id="tbl2"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 2. SAR of 3-(OAr) Azetidines</div></div></div><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0015.gif" alt="" id="fx3" /></img><img class="imgWithoutFigViewer " src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0016.gif" alt="" id="fx4" /></img><div></div></div><div class="NLM_p">A series of analogues was prepared wherein the OR<sup>2</sup> group was varied using substituted phenols (Table <a class="ref showTableEvent internalNav" data-ID="tbl2" href="#tbl2">2</a>). Halogenation of the aryl group (<b>10a</b>–<b>c</b>) led to no improvement in potency and increases in HLM Cl, most likely being driven by increased lipophilicity. Additionally, assessment of DAT activity showed little change (e.g., <b>10a</b> DAT <i>K</i><sub>i</sub> = 1.2 μM). The incorporation of polar functionality such as <i>p</i>-CN (<b>10d</b>) reduced DAT affinity significantly (<i>K</i><sub>i</sub> > 10 μM) as well as HLM Cl, but signs of increased efflux were observed in the MDR assay. To balance the increased polarity of the CN group that led to significant reduction in cLogP and potentially led to efflux, halogens were added (<b>10e</b>–<b>g</b>), bringing lipophilicity in line with previous compounds that did not have MDR efflux. Unfortunately, reductions in MDR efflux were not observed.</div><div class="NLM_p">The exploration of other polar aryl groups led to heterocycles, especially 1,3-pyrimidine, which afforded compounds with good potency, low HLM Cl, and modest efflux (MDR BA/AB) as demonstrated in <b>15</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig9" id="" class=" internalNav">9</a>). Unfortunately, in vivo assessment of brain penetration in rat showed a brain/plasma ratio of 0.1 and with <i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub> ratio of 0.05, indicative of impaired brain access.</div><div class="NLM_p">It was surmised that the relatively high TPSA of <b>15</b> (111 Å<sup>2</sup>) could be a factor contributing to the efflux, so we next prepared the less polar cyclopentyl analogue <b>16</b> (TPSA = 102 Å<sup>2</sup>). In this case, improved potency, moderate HLM Cl, high permeability with no P-gp-efflux, and acceptable PDE1C selectivity were observed. Assessment of brain penetration in rat demonstrated a significantly improved brain/plasma ratio of 1.8 and CSF/<i>C</i><sub>pu</sub> ratio of 2.2, confirming good brain penetration in vivo. The corresponding CNS MPO score of 5.3/6 indicated that <b>16</b> resided in excellent physicochemical property space, in line with the observed in vitro and in vivo ADME properties. Additionally, the strategy of disrupting the phenylpiperidine pharmacophore was clearly successful with human DAT <i>K</i><sub>i</sub> > 10 μM.</div><figure id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0017.jpeg" id="gr9" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Lead analogue <b>15</b> and less polar derivative <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">On the basis of the favorable results with <b>16</b>, it was further evaluated, revealing a significant chemical instability issue in aqueous acidic and neutral systems (pH = 1–6.8). HPLC analysis showed a new peak forming with the same mass as <b>16</b>, with a subsequent peak that grew in intensity with mass 18 AMU greater than parent, suggestive of the addition of water. Spectral analysis of a sample of <b>16</b> treated with acid was not conclusive due to the presence of overlapping diastereomeric NMR signals, but hydrolytic opening of the azetidine was suggested. To more definitively understand the mechanism of this process, the achiral precursor <b>17</b> was treated with aqueous hydrochloric acid (Scheme <a class="ref internalNav" href="#sch4" aria-label="4">4</a>). Clean conversion to a new product with mass 18 AMU higher than the starting material was observed . Spectral analysis (<sup>1</sup>H NMR, <sup>13</sup>C NMR, and IR) indicated that <b>18</b> was the final product. The mechanism for formation is proposed to proceed via initial protonation of the azetidine nitrogen followed by intramolecular attack of the pyrimidine nitrogen on the azetidine carbon at the 2-position, driven by relief of ring strain. The cyclic pyrimidinium intermediate is subsequently hydrolyzed via attack of water on the 2-position carbon, leading to the observed product. Correspondingly, the phenoxy derivative <b>7</b> showed excellent stability in aqueous acid, supporting the key role of the appropriately aligned nucleophilic pyrimidine nitrogen in the reactivity of <b>16</b>.</div><figure id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0018.jpeg" id="gr16" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Proposed Mechanism for Rearrangement of <b>17</b> to <b>18</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">To address this issue, we sought to alter the nucleophilic trajectory of the pyrimidine nitrogens toward the azetidine 2-position via removal of the oxygen linker. Docking of <b>19</b> (Figure <a data-tab="pane-pcw-Figures" href="#fig10" id="" class=" internalNav">10</a>) in the PDE9A crystal structure suggested that this structural modification would be tolerated, and results validated this prediction. Indeed, the acid stability of <b>19</b> was greatly improved as compared to <b>16</b> with no decomposition noted after 10 h at pH < 2. The PDE9A potency of <b>19</b> was good (IC<sub>50</sub> = 32 nM), with acceptable selectivity over PDE1C (30-fold). Examination of the X-ray crystal structure of <b>19</b> bound to PDE9A showed a similar binding as previous analogues, except that removal of the oxygen linker between the pyrimidine and azetidine resulted in a π-stacking interaction between the pyrimidine and Phe441 as opposed to Phe456 (Figure <a data-tab="pane-pcw-Figures" href="#fig11" id="" class=" internalNav">11</a>). Excluding PDE1, no inhibition (≤10% at 1 μM) was observed against all other PDE families and no significant activity was seen against a broad selectivity panel at 10 μM. Microsomal clearance was low and permeability was high with no sign of P-gp-efflux. Physicochemical properties were in highly desirable ranges for <b>19</b> with regard to CNS MPO (5.7/6) as well as toxicity.<a onclick="showRef(event, 'ref9'); return false;" href="javascript:void(0);" class="ref ref9">(9)</a> Cytochrome p450 inhibition assays suggested a low likelihood of drug–drug interactions.</div><figure id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0019.jpeg" id="gr10" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Calculated physicochemical properties and in vitro data for <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0020.jpeg" id="gr11" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. X-ray crystal structure of <b>19</b> bound to PDE9A (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2L">4G2L</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p">Further profiling of <b>19</b> in vivo was performed due to its promising in vitro profile. Assessment of rat brain penetration showed a brain/plasma ratio of 1.4 and a <i>C</i><sub>bu</sub>/<i>C</i><sub>pu</sub> ratio and CSF/<i>C</i><sub>pu</sub> ratio of 1.4, indicative of unrestricted CNS access. Oral pharmacokinetics in both rat and dog were favorable with high oral bioavailability, moderate (rat) to low (dog) clearance, and moderate volumes of distribution (Table <a class="ref showTableEvent internalNav" data-ID="tbl3" href="#tbl3">3</a>). Predicted human pharmacokinetics based upon microsomal scaling and adjusting for human fraction unbound in plasma (fu<sub>p</sub>) and microsomes (fu<sub>mic</sub>) suggested high oral bioavailability and moderate to low clearance with with a predicted <i>T</i><sub>1/2</sub> of 5 h.<a onclick="showRef(event, 'ref19'); return false;" href="javascript:void(0);" class="ref ref19">(19)</a> Additional in vitro safety profiling included the assessment of hERG channel affinity (IC<sub>50</sub> = 53.5 μM) that suggested a low liability for QTC prolongation and a general cellular toxicity assay that showed little toxicity at 300 μM.</div><div class="NLM_table-wrap" id="tbl3"><div class="hlFld-FigureCaption"><div class="NLM_caption" id=""><div class="title2">Table 3. Measured Preclinical Pharmacokinetics and Predicted Human Pharmacokinetics of <b>19</b></div></div></div><div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="left" /></col><col align="left" /></col><col align="left" /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center">rat</th><th class="colsep0 rowsep0" align="center">dog</th><th class="colsep0 rowsep0" align="center">human (predicted)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">% <i>F</i></td><td class="colsep0 rowsep0" align="left">63</td><td class="colsep0 rowsep0" align="left">71</td><td class="colsep0 rowsep0" align="left">80</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left">Cl (mL/min/kg)</td><td class="colsep0 rowsep0" align="left">47</td><td class="colsep0 rowsep0" align="left">6.5</td><td class="colsep0 rowsep0" align="left">5</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>V</i>(L/kg)</td><td class="colsep0 rowsep0" align="left">1.8</td><td class="colsep0 rowsep0" align="left">1.7</td><td class="colsep0 rowsep0" align="left">2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><i>T</i>1/2 (h)</td><td class="colsep0 rowsep0" align="left">1.1</td><td class="colsep0 rowsep0" align="left">4.4</td><td class="colsep0 rowsep0" align="left">5</td></tr></tbody></table></div></div><div class="NLM_p">In vivo elevation of CSF cGMP in rat with <b>19</b> was evaluated to demonstrate a pharmacodynamic response resulting from PDE9A inhibition, which has been previously translated from preclinical to human clinical studies with <b>2</b>.<a onclick="showRef(event, 'ref20'); return false;" href="javascript:void(0);" class="ref ref20">(20)</a> Therefore, a solution of <b>19</b> was dosed subcutaneously to rats at a dose of 3.2 mg/kg and CSF cGMP and <b>19</b> levels were measured over the time period of 30 min to 7 h (Figure <a data-tab="pane-pcw-Figures" href="#fig12" id="" class=" internalNav">12</a>). A doubling in CSF cGMP was observed at one hour, at which point CSF drug levels of <b>19</b> were measured to be 389 nM, approximately 10-fold the PDE9A IC<sub>50</sub>. This pharmacodynamic elevation of CSF cGMP aligns with the preclinical response observed with <b>2</b>. Therefore, the excellent pharmacokinetics, selectivity, and safety properties of <b>19</b> in conjunction with the clearly demonstrated in vivo efficacy led to its nomination as a preclinical candidate.</div><figure id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0021.jpeg" id="gr12" class="inline-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. CSF cGMP levels in rats treated with compound <b>19</b> as compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure><div class="NLM_p last">In summary, a novel series of PDE9A inhibitors was identified via a strategy utilizing structure-based design, parallel chemistry, and physical property optimization. Taking advantage of the synthetically enabled nature of the phenoxy group in <b>3h</b>-(<i>R</i>) afforded pyrimidine <b>16</b>, which addressed undesired DAT inhibition. Mechanistic understanding of the unexpected chemical instability of <b>16</b> was used to prepare the chemically stable compound <b>19</b> that met key criteria for HLM Cl, MDR BA/AB, and physical properties (TPSA, clogP), which has been successfully advanced through preclinical in vivo pharmacokinetic, efficacy, and safety studies resulting in its nomination as a preclinical candidate.</div></div><div id="sec2" class="NLM_sec NLM_sec_level_1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i7">Experimental Section</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_43640" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_43640" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><div id="sec2_1" class="NLM_sec NLM_sec_level_2"><div id="ac_i8" class="anchor-spacer"></div><h3 class="article-section__title" id="_i8"> Biological Data</h3><div class="NLM_p">All compounds were screened in PDE9A inhibition assay as described below. Each IC<sub>50</sub> value is comprised of at least two measurements of inhibition per data point.</div><div class="NLM_p last">PDE9A IC<sub>50</sub>, 384-well assay: Test compounds were solubilized in 100% dimethyl sulfoxide and diluted to the required concentrations in 15% dimethyl sulfoxide/water. The PDE9A enzyme was thawed slowly and diluted in 50 mM Tris HCI buffer (pH 7.5 at room temperature) containing 1.3 mM MgCl<sub>2</sub>. Incubations were initiated by the addition of PDE9A enzyme to 384-well plates containing test drugs and radioligand (50 nM <sup>3</sup>H-cGMP). After a 30 min incubation at room temperature, 10 μM 6-benzyl-1-cyclopentyl-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one was added to each well of the plate to stop the reaction. Phosphodiesterase SPA beads (Amersham/GE) were then added to the assay plate at a concentration of 0.2 mg/well. Activity of test compounds was assessed by measuring the amount of <sup>3</sup>H-5′GMP resulting from enzyme cleavage of <sup>3</sup>H-cGMP radioligand. Levels of <sup>3</sup>H-5′GMP bound to SPA beads were determined by paralux counting of the assay plates in a Microbeta Trilux counter (PerkinElmer). Nonspecific binding was determined by radioligand binding in the presence of a saturating concentration of 6-benzyl-1-cyclopentyl-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (10 μM). The IC<sub>50</sub> value of each test compound (concentration at which 50% inhibition of specific binding occurs) was calculated by nonlinear regression (curve fitting) of the concentration–response.</div></div><div id="sec2_2" class="NLM_sec NLM_sec_level_2"><div id="ac_i9" class="anchor-spacer"></div><h3 class="article-section__title" id="_i9"> Chemistry Experimentals</h3><div class="NLM_p">Experiments were generally carried out under inert atmosphere (nitrogen or argon), particularly in cases where oxygen- or moisture-sensitive reagents or intermediates were employed. Commercial solvents and reagents were generally used without further purification, including anhydrous solvents where appropriate (generally Sure-Seal products from the Aldrich Chemical Co., Milwaukee, WI). Mass spectrometry data is reported from either liquid chromatography–mass spectrometry (LCMS) or atmospheric pressure chemical ionization (APCI) instrumentation. Chemical shifts for nuclear magnetic resonance (NMR) data are expressed in parts per million (ppm, δ) referenced to residual peaks from the deuterated solvents employed, or to tetramethylsilane standard with multiplicities given as s (singlet), br (broad), d (doublet), t (triplet), dt (doublet of triplets), m (multiplet). Compound purity is determined by high performance liquid chromatography (HPLC), and all final test compounds were >95% purity. The purity of title compounds used in pharmacology testing was verified by HPLC-MS using the following method: 12 min gradient on a HP1100C pump of increasing concentrations of acetonitrile in water (5→95%) containing 0.1% formic acid with a flow rate of 1 mL/min and UV detection at λ 220 and 254 nm on a Gemini C18 150 mm ×4.6 mm, 5 μm column (Phenomenex, Torrance, CA).</div><div id="sec2_2_1" class="NLM_sec NLM_sec_level_3"><div id="ac_i10" class="anchor-spacer"></div><h4 class="article-section__title" id="_i10"> 5-Amino-1-cyclopentyl-1<i>H</i>-pyrazole-4-carbonitrile (<b>4a</b>)</h4><div class="NLM_p last">A solution of cyclopentylhydrazine dihydrochloride (50.9 g, 0.294 mol) in anhydrous ethanol (640 mL) was cooled to 0 °C and treated with sodium ethoxide (40.0 g, 0.588 mol) in portions over 2 h. The mixture was stirred at 0 °C for 45 min and then treated dropwise with a solution of (ethoxymethylene)malononitrile (35.9 g, 0.294 mol) in ethanol over 1 h. Following the addition, the reaction was stirred at 0 °C for 30 min and then warmed to room temperature over 1 h. The mixture was heated at reflux for 2 h, cooled to room temperature, and concentrated in vacuo, after which the residue was mixed with water, and the resulting suspension was filtered. The collected solids were washed three times with water and then three times with a 1:1 mixture of diethyl ether and hexanes, providing the titled compound as a beige solid. Yield: 44.0 g, 0.250 mol, 85%. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.69 (m, 2H), 1.92 (m, 2H), 2.06 (m, 4H), 4.34 (m, 1H), 7.50 (s, 1H).</div></div><div id="sec2_2_2" class="NLM_sec NLM_sec_level_3"><div id="ac_i11" class="anchor-spacer"></div><h4 class="article-section__title" id="_i11"> 5-Amino-1-cyclopentyl-1<i>H</i>-pyrazole-4-carboxamide (<b>5a</b>)</h4><div class="NLM_p last">5-Amino-1-cyclopentyl-1<i>H</i>-pyrazole-4-carbonitrile (44.0 g, 0.250 mol) was added portionwise to concentrated sulfuric acid (200 mL) at 0 °C. After completion of the addition, the reaction mixture was allowed to warm from 0 °C to room temperature and stirred for about 18 h. The reaction mixture was poured onto ice and then brought to pH 9–10 by addition of concentrated aqueous ammonium hydroxide solution. The resulting solids were collected by filtration, washed three times with water, and then washed three times with a 1:1 mixture of diethyl ether and hexanes to provide <b>5a</b> as an off-white solid. Yield: 39.8 g, 0.205 mol, 82%. LCMS <i>m</i>/<i>z</i> 195.4 (M + 1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.57 (m, 2H), 1.80 (m, 4H), 1.92 (m, 2H), 4.52 (m, 1H), 6.15 (s, 2H), 6.61 (br s, 1H), 7.15 (br s, 1H), 7.62 (s, 1H).</div></div><div id="sec2_2_3" class="NLM_sec NLM_sec_level_3"><div id="ac_i12" class="anchor-spacer"></div><h4 class="article-section__title" id="_i12"> 6-(1-Bromoethyl)-1-cyclopentyl-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>6a</b>)</h4><div class="NLM_p last">A solution of <b>5a</b> (5.0 g, 25.8 mmol) and triethylamine (4.0 mL, 28.4 mmol) in anhydrous dimethylformamide (50 mL) was cooled in an ice bath and treated dropwise with 2-bromopropanoyl bromide (2.8 mL, 28.4 mmol). The mixture was stirred at 0 °C for 20 min, warmed to room temperature, and stirred at ambient temperature for an additional 2 h. The reaction mixture was diluted with ethyl acetate (500 mL) and washed sequentially with aqueous 3N hydrochloric acid (3 × 300 mL; then 2 × 50 mL), saturated aqueous sodium bicarbonate solution (2 × 300 mL), and saturated aqueous sodium chloride solution (300 mL). The organic layer was dried over magnesium sulfate, filtered, and concentrated. The resulting crude residue was stirred as a suspension in toluene (200 mL) with <i>para</i>-toluenesulfonic acid (2.45 g, 12.9 mmol), and the mixture was heated to reflux for 4 h using a Dean–Stark trap. The mixture was then cooled to room temperature, diluted with ethyl acetate, and washed with aqueous sodium bicarbonate solution followed by saturated aqueous sodium chloride solution. The organic layer was dried over magnesium sulfate, filtered, and concentrated to provide a residue that was purified by silica gel chromatography (eluant: 100:1 chloroform/methanol). The resulting yellow–orange solid was subjected to a second silica gel column (eluant 100:1 chloroform/methanol) to provide 1.8 g (22%) of <b>6</b> as a solid. LCMS <i>m</i>/<i>z</i> 311, 313 for the two bromine isotopes (M + 1). [α]<sub>D</sub> = −32.1 (<i>c</i> 0.005 g/mL, MeOH). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.60–2.24 (m, 8H), 2.11 (d, <i>J</i> = 7.0 Hz, 3H), 5.04 (q, <i>J</i> = 7.0, 1H), 5.20 (quintet, <i>J</i> = 7.5 Hz, 1H), 8.10 (s, 1H), 11.85 (br s, 1H).</div></div><div id="sec2_2_4" class="NLM_sec NLM_sec_level_3"><div id="ac_i13" class="anchor-spacer"></div><h4 class="article-section__title" id="_i13"> Library Preparation of <i>N</i>-Substituted 6-(1-Aminoethyl)-1-cyclopentyl-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-ones (<b>3</b>)</h4><div class="NLM_p">The amines (0.14 mmol) were weighed into vials and treated with a solution of <b>6a</b> (22 mg, 0.07 mmol) in a 1:5 mixture of dimethylformamide/acetonitrile (0.6 mL). Potassium carbonate (29 mg, 0.21 mmol) was added, and the reactions were shaken and heated at 82 °C for 8 h. The reactions were then cooled to room temperature, and water (1.5 mL) and ethyl acetate (2.5 mL) were added. After vortexing the reactions, the organic portions were separated and passed through a short column of sodium sulfate. This process was repeated two times. The combined filtrates for each reaction were concentrated in vacuo and then treated with a 3% solution of trifluoroacetic acid in dichloromethane (0.5 mL). The mixtures were shaken for 15 min, solvent was removed in vacuo, and the crude samples were dissolved in dimethyl sulfoxide (1 mL) and purified by preparative HPLC (column: Xterra PrepMS C<sub>18</sub>, 5 μm, 19 mm × 100 mm; solvent A, 0.1% trifluoroacetic acid in water (v/v); solvent B, acetonitrile; gradient, 5% to 95% B), to afford the final examples <b>3</b> as trifluoroacetic acid salts (Table <a class="ref showTableEvent internalNav" data-ID="tbl4" href="#tbl4">4</a>).</div><div class="NLM_table-wrap" id="tbl4">Table 4<div class="scrollable-table-wrap"><table class="table" border="0"><colgroup><col align="left" /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col><col align="char" char="." /></col></colgroup><thead><tr valign="top" class="colsep0"><th class="colsep0 rowsep0" align="center"> </th><th class="colsep0 rowsep0" align="center" char=".">exact mass</th><th class="colsep0 rowsep0" align="center" char=".">MS (obsd)</th><th class="colsep0 rowsep0" align="center" char=".">% ELSD purity</th><th class="colsep0 rowsep0" align="center" char=".">% UV purity (220 nM)</th><th class="colsep0 rowsep0" align="center" char=".">retention time (min)</th><th class="colsep0 rowsep0" align="center" char=".">amount (mg)</th></tr></thead><tbody><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3a</b></td><td class="colsep0 rowsep0" align="char" char=".">315.21</td><td class="colsep0 rowsep0" align="char" char=".">316.37</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.65</td><td class="colsep0 rowsep0" align="char" char=".">18.2</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3b</b></td><td class="colsep0 rowsep0" align="char" char=".">319.18</td><td class="colsep0 rowsep0" align="char" char=".">320.16</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.49</td><td class="colsep0 rowsep0" align="char" char=".">21</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3c</b></td><td class="colsep0 rowsep0" align="char" char=".">287.15</td><td class="colsep0 rowsep0" align="char" char=".">288.24</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.41</td><td class="colsep0 rowsep0" align="char" char=".">19</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3d</b></td><td class="colsep0 rowsep0" align="char" char=".">397.17</td><td class="colsep0 rowsep0" align="char" char=".">398.09</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">3.08</td><td class="colsep0 rowsep0" align="char" char=".">22.4</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3e</b></td><td class="colsep0 rowsep0" align="char" char=".">405.25</td><td class="colsep0 rowsep0" align="char" char=".">406.18</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">93</td><td class="colsep0 rowsep0" align="char" char=".">3.23</td><td class="colsep0 rowsep0" align="char" char=".">22.9</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3f</b></td><td class="colsep0 rowsep0" align="char" char=".">377.22</td><td class="colsep0 rowsep0" align="char" char=".">378.23</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">2.98</td><td class="colsep0 rowsep0" align="char" char=".">21.1</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3g</b></td><td class="colsep0 rowsep0" align="char" char=".">423.23</td><td class="colsep0 rowsep0" align="char" char=".">424.21</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">85</td><td class="colsep0 rowsep0" align="char" char=".">2.96</td><td class="colsep0 rowsep0" align="char" char=".">26.3</td></tr><tr valign="top" class="colsep0"><td class="colsep0 rowsep0" align="left"><b>3h</b></td><td class="colsep0 rowsep0" align="char" char=".">379.20</td><td class="colsep0 rowsep0" align="char" char=".">380.29</td><td class="colsep0 rowsep0" align="char" char=".">100</td><td class="colsep0 rowsep0" align="char" char=".">94</td><td class="colsep0 rowsep0" align="char" char=".">2.99</td><td class="colsep0 rowsep0" align="char" char=".">17.8</td></tr></tbody></table></div></div></div><div id="sec2_2_5" class="NLM_sec NLM_sec_level_3"><div id="ac_i14" class="anchor-spacer"></div><h4 class="article-section__title" id="_i14"> 1-Cyclopentyl-6-[(1<i>R</i>)-1-(3-phenoxyazetidin-1-yl)ethyl]-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>3h</b>-(<i>R</i>))</h4><div class="NLM_p last">A mixture of <b>6a</b> (400 mg, 1.29 mmol), 3-hydroxyazetidine hydrochloride (479 mg, 2.58 mmol), and potassium carbonate (534 mg, 3.87 mmol) in acetonitrile (15 mL) was stirred at room temp for 2 h and then refluxed for 2 h. The reaction mixture was cooled, diluted with water, and extracted with methylene chloride. The organic layer was washed with brine, dried over magnesium sulfate, filtered, concentrated, and chromatographed (eluant: 1:1 ethyl acetate/hexanes with 1% ammonium hydroxide) to provide 240 mg of <b>3h</b> as a solid. Chiral separation of racemate <b>3h</b> was performed using the following conditions: Chiralcel OD, 10 cm × 50 cm, 250 mL/min; eluant 65:35 heptane/ethanol. The undesired enantiomer was isolated first and provided 111 mg of solid. The second enantiomer was isolated with a retention time of 26 min and provided 82 mg of the desired enantiomer <b>3h</b>-(<i>R</i>) solid. LCMS <i>m</i>/<i>z</i> 380.0 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.35 (d, 3H, <i>J</i> = 6.6), 1.65–1.68 (m, 2H), 1.92–2.08 (m, 2H), 2.08–2.15 (m, 4H), 3.24 (br s, 1H), 3.38–3.42 (br m, 1H), 3.57 (br s, 1H), 3.88 (br s, 1H), 4.80–4.86 (m, 1H), 5.12–5.19 (m, 1H), 6.76 (d, 2H, <i>J</i> = 7.9), 6.95–6.99 (m, 1H), 7.25–7.29 (m, 2H), 8.05 (s, 1H), 9.78 (br s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ18.07, 24.72, 32.39, 32.45, 57.77, 58.77, 60.49, 65.23, 65.55, 105.08, 114.55, 121.47, 129.67, 134.57, 151.98, 156.69, 157.93.</div></div><div id="sec2_2_6" class="NLM_sec NLM_sec_level_3"><div id="ac_i15" class="anchor-spacer"></div><h4 class="article-section__title" id="_i15"> 5-Amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carbonitrile (<b>4b</b>)</h4><div class="NLM_p last">To a solution of tetrahydro-2<i>H</i>-pyran-4-ylhydrazine dihydrochloride (see ref <a onclick="showRef(event, 'ref21'); return false;" href="javascript:void(0);" class="ref ref21">21</a>) (43 g, 228 mmol) in ethanol (300 mL) was slowly added sodium ethoxide (32.6 g, 479 mmol), and the resulting mixture was stirred at room temperature for 1 h. The reaction mixture was then transferred into a solution of (ethoxymethylene)malononitrile (27.8 g, 228 mmol) in ethanol (300 mL). After being stirred at room temperature for 30 min, the reaction was heated at reflux for 2 h. It was then cooled to room temperature and concentrated in vacuo to afford the titled compound as an orange solid, which was used in the next step without purification.</div></div><div id="sec2_2_7" class="NLM_sec NLM_sec_level_3"><div id="ac_i16" class="anchor-spacer"></div><h4 class="article-section__title" id="_i16"> 5-Amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carboxamide (<b>5b</b>)</h4><div class="NLM_p last">A solution of 5-amino-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazole-4-carbonitrile (<b>4b</b>, ≤228 mmol) in ethanol (300 mL) was treated with 35% aqueous hydrogen peroxide (100 mL), followed by concentrated aqueous ammonia solution (300 mL). The reaction mixture was stirred for 48 h at room temperature and then quenched with saturated aqueous sodium thiosulfate solution (800 mL). Removal of most of the ethanol in vacuo provided a solid that was isolated by filtration and washed with water (2 × 200 mL) and diethyl ether (2 × 150 mL) to provide <b>5b</b> as a solid. Yield: 31 g, 147 mmol, 64% for 2 steps. LCMS <i>m</i>/<i>z</i> 211.2 (M + 1). <sup>1</sup>H NMR (300 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.70 (m, 2H), 1.93 (m, 2H), 3.40 (m, 2H), 3.95 (dd, <i>J</i> = 11.1, 3.2 Hz, 2H), 4.26 (m, 1H), 6.24 (m, 2H), 6.67 (br s, 1H), 7.20 (br s, 1H), 7.66 (s, 1H).</div></div><div id="sec2_2_8" class="NLM_sec NLM_sec_level_3"><div id="ac_i17" class="anchor-spacer"></div><h4 class="article-section__title" id="_i17"> 6-(1-Bromoethyl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>6b</b>)</h4><div class="NLM_p last">A solution of <b>5b</b> (5.0 g, 23.8 mmol) and triethylamine (3.65 mL, 26.2 mmol) in anhydrous dimethylformamide (50 mL) was cooled in an ice bath and treated dropwise with 2-bromopropanoyl bromide (5.4 g, 25 mmol). The mixture was stirred at 0 °C for 30 min, warmed to room temperature, and stirred at ambient temperature for an additional 2 h. The reaction was partitioned between ethyl acetate (200 mL) and aqueous 2N hydrochloric acid (500 mL); the organic phase was washed with saturated aqueous sodium bicarbonate solution (400 mL), followed by saturated aqueous sodium chloride solution (200 mL) and then dried over sodium sulfate, filtered, and concentrated. The resulting orange residue was suspended in toluene (100 mL), treated with <i>para</i>-toluenesulfonic acid (2.3 g, 11.9 mmol), and heated to reflux for 6 h using a Dean–Stark trap. The mixture was then cooled to room temperature, diluted with ethyl acetate, and washed with aqueous sodium bicarbonate solution, followed by saturated aqueous sodium chloride solution. The organic layer was dried over sodium sulfate, filtered, and concentrated in vacuo to provide a residue that was purified by silica gel chromatography (eluant: 100:1 chloroform/methanol). The resulting yellow–orange solid was subjected to a second silica gel column (eluant 100:1 chloroform/methanol) to provide the titled compound as a yellow solid. Yield: 1.1 g, 3.36 mmol, 14% over two steps. Purity: 85% by LCMS. LCMS <i>m</i>/<i>z</i> 327.0, 329.1 for the two bromine isotopes (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.92 (m, 2H), 2.06 (d, <i>J</i> = 6.3 Hz, 3H), 2.31 (m, 2H), 3.63 (m, 2H), 4.08 (m, 2H), 4.94 (m, 1H), 5.09 (q, <i>J</i> = 6.6 Hz, 1H), 8.05 (s, 1H).</div></div><div id="sec2_2_9" class="NLM_sec NLM_sec_level_3"><div id="ac_i18" class="anchor-spacer"></div><h4 class="article-section__title" id="_i18"> 6-[1-(3-Hydroxyazetidin-1-yl)ethyl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>8</b>)</h4><div class="NLM_p last">A solution of <i>tert</i>-butyl 3-hydroxyazetidine-1-carboxylate (519 mg, 3.00 mmol) in dichloromethane (10 mL) was treated with trifluoroacetic acid (0.77 mL, 10 mmol), and the resulting mixture was stirred at room temperature for about 18 h. Additional trifluoroacetic acid (0.5 mL) was added, and the reaction was stirred for an additional 3 h. Solvents were removed under reduced pressure, and acetonitrile (40 mL) was added to the residue, followed by solid potassium carbonate (2.76 g, 20 mmol) and 6-(1-bromoethyl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>6b</b>, 654 mg, 2.00 mmol). The mixture was stirred at room temperature for 2 h and then heated to 90 °C for 3 h. The reaction was cooled to room temperature, diluted with dichloromethane, and filtered; the remaining solid was washed with additional dichloromethane. The combined filtrates were concentrated in vacuo and then subjected to silica gel chromatography (eluant: 40:1 to 20:1 chloroform/methanol) to provide the titled compound <b>8b</b> (368 mg, 58%). MS (APCI) <i>m</i>/<i>z</i> 320.0 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.34 (d, <i>J</i> = 6.8 Hz, 3H), 1.91 (m, 2H), 2.38 (dddd, apparent qd, <i>J</i> = 12, 12, 12, 4.6 Hz, 2H), 3.17 (br s, 1H), 3.28 (br s, 1H), 3.52–3.68 (m, 5H), 4.14 (dd, <i>J</i> = 11.3, 3.6 Hz, 2H), 4.46 (m, 1H), 4.85 (tt, <i>J</i> = 11.6, 4.2 Hz, 1H), 8.10 (s, 1H).</div></div><div id="sec2_2_10" class="NLM_sec NLM_sec_level_3"><div id="ac_i19" class="anchor-spacer"></div><h4 class="article-section__title" id="_i19"> 1-{1-[4-Oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl}azetidin-3-yl Methanesulfonate (<b>9</b>)</h4><div class="NLM_p last">A solution of <b>8</b> (1.34 g, 4.20 mmol) in dichloromethane (30 mL) was treated with triethylamine (1.17 mL, 8.41 mmol) and then dropwise with methanesulfonyl chloride (0.49 mL, 6.3 mmol). The reaction was allowed to stir at room temperature for about 18 h, then saturated aqueous sodium carbonate solution was added, and the aqueous layer was extracted twice with dichloromethane. The combined organic layers were dried over magnesium sulfate, filtered, and concentrated. The residue was purified twice by silica gel chromatography (gradient, 0–4% methanol in dichloromethane), to afford the titled compound <b>9</b> as a solid (1.12 g, 67%). LCMS <i>m</i>/<i>z</i> 398.3 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.36 (d, <i>J</i> = 6.6 Hz, 3H), 1.90 (m, 2H), 2.29 (m, 2H), 3.10 (s, 3H), 3.39 (dd, <i>J</i> = 8.3, 5.4 Hz, 1H), 3.44 (dd, <i>J</i> = 8.4, 5.3 Hz, 1H), 3.62 (m, 3H), 3.76 (br dd, <i>J</i> = 7.4, 7.4 Hz, 1H), 3.84 (br dd, <i>J</i> = 7.4, 7.4 Hz, 1H), 4.10 (br d, <i>J</i> = 11.6 Hz, 2H), 4.97 (tt, <i>J</i> = 11.6, 4.2 Hz, 1H), 5.15 (m, 1H), 8.03 (s, 1H).</div></div><div id="sec2_2_11" class="NLM_sec NLM_sec_level_3"><div id="ac_i20" class="anchor-spacer"></div><h4 class="article-section__title" id="_i20"> 1-Cyclopentyl-6-[(1<i>S</i>)-1-hydroxyethyl]-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>11a</b>)</h4><div class="NLM_p last">(1<i>S</i>)-2-Chloro-1-methyl-2-oxoethyl acetate (12 mL, 95 mmol) was slowly added dropwise to an ice-cooled suspension of <b>5a</b> (16.4 g, 84.4 mmol) in anhydrous 1,4-dioxane (200 mL). After being stirred at 0 °C for 40 min, the reaction mixture was heated at reflux for 2 h. It was then cooled to room temperature and concentrated in vacuo, and the resulting crude material was dissolved in a mixture of water (200 mL) and tetrahydrofuran (20 mL). To this solution was added potassium carbonate (60 g, 0.43 mol), and the resulting mixture was heated at 50 °C for 2 days. The reaction mixture was cooled to room temperature and extracted with ethyl acetate (2 × 200 mL). The combined organic extracts were washed with saturated aqueous sodium chloride solution, dried over sodium sulfate, filtered, and concentrated in vacuo to provide <b>11a</b> as a tan solid. Yield: 17.5 g, 70.5 mmol, 84% over 2 steps. LCMS <i>m</i>/<i>z</i> 249.4 (M + 1). <sup>1</sup>H NMR (400 MHz, DMSO-<i>d</i><sub>6</sub>) δ 1.41 (d, <i>J</i> = 6.6 Hz, 3H), 1.67 (m, 2H), 1.90 (m, 4H), 2.06 (m, 2H), 4.61 (q, <i>J</i> = 6.6 Hz, 1H), 5.13 (m, 1H), 8.02 (s, 1H).</div></div><div id="sec2_2_12" class="NLM_sec NLM_sec_level_3"><div id="ac_i21" class="anchor-spacer"></div><h4 class="article-section__title" id="_i21"> (1<i>S</i>)-1-(1-Cyclopentyl-4-oxo-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl)ethyl Methanesulfonate (<b>12a</b>)</h4><div class="NLM_p last">A solution of <b>11a</b> (93% purity by weight, 87.7 g, 329 mmol) in 2-methyltetrahydrofuran (408 mL) was treated with 4-methylmorpholine (54.4 mL, 495 mmol), followed, after 5 min, by methanesulfonyl chloride (26.7 mL, 345 mmol). The temperature of the reaction was maintained between 25 and 40 °C for 3 h. After cooling to room temperature, the reaction mixture was filtered through Celite to remove morpholine salts, and the filter cake was washed with 5–10 volumes of 2-methyltetrahydrofuran. The filtrate was concentrated in vacuo and then purified by silica gel chromatography (eluant: 9:1 ethyl acetate/hexanes). Pure fractions were combined and concentrated to afford <b>9a</b> as a slightly yellow solid. Yield: 48.6 g, 149 mmol, 45%. Mixed fractions were combined and concentrated to provide 40 g of a residue which was purified by trituration with methyl <i>tert</i>-butyl ether (100 mL) to provide additional <b>9a</b> as a white solid. Combined yield: 79.5 g, 244 mmol, 74%. LCMS <i>m</i>/<i>z</i> 325.1 (M – 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.75 (m, 2H), 1.86 (d, <i>J</i> = 6.8 Hz, 3H), 1.99 (m, 2H), 2.13 (m, 4H), 3.23 (s, 3H), 5.18 (m, 1H), 5.70 (q, <i>J</i> = 6.7 Hz, 1H), 8.07 (s, 1H), 11.04 (br s, 1H).</div></div><div id="sec2_2_13" class="NLM_sec NLM_sec_level_3"><div id="ac_i22" class="anchor-spacer"></div><h4 class="article-section__title" id="_i22"> 6-[(1<i>S</i>)-1-Hydroxyethyl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>11b</b>)</h4><div class="NLM_p last">(1<i>S</i>)-2-Chloro-1-methyl-2-oxoethyl acetate (30 g, 199 mmol) was added to a suspension of <b>5b</b> (38.1 g, 181 mmol) in dry dioxane (1000 mL). The mixture was heated at reflux for 2 h amd then concentrated in vacuo to provide (1<i>S</i>)-2-{[4-carbamoyl-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1<i>H</i>-pyrazol-5-yl]amino}-1-methyl-2-oxoethyl acetate, which was suspended in water (700 mL) and treated with anhydrous potassium carbonate (100 g). The mixture was heated at 45 °C for about 18 h and then neutralized with acetic acid and extracted with chloroform (4 × 1 L). The combined organic layers were washed with saturated aqueous sodium chloride solution and dried over sodium sulfate. Filtration and removal of solvents in vacuo provided <b>11b</b> as an off-white solid. Yield: 43.1 g, 163 mmol, 90% over 2 steps. LCMS <i>m</i>/<i>z</i> 265.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.67 (d, <i>J</i> = 6.6 Hz, 3H), 1.92 (br d, <i>J</i> = 13 Hz, 2H), 2.39 (m, 2H), 3.62 (br dd, apparent br t, <i>J</i> = 12, 12 Hz, 2H), 4.15 (br dd, <i>J</i> = 11.7, 4 Hz, 2H), 4.84 (tt, <i>J</i> = 11.6, 4.3 Hz, 1H), 4.90 (q, <i>J</i> = 6.7 Hz, 1H), 8.08 (s, 1H), 10.65 (br s, 1H).</div></div><div id="sec2_2_14" class="NLM_sec NLM_sec_level_3"><div id="ac_i23" class="anchor-spacer"></div><h4 class="article-section__title" id="_i23"> (1<i>S</i>)-1-[4-Oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl Methanesulfonate (<b>12b</b>)</h4><div class="NLM_p last">A solution of <b>11b</b> (20.0 g, 75.7 mmol) in dichloromethane (400 mL) was treated with triethylamine (15.8 mL, 113 mmol), cooled to 0 °C, and stirred for 30 min. Methanesulfonyl chloride (99%, 5.92 mL, 75.7 mmol) was added dropwise to the cold reaction, which was allowed to warm to room temperature over the next 18 h. Solvents were removed in vacuo, and the residue was purified by silica gel chromatography (gradient 0–5% methanol in dichloromethane). Rechromatography of mixed fractions provided additional product to afford <b>12b</b> as a solid. Total yield: 10.6 g, 31.0 mmol, 41%. LCMS <i>m</i>/<i>z</i> 341.1 (M – 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.86 (d, <i>J</i> = 6.6 Hz, 3H), 1.93 (br d, <i>J</i> = 12 Hz, 2H), 2.39 (m, 2H), 3.23 (s, 3H), 3.61 (ddd, apparent td, <i>J</i> = 12, 12, 2.1 Hz, 2H), 4.16 (br dd, <i>J</i> = 11.4, 3.5 Hz, 2H), 4.86 (tt, <i>J</i> = 11.7, 4.2 Hz, 1H), 5.70 (q, <i>J</i> = 6.7 Hz, 1H), 8.08 (s, 1H).</div></div><div id="sec2_2_15" class="NLM_sec NLM_sec_level_3"><div id="ac_i24" class="anchor-spacer"></div><h4 class="article-section__title" id="_i24"> 6-[(1<i>R</i>)-1-(3-Phenoxyazetidin-1-yl)ethyl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>7</b>)</h4><div id="sec2_2_15_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i25" class="anchor-spacer"></div><h5 class="article-section__title" id="_i25"> Step 1: 3-Phenoxyazetidine</h5><div class="NLM_p last">Commercial 3-phenoxyazetidine hydrochloride (5.57 g, 30.0 mmol) and sodium hydroxide (1.44 g, 36.0 mmol) were stirred at room temperature in dichloromethane (150 mL) and water (50 mL). The mixture was stirred at room temperature for 5 h. The organic layer was separated, and the water layer was extracted with dichloromethane. The combined organic phases were dried over MgSO<sub>4</sub>, filtered, and concentrated to give 4.4 g of 3-phenoxyazetidine as the free base, which was used without further purification.</div></div><div id="sec2_2_15_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i26" class="anchor-spacer"></div><h5 class="article-section__title" id="_i26"> Step 2: 6-[(1<i>R</i>)-1-(3-Phenoxyazetidin-1-yl)ethyl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one, (<b>7</b>)</h5><div class="NLM_p last">Mesylate <b>12b</b> (4.6 g, 13.4 mmol) and 3-phenoxyazetidine (3.01 g, 20.2 mmol) were combined with triethylamine (9.36 mL, 67.2 mmol), acetonitrile (50 mL), and toluene (50 mL). The mixture was heated at 90 °C for 5 h with stirring and then concentrated. The residue was purified by silica gel chromatography (1% methanol in chloroform) to provide 4.93 g (93% yield) of <b>9</b> as a solid. LCMS <i>m</i>/<i>z</i> 396.4 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.38 (d, <i>J</i> = 6.8 Hz, 3H), 1.89 (m, 2H), 2.29 (m, 2H), 3.28 (dd, assumed, partially obscured by solvent peak, <i>J</i> = 8.1, 5.2 Hz, 1H), 3.34 (dd, assumed, partially obscured by solvent peak, <i>J</i> = 7.9, 5.4 Hz, 1H), 3.61 (m, 3H), 3.85 (dd, <i>J</i> = 7.0, 7.0 Hz, 1H), 3.93 (dd, <i>J</i> = 6.9, 6.9 Hz, 1H), 4.08 (m, 2H), 4.87 (m, 1H), 4.98 (tt, <i>J</i> = 11.7, 4.2 Hz, 1H), 6.80 (d, <i>J</i> = 8.2 Hz, 2H), 6.93 (t, <i>J</i> = 7.8 Hz, 1H), 7.26 (dd, <i>J</i> = 7.8, 7.8 Hz, 2H), 8.03 (s, 1H).</div></div></div><div id="sec2_2_16" class="NLM_sec NLM_sec_level_3"><div id="ac_i27" class="anchor-spacer"></div><h4 class="article-section__title" id="_i27"> 1-Cyclopentyl-6-{(1<i>R</i>)-1-(3-hydroxyazetidin-1-yl)ethyl}-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>13a</b>)</h4><div class="NLM_p last"><i>N</i>-Boc-3-hydroxyazetidine (2.50 g, 14.4 mmol) was treated with trifluoroacetic acid (3.7 mL) in dichloromethane (20 mL). The mixture was stirred at room temperature overnight and then concentrated. To the resulting residue was added acetonitrile (20 mL) and toluene (20 mL), followed by potassium carbonate (finely ground, 13.3 g, 96.0 mmol). Mesylate <b>12a</b> (3.13 g, 9.60 mmol) was then added, and the mixture was heated to 90 °C for 5 h with stirring. The mixture was concentrated to remove all solvents, diluted with water, and extracted with methylene chloride. The combined extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated, and chromatographed (eluant 50:1 CHCl<sub>3</sub>/CH<sub>3</sub>OH) to give 2.0 g of <b>13a</b>. LCMS <i>m</i>/<i>z</i> 304.4 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.31 (d, 3H, <i>J</i> = 6.6), 1.64–1.74 (m, 2H), 1.90–2.15 (m, 6H), 3.14–3.17 (br m, 1H), 3.25–3.27 (br m, 1H), 3.48–3.62 (m, 3H), 4.39–4.44 (m, 1H), 5.15 (apparent quintet, 1H, <i>J</i> = 7.6), 8.08 (s, 1H).</div></div><div id="sec2_2_17" class="NLM_sec NLM_sec_level_3"><div id="ac_i28" class="anchor-spacer"></div><h4 class="article-section__title" id="_i28"> 6-[(1<i>R</i>)-1-(3-Hydroxyazetidin-1-yl)ethyl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>13b</b>)</h4><div class="NLM_p last">The title compound was prepared in a manner analogous to <b>13a</b> with the substitution of starting material <b>12b</b> in place of <b>12a</b> to afford 1.6 g (72% yield) of <b>13b</b>. MS (APCI) <i>m</i>/<i>z</i> 320.0 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.34 (d, <i>J</i> = 6.8 Hz, 3H), 1.91 (m, 2H), 2.38 (dddd, apparent qd, <i>J</i> = 12, 12, 12, 4.6 Hz, 2H), 3.17 (br s, 1H), 3.28 (br s, 1H), 3.52–3.68 (m, 5H), 4.14 (dd, <i>J</i> = 11.3, 3.6 Hz, 2H), 4.46 (m, 1H), 4.85 (tt, <i>J</i> = 11.6, 4.2 Hz, 1H), 8.10 (s, 1H).</div></div><div id="sec2_2_18" class="NLM_sec NLM_sec_level_3"><div id="ac_i29" class="anchor-spacer"></div><h4 class="article-section__title" id="_i29"> (<i>R</i>)-1-{1-[4-Oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl}azetidin-3-yl methanesulfonate, (<b>14b</b>)</h4><div class="NLM_p last">The title compound was prepared in a manner analogous to that of <b>9</b> to afford 1.72 g (77% yield) of <b>14b</b>. LCMS <i>m</i>/<i>z</i> 398.3 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.36 (d, <i>J</i> = 6.6 Hz, 3H), 1.90 (m, 2H), 2.29 (m, 2H), 3.10 (s, 3H), 3.39 (dd, <i>J</i> = 8.3, 5.4 Hz, 1H), 3.44 (dd, <i>J</i> = 8.4, 5.3 Hz, 1H), 3.62 (m, 3H), 3.76 (br dd, <i>J</i> = 7.4, 7.4 Hz, 1H), 3.84 (br dd, <i>J</i> = 7.4, 7.4 Hz, 1H), 4.10 (br d, <i>J</i> = 11.6 Hz, 2H), 4.97 (tt, <i>J</i> = 11.6, 4.2 Hz, 1H), 5.15 (m, 1H), 8.03 (s, 1H).</div></div><div id="sec2_2_19" class="NLM_sec NLM_sec_level_3"><div id="ac_i30" class="anchor-spacer"></div><h4 class="article-section__title" id="_i30"> 6-{1-[3-(4-Fluorophenoxy)azetidin-1-yl]ethyl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>10a</b>)</h4><div id="sec2_2_19_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i31" class="anchor-spacer"></div><h5 class="article-section__title" id="_i31"> Step 1: 3-(4-Fluorophenoxy)azetidine</h5><div class="NLM_p last">Palladium hydroxide (500 mg) and 1-(diphenylmethyl)-3-(4-fluorophenoxy)azetidine (500 mg, 1.50 mmol) were combined in ethanol (50 mL) and hydrogenated at 50 psi for 18 h. The reaction mixture was then filtered through Celite and concentrated in vacuo. The residue was purified via silica gel chromatography (eluant 100:5:2 chloroform/methanol/concentrated aqueous ammonium hydroxide) to provide titled compound (188 mg, 75%). LCMS <i>m</i>/<i>z</i> 168.1 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 2.44 (br s, 1H), 3.76 (m, 2H), 3.89 (m, 2H), 4.91 (m, 1H), 6.66 (m, 2H), 6.93 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 54.55, 70.81, 115.43, 115.51, 115.76, 115.99, 152.96, 156.15, 158.53.</div></div><div id="sec2_2_19_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i32" class="anchor-spacer"></div><h5 class="article-section__title" id="_i32"> Step 2: 6-{1-[3-(4-Fluorophenoxy)azetidin-1-yl]ethyl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one, (<b>10a</b>)</h5><div class="NLM_p last">A mixture of 6-(1-bromoethyl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>6b</b>, 100 mg/0.306 mmol), 3-(4-fluorophenoxy)azetidine (102 mg/0.611 mmol), and potassium carbonate (92.9 mg/0.672 mmol) in acetonitrile (10 mL) was stirred at room temperature for 2 h and refluxed overnight. The mixture was cooled, concentrated, diluted with brine (25 mL) and 1N NaOH (25 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined extracts were concentrated, dissolved in DMSO (3.0 mL), and filtered through an Acrodisc syringe filter (0.2 um). The filtrate was concentrated and purified with a Shimadzu HPLC (Xterra 30 mm × 100 mm; 30–70% water/acetonitrile gradient elution with 0.1% NH<sub>4</sub>OH). The resulting material was further purified by dissolving it in MeOH (3 mL) and passing through an Oasis MCX LP extraction cartridge (1 g) with MeOH, and then the product was eluted with ammonia in MeOH and concentrated to provide 29 mg of <b>10a</b>. LCMS <i>m</i>/<i>z</i> 414.4 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.36 (d, <i>J</i> = 6.6 Hz, 3H), 1.91 (br d, <i>J</i> = 12.6 Hz, 2H), 2.37 (m, 2H), 3.23 (br s, 1H), 3.40 (m, 1H), 3.61 (m, 3H), 3.88 (br s, 2H), 4.14 (dd, <i>J</i> = 11.5, 4.0 Hz, 2H), 4.75–4.88 (m, 2H), 6.71 (m, 2H), 6.97 (m, 2H), 8.06 (s, 1H).</div></div></div><div id="sec2_2_20" class="NLM_sec NLM_sec_level_3"><div id="ac_i33" class="anchor-spacer"></div><h4 class="article-section__title" id="_i33"> 4-[(1-{1-[4-Oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl}azetidin-3-yl)oxy]benzonitrile (<b>10d</b>)</h4><div id="sec2_2_20_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i34" class="anchor-spacer"></div><h5 class="article-section__title" id="_i34"> Step 1: 1-(Diphenylmethyl)azetidin-3-ol Hydrochloride</h5><div class="NLM_p last">A solution of 2-(chloromethyl)oxirane (260 g, 2.81 mol) and diphenylmethanamine (500 g, 2.73 mol) in MeOH (1 L) was heated at reflux for 4 days. Solvent was removed under reduced pressure to provide a white precipitate, which was collected by filtration. The solid was washed with acetone and dried to provide title compound, which was used in the next step without further purification.</div></div><div id="sec2_2_20_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i35" class="anchor-spacer"></div><h5 class="article-section__title" id="_i35"> Step 2: 1-(Diphenylmethyl)azetidin-3-yl Methanesulfonate</h5><div class="NLM_p last">Methanesulfonyl chloride (180 g, 1.57 mol) was added to a solution of 1-(diphenylmethyl)azetidin-3-ol hydrochloride (360 g, 1.31 mol) and triethylamine (330 g, 3.26 mol) in dichloromethane (3 L) at 0 °C. The reaction mixture was stirred at room temperature for 3 h, quenched with saturated aqueous sodium bicarbonate solution, and then extracted with dichloromethane. The combined organic layers were dried over anhydrous sodium sulfate, filtered, and concentrated in vacuo to afford 360 g (87%) of the titled compound.</div></div><div id="sec2_2_20_3" class="NLM_sec NLM_sec_level_4"><div id="ac_i36" class="anchor-spacer"></div><h5 class="article-section__title" id="_i36"> Step 3: 4-((1-Benzhydrylazetidin-3-yl)oxy)benzonitrile</h5><div class="NLM_p last">A mixture of 4-hydroxybenzonitrile (51.5 g, 0.432 mol) and potassium carbonate (120 g, 0.868 mol) in acetonitrile (1.5 L) was refluxed for 1 h. The mixture was cooled, and a solution of 1-(diphenylmethyl)azetidin-3-yl methanesulfonate (124.6 g, 0.392 mol) in acetonitrile (500 mL) was added. The mixture was refluxed for 20 h, cooled to room temperature, poured onto water (2 L), and extracted with ethyl acetate (4 × 700 mL). The combined extracts were washed with 10% aq NaOH (3 × 500 mL), water (500 mL), and brine (100 mL). The organic layer was dried over magnesium sulfate, filtered, and concentrated. The resulting cream-colored solid was shaken with diethyl ether (200 mL) and filtered, rinsing with 1:1 diethyl ether/hexanes (20 mL). After air drying for 2 h, the titled compound was afforded as a white solid (93.1 g, 69.8%).</div></div><div id="sec2_2_20_4" class="NLM_sec NLM_sec_level_4"><div id="ac_i37" class="anchor-spacer"></div><h5 class="article-section__title" id="_i37"> Step 4: 4-(Azetidin-3-yloxy)benzonitrile Hydrochloride</h5><div class="NLM_p last">To a solution of 4-((1-benzhydrylazetidin-3-yl)oxy)benzonitrile (80 g, 0.235 mol) in 1,2-dichloroethane (1 L) at −5 °C was added 1-chloroethyl chloroformate (25.4 mL, 0.235 mol) over 15 min while maintaining the temperature. The reaction mixture was stirred for 15 min at −5 °C, 1 h at room temperature and 1 h at reflux. The mixture was concentrated, dissolved in methanol (1 L), heated to reflux for 2.5 h, and concentrated to approximately 500 mL. Ethyl acetate (500 mL) was added, and the mixture again concentrated to almost 500 mL. Ethyl acetate (500 mL) was again added, and the resulting suspension was stirred for 20 h and then filtered. The resulting solid was dried to afford 34.9 g (70.5%) of the titled compound as a white solid (mp 88–90 °C).</div></div><div id="sec2_2_20_5" class="NLM_sec NLM_sec_level_4"><div id="ac_i38" class="anchor-spacer"></div><h5 class="article-section__title" id="_i38"> Step 5: 4-[(1-{1-[4-Oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl}azetidin-3-yl)oxy]benzonitrile (<b>10d</b>)</h5><div class="NLM_p last">A mixture of 6-(1-bromoethyl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>6b</b>, 100 mg/0.306 mmol), 4-(azetidin-3-yloxy)benzonitrile hydrochloride (65 mg/0.32 mmol), and potassium carbonate (50.7 mg/0.367 mmol) in acetonitrile (10 mL) was stirred at room temperature for 2 h and refluxed for 3 h. Triethylamine (0.085 mL, 0.61 mmol) was added, and the mixture was refluxed overnight. The mixture was cooled, concentrated, diluted with brine (25 mL) and 1N NaOH (25 mL), and extracted with CH<sub>2</sub>Cl<sub>2</sub>. The combined extracts were concentrated, dissolved in DMSO (3.0 mL), and filtered through an Acrodisc syringe filter (0.2 um). The filtrate was concentrated and purified with a Shimadzu HPLC (Xterra 30 × 100 mm; 30 – 70% water/acetonitrile gradient elution with 0.1% NH<sub>4</sub>OH). The resulting material was further purified by dissolving it in MeOH (3 mL) and passing through an Oasis MCX LP extraction cartridge (1 g) with MeOH, and then the product was eluted with ammonia in MeOH and concentrated to provide 12 mg of <b>10f</b>. LCMS <i>m</i>/<i>z</i> 421.5 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.38 (d, <i>J</i> = 6.6 Hz, 3H), 1.89 (m, 2H), 2.29 (m, 2H), 3.30 (m, 1H, assumed, obscured by solvent peak), 3.37 (dd, <i>J</i> = 8.1, 5.2 Hz, 1H), 3.61 (m, 3H), 3.88 (dd, <i>J</i> = 7.0, 7.0 Hz, 1H), 3.94 (dd, <i>J</i> = 7.1, 7.1 Hz, 1H), 4.09 (m, 2H), 4.97 (m, 2H), 6.98 (d, <i>J</i> = 8.7 Hz, 2H), 7.65 (d, <i>J</i> = 8.7 Hz, 2H), 8.03 (s, 1H).</div></div></div><div id="sec2_2_21" class="NLM_sec NLM_sec_level_3"><div id="ac_i39" class="anchor-spacer"></div><h4 class="article-section__title" id="_i39"> 2-Fluoro-5-[(1-{1-[4-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl}azetidin-3-yl)oxy]benzonitrile (<b>10g</b>)</h4><div class="NLM_p last">Mesylate <b>14b</b> (50 mg, 0.13 mmol), 2-fluoro-5-hydroxybenzonitrile (34.5 mg, 0.25 mmol), and potassium carbonate (52.2 mg, 0.38 mmol) were combined in acetonitrile (5 mL), and the mixture was heated at reflux for about 18 h. Removal of solvents in vacuo provided a residue which was purified by silica gel chromatography (gradient 1–3% methanol in dichloromethane) to provide <b>10g</b> as a solid (19 mg, 33%). LCMS <i>m</i>/<i>z</i> 439.3 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.37 (d, <i>J</i> = 6.6 Hz, 3H), 1.89 (m, 2H), 2.29 (dddd, <i>J</i> = 12, 12, 12, 5 Hz, 2H), 3.28 (dd, <i>J</i> = 8.3, 5.4 Hz, 1H), 3.35 (m, 1H), 3.61 (m, 3H), 3.86 (br dd, <i>J</i> = 7, 7 Hz, 1H), 3.92 (br dd, <i>J</i> = 7, 7 Hz, 1H), 4.09 (br dd, <i>J</i> = 11.6, 3.7 Hz, 2H), 4.90 (m, obscured by water peak, 1H assumed), 4.98 (tt, <i>J</i> = 11.6, 4.3 Hz, 1H), 7.19 (m, 2H), 7.28 (m, 1H), 8.03 (s, 1H).</div></div><div id="sec2_2_22" class="NLM_sec NLM_sec_level_3"><div id="ac_i40" class="anchor-spacer"></div><h4 class="article-section__title" id="_i40"> 2-Fluoro-4-[(1-{1-[4-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl}azetidin-3-yl)oxy]benzonitrile (<b>10e</b>)</h4><div class="NLM_p last">Prepared according to the same method as example <b>10g</b> except using 2-fluoro-4-hydroxybenzonitrile and heating for 1 h in the microwave at 140 °C and 75W. LCMS <i>m</i>/<i>z</i> 439.4 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.37 (d, <i>J</i> = 6.6 Hz, 3H), 1.89 (m, 2H), 2.29 (m, 2H), 3.31 (m, 1H, assumed, obscured by solvent peak), 3.38 (dd, <i>J</i> = 8.3, 5.0 Hz, 1H), 3.62 (m, 3H), 3.87 (dd, <i>J</i> = 7.1, 7.1 Hz, 1H), 3.94 (dd, <i>J</i> = 7.0, 7.0 Hz, 1H), 4.09 (br d, <i>J</i> = 11.6 Hz, 2H), 4.97 (m, 2H), 6.85 (m, 2H), 7.66 (dd, <i>J</i> = 8.1, 8.1 Hz, 1H), 8.03 (s, 1H).</div></div><div id="sec2_2_23" class="NLM_sec NLM_sec_level_3"><div id="ac_i41" class="anchor-spacer"></div><h4 class="article-section__title" id="_i41"> 2-Chloro-4-[(1-{1-[4-oxo-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-4,5-dihydro-1<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-6-yl]ethyl}azetidin-3-yl)oxy]benzonitrile (<b>10f</b>)</h4><div class="NLM_p last">Same procedure as example <b>10g</b> except using 2-chloro-4-hydroxybenzonitrile. LCMS <i>m</i>/<i>z</i> 455.3 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 1.38 (d, <i>J</i> = 6.6 Hz, 3H), 1.89 (m, 2H), 2.29 (m, 2H), 3.31 (m, 1H, assumed, obscured by solvent peak), 3.38 (dd, <i>J</i> = 8.1, 5.2 Hz, 1H), 3.61 (m, 3H), 3.87 (dd, <i>J</i> = 7.1, 7.1 Hz, 1H), 3.93 (dd, <i>J</i> = 7.1, 7.1 Hz, 1H), 4.09 (m, 2H), 4.98 (m, 2H), 6.95 (dd, <i>J</i> = 8.7, 2.5 Hz, 1H), 7.11 (d, <i>J</i> = 2.5 Hz, 1H), 7.71 (d, <i>J</i> = 8.7 Hz, 1H), 8.03 (s, 1H).</div></div><div id="sec2_2_24" class="NLM_sec NLM_sec_level_3"><div id="ac_i42" class="anchor-spacer"></div><h4 class="article-section__title" id="_i42"> Library Protocol for <i>O</i>-Substituted 6-[1-(3-Hydroxyazetidin-1-yl)ethyl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-ones (<b>10b</b> and <b>10c</b>)</h4><div class="NLM_p last">To the appropriate phenol (0.1 mmol) was added <b>14b</b> (20 mg, 0.05 mmol) in dimethylformamide (0.77 mL). Cesium carbonate (49 mg, 0.15 mmol) was added, and the reactions were heated to 70 °C for 20 h. The reactions were cooled to room temperature, and ethyl acetate (2 mL) was added, after which the reactions were heated to 35 °C and shaken. Reactions were centrifuged to segregate particulates, and 2.4 mL of the reaction mixtures was transferred to SCX-SPE columns. An additional 2.4 mL of ethyl acetate was added to the reaction vessel and transferred to the SCX-SPE column. The columns were washed with methanol (5 mL), and the desired products were then released by eluting with a solution of triethylamine in methanol (6 mL). The solvent was removed in vacuo. A solution of trifluoroacetic acid in dichloromethane (10%, 0.5 mL) was added, and the mixtures were shaken for 15 min. Solvents were removed in vacuo, and the crude samples were dissolved in dimethyl sulfoxide (0.6 mL) and purified by preparative HPLC (column: Xterra PrepMS C<sub>18</sub>, 5 μm, 19 mm × 100 mm; solvent A, 0.1% trifluoroacetic acid in water (v/v); solvent B, acetonitrile; gradient 5–95% B), to afford the final examples <b>10b</b> and <b>10c</b>.</div></div><div id="sec2_2_25" class="NLM_sec NLM_sec_level_3"><div id="ac_i43" class="anchor-spacer"></div><h4 class="article-section__title" id="_i43"> 6-{1-[3-(2,5-Difluorophenoxy)azetidin-1-yl]ethyl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one, Trifluoroacetate Salt (<b>10b</b>)</h4><div class="NLM_p last">Library protocol provided 5.17 mg of <b>10d</b> with a retention time of 2.61 min. HPLC purity 89%. LCMS <i>m</i>/<i>z</i> 432.1 (M + 1).</div></div><div id="sec2_2_26" class="NLM_sec NLM_sec_level_3"><div id="ac_i44" class="anchor-spacer"></div><h4 class="article-section__title" id="_i44"> 6-{1-[3-(3-Chloro-4-fluorophenoxy)azetidin-1-yl]ethyl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one, Trifluoroacetate Salt (<b>10c</b>)</h4><div class="NLM_p last">Library protocol provided 1.9 mg of <b>10e</b> with a retention time of 2.77 min. HPLC purity 94%. LCMS <i>m</i>/<i>z</i> 448 (M + 1).</div></div><div id="sec2_2_27" class="NLM_sec NLM_sec_level_3"><div id="ac_i45" class="anchor-spacer"></div><h4 class="article-section__title" id="_i45"> 6-{1-[3-(Pyrimidin-2-yloxy)azetidin-1-yl]ethyl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>15</b>)</h4><div id="sec2_2_27_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i46" class="anchor-spacer"></div><h5 class="article-section__title" id="_i46"> Step 1: <i>tert</i>-Butyl 3-(Pyrimidin-2-yloxy)azetidine-1-carboxylate</h5><div class="NLM_p last">A mixture of <i>N</i>-BOC-3-hydroxyazetidine (0.50 g, 2.9 mmol), 2-chloropyrimidine (0.33 g, 2.9 mmol), and potassium <i>tert</i>-butoxide (0.49 g, 4.3 mmol) in THF (20 mL) was heated to reflux for 6 h and then concentrated. The residue was diluted with water and extracted with methylene chloride. The organic extract was washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated, and chromatographed (eluant 10:1 heptanes/ethyl acetate) to provide 508 mg of the titled compound. <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.42 (s, 9H), 4.02 (m, 2H), 4.30 (m, 2H), 5.29 (m, 1H), 6.97 (t, <i>J</i> = 4.9 Hz, 1H), 8.50 (d, <i>J</i> = 4.9 Hz, 2H).</div></div><div id="sec2_2_27_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i47" class="anchor-spacer"></div><h5 class="article-section__title" id="_i47"> Step 2: 6-{1-[3-(Pyrimidin-2-yloxy)azetidin-1-yl]ethyl}-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>15</b>)</h5><div class="NLM_p last">To a solution of <i>tert</i>-butyl 3-(pyrimidin-2-yloxy)azetidine-1-carboxylate (150 mg, 0.6 mmol) in methylene chloride (2 mL) was added trifluoroacetic acid (0.154 mL). The mixture was stirred at room temperature overnight and then concentrated. Acetonitrile (10 mL) was added to the resulting residue, followed by the addition of potassium carbonate (552 mg, 4 mmol) and 6-(1-bromoethyl)-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>6b</b>, 131 mg, 0.4 mmol). The reaction mixture was stirred at room temperature for 2 h and then heated to 90 °C for 3 h and concentrated. The residue was partitioned between water and methylene chloride. The organic layer was separated, washed with brine, dried over magnesium sulfate, filtered, concentrated, and chromatographed (eluant 200:1 chloroform/methanol) to provide 88 mg of <b>15</b> as a solid. LCMS <i>m</i>/<i>z</i> 398.0 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.34 (d, 3H, <i>J</i> = 7.0), 1.88–1.92 (m, 2H), 2.30–2.41 (m, 2H), 3.24 (br m, 1H), 3.40 (br m, 1H), 3.55 (br m, 3H), 3.60 (t, 2H, <i>J</i> = 11.6), 3.91 (br m, 2H), 4.12 (dd, 2H, <i>J</i> = 3.9, 11.4), 4.78–4.86 (m, 1H), 5.24–5.30 (m, 1H), 6.97 (t, 1H, <i>J</i> = 4.8), 8.05 (s, 1H), 8.49 (d, 2H, <i>J</i> = 5.0), 9.85 (br s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 18.14, 32.17, 53.73, 58.49, 60.30, 65.20, 65.32, 67.00, 105.28, 115.63, 134.74, 151.76, 157.75, 159.41.</div></div></div><div id="sec2_2_28" class="NLM_sec NLM_sec_level_3"><div id="ac_i48" class="anchor-spacer"></div><h4 class="article-section__title" id="_i48"> 1-(Cyclopentyl)-6-{(1<i>R</i>)-1-[3-(pyrimidin-2-yloxy)azetidin-1-yl]ethyl}-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>16</b>)</h4><div class="NLM_p last">A mixture of <b>13a</b> (500 mg, 1.65 mmol), 2-chloropyrimidine (189 mg, 1.65 mmol), and potassium <i>t</i>-butoxide (388 mg, 3.46 mmol) in THF (10 mL) was heated to reflux for 8 h. The mixture was cooled and concentrated. The resulting residue was diluted with water and extracted with methylene chloride. The combined extracts were washed with brine, dried over MgSO<sub>4</sub>, filtered, concentrated, and chromatographed (gradient elution of 200:1 to 100:1 CHCl<sub>3</sub>–CH<sub>3</sub>OH) to give 130 mg of a solid. The 130 mg of enantio-enriched solid was separated by SFC chromatography using a Chiralcel AS-H column (4.6 mm × 25 cm) with a mobile phase of 90/10 carbon dioxide/methanol and a flow of 2.5 mL/min. The desired first enantiomer peak had a retention time of 6.65 min. The solid was further repurified by standard chromatography (eluant 100:1 chloroform/methanol) to yield 68 mg (100% ee) of <b>16</b> as a solid. LCMS <i>m</i>/<i>z</i> 382.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.36 (d, 3H, <i>J</i> = 5.0), 1.63–1.76 (m, 2H), 1.88–2.16 (m, 6H), 3.29 (br s, 1H), 3.45 (br s, 1H), 3.58 (br s, 1H), 3.94 (br s, 2H), 5.15 (apparent quintet, 1H, <i>J</i> = 7.5), 5.25–5.31 (m, 1H), 6.97 (t, 1H, <i>J</i> = 4.8), 8.03 (s, 1H), 8.49 (d, 2H, <i>J</i> = 4.6), 9.85 (br s, 1H).</div></div><div id="sec2_2_29" class="NLM_sec NLM_sec_level_3"><div id="ac_i49" class="anchor-spacer"></div><h4 class="article-section__title" id="_i49"> 2-((1-Benzhydrylazetidin-3-yl)oxy)pyrimidine (<b>17</b>)</h4><div class="NLM_p last">To a suspension of sodium hydride (762 mg of a 60% dispersion in oil, 19 mmol) and THF (9 mL) was added 1-(diphenylmethyl)-3-hydroxyazetidine (1.50 g, 6.27 mmol). After 10 min, gas evolution ceased and 2-chloropyrimidine was added. The reaction mixture was heated to 50 °C overnight and then cooled. The mixture was partitioned between water (50 mL) and EtOAc (100 mL). The separated organic layer was washed with water (50 mL) and brine (50 mL), concentrated, and chromatographed (eluant 80:20 heptanes/ethyl acetate) to provide 1.99 g of <b>17</b> as a solid. LCMS <i>m</i>/<i>z</i> 318.0 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 3.19 (br s, 2H), 3.80 (br s, 2H), 4.48 (br s, 1H), 5.24–5.32 (m, 1H), 6.88–6.91 (m, 1H), 7.16–7.20 (m, 2H), 7.25–7.29 (m, 4H), 7.42–7.44 (m, 4H), 8.44 (d, <i>J</i> = 4.6 Hz, 2H).</div></div><div id="sec2_2_30" class="NLM_sec NLM_sec_level_3"><div id="ac_i50" class="anchor-spacer"></div><h4 class="article-section__title" id="_i50"> 1-(3-(Benzhydrylamino)-2-hydroxypropyl)pyrimidin-2(1<i>H</i>)-one (<b>18</b>)</h4><div class="NLM_p last">A mixture of <b>17</b> (100 mg, 0.315 mmol), 1N HCl (0.317 mL, 0.317 mmol), and water (1.68 mL) was stirred overnight at room temperature. The mixture was divided in half and to one-half was added additional aqueous HCl (0.16 mL of 1N, 0.16 mmol) and the mixture was stirred for 3 days, at which point LCMS showed an approximate ratio of <b>17</b>/<b>18</b> of 1:2. The mixture was stirred for another 4 days, concentrated and partitioned between 1N NaOH (1 mL) and ethyl acetate (2 mL). The organic layer was concentrated and purified by LCMS to provide <b>18</b>. LCMS <i>m</i>/<i>z</i> 336.1 (M + 1). <sup>1</sup>H NMR (400 MHz, CD<sub>3</sub>OD) δ 3.00 (dd, 1H, <i>J</i> = 10.0, 12.9), 3.14 (dd, 1H, <i>J</i> = 3.3, 12.9), 3.76 (dd, 1H, <i>J</i> = 7.9, 13.3), 4.18 (dd, 1H, <i>J</i> = 3.1, 13.5), 4.35–4.43 (m, 1H), 5.60 (s, 1H), 6.58–6.61 (m, 1H), 7.38–7.55 (m, 10H), 8.15–8.17 (m, 1H), 8.63 (br s, 1H). IR: 1670, 1200, 1132 cm<sup>–1</sup>.</div></div><div id="sec2_2_31" class="NLM_sec NLM_sec_level_3"><div id="ac_i51" class="anchor-spacer"></div><h4 class="article-section__title" id="_i51"> 1-Cyclopentyl-6-[(1<i>R</i>)-1-(3-pyrimidin-2-ylazetidin-1-yl)ethyl]-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>19</b>)</h4><div id="sec2_2_31_1" class="NLM_sec NLM_sec_level_4"><div id="ac_i52" class="anchor-spacer"></div><h5 class="article-section__title" id="_i52">a 2-(Azetidin-3-yl)pyrimidine Bis-methanesulfonate</h5><div class="NLM_p">Step 1. A solution of <i>tert</i>-butyl 3-hydroxyazetidine-1-carboxylate (97%, 5.0 g, 28 mmol) in dichloromethane (50 mL) was treated with triethylamine (7.8 mL, 56 mmol) and cooled to 0 °C. A solution of methanesulfonyl chloride (2.28 mL, 29.3 mmol) in dichloromethane was added dropwise to the cold reaction, which was maintained at 0 °C for 2 h and then allowed to warm to room temperature over the next 18 h. Solvents were removed in vacuo, and the residue was taken up in ether and filtered. The filtrate was concentrated in vacuo, and the residue purified via silica gel chromatography (eluant: 5:1 heptane/ethyl acetate, then 2:1 heptane/ethyl acetate) to provide <i>tert</i>-butyl 3-[(methylsulfonyl)oxy]azetidine-1-carboxylate as a solid. Yield: 6.5 g, 26.0 mmol, 93%. LCMS <i>m</i>/<i>z</i> 503.1 (2M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.44 (s, 9H), 3.06 (s, 3H), 4.09 (ddd, <i>J</i> = 10.4, 4.2, 1.2, 2H), 4.27 (ddd, <i>J</i> = 10.4, 6.6, 1.2 Hz, 2H), 5.19 (tt, <i>J</i> = 6.6, 4.2 Hz, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 28.23, 38.33, 56.45 (br), 67.25, 80.29, 155.80.</div><div class="NLM_p">Step 2. Potassium iodide (12.9 g, 77.7 mmol) and <i>tert</i>-butyl 3-[(methylsulfonyl)oxy]azetidine-1-carboxylate (6.5 g, 26.0 mmol) were combined in dimethylformamide (40 mL). The reaction mixture was stirred at 110 °C for 16 h and then concentrated in vacuo, diluted with water, and extracted with ethyl acetate. The combined organic layers were washed with water and then washed with saturated aqueous sodium chloride solution and dried over magnesium sulfate. Filtration and removal of solvent in vacuo gave a residue, which was purified by silica gel chromatography (eluant: 4:1 heptane/ethyl acetate) to afford <i>tert</i>-butyl 3-iodoazetidine-1-carboxylate as a solid. Yield: 6.2 g, 21.9 mmol, 84%. LCMS <i>m</i>/<i>z</i> 284.0 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.43 (s, 9H), 4.28 (m, 2H), 4.46 (m, 1H), 4.64 (m, 2H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 2.57, 28.27, 61.49, 80.09, 155.52.</div><div class="NLM_p">Step 3. Zinc powder (150.1 g, 2.30 mol) and molecular sieves (50 g) were combined in a reaction flask and flame-dried under vacuum for 10 min. Once the flask had returned to room temperature, it was charged with tetrahydrofuran (4 L), and 1,2-dibromoethane (24.4 mL, 0.28 mol) was added. The reaction mixture was heated to 50 °C for 10 min and then allowed to come to ambient temperature, at which time trimethylsilyl chloride (33.5 mL, 0.264 mol) was added (<i>Caution: slightly exothermic</i>). The mixture was allowed to stir at room temperature for about 18 h. Slow addition of <i>tert</i>-butyl 3-iodoazetidine-1-carboxylate (500 g, 1.77 mol) over 1.5 h was followed by stirring for an additional 18 h. In a separate flask, 2-bromopyrimidine (253 g, 1.59 mol) was combined with molecular sieves (85 g) in tetrahydrofuran (1.3 L), and the mixture was degassed. This mixture was treated with tetrakis(triphenylphosphine)palladium(0) (32.7 g, 0.0283 mol) and then added to the flask containing the reaction mixture from <i>tert</i>-butyl 3-iodoazetidine-1-carboxylate. The reaction was stirred for 25 h and then filtered through Celite. The filtrate was concentrated under reduced pressure and then partitioned between saturated aqueous sodium carbonate solution (2 L) and ethyl acetate (2 L). The aqueous layer was extracted with ethyl acetate (2 × 2 L), and the combined organic layers were dried over sodium sulfate and concentrated in vacuo. The resulting yellow liquid residue was triturated with methyl <i>tert</i>-butyl ether (500 mL), and the precipitate was removed by filtration. Partial concentration of the filtrate resulted in precipitation of a solid; the mixture at this point was cooled in an ice–water bath. Filtration then provided a solid, which was washed with a minimum quantity of cold methyl <i>tert</i>-butyl ether to afford <i>tert</i>-butyl 3-pyrimidin-2-ylazetidine-1-carboxylate as a white solid, which was taken directly into the next step. Yield: 131 g, 0.557 mol, 31%. GCMS <i>m</i>/<i>z</i> 180 ([M – <i>tert</i>-butyl] + 1); 136 ([M – BOC] + 1). <sup>1</sup>H NMR (300 MHz, CDCl<sub>3</sub>) δ 1.45 (s, 9H), 4.0 (m, 1H), 4.3 (m, 4H), 7.2 (t, 1H), 8.75 (d, 2H).</div><div class="NLM_p last">Step 4. Methanesulfonic acid (108.3 mL, 1.67 mol) was added to an ice-cold solution of <i>tert</i>-butyl 3-pyrimidin-2-ylazetidine-1-carboxylate (131 g, 0.557 mol, from previous step) in dichloromethane/dioxane (9:1 ratio, 1 L). The mixture was allowed to warm to room temperature over about 18 h with stirring. The precipitate was filtered and washed with methyl <i>tert</i>-butyl ether to provide 2-(azetidin-3-yl)pyrimidine dimethylsulfonate as a white solid. Yield: 180 g, 0.550 mol, 99%. LCMS <i>m</i>/<i>z</i> 136.2 (M + 1). <sup>1</sup>H NMR (300 MHz, D<sub>2</sub>O) δ 2.55 (s, 6H), 4.33 (m, 5H), 7.64 (t, <i>J</i> = 5.3 Hz, 1H), 8.90 (d, <i>J</i> = 5.2 Hz, 2H). <sup>13</sup>C NMR (75 MHz, D<sub>2</sub>O) δ 36.47, 38.53, 49.98, 121.63, 158.08, 164.37.</div></div><div id="sec2_2_31_2" class="NLM_sec NLM_sec_level_4"><div id="ac_i53" class="anchor-spacer"></div><h5 class="article-section__title" id="_i53">b 1-Cyclopentyl-6-[(1<i>R</i>)-1-(3-pyrimidin-2-ylazetidin-1-yl)ethyl]-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (<b>19</b>)</h5><div class="NLM_p last">Compound <b>12a</b> (35 g, 107 mmol) and 2-(azetidin-3-yl)pyrimidine dimethylsulfonate (38.62 g, 118 mmol) were mixed with acetonitrile (700 mL), and the heterogeneous reaction mixture was treated with triethylamine (134 mL, 961 mmol) and heated to 80 °C for 3.5 h. The reaction became homogeneous and light yellow. The product was concentrated by distillation at a pot temperature of 80–90 °C, until 350–500 mL of acetonitrile remained. It was then allowed to crystallize as it cooled to room temperature. The mixture was stirred for about 18 h and then filtered to obtain <b>19</b> as a solid. Yield: 21 g, 57.5 mmol, 54%. For samples of <b>19</b> prepared under similar conditions, but chromatographed rather than crystallized, the minor enantiomer of the product was removed by chiral chromatography using a Chiralpak AD-H column (5 μm; 2.1 cm × 25 cm; mobile phase, 70:30 carbon dioxide/methanol; flow rate 65 g/min). Compound <b>19</b> was the second-eluting enantiomer, retention time approximately 3.35 min. LCMS <i>m</i>/<i>z</i> 366.2 (M + 1). <sup>1</sup>H NMR (400 MHz, CDCl<sub>3</sub>) δ 1.33 (d, <i>J</i> = 6.6 Hz, 3H), 1.72 (m, 2H), 1.97 (m, 2H), 2.11 (m, 4H), 3.58 (m, 2H), 3.71 (dd, <i>J</i> = 7.1, 7.1 Hz, 1H), 3.79 (m, 2H), 4.00 (m, 1H), 5.16 (m, 1H), 7.19 (t, <i>J</i> = 4.9 Hz, 1H), 8.05 (s, 1H), 8.72 (d, <i>J</i> = 5.0 Hz, 2H), 9.86 (br s, 1H). <sup>13</sup>C NMR (100 MHz, CDCl<sub>3</sub>) δ 18.07, 24.73, 32.38, 32.45, 37.61, 56.69, 57.69, 57.78, 65.09, 105.09, 119.00, 134.54, 157.11, 157.93, 160.39, 169.82 (one aromatic signal not observed).</div></div></div></div></div><div class="NLM_back"><div class="article_supporting-info" id="notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i54"><a href="/doi/suppl/10.1021/jm3009635">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_14822" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_14822" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><p class="last">Data table for PDE9 IC<sub>50</sub> values on key compound. LC/MS data for presence of α-chloro intermediate in amine displacement of <b>12b</b> when using the amine-HCl salt. This material is available free of charge via the Internet at <a href="http://pubs.acs.org" class="extLink">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3009635/suppl_file/jm3009635_si_001.pdf">jm3009635_si_001.pdf (417.01 kb)</a></li></ul></div></div></div><div class="testing" data-doi="10.1021/jm3009635" data-url="https://widgets.figshare.com/static/figshare.js" id="figshare-widget"></div><div class="TermsAndConditionsDropzone3" data-pb-dropzone="TermsAndConditionsDropzone3"><div data-widget-def="UX3HTMLWidget" data-widget-id="85b54935-30e9-4058-a6d2-0b40fb754a85" class="mb-4">
        



        
            <h2 class="">
                Terms & Conditions
            </h2>
        
        <p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system: <a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div><div class="authorInformationSection"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="authorInformationSection">Author Information</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_76855" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_76855" class="dropBlock__holder"></div></div></div></div></div><hr /></hr><ul><li><span class="author-information-subsection-header">Corresponding Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle M. Claffey</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#e18c888289848d8d84cf8ccf828d8087878498a19187889b8493cf828e8cc18289938892cf8bcf89848d808da19187889b8493cf828e8c"><span class="__cf_email__" data-cfemail="462b2f252e232a2a23682b68252a272020233f0636202f3c23346825292b">[email protected]</span> <span class="__cf_email__" data-cfemail="4a2922382339642064222f262b260a3a2c23302f3864292527">[email protected]</span></a></span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Helal</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span>; 
    <span class="author-email">
                Email: <a href="/cdn-cgi/l/email-protection#b4d9ddd7dcd1d8d8d19ad99ad7d8d5d2d2d1cdf4c4d2ddced1c69ad7dbd994d7dcc6ddc79ade9adcd1d8d5d8f4c4d2ddced1c69ad7dbd9"><span class="__cf_email__" data-cfemail="a9c4c0cac1ccc5c5cc87c487cac5c8cfcfccd0e9d9cfc0d3ccdb87cac6c4">[email protected]</span> <span class="__cf_email__" data-cfemail="3152594358421f5b1f59545d505d714157584b54431f525e5c">[email protected]</span></a></span></div></li></ul></li><li><span class="author-information-subsection-header">Authors</span><ul><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Patrick R. Verhoest</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Zhijun Kang</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kristina S. Fors</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stanley Jung</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Jiaying  Zhong</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mark W. Bundesmann</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Xinjun Hou</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Shenping Lui</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Robin J. Kleiman</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Michelle Vanase-Frawley</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Anne W. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frank Menniti</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Christopher J. Schmidt</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">William E. Hoffman</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mihaly Hajos</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Laura McDowell</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Rebecca E. O’Connor</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Mary MacDougall-Murphy</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Kari R. Fonseca</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Stacey L. Becker</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Frederick R. Nelson</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li><li><div class="authorItemInformation"><span class="hlFld-ContribAuthor strong">Spiros Liras</span> - <span class="hlFld-Affiliation affiliation">Pfizer Worldwide
Research and Development, Eastern
Point Road, Groton, Connecticut 06340, United States</span></div></li></ul></li><li></li><li></li><li><span class="author-information-subsection-header">Notes</span><div class="authorInformation_notesSection">The authors declare no competing financial interest.<br /></br></div></li></ul></div><div id="" class="NLM_sec NLM_sec_level_1"><div id="ac_i55" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i55"> </h2><div class="NLM_p last"><table summary="" class="NLM_def-list" id="dl1"><div id="ac_i56" class="anchor-spacer"></div><h2 class="article-section__title section__title" id="_i56"> Abbreviations Used</h2><tr><td class="NLM_term">PDE</td><td class="NLM_def"><p class="first last">phosphodiesterase</p></td></tr><tr><td class="NLM_term"><i>C</i><sub>bu</sub></td><td class="NLM_def"><p class="first last">unbound brain concentration</p></td></tr><tr><td class="NLM_term">cGMP</td><td class="NLM_def"><p class="first last">cyclic guanosine monophosphate</p></td></tr><tr><td class="NLM_term">cAMP</td><td class="NLM_def"><p class="first last">cyclic adenosine monophosphate</p></td></tr><tr><td class="NLM_term">CSF</td><td class="NLM_def"><p class="first last">cerebrospinal fluid</p></td></tr><tr><td class="NLM_term">fu<sub>p</sub></td><td class="NLM_def"><p class="first last">fraction unbound in plasma</p></td></tr><tr><td class="NLM_term">fu<sub>mic</sub></td><td class="NLM_def"><p class="first last">fraction unbound in microsomes</p></td></tr><tr><td class="NLM_term"><i>K</i><sub>m</sub></td><td class="NLM_def"><p class="first last">Michallis constant</p></td></tr><tr><td class="NLM_term">LE</td><td class="NLM_def"><p class="first last">ligand efficiency</p></td></tr><tr><td class="NLM_term">MDR BA/AB</td><td class="NLM_def"><p class="first last">ratio of basal to apical (BA) to apical to basal (AB) transport in MDR1A overexpressing canine kidney cells</p></td></tr><tr><td class="NLM_term">MPO</td><td class="NLM_def"><p class="first last">multiparametric optimization</p></td></tr><tr><td class="NLM_term">MW</td><td class="NLM_def"><p class="first last">molecular weight</p></td></tr><tr><td class="NLM_term">TPSA</td><td class="NLM_def"><p class="first last">topological polar surface area</p></td></tr><tr><td class="NLM_term">HLM Cl</td><td class="NLM_def"><p class="first last">human liver microsomal clearance (mL/min/kg)</p></td></tr><tr><td class="NLM_term">P-gp</td><td class="NLM_def"><p class="first last">P-glycoprotein</p></td></tr><tr><td class="NLM_term">Cpu</td><td class="NLM_def"><p class="first last">unbound plasma concentration</p></td></tr></table></div></div><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_38261" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_38261" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="references-count">
            This article references 21 other publications.
        </p><ol id="references" class="useLabel"><li id="ref1"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref1'); return false;" data-citation="" class="refNumLink">1</a></strong><div class="NLM_citation" id="cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suiciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1<i>H</i>-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920)(I) for the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+Novel+Class+of+Phosphodiesterase+10A+Inhibitors+and+Identification+of+Clinical+Candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%29-phenoxymethyl%5D-quinoline+%28PF-2545920%29%28I%29+for+the+Treatment+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Phosphodiesterase%252010A%2520Inhibitors%2520and%2520Identification%2520of%2520Clinical%2520Candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%2529-phenoxymethyl%255D-quinoline%2520%2528PF-2545920%2529%2528I%2529%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F. V.</span><span> </span><span class="NLM_article-title">Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=182-185&author=T.+A.+Chappieauthor=J.+M.+Humphreyauthor=M.+P.+Allenauthor=K.+G.+Estepauthor=C.+B.+Foxauthor=L.+A.+Lebelauthor=S.+Lirasauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=J.+Panditauthor=C.+J.+Schmidtauthor=M.+Tuauthor=R.+D.+Williamsauthor=F.+V.+Yang&title=Discovery+of+a+Series+of+6%2C7-Dimethoxy-4-pyrrolidylquinazoline+PDE10A+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Fjm060653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060653b%26sid%3Dliteratum%253Aachs%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BP.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DYang%26aufirst%3DF.%2BV.%26atitle%3DDiscovery%2520of%2520a%2520Series%2520of%25206%252C7-Dimethoxy-4-pyrrolidylquinazoline%2520PDE10A%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D182%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref2"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref2'); return false;" data-citation="" class="refNumLink">2</a></strong><div class="NLM_citation" id="cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Andreeva, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. A.</span><span> </span><span class="NLM_article-title">Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">9068</span><span class="NLM_x">–</span> <span class="NLM_lpage">9076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=11698617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosleku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=9068-9076&author=S.+G.+Andreevaauthor=P.+Dikkesauthor=P.+M.+Epsteinauthor=P.+A.+Rosenberg&title=Expression+of+cGMP-specific+phosphodiesterase+9A+mRNA+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain</span></div><div class="casAuthors">Andreeva, Svetlana G.; Dikkes, Pieter; Epstein, Paul M.; Rosenberg, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9068-9076</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">CGMP has been implicated in the regulation of many essential functions in the brain, such as synaptic plasticity, phototransduction, olfaction, and behavioral state.  Cyclic nucleotide phosphodiesterase (PDE) hydrolysis of cGMP is the major mechanism underlying the clearance of cGMP and is likely to be important in any process that depends on intracellular cGMP.  PDE9A has the highest affinity for cGMP of any PDE, and, here, we studied the localization of this enzyme in the rat brain using in situ hybridization.  PDE9A mRNA is widely distributed throughout the brain with varying regional expression.  The pattern of PDE9A mRNA expression closely resembles that of sol. guanylyl cyclase (sGC) in the rat brain, suggesting a possible functional assocn. or coupling of these two enzymes in the regulation of cGMP levels.  Most of the brain areas expressing PDE9A mRNA also contain neuronal nitric oxide synthase (NOS), the enzymic source of NO and the principal activator of sGC.  PDE9A is the only cGMP-specific PDE with significant expression in the forebrain, and, as such, is likely to play an important role in NO-cGMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUKbKoOp02BrVg90H21EOLACvtfcHk0lhATx2IGF4fbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosleku7k%253D&md5=2f5e27e779e3494c89af02701c8e5745</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeva%26aufirst%3DS.%2BG.%26aulast%3DDikkes%26aufirst%3DP.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26aulast%3DRosenberg%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520cGMP-specific%2520phosphodiesterase%25209A%2520mRNA%2520in%2520the%2520rat%2520brain%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3D9068%26epage%3D9076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fisher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillar, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Denis, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. B.</span><span> </span><span class="NLM_article-title">Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">15559</span><span class="NLM_x">–</span> <span class="NLM_lpage">15564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15559-15564&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+St.+Denisauthor=J.+B.+Cheng&title=Isolation+and+characterization+of+PDE9A%2C+a+novel+human+cGMP-specific+phosphodiesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DSt.%2BDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520PDE9A%252C%2520a%2520novel%2520human%2520cGMP-specific%2520phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15559%26epage%3D15564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref3"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref3'); return false;" data-citation="" class="refNumLink">3</a></strong><div class="NLM_citation" id="cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1124%2Fjpet.111.191353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=22328573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=396-409&author=R.+J.+Kleimanauthor=D.+S.+Chapinauthor=C.+Christoffersenauthor=J.+Freemanauthor=K.+R.+Fonsecaauthor=K.+F.+Geogheganauthor=S.+Grimwoodauthor=V.+Guanowskyauthor=M.+Hajosauthor=J.+F.+Harmsauthor=C.+J.+Helalauthor=W.+E.+Hoffmannauthor=G.+P.+Kocanauthor=M.+J.+Majchrzakauthor=D.+McGinnisauthor=S.+McLeanauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+Roofauthor=A.+W.+Schmidtauthor=P.+A.+Seymourauthor=D.+T.+Stephensonauthor=F.+D.+Tingleyauthor=M.+Vanase-Frawleyauthor=P.+R.+Verhoestauthor=C.+J.+Schmidt&title=Phosphodiesterase+9A+regulates+central+cGMP+and+modulates+responses+to+cholinergic+and+monoaminergic+perturbation+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo</span></div><div class="casAuthors">Kleiman, Robin J.; Chapin, Douglas S.; Christoffersen, Curt; Freeman, Jody; Fonseca, Kari R.; Geoghegan, Kieran F.; Grimwood, Sarah; Guanowsky, Victor; Hajos, Mihaly; Harms, John F.; Helal, Christopher J.; Hoffmann, William E.; Kocan, Geralyn P.; Majchrzak, Mark J.; McGinnis, Dina; McLean, Stafford; Menniti, Frank S.; Nelson, Fredrick; Roof, Robin; Schmidt, Anne W.; Seymour, Patricia A.; Stephenson, Diane T.; Tingley, Francis David; Vanase-Frawley, Michelle; Verhoest, Patrick R.; Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">396-409</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cyclic nucleotides are crit. regulators of synaptic plasticity and participate in requisite signaling cascades implicated across multiple neurotransmitter systems.  Phosphodiesterase 9A (PDE9A) is a high-affinity, cGMP-specific enzyme widely expressed in the rodent central nervous system.  In the current study, we obsd. neuronal staining with antibodies raised against PDE9A protein in human cortex, cerebellum, and subiculum.  We have also developed several potent, selective, and brain-penetrant PDE9A inhibitors and used them to probe the function of PDE9A in vivo.  Administration of these compds. to animals led to dose-dependent accumulation of cGMP in brain tissue and cerebrospinal fluid, producing a range of biol. effects that implied functional significance for PDE9A-regulated cGMP in dopaminergic, cholinergic, and serotonergic neurotransmission and were consistent with the widespread distribution of PDE9A.  In vivo effects of PDE9A inhibition included reversal of the resp. disruptions of working memory by ketamine, episodic and spatial memory by scopolamine, and auditory gating by amphetamine, as well as potentiation of Risperidone-induced improvements in sensorimotor gating and reversal of the stereotypic scratching response to the hallucinogenic 5-hydroxytryptamine 2A agonist mescaline.  The results suggested a role for PDE9A in the regulation of monoaminergic circuitry assocd. with sensory processing and memory.  Thus, PDE9A activity regulates neuronal cGMP signaling downstream of multiple neurotransmitter systems, and inhibition of PDE9A may provide therapeutic benefits in psychiatric and neurodegenerative diseases promoted by the dysfunction of these diverse neurotransmitter systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowRPHmE1fhCLVg90H21EOLACvtfcHk0lhATx2IGF4fbw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kntb8%253D&md5=f4a217c7e731f7909557a1d493c9192d</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.191353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.191353%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DKocan%26aufirst%3DG.%2BP.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DRoof%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%25209A%2520regulates%2520central%2520cGMP%2520and%2520modulates%2520responses%2520to%2520cholinergic%2520and%2520monoaminergic%2520perturbation%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D396%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finger, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschle, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindgen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Mair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-676&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mairauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+%286-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+enhances+synaptic+plasticity+and+cognitive+function+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mair%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520%25286-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520enhances%2520synaptic%2520plasticity%2520and%2520cognitive%2520function%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vardigan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&author=J.+D.+Vardiganauthor=A.+Conversoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=The+Selective+Phosphodiesterase+9+%28PDE9%29+Inhibitor+PF-04447943+Attenuates+a+Scopolamine-Induced+Deficit+in+a+Novel+Rodent+Attention+Task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0lir_PmauXLTxA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Selective%2520Phosphodiesterase%25209%2520%2528PDE9%2529%2520Inhibitor%2520PF-04447943%2520Attenuates%2520a%2520Scopolamine-Induced%2520Deficit%2520in%2520a%2520Novel%2520Rodent%2520Attention%2520Task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Halene, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">PDE inhibitors in psychiatry—future options for dementia, depression and schizophrenia?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">870</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=870-878&author=T.+B.+Haleneauthor=S.+J.+Siegel&title=PDE+inhibitors+in+psychiatry%E2%80%94future+options+for+dementia%2C+depression+and+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalene%26aufirst%3DT.%2BB.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DPDE%2520inhibitors%2520in%2520psychiatry%25E2%2580%2594future%2520options%2520for%2520dementia%252C%2520depression%2520and%2520schizophrenia%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D870%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Reneerkens, O. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbusch, H. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span> </span><span class="NLM_article-title">Selective phosphodiesterase inhibitors: a promising target for cognition enhancement</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1007%2Fs00213-008-1273-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=18709359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ehtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2009&pages=419-443&author=O.+A.+H.+Reneerkensauthor=K.+Ruttenauthor=H.+W.+M.+Steinbuschauthor=A.+Bloklandauthor=J.+Prickaerts&title=Selective+phosphodiesterase+inhibitors%3A+a+promising+target+for+cognition+enhancement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective phosphodiesterase inhibitors: a promising target for cognition enhancement</span></div><div class="casAuthors">Reneerkens, Olga A. H.; Rutten, Kris; Steinbusch, Harry W. M.; Blokland, Arjan; Prickaerts, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">419-443</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: One of the major complaints most people face during aging is an impairment in cognitive functioning.  This has a neg. impact on the quality of daily life and is even more prominent in patients suffering from neurodegenerative and psychiatric disorders including Alzheimer's disease, schizophrenia, and depression.  So far, the majority of cognition enhancers are generally targeting one particular neurotransmitter system.  However, recently phosphodiesterases (PDEs) have gained increased attention as a potential new target for cognition enhancement.  Inhibition of PDEs increases the intracellular availability of the second messengers cGMP and/or cAMP.  Objective: The aim of this review was to provide an overview of the effects of phosphodiesterase inhibitors (PDE-Is) on cognition, the possible underlying mechanisms, and the relation to current theories about memory formation.  Materials and methods: Studies of the effects of inhibitors of different PDE families (2, 4, 5, 9, and 10) on cognition were reviewed.  In addn., studies related to PDE-Is and blood flow, emotional arousal, and long-term potentiation (LTP) were described.  Results: PDE-Is have a pos. effect on several aspects of cognition, including information processing, attention, memory, and executive functioning.  At present, these data are likely to be explained in terms of an LTP-related mechanism of action.  Conclusion: PDE-Is are a promising target for cognition enhancement; the most suitable candidates appear to be PDE2-Is or PDE9-Is.  The future for PDE-Is as cognition enhancers lies in the development of isoform-specific PDE-Is that have limited aversive side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGdOOMyV-UrVg90H21EOLACvtfcHk0lhQL1H0641zRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ehtLY%253D&md5=77cb3c20950eff0d5590c704e74e4ba8</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1007%2Fs00213-008-1273-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-008-1273-x%26sid%3Dliteratum%253Aachs%26aulast%3DReneerkens%26aufirst%3DO.%2BA.%2BH.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%2BM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DSelective%2520phosphodiesterase%2520inhibitors%253A%2520a%2520promising%2520target%2520for%2520cognition%2520enhancement%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2009%26volume%3D202%26spage%3D419%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors as potential cognition enhancing agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.2174%2F156802610790411009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=20166957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=222-230&author=C.+J.+Schmidt&title=Phosphodiesterase+inhibitors+as+potential+cognition+enhancing+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit3fR"><div class="casContent"><span class="casTitleNuber">3f</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors as potential cognition enhancing agents</span></div><div class="casAuthors">Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-230</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As might be predicted for an organ designed for cell to cell communication, cyclic nucleotide signaling in the brain is highly organized and regulated.  Augmentation of cyclic nucleotide signaling by means of phosphodiesterase inhibition appears to be a viable and tractable means of enhancing neuronal communication.  Of the various CNS disorders that have been considered as target indications for phosphodiesterase inhibitors, no condition has received more attention than cognitive dysfunction.  This review provides a background for understanding the expanding literature in this field as well as a brief update on the rationale driving the search for selective inhibitors of targets such as PDE1B, PDE2, PDE5 and PDE9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBVYtnViej97Vg90H21EOLACvtfcHk0lhQL1H0641zRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D&md5=47e8397d9f69207c27940575411bbe12</span></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=10.2174%2F156802610790411009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790411009%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%2520inhibitors%2520as%2520potential%2520cognition%2520enhancing%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D222%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span> </span><span class="NLM_article-title">The role of phosphodiesterases in schizophrenia: therapeutic implications</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=983-993&author=J.+A.+Siuciak&title=The+role+of+phosphodiesterases+in+schizophrenia%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520phosphodiesterases%2520in%2520schizophrenia%253A%2520therapeutic%2520implications%26jtitle%3DCNS%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D983%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit3h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">van der Staay, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baerfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karthaus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tersteegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kampen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span> </span><span class="NLM_article-title">The novel selective PDE9 inhibitor BAY 73–6691 improves learning and memory in rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&author=F.+J.+van+der+Staayauthor=K.+Ruttenauthor=L.+Baerfackerauthor=J.+DeVryauthor=C.+Erbauthor=H.+Heckrothauthor=D.+Karthausauthor=A.+Tersteegenauthor=M.+van+Kampenauthor=A.+Bloklandauthor=J.+Prickaertsauthor=K.+G.+Reymannauthor=U.+H.+Schroederauthor=M.+Hendrix&title=The+novel+selective+PDE9+inhibitor+BAY+73%E2%80%936691+improves+learning+and+memory+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBaerfacker%26aufirst%3DL.%26aulast%3DDeVry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroeder%26aufirst%3DU.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520novel%2520selective%2520PDE9%2520inhibitor%2520BAY%252073%25E2%2580%25936691%2520improves%2520learning%2520and%2520memory%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D908%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref4"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref4'); return false;" data-citation="" class="refNumLink">4</a></strong><div class="NLM_citation" id="cit4"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-Lafrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Identification of a brain penetrant PDE9A inhibitor utilizing prospective design and chemical enablement as a rapid lead optimization strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7946</span><span class="NLM_x">–</span> <span class="NLM_lpage">7949</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7946-7949&author=P.+R.+Verhoestauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=L.+Chenardauthor=C.+J.+Helalauthor=X.+Houauthor=R.+Kleimanauthor=S.+Liuauthor=E.+Marrauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=R.+D.+Williamsauthor=F.+R.+Nelsonauthor=K.+R.+Fonsecaauthor=S.+Liras&title=Identification+of+a+brain+penetrant+PDE9A+inhibitor+utilizing+prospective+design+and+chemical+enablement+as+a+rapid+lead+optimization+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy</span></div><div class="casAuthors">Verhoest, Patrick R.; Proulx-Lafrance, Caroline; Corman, Michael; Chenard, Lois; Helal, Christopher J.; Hou, Xinjun; Kleiman, Robin; Liu, Shenping; Marr, Eric; Menniti, Frank S.; Schmidt, Christopher J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Williams, Robert D.; Nelson, Frederick R.; Fonseca, Kari R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7946-7949</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of selective, brain penetrant PDE9A inhibitors I (R1 = i-Pr, i-Bu, cyclopentyl, R2 = Ph; R1 = cyclopentyl, R2 = 3-MeC6H4, 2-pyridyl, 6-quinoxalinyl, etc.) has been identified that are capable of producing in vivo elevations of brain cGMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou_Q49qDJV3bVg90H21EOLACvtfcHk0lhQL1H0641zRA"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI&md5=4e1a67684031737596a83d1feb4bee08</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm9015334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015334%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520brain%2520penetrant%2520PDE9A%2520inhibitor%2520utilizing%2520prospective%2520design%2520and%2520chemical%2520enablement%2520as%2520a%2520rapid%2520lead%2520optimization%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7946%26epage%3D7949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref5"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref5'); return false;" data-citation="" class="refNumLink">5</a></strong><div class="NLM_citation" id="cit5"><span><span class="NLM_contrib-group">Hopkins Andrew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom Colin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=L.+Hopkins+Andrewauthor=R.+Groom+Colinauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%2BAndrew%26aufirst%3DL.%26aulast%3DGroom%2BColin%26aufirst%3DR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref6"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref6'); return false;" data-citation="" class="refNumLink">6</a></strong><div class="NLM_citation" id="cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+Set+of+Simple%2C+Interpretable+ADMET+Rules+of+Thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0lhmSZ80o9XJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520Set%2520of%2520Simple%252C%2520Interpretable%2520ADMET%2520Rules%2520of%2520Thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+Modifications+that+Alter+the+P-Glycoprotein+Efflux+Properties+of+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520Modifications%2520that%2520Alter%2520the%2520P-Glycoprotein%2520Efflux%2520Properties%2520of%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref7"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref7'); return false;" data-citation="" class="refNumLink">7</a></strong><div class="NLM_citation" id="cit7"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0lhmSZ80o9XJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref8"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref8'); return false;" data-citation="" class="refNumLink">8</a></strong><div class="NLM_citation" id="cit8"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0lhmSZ80o9XJ0g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref9"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref9'); return false;" data-citation="" class="refNumLink">9</a></strong><div class="NLM_citation" id="cit9"><span><span class="NLM_contrib-group">Verhoest, P. R.; Fonseca, K. R.; Hou, X.; Proulx-LaFrance, C.; Corman, M.; Helal, C. J.; Claffey, M. M.; Tuttle, J.; Coffman, K. J.; Liu, S.; Nelson, F.; Kleiman, R. J.; Menniti, F. S.; Schmidt, C. J.; Vanase-Frawley, M.; Liras, S.</span><span> </span><span class="NLM_article-title">Design and Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders</span>,  <span class="citation_source-journal">J. Med. Chem.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>DOI <a href="http://pubs.acs.org/doi/abs/10.1021/jm3007799" class="extLink">http://pubs.acs.org/doi/abs/10.1021/jm3007799</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+R.+Verhoest&author=K.+R.+Fonseca&author=X.+Hou&author=C.+Proulx-LaFrance&author=M.+Corman&author=C.+J.+Helal&author=M.+M.+Claffey&author=J.+Tuttle&author=K.+J.+Coffman&author=S.+Liu&author=F.+Nelson&author=R.+J.+Kleiman&author=F.+S.+Menniti&author=C.+J.+Schmidt&author=M.+Vanase-Frawley&author=S.+Liras&title=Design+and+Discovery+of+6-%5B%283S%2C4S%29-4-Methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+%28PF-04447943%29%2C+a+Selective+Brain+Penetrant+PDE9A+Inhibitor+for+the+Treatment+of+Cognitive+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDesign%2520and%2520Discovery%2520of%25206-%255B%25283S%252C4S%2529-4-Methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520%2528PF-04447943%2529%252C%2520a%2520Selective%2520Brain%2520Penetrant%2520PDE9A%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cognitive%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref10"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref10'); return false;" data-citation="" class="refNumLink">10</a></strong><div class="NLM_citation" id="cit10"><span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joannides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limberakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotti, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottolini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauckhorst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivault, F.</span><span> </span><span class="NLM_article-title">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2150</span><span class="NLM_x">–</span> <span class="NLM_lpage">2155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1016%2Fj.bmcl.2007.01.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=17303420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2150-2155&author=S.+T.+Murphyauthor=H.+L.+Caseauthor=E.+Ellsworthauthor=S.+Hagenauthor=M.+Hubandauthor=T.+Joannidesauthor=C.+Limberakisauthor=K.+R.+Marottiauthor=A.+M.+Ottoliniauthor=M.+Rauckhorstauthor=J.+Starrauthor=M.+Stierauthor=C.+Taylorauthor=T.+Zhuauthor=A.+Blaserauthor=W.+A.+Dennyauthor=G.-L.+Luauthor=J.+B.+Smaillauthor=F.+Rivault&title=The+synthesis+and+biological+evaluation+of+novel+series+of+nitrile-containing+fluoroquinolones+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span></div><div class="casAuthors">Murphy, Sean T.; Case, Heather L.; Ellsworth, Edmund; Hagen, Susan; Huband, Michael; Joannides, Themis; Limberakis, Chris; Marotti, Keith R.; Ottolini, Amy M.; Rauckhorst, Mark; Starr, Jeremy; Stier, Michael; Taylor, Clarke; Zhu, Tong; Blaser, Adrian; Denny, William A.; Lu, Guo-Liang; Smaill, Jeff B.; Rivault, Freddy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2150-2155</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several novel series of nitrile-contg. fluoroquinolones, e.g., I and II, with weakly basic amines are reported which have reduced potential for hERG (human ether-a-go-go gene) channel inhibition as measured by the dofetilide assay.  The new fluoroquinolones are potent against both Gram-pos. and fastidious Gram-neg. strains, including Methicillin resistant Staphylococcus aureus and fluoroquinolone-resistant Streptococcus pneumoniae.  Several analogs also showed low potential for human genotoxicity as measured by the clonogenicity test.  I and II (designated PF-00951966 and PF-02298732, resp.), which had good in vitro activity and in vitro safety profiles, also showed good pharmacokinetic properties in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhTahx73DqHrVg90H21EOLACvtfcHk0liACRqBAvld7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D&md5=708231abc3eafe5e302e9391d5ae58cc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.090%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DCase%26aufirst%3DH.%2BL.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DHagen%26aufirst%3DS.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DJoannides%26aufirst%3DT.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DMarotti%26aufirst%3DK.%2BR.%26aulast%3DOttolini%26aufirst%3DA.%2BM.%26aulast%3DRauckhorst%26aufirst%3DM.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DLu%26aufirst%3DG.-L.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DRivault%26aufirst%3DF.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520series%2520of%2520nitrile-containing%2520fluoroquinolones%2520as%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2150%26epage%3D2155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref11"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref11'); return false;" data-citation="" class="refNumLink">11</a></strong><div class="NLM_citation" id="cit11"><span><span class="NLM_contrib-group">Hoffmann, R. W.</span><span> </span><span class="NLM_article-title">Allylic 1,3-strain as a controlling factor in stereoselective transformations</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00098a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1989&pages=1841-1860&author=R.+W.+Hoffmann&title=Allylic+1%2C3-strain+as+a+controlling+factor+in+stereoselective+transformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fcr00098a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00098a009%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DR.%2BW.%26atitle%3DAllylic%25201%252C3-strain%2520as%2520a%2520controlling%2520factor%2520in%2520stereoselective%2520transformations%26jtitle%3DChem.%2520Rev.%26date%3D1989%26volume%3D89%26spage%3D1841%26epage%3D1860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref12"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref12'); return false;" data-citation="" class="refNumLink">12</a></strong><div class="NLM_citation" id="cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sadowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-Ray Structures</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci00020a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1000-1008&author=J.+Sadowskiauthor=J.+Gasteigerauthor=G.+Klebe&title=Comparison+of+Automatic+Three-Dimensional+Model+Builders+Using+639+X-Ray+Structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1000-8</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    </div><div class="casAbstract">Several criteria were defined to select a dataset of high-quality x-ray structures from the Cambridge file resulting in 639 mols.  Six currently available programs for automatic 3D structure generation were compared by converting the connectivity tables, including appropriate stereodescriptors from this dataset of 639 mol. structures into 3D geometries: CONCORD, ALCOGEN, Chem-X, MOLGEO, COBRA, and CORINA.  The geometries produced by the different programs were evaluated in terms of several quality criteria and discussed in detail.  These criteria measure how well the different programs reproduce the x-ray geometries of the 639 input structures.  Accordingly, the major strengths and weaknesses of the programs are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8vEtyDrrlq7Vg90H21EOLACvtfcHk0liACRqBAvld7g"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D&md5=246e4d66f11178a18daad2563c48331c</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fci00020a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00020a039%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DComparison%2520of%2520Automatic%2520Three-Dimensional%2520Model%2520Builders%2520Using%2520639%2520X-Ray%2520Structures%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1994%26volume%3D34%26spage%3D1000%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="cit12b"><span><span class="NLM_label">(b) </span><span> </span><span class="NLM_article-title">The 3-D structure generator CORINA is available from Molecular Networks GmbH</span>, Erlangen, Germany (<a href="http://www.molecular-networks.com" class="extLink">http://www.molecular-networks.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+3-D+structure+generator+CORINA+is+available+from+Molecular+Networks+GmbH%2C+Erlangen%2C+Germany+%28http%3A%2F%2Fwww.molecular-networks.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DThe%25203-D%2520structure%2520generator%2520CORINA%2520is%2520available%2520from%2520Molecular%2520Networks%2520GmbH" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref13"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref13'); return false;" data-citation="" class="refNumLink">13</a></strong><div class="NLM_citation" id="cit13"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular Recognition of the Inhibitor AG-1343 by HIV-1 Protease: Conformationally Flexible Docking by Evolutionary Programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+Recognition+of+the+Inhibitor+AG-1343+by+HIV-1+Protease%3A+Conformationally+Flexible+Docking+by+Evolutionary+Programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0lgkYs9XD-8Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520Recognition%2520of%2520the%2520Inhibitor%2520AG-1343%2520by%2520HIV-1%2520Protease%253A%2520Conformationally%2520Flexible%2520Docking%2520by%2520Evolutionary%2520Programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref14"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref14'); return false;" data-citation="" class="refNumLink">14</a></strong><div class="NLM_citation" id="cit14"><span><span class="NLM_contrib-group">Marrone, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luty, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. W.</span><span> </span><span class="NLM_article-title">Discovering High-Affinity Ligands from the Computationally Predicted Structures and Affinities of Small Molecules Bound to A Target: A Virtual Screening Approach</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1023%2FA%3A1008741308684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=209-230&author=T.+J.+Marroneauthor=B.+A.+Lutyauthor=P.+W.+Rose&title=Discovering+High-Affinity+Ligands+from+the+Computationally+Predicted+Structures+and+Affinities+of+Small+Molecules+Bound+to+A+Target%3A+A+Virtual+Screening+Approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span></div><div class="casAuthors">Marrone, Tami J.; Luty, Brock A.; Rose, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-230</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We describe a "virtual NMR screening" method to assist in the design of inhibitors that occupy different sites within a target.  We dock small mols. into the active site of an enzyme and score them.  Keeping the tightest-binding lead fixed in space, we dock and score other small mols. in its presence.  Using this approach, linker groups are used to join the compds. together to form a high-affinity inhibitor.  We present validation of our computational approach by reproducing exptl. results for FKBP and stromelysin.  Docking simulations are not subject to exptl. problems such as proteolysis, protein or compd. insoly., or enzyme size.  Because docking is fast and our scoring method can distinguish between high- and low-affinity inhibitors, this docking procedure shows promise as integral part of a drug-design strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql26ToXhh4jbVg90H21EOLACvtfcHk0lgkYs9XD-8Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSg&md5=cea3010bea46c3636970ece8ee764ae2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008741308684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008741308684%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DT.%2BJ.%26aulast%3DLuty%26aufirst%3DB.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26atitle%3DDiscovering%2520High-Affinity%2520Ligands%2520from%2520the%2520Computationally%2520Predicted%2520Structures%2520and%2520Affinities%2520of%2520Small%2520Molecules%2520Bound%2520to%2520A%2520Target%253A%2520A%2520Virtual%2520Screening%2520Approach%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D20%26spage%3D209%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref15"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref15'); return false;" data-citation="" class="refNumLink">15</a></strong><div class="NLM_citation" id="cit15"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lgkYs9XD-8Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref16"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref16'); return false;" data-citation="" class="refNumLink">16</a></strong><div class="NLM_citation" id="cit16"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0lgkYs9XD-8Lug"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref17"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref17'); return false;" data-citation="" class="refNumLink">17</a></strong><div class="NLM_citation" id="cit17"><span><div class="note"><p class="first last">For a recent review on methods used to pre-clinically evaluate brain penetration of compounds, see:</p></div><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Defining neuropharmacokinetic parameters in CNS drug discovery to determine cross-species pharmacologic exposure–response relationships</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=55-70&author=C.+L.+Shaffer&title=Defining+neuropharmacokinetic+parameters+in+CNS+drug+discovery+to+determine+cross-species+pharmacologic+exposure%E2%80%93response+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDefining%2520neuropharmacokinetic%2520parameters%2520in%2520CNS%2520drug%2520discovery%2520to%2520determine%2520cross-species%2520pharmacologic%2520exposure%25E2%2580%2593response%2520relationships%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D55%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref18"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref18'); return false;" data-citation="" class="refNumLink">18</a></strong><div class="NLM_citation" id="cit18"><span><span class="NLM_contrib-group">Choi, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmaleh, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoup, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischman, A. J.</span><span> </span><span class="NLM_article-title">Novel (bisarylmethoxy)butylpiperidine analogues as neurotransmitter transporter inhibitors with activity at dopamine receptor sites</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4091</span><span class="NLM_x">–</span> <span class="NLM_lpage">4102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=4091-4102&author=S.-W.+Choiauthor=D.+R.+Elmalehauthor=R.+N.+Hansonauthor=T.+M.+Shoupauthor=A.+J.+Fischman&title=Novel+%28bisarylmethoxy%29butylpiperidine+analogues+as+neurotransmitter+transporter+inhibitors+with+activity+at+dopamine+receptor+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.-W.%26aulast%3DElmaleh%26aufirst%3DD.%2BR.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26aulast%3DShoup%26aufirst%3DT.%2BM.%26aulast%3DFischman%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520%2528bisarylmethoxy%2529butylpiperidine%2520analogues%2520as%2520neurotransmitter%2520transporter%2520inhibitors%2520with%2520activity%2520at%2520dopamine%2520receptor%2520sites%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D4091%26epage%3D4102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref19"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref19'); return false;" data-citation="" class="refNumLink">19</a></strong><div class="NLM_citation" id="cit19"><span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Strategic Use of Plasma and Microsome Binding To Exploit in Vitro Clearance in Early Drug Discovery</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900012h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=50-53&author=G.+Changauthor=S.+J.+Steynauthor=J.+P.+Umlandauthor=D.+O.+Scott&title=Strategic+Use+of+Plasma+and+Microsome+Binding+To+Exploit+in+Vitro+Clearance+in+Early+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml900012h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900012h%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DG.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DStrategic%2520Use%2520of%2520Plasma%2520and%2520Microsome%2520Binding%2520To%2520Exploit%2520in%2520Vitro%2520Clearance%2520in%2520Early%2520Drug%2520Discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D50%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref20"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref20'); return false;" data-citation="" class="refNumLink">20</a></strong><div class="NLM_citation" id="cit20"><span><span class="NLM_contrib-group">Nicholas, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styren, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span> </span><span class="NLM_article-title">(2009) PF-04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: translation from non-clinical species to healthy human volunteers</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">P330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=P330&author=T+Nicholasauthor=R+Evansauthor=S+Styrenauthor=R+Quiauthor=E.+Q.+Wangauthor=F+Nelsonauthor=V+Leauthor=S+Grimwoodauthor=C+Christoffersenauthor=S+Banerjeeauthor=B.+Corriganauthor=G.+Kocanauthor=K.+Geogheganauthor=C.+Carrieriauthor=N.+Rahaauthor=P.+Verhoestauthor=H.+Soares&title=%282009%29+PF-04447943%2C+a+novel+PDE9A+inhibitor%2C+increases+cGMP+levels+in+cerebrospinal+fluid%3A+translation+from+non-clinical+species+to+healthy+human+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicholas%26aufirst%3DT%26aulast%3DEvans%26aufirst%3DR%26aulast%3DStyren%26aufirst%3DS%26aulast%3DQui%26aufirst%3DR%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DNelson%26aufirst%3DF%26aulast%3DLe%26aufirst%3DV%26aulast%3DGrimwood%26aufirst%3DS%26aulast%3DChristoffersen%26aufirst%3DC%26aulast%3DBanerjee%26aufirst%3DS%26aulast%3DCorrigan%26aufirst%3DB.%26aulast%3DKocan%26aufirst%3DG.%26aulast%3DGeoghegan%26aufirst%3DK.%26aulast%3DCarrieri%26aufirst%3DC.%26aulast%3DRaha%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSoares%26aufirst%3DH.%26atitle%3D%25282009%2529%2520PF-04447943%252C%2520a%2520novel%2520PDE9A%2520inhibitor%252C%2520increases%2520cGMP%2520levels%2520in%2520cerebrospinal%2520fluid%253A%2520translation%2520from%2520non-clinical%2520species%2520to%2520healthy%2520human%2520volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3DP330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="ref21"><div class="reference"><strong class="refLabel"><a href="javascript:void(0);" onclick="showRef(event, 'ref21'); return false;" data-citation="" class="refNumLink">21</a></strong><div class="NLM_citation" id="cit21"><span><span class="NLM_contrib-group">Ranatunge, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyniak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandarage, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earl, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janero, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letts, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murty, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trocha, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. V.</span><span> </span><span class="NLM_article-title">Synthesis and Selective Cyclooxygenase-2 Inhibitory Activity of a Series of Novel, Nitric Oxide Donor-Containing Pyrazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2180</span><span class="NLM_x">–</span> <span class="NLM_lpage">2193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030276s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2180-2193&author=R.+R.+Ranatungeauthor=M.+Augustyniakauthor=U.+K.+Bandarageauthor=R.+A.+Earlauthor=J.+L.+Ellisauthor=D.+S.+Garveyauthor=D.+R.+Janeroauthor=L.+G.+Lettsauthor=A.+M.+Martinoauthor=M.+G.+Murtyauthor=S.+K.+Richardsonauthor=J.+D.+Schroederauthor=M.+J.+Shumwayauthor=S.+W.+Tamauthor=A.+M.+Trochaauthor=D.+V.+Young&title=Synthesis+and+Selective+Cyclooxygenase-2+Inhibitory+Activity+of+a+Series+of+Novel%2C+Nitric+Oxide+Donor-Containing+Pyrazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm030276s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030276s%26sid%3Dliteratum%253Aachs%26aulast%3DRanatunge%26aufirst%3DR.%2BR.%26aulast%3DAugustyniak%26aufirst%3DM.%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DEarl%26aufirst%3DR.%2BA.%26aulast%3DEllis%26aufirst%3DJ.%2BL.%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DLetts%26aufirst%3DL.%2BG.%26aulast%3DMartino%26aufirst%3DA.%2BM.%26aulast%3DMurty%26aufirst%3DM.%2BG.%26aulast%3DRichardson%26aufirst%3DS.%2BK.%26aulast%3DSchroeder%26aufirst%3DJ.%2BD.%26aulast%3DShumway%26aufirst%3DM.%2BJ.%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTrocha%26aufirst%3DA.%2BM.%26aulast%3DYoung%26aufirst%3DD.%2BV.%26atitle%3DSynthesis%2520and%2520Selective%2520Cyclooxygenase-2%2520Inhibitory%2520Activity%2520of%2520a%2520Series%2520of%2520Novel%252C%2520Nitric%2520Oxide%2520Donor-Containing%2520Pyrazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2180%26epage%3D2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></div><script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="text/javascript">window.refViewer={'ref1':['cit1a','cit1b'],'ref2':['cit2a','cit2b'],'ref3':['cit3a','cit3b','cit3c','cit3d','cit3e','cit3f','cit3g','cit3h'],'ref4':['cit4'],'ref5':['cit5'],'ref6':['cit6a','cit6b'],'ref7':['cit7'],'ref8':['cit8'],'ref9':['cit9'],'ref10':['cit10'],'ref11':['cit11'],'ref12':['cit12a','cit12b'],'ref13':['cit13'],'ref14':['cit14'],'ref15':['cit15'],'ref16':['cit16'],'ref17':['cit17'],'ref18':['cit18'],'ref19':['cit19'],'ref20':['cit20'],'ref21':['cit21']}</script><div class="articleCitedByDropzone" data-pb-dropzone="articleCitedByDropzone"><div class="cited-by"><div class="article_content-header cited-content_header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="citeThis">Cited By</h2></div></div></div><hr/></hr><div class="cited-by__content"><div class="cited-content hlFld-Abstract"><p>This article is cited by 43 publications.</p><ol class="cited-content_cbyCitation"><li><span class="cited-content_cbyCitation_article-contributors">Yinuo Wu, Quan Wang, Mei-Yan Jiang, Yi-You Huang, Ziran Zhu, Chuan Han, Yi-Jing Tian, Bei Zhang, <span class="NLM_string-name hlFld-ContribAuthor">Hai-Bin Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of Potent Phosphodiesterase-9 Inhibitors for the Treatment of Hepatic Fibrosis. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (13)
                                     , 9537-9549. <a href="https://doi.org/10.1021/acs.jmedchem.1c00862" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00862</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00862&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00862%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BPotent%252BPhosphodiesterase-9%252BInhibitors%252Bfor%252Bthe%252BTreatment%252Bof%252BHepatic%252BFibrosis%26aulast%3DWu%26aufirst%3DYinuo%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D12052021%26date%3D18062021%26volume%3D64%26issue%3D13%26spage%3D9537%26epage%3D9549" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jiyun Sun, Zhiwei Xiao, Ahmed Haider, Catherine Gebhard, Hao Xu, Hai-Bin Luo, Han-Ting Zhang, Lee Josephson, Lu Wang, <span class="NLM_string-name hlFld-ContribAuthor">Steven H. Liang</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in Cyclic Nucleotide Phosphodiesterase-Targeted PET Imaging and Drug Discovery. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>64 </em>
                                    (11)
                                     , 7083-7109. <a href="https://doi.org/10.1021/acs.jmedchem.1c00115" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.1c00115</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.1c00115&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.1c00115%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DAdvances%252Bin%252BCyclic%252BNucleotide%252BPhosphodiesterase-Targeted%252BPET%252BImaging%252Band%252BDrug%252BDiscovery%26aulast%3DSun%26aufirst%3DJiyun%26date%3D2021%26date%3D2021%26date%3D2021%26date%3D21012021%26date%3D27052021%26volume%3D64%26issue%3D11%26spage%3D7083%26epage%3D7109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Obdulia Rabal, Juan A. Sánchez-Arias, Mar Cuadrado-Tejedor, Irene de Miguel, Marta Pérez-González, Carolina García-Barroso, Ana Ugarte, Ander Estella-Hermoso de Mendoza, Elena Sáez, Maria Espelosin, Susana Ursua, Haizhong Tan, Wei Wu, Musheng Xu, Antonio Pineda-Lucena, Ana Garcia-Osta, <span class="NLM_string-name hlFld-ContribAuthor">Julen Oyarzabal</span>. </span><span class="cited-content_cbyCitation_article-title">Multitarget Approach for the Treatment of Alzheimer’s Disease: Inhibition of Phosphodiesterase 9 (PDE9) and Histone Deacetylases (HDACs) Covering Diverse Selectivity Profiles. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (9)
                                     , 4076-4101. <a href="https://doi.org/10.1021/acschemneuro.9b00303" title="DOI URL">https://doi.org/10.1021/acschemneuro.9b00303</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.9b00303&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.9b00303%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DMultitarget%252BApproach%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%25253A%252BInhibition%252Bof%252BPhosphodiesterase%252B9%252B%252528PDE9%252529%252Band%252BHistone%252BDeacetylases%252B%252528HDACs%252529%252BCovering%252BDiverse%252BSelectivity%252BProfiles%26aulast%3DRabal%26aufirst%3DObdulia%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D24052019%26date%3D23082019%26date%3D04092019%26date%3D23082019%26volume%3D10%26issue%3D9%26spage%3D4076%26epage%3D4101" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Christopher J. Helal, Mark Bundesmann, Susan Hammond, Melissa Holmstrom, Jacquelyn Klug-McLeod, Bruce A. Lefker, Dale McLeod, Chakrapani Subramanyam, Oleg Zakaryants, <span class="NLM_string-name hlFld-ContribAuthor">Sylvie Sakata</span>. </span><span class="cited-content_cbyCitation_article-title">Quick Building Blocks (QBB): An Innovative and Efficient Business Model To Speed Medicinal Chemistry Analog Synthesis. </span><span class="cited-content_cbyCitation_journal-name">ACS Medicinal Chemistry Letters</span><span> <strong>2019,</strong> <em>10 </em>
                                    (8)
                                     , 1104-1109. <a href="https://doi.org/10.1021/acsmedchemlett.9b00205" title="DOI URL">https://doi.org/10.1021/acsmedchemlett.9b00205</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acsmedchemlett.9b00205&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facsmedchemlett.9b00205%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DQuick%252BBuilding%252BBlocks%252B%252528QBB%252529%25253A%252BAn%252BInnovative%252Band%252BEfficient%252BBusiness%252BModel%252BTo%252BSpeed%252BMedicinal%252BChemistry%252BAnalog%252BSynthesis%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D2019%26date%3D06052019%26date%3D05072019%26date%3D18072019%26date%3D05072019%26volume%3D10%26issue%3D8%26spage%3D1104%26epage%3D1109" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors">Jinhui Hu, Ya-Dan Huang, Tingting Pan, Tianhua Zhang, Tao Su, Xingshu Li, Hai-Bin Luo, <span class="NLM_string-name hlFld-ContribAuthor">Ling Huang</span>. </span><span class="cited-content_cbyCitation_article-title">Design, Synthesis, and Biological Evaluation of Dual-Target Inhibitors of Acetylcholinesterase (AChE) and Phosphodiesterase 9A (PDE9A) for the Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2019,</strong> <em>10 </em>
                                    (1)
                                     , 537-551. <a href="https://doi.org/10.1021/acschemneuro.8b00376" title="DOI URL">https://doi.org/10.1021/acschemneuro.8b00376</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.8b00376&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.8b00376%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDesign%25252C%252BSynthesis%25252C%252Band%252BBiological%252BEvaluation%252Bof%252BDual-Target%252BInhibitors%252Bof%252BAcetylcholinesterase%252B%252528AChE%252529%252Band%252BPhosphodiesterase%252B9A%252B%252528PDE9A%252529%252Bfor%252Bthe%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DHu%26aufirst%3DJinhui%26date%3D2019%26date%3D2018%26date%3D2018%26date%3D2018%26date%3D10082018%26date%3D25092018%26date%3D12102018%26date%3D25092018%26volume%3D10%26issue%3D1%26spage%3D537%26epage%3D551" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yan-Fa  Yu</span>, <span class="hlFld-ContribAuthor ">Ya-Dan  Huang</span>, <span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Xu-Nian  Wu</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Deyan  Wu</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, and <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Novel Pyrazolopyrimidinone Derivatives as Phosphodiesterase 9A Inhibitors Capable of Inhibiting Butyrylcholinesterase for Treatment of Alzheimer’s Disease. </span><span class="cited-content_cbyCitation_journal-name">ACS Chemical Neuroscience</span><span> <strong>2017,</strong> <em>8 </em>
                                    (11)
                                     , 2522-2534. <a href="https://doi.org/10.1021/acschemneuro.7b00268" title="DOI URL">https://doi.org/10.1021/acschemneuro.7b00268</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acschemneuro.7b00268&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facschemneuro.7b00268%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Chemical%2520Neuroscience%26atitle%3DDiscovery%252Bof%252BNovel%252BPyrazolopyrimidinone%252BDerivatives%252Bas%252BPhosphodiesterase%252B9A%252BInhibitors%252BCapable%252Bof%252BInhibiting%252BButyrylcholinesterase%252Bfor%252BTreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252BDisease%26aulast%3DYu%26aufirst%3DYan-Fa%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D13072017%26date%3D07082017%26date%3D23082017%26date%3D15112017%26date%3D07082017%26volume%3D8%26issue%3D11%26spage%3D2522%26epage%3D2534" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Akshay A.  Shah</span>, <span class="hlFld-ContribAuthor ">Lois K.  Chenard</span>, <span class="hlFld-ContribAuthor ">Joseph W.  Tucker</span>, and <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>  . </span><span class="cited-content_cbyCitation_article-title">Parallel Synthesis of 1H-Pyrazolo[3,4-d]pyrimidines via Condensation of N-Pyrazolylamides and Nitriles. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2017,</strong> <em>19 </em>
                                    (11)
                                     , 675-680. <a href="https://doi.org/10.1021/acscombsci.7b00116" title="DOI URL">https://doi.org/10.1021/acscombsci.7b00116</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.7b00116&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.7b00116%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DParallel%252BSynthesis%252Bof%252B1H-Pyrazolo%25255B3%25252C4-d%25255Dpyrimidines%252Bvia%252BCondensation%252Bof%252BN-Pyrazolylamides%252Band%252BNitriles%26aulast%3DShah%26aufirst%3DAkshay%2BA.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D26072017%26date%3D01102017%26date%3D20102017%26date%3D13112017%26date%3D06102017%26volume%3D19%26issue%3D11%26spage%3D675%26epage%3D680" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Eric P.  Arnold</span>, <span class="hlFld-ContribAuthor ">Tracey L.  Boyden</span>, <span class="hlFld-ContribAuthor ">Cheng  Chang</span>, <span class="hlFld-ContribAuthor ">Thomas A.  Chappie</span>, <span class="hlFld-ContribAuthor ">Kimberly F.  Fennell</span>, <span class="hlFld-ContribAuthor ">Michael D.  Forman</span>, <span class="hlFld-ContribAuthor ">Mihaly  Hajos</span>, <span class="hlFld-ContribAuthor ">John F.  Harms</span>, <span class="hlFld-ContribAuthor ">William E.  Hoffman</span>, <span class="hlFld-ContribAuthor ">John M.  Humphrey</span>, <span class="hlFld-ContribAuthor ">Zhijun  Kang</span>, <span class="hlFld-ContribAuthor ">Robin J.  Kleiman</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>, <span class="hlFld-ContribAuthor ">Che-Wah  Lee</span>, <span class="hlFld-ContribAuthor ">Jiemin  Lu</span>, <span class="hlFld-ContribAuthor ">Noha  Maklad</span>, <span class="hlFld-ContribAuthor ">Laura  McDowell</span>, <span class="hlFld-ContribAuthor ">Scot  Mente</span>, <span class="hlFld-ContribAuthor ">Rebecca E.  O’Connor</span>, <span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>, <span class="hlFld-ContribAuthor ">Mary  Piotrowski</span>, <span class="hlFld-ContribAuthor ">Anne W.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Schmidt</span>, <span class="hlFld-ContribAuthor ">Hirokazu  Ueno</span>, <span class="hlFld-ContribAuthor ">Patrick R.  Verhoest</span>, and <span class="hlFld-ContribAuthor ">Edward X.  Yang</span>  . </span><span class="cited-content_cbyCitation_article-title">Application of Structure-Based Design and Parallel Chemistry to Identify a Potent, Selective, and Brain Penetrant Phosphodiesterase 2A Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (13)
                                     , 5673-5698. <a href="https://doi.org/10.1021/acs.jmedchem.7b00397" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00397</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00397&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00397%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DApplication%252Bof%252BStructure-Based%252BDesign%252Band%252BParallel%252BChemistry%252Bto%252BIdentify%252Ba%252BPotent%25252C%252BSelective%25252C%252Band%252BBrain%252BPenetrant%252BPhosphodiesterase%252B2A%252BInhibitor%26aulast%3DHelal%26aufirst%3DChristopher%2BJ.%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D14032017%26date%3D16062017%26date%3D13072017%26date%3D02062017%26volume%3D60%26issue%3D13%26spage%3D5673%26epage%3D5698" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Brian  Dyck</span>, <span class="hlFld-ContribAuthor ">Bryan  Branstetter</span>, <span class="hlFld-ContribAuthor ">Tawfik  Gharbaoui</span>, <span class="hlFld-ContribAuthor ">Andrew R.  Hudson</span>, <span class="hlFld-ContribAuthor ">J. Guy  Breitenbucher</span>, <span class="hlFld-ContribAuthor ">Laurent  Gomez</span>, <span class="hlFld-ContribAuthor ">Iriny  Botrous</span>, <span class="hlFld-ContribAuthor ">Tami  Marrone</span>, <span class="hlFld-ContribAuthor ">Richard  Barido</span>, <span class="hlFld-ContribAuthor ">Charles K.  Allerston</span>, <span class="hlFld-ContribAuthor ">E. Peder  Cedervall</span>, <span class="hlFld-ContribAuthor ">Rui  Xu</span>, <span class="hlFld-ContribAuthor ">Vandana  Sridhar</span>, <span class="hlFld-ContribAuthor ">Ryan  Barker</span>, <span class="hlFld-ContribAuthor ">Kathleen  Aertgeerts</span>, <span class="hlFld-ContribAuthor ">Kara  Schmelzer</span>, <span class="hlFld-ContribAuthor ">David  Neul</span>, <span class="hlFld-ContribAuthor ">Dong  Lee</span>, <span class="hlFld-ContribAuthor ">Mark Eben  Massari</span>, <span class="hlFld-ContribAuthor ">Carsten B.  Andersen</span>, <span class="hlFld-ContribAuthor ">Kristen  Sebring</span>, <span class="hlFld-ContribAuthor ">Xianbo  Zhou</span>, <span class="hlFld-ContribAuthor ">Robert  Petroski</span>, <span class="hlFld-ContribAuthor ">James  Limberis</span>, <span class="hlFld-ContribAuthor ">Martin  Augustin</span>, <span class="hlFld-ContribAuthor ">Lawrence E.  Chun</span>, <span class="hlFld-ContribAuthor ">Thomas E.  Edwards</span>, <span class="hlFld-ContribAuthor ">Marco  Peters</span>, and <span class="hlFld-ContribAuthor ">Ali  Tabatabaei</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of Selective Phosphodiesterase 1 Inhibitors with Memory Enhancing Properties. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2017,</strong> <em>60 </em>
                                    (8)
                                     , 3472-3483. <a href="https://doi.org/10.1021/acs.jmedchem.7b00302" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.7b00302</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.7b00302&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.7b00302%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252BSelective%252BPhosphodiesterase%252B1%252BInhibitors%252Bwith%252BMemory%252BEnhancing%252BProperties%26aulast%3DDyck%26aufirst%3DBrian%26date%3D2017%26date%3D2017%26date%3D2017%26date%3D22022017%26date%3D13042017%26date%3D27042017%26volume%3D60%26issue%3D8%26spage%3D3472%26epage%3D3483" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chimed  Jansen</span>, <span class="hlFld-ContribAuthor ">Albert J.  Kooistra</span>, <span class="hlFld-ContribAuthor ">Georgi K.  Kanev</span>, <span class="hlFld-ContribAuthor ">Rob  Leurs</span>, <span class="hlFld-ContribAuthor ">Iwan J. P.  de Esch</span>, and <span class="hlFld-ContribAuthor ">Chris  de Graaf</span>  . </span><span class="cited-content_cbyCitation_article-title">PDEStrIAn: A Phosphodiesterase Structure and Ligand Interaction Annotated Database As a Tool for Structure-Based Drug Design. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2016,</strong> <em>59 </em>
                                    (15)
                                     , 7029-7065. <a href="https://doi.org/10.1021/acs.jmedchem.5b01813" title="DOI URL">https://doi.org/10.1021/acs.jmedchem.5b01813</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acs.jmedchem.5b01813&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facs.jmedchem.5b01813%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DPDEStrIAn%25253A%252BA%252BPhosphodiesterase%252BStructure%252Band%252BLigand%252BInteraction%252BAnnotated%252BDatabase%252BAs%252Ba%252BTool%252Bfor%252BStructure-Based%252BDrug%252BDesign%26aulast%3DJansen%26aufirst%3DChimed%26date%3D2016%26date%3D2016%26date%3D2015%26date%3D20112015%26date%3D18032016%26date%3D11082016%26date%3D23022016%26volume%3D59%26issue%3D15%26spage%3D7029%26epage%3D7065" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Joseph W.  Tucker</span>, <span class="hlFld-ContribAuthor ">Lois  Chenard</span>, and <span class="hlFld-ContribAuthor ">Joseph M.  Young</span>  . </span><span class="cited-content_cbyCitation_article-title">Selective Access to Heterocyclic Sulfonamides and Sulfonyl Fluorides via a Parallel Medicinal Chemistry Enabled Method. </span><span class="cited-content_cbyCitation_journal-name">ACS Combinatorial Science</span><span> <strong>2015,</strong> <em>17 </em>
                                    (11)
                                     , 653-657. <a href="https://doi.org/10.1021/acscombsci.5b00120" title="DOI URL">https://doi.org/10.1021/acscombsci.5b00120</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/acscombsci.5b00120&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Facscombsci.5b00120%26sid%3Dliteratum%253Aachs%26jtitle%3DACS%2520Combinatorial%2520Science%26atitle%3DSelective%252BAccess%252Bto%252BHeterocyclic%252BSulfonamides%252Band%252BSulfonyl%252BFluorides%252Bvia%252Ba%252BParallel%252BMedicinal%252BChemistry%252BEnabled%252BMethod%26aulast%3DTucker%26aufirst%3DJoseph%2BW.%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D2015%26date%3D21072015%26date%3D23092015%26date%3D14102015%26date%3D09112015%26date%3D04102015%26volume%3D17%26issue%3D11%26spage%3D653%26epage%3D657" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Yong-xian  Shao</span>, <span class="hlFld-ContribAuthor ">Manna  Huang</span>, <span class="hlFld-ContribAuthor ">Wenjun  Cui</span>, <span class="hlFld-ContribAuthor ">Ling-Jun  Feng</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Yinghong  Cai</span>, <span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Xinhai  Zhu</span>, <span class="hlFld-ContribAuthor ">Peiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqian  Wan</span>, <span class="hlFld-ContribAuthor ">Hengming  Ke</span>, and <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>  . </span><span class="cited-content_cbyCitation_article-title">Discovery of a Phosphodiesterase 9A Inhibitor as a Potential Hypoglycemic Agent. </span><span class="cited-content_cbyCitation_journal-name">Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>57 </em>
                                    (24)
                                     , 10304-10313. <a href="https://doi.org/10.1021/jm500836h" title="DOI URL">https://doi.org/10.1021/jm500836h</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1021/jm500836h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1021%2Fjm500836h%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Ba%252BPhosphodiesterase%252B9A%252BInhibitor%252Bas%252Ba%252BPotential%252BHypoglycemic%252BAgent%26aulast%3DShao%26aufirst%3DYong-xian%26date%3D2014%26date%3D2014%26date%3D2014%26date%3D01062014%26date%3D08122014%26date%3D26122014%26date%3D28112014%26volume%3D57%26issue%3D24%26spage%3D10304%26epage%3D10313" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivedita  Singh</span>, <span class="hlFld-ContribAuthor ">Akhtar Hussain  Malik</span>, <span class="hlFld-ContribAuthor ">Parameswar Krishnan  Iyer</span>, <span class="hlFld-ContribAuthor ">Sanjukta  Patra</span>. </span><span class="cited-content_cbyCitation_article-title">Diversifying the xanthine scaffold for potential phosphodiesterase 9A inhibitors: synthesis and validation. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Chemistry Research</span><span> <strong>2021,</strong> <em>30 </em>
                                    (6)
                                     , 1199-1219. <a href="https://doi.org/10.1007/s00044-021-02722-9" title="DOI URL">https://doi.org/10.1007/s00044-021-02722-9</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/s00044-021-02722-9&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2Fs00044-021-02722-9%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Chemistry%2520Research%26atitle%3DDiversifying%252Bthe%252Bxanthine%252Bscaffold%252Bfor%252Bpotential%252Bphosphodiesterase%252B9A%252Binhibitors%25253A%252Bsynthesis%252Band%252Bvalidation%26aulast%3DSingh%26aufirst%3DNivedita%26date%3D2021%26date%3D2021%26volume%3D30%26issue%3D6%26spage%3D1199%26epage%3D1219" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Matthias R.  Bauer</span>, <span class="hlFld-ContribAuthor ">Paolo  Di Fruscia</span>, <span class="hlFld-ContribAuthor ">Simon C. C.  Lucas</span>, <span class="hlFld-ContribAuthor ">Iacovos N.  Michaelides</span>, <span class="hlFld-ContribAuthor ">Jennifer E.  Nelson</span>, <span class="hlFld-ContribAuthor ">R. Ian  Storer</span>, <span class="hlFld-ContribAuthor ">Benjamin C.  Whitehurst</span>. </span><span class="cited-content_cbyCitation_article-title">Put a ring on it: application of small aliphatic rings in medicinal chemistry. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (4)
                                     , 448-471. <a href="https://doi.org/10.1039/D0MD00370K" title="DOI URL">https://doi.org/10.1039/D0MD00370K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00370K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00370K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DPut%252Ba%252Bring%252Bon%252Bit%25253A%252Bapplication%252Bof%252Bsmall%252Baliphatic%252Brings%252Bin%252Bmedicinal%252Bchemistry%26aulast%3DBauer%26aufirst%3DMatthias%2BR.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D4%26spage%3D448%26epage%3D471" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Alexandria M.  Chan</span>, <span class="hlFld-ContribAuthor ">Steven  Fletcher</span>. </span><span class="cited-content_cbyCitation_article-title">Shifting the paradigm in treating multi-factorial diseases: polypharmacological co-inhibitors of HDAC6. </span><span class="cited-content_cbyCitation_journal-name">RSC Medicinal Chemistry</span><span> <strong>2021,</strong> <em>12 </em>
                                    (2)
                                     , 178-196. <a href="https://doi.org/10.1039/D0MD00286K" title="DOI URL">https://doi.org/10.1039/D0MD00286K</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/D0MD00286K&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FD0MD00286K%26sid%3Dliteratum%253Aachs%26jtitle%3DRSC%2520Medicinal%2520Chemistry%26atitle%3DShifting%252Bthe%252Bparadigm%252Bin%252Btreating%252Bmulti-factorial%252Bdiseases%25253A%252Bpolypharmacological%252Bco-inhibitors%252Bof%252BHDAC6%26aulast%3DChan%26aufirst%3DAlexandria%2BM.%26date%3D2021%26date%3D2021%26volume%3D12%26issue%3D2%26spage%3D178%26epage%3D196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nathalia Fonseca  Nadur</span>, <span class="hlFld-ContribAuthor ">Luciana Luiz  de Azevedo</span>, <span class="hlFld-ContribAuthor ">Lucas  Caruso</span>, <span class="hlFld-ContribAuthor ">Cedric Stephan  Graebin</span>, <span class="hlFld-ContribAuthor ">Renata Barbosa  Lacerda</span>, <span class="hlFld-ContribAuthor ">Arthur Eugen  Kümmerle</span>. </span><span class="cited-content_cbyCitation_article-title">The long and winding road of designing phosphodiesterase inhibitors for the treatment of heart failure. </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2021,</strong> <em>212 </em>, 113123. <a href="https://doi.org/10.1016/j.ejmech.2020.113123" title="DOI URL">https://doi.org/10.1016/j.ejmech.2020.113123</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2020.113123&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2020.113123%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DThe%252Blong%252Band%252Bwinding%252Broad%252Bof%252Bdesigning%252Bphosphodiesterase%252Binhibitors%252Bfor%252Bthe%252Btreatment%252Bof%252Bheart%252Bfailure%26aulast%3DNadur%26aufirst%3DNathalia%2BFonseca%26date%3D2021%26volume%3D212%26spage%3D113123" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Eddie L  Myers</span>. </span><span class="cited-content_cbyCitation_article-title">Bicyclic 5–6 Systems: Other Four Heteroatoms 2:2. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2021,</strong>,<a href="https://doi.org/10.1016/B978-0-12-818655-8.00056-1" title="DOI URL">https://doi.org/10.1016/B978-0-12-818655-8.00056-1</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-818655-8.00056-1&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-818655-8.00056-1%26sid%3Dliteratum%253Aachs%26atitle%3DBicyclic%252B5%2525E2%252580%2525936%252BSystems%25253A%252BOther%252BFour%252BHeteroatoms%252B2%25253A2%26aulast%3DMyers%26aufirst%3DEddie%2BL%26date%3D2021%26pub%3DElsevier%26atitle%3DReference%252BModule%252Bin%252BChemistry%25252C%252BMolecular%252BSciences%252Band%252BChemical%252BEngineering%26date%3D2021%26volume%3D22" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Daniel A.  Rodrigues</span>, <span class="hlFld-ContribAuthor ">Pedro de S. M.  Pinheiro</span>, <span class="hlFld-ContribAuthor ">Fernanda S.  Sagrillo</span>, <span class="hlFld-ContribAuthor ">Maria L.  Bolognesi</span>, <span class="hlFld-ContribAuthor ">Carlos A. M.  Fraga</span>. </span><span class="cited-content_cbyCitation_article-title">Histone deacetylases as targets for the treatment of neurodegenerative disorders: Challenges and future opportunities. </span><span class="cited-content_cbyCitation_journal-name">Medicinal Research Reviews</span><span> <strong>2020,</strong> <em>40 </em>
                                    (6)
                                     , 2177-2211. <a href="https://doi.org/10.1002/med.21701" title="DOI URL">https://doi.org/10.1002/med.21701</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/med.21701&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fmed.21701%26sid%3Dliteratum%253Aachs%26jtitle%3DMedicinal%2520Research%2520Reviews%26atitle%3DHistone%252Bdeacetylases%252Bas%252Btargets%252Bfor%252Bthe%252Btreatment%252Bof%252Bneurodegenerative%252Bdisorders%25253A%252BChallenges%252Band%252Bfuture%252Bopportunities%26aulast%3DRodrigues%26aufirst%3DDaniel%2BA.%26date%3D2020%26date%3D2020%26volume%3D40%26issue%3D6%26spage%3D2177%26epage%3D2211" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pei  Zhang</span>, <span class="hlFld-ContribAuthor ">Mei-Yan  Jiang</span>, <span class="hlFld-ContribAuthor ">Mei-Ling  Le</span>, <span class="hlFld-ContribAuthor ">Bei  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Design, synthesis and evaluation of pyrazolopyrimidinone derivatives as novel PDE9A inhibitors for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic & Medicinal Chemistry Letters</span><span> <strong>2020,</strong> <em>30 </em>
                                    (14)
                                     , 127254. <a href="https://doi.org/10.1016/j.bmcl.2020.127254" title="DOI URL">https://doi.org/10.1016/j.bmcl.2020.127254</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bmcl.2020.127254&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bmcl.2020.127254%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520%2526%2520Medicinal%2520Chemistry%2520Letters%26atitle%3DDesign%25252C%252Bsynthesis%252Band%252Bevaluation%252Bof%252Bpyrazolopyrimidinone%252Bderivatives%252Bas%252Bnovel%252BPDE9A%252Binhibitors%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DPei%26date%3D2020%26volume%3D30%26issue%3D14%26spage%3D127254" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Seyed Mohammad  Nabavi</span>, <span class="hlFld-ContribAuthor ">Sylwia  Talarek</span>, <span class="hlFld-ContribAuthor ">Joanna  Listos</span>, <span class="hlFld-ContribAuthor ">Seyed Fazel  Nabavi</span>, <span class="hlFld-ContribAuthor ">Kasi Pandima  Devi</span>, <span class="hlFld-ContribAuthor ">Marcos  Roberto de Oliveira</span>, <span class="hlFld-ContribAuthor ">Devesh  Tewari</span>, <span class="hlFld-ContribAuthor ">Sandro  Argüelles</span>, <span class="hlFld-ContribAuthor ">Saeed  Mehrzadi</span>, <span class="hlFld-ContribAuthor ">Azam  Hosseinzadeh</span>, <span class="hlFld-ContribAuthor ">Grazia  D'onofrio</span>, <span class="hlFld-ContribAuthor ">Ilkay Erdogan  Orhan</span>, <span class="hlFld-ContribAuthor ">Antoni  Sureda</span>, <span class="hlFld-ContribAuthor ">Suowen  Xu</span>, <span class="hlFld-ContribAuthor ">Saeedeh  Momtaz</span>, <span class="hlFld-ContribAuthor ">Mohammad Hosein  Farzaei</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase inhibitors say NO to Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Food and Chemical Toxicology</span><span> <strong>2019,</strong> <em>134 </em>, 110822. <a href="https://doi.org/10.1016/j.fct.2019.110822" title="DOI URL">https://doi.org/10.1016/j.fct.2019.110822</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.fct.2019.110822&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.fct.2019.110822%26sid%3Dliteratum%253Aachs%26jtitle%3DFood%2520and%2520Chemical%2520Toxicology%26atitle%3DPhosphodiesterase%252Binhibitors%252Bsay%252BNO%252Bto%252BAlzheimer%252527s%252Bdisease%26aulast%3DNabavi%26aufirst%3DSeyed%2BMohammad%26date%3D2019%26volume%3D134%26spage%3D110822" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Barbara  Wenzel</span>, <span class="hlFld-ContribAuthor ">Jianrong  Liu</span>, <span class="hlFld-ContribAuthor ">Sladjana  Dukic-Stefanovic</span>, <span class="hlFld-ContribAuthor ">Winnie  Deuther-Conrad</span>, <span class="hlFld-ContribAuthor ">Rodrigo  Teodoro</span>, <span class="hlFld-ContribAuthor ">Friedrich-Alexander  Ludwig</span>, <span class="hlFld-ContribAuthor ">Jean-Michel  Chezal</span>, <span class="hlFld-ContribAuthor ">Emmanuel  Moreau</span>, <span class="hlFld-ContribAuthor ">Peter  Brust</span>, <span class="hlFld-ContribAuthor ">Aurelie  Maisonial-Besset</span>. </span><span class="cited-content_cbyCitation_article-title">Targeting cyclic nucleotide phosphodiesterase 5 (PDE5) in brain: Toward the development of a PET radioligand labeled with fluorine-18. </span><span class="cited-content_cbyCitation_journal-name">Bioorganic Chemistry</span><span> <strong>2019,</strong> <em>86 </em>, 346-362. <a href="https://doi.org/10.1016/j.bioorg.2019.01.037" title="DOI URL">https://doi.org/10.1016/j.bioorg.2019.01.037</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.bioorg.2019.01.037&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.bioorg.2019.01.037%26sid%3Dliteratum%253Aachs%26jtitle%3DBioorganic%2520Chemistry%26atitle%3DTargeting%252Bcyclic%252Bnucleotide%252Bphosphodiesterase%252B5%252B%252528PDE5%252529%252Bin%252Bbrain%25253A%252BToward%252Bthe%252Bdevelopment%252Bof%252Ba%252BPET%252Bradioligand%252Blabeled%252Bwith%252Bfluorine-18%26aulast%3DWenzel%26aufirst%3DBarbara%26date%3D2019%26volume%3D86%26spage%3D346%26epage%3D362" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Pawan  Kumar</span>, <span class="hlFld-ContribAuthor ">Indira  Ghosh</span>. </span><span class="cited-content_cbyCitation_article-title">Application of In Silico Drug Repurposing in Infectious Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2019,</strong>,, 427-462. <a href="https://doi.org/10.1016/B978-0-12-816125-8.00015-8" title="DOI URL">https://doi.org/10.1016/B978-0-12-816125-8.00015-8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-12-816125-8.00015-8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-12-816125-8.00015-8%26sid%3Dliteratum%253Aachs%26atitle%3DApplication%252Bof%252BIn%252BSilico%252BDrug%252BRepurposing%252Bin%252BInfectious%252BDiseases%26aulast%3DKumar%26aufirst%3DPawan%26date%3D2019%26spage%3D427%26epage%3D462%26pub%3DElsevier%26atitle%3DIn%252BSilico%252BDrug%252BDesign%26date%3D2019" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xian-Feng  Huang</span>, <span class="hlFld-ContribAuthor ">Wen-Tao  Jiang</span>, <span class="hlFld-ContribAuthor ">Li  Liu</span>, <span class="hlFld-ContribAuthor ">Fang-Chen  Song</span>, <span class="hlFld-ContribAuthor ">Xia  Zhu</span>, <span class="hlFld-ContribAuthor ">Gui-Lan  Shi</span>, <span class="hlFld-ContribAuthor ">Shu-Ming  Ding</span>, <span class="hlFld-ContribAuthor ">Heng-Ming  Ke</span>, <span class="hlFld-ContribAuthor ">Wei  Wang</span>, <span class="hlFld-ContribAuthor ">James M.  O'Donnell</span>, <span class="hlFld-ContribAuthor ">Han-Ting  Zhang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>, <span class="hlFld-ContribAuthor ">Yi-Qian  Wan</span>, <span class="hlFld-ContribAuthor ">Guo-Qiang  Song</span>, <span class="hlFld-ContribAuthor ">Ying  Xu</span>. </span><span class="cited-content_cbyCitation_article-title">A novel PDE9 inhibitor WYQ-C36D ameliorates corticosterone-induced neurotoxicity and depression-like behaviors by cGMP-CREB-related signaling. </span><span class="cited-content_cbyCitation_journal-name">CNS Neuroscience & Therapeutics</span><span> <strong>2018,</strong> <em>24 </em>
                                    (10)
                                     , 889-896. <a href="https://doi.org/10.1111/cns.12864" title="DOI URL">https://doi.org/10.1111/cns.12864</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/cns.12864&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fcns.12864%26sid%3Dliteratum%253Aachs%26jtitle%3DCNS%2520Neuroscience%2520%2526%2520Therapeutics%26atitle%3DA%252Bnovel%252BPDE9%252Binhibitor%252BWYQ-C36D%252Bameliorates%252Bcorticosterone-induced%252Bneurotoxicity%252Band%252Bdepression-like%252Bbehaviors%252Bby%252BcGMP-CREB-related%252Bsignaling%26aulast%3DHuang%26aufirst%3DXian-Feng%26date%3D2018%26date%3D2018%26volume%3D24%26issue%3D10%26spage%3D889%26epage%3D896" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Baoling  Lai</span>, <span class="hlFld-ContribAuthor ">Miao  Li</span>, <span class="hlFld-ContribAuthor ">Wanling  Hu</span>, <span class="hlFld-ContribAuthor ">Wei  Li</span>, <span class="hlFld-ContribAuthor ">Wen-Biao  Gan</span>. </span><span class="cited-content_cbyCitation_article-title">The Phosphodiesterase 9 Inhibitor PF-04449613 Promotes Dendritic Spine Formation and Performance Improvement after Motor Learning. </span><span class="cited-content_cbyCitation_journal-name">Developmental Neurobiology</span><span> <strong>2018,</strong> <em>78 </em>
                                    (9)
                                     , 859-872. <a href="https://doi.org/10.1002/dneu.22623" title="DOI URL">https://doi.org/10.1002/dneu.22623</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/dneu.22623&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2Fdneu.22623%26sid%3Dliteratum%253Aachs%26jtitle%3DDevelopmental%2520Neurobiology%26atitle%3DThe%252BPhosphodiesterase%252B9%252BInhibitor%252BPF-04449613%252BPromotes%252BDendritic%252BSpine%252BFormation%252Band%252BPerformance%252BImprovement%252Bafter%252BMotor%252BLearning%26aulast%3DLai%26aufirst%3DBaoling%26date%3D2018%26date%3D2018%26volume%3D78%26issue%3D9%26spage%3D859%26epage%3D872" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Xu-Nian  Wu</span>, <span class="hlFld-ContribAuthor ">Ya-Dan  Huang</span>, <span class="hlFld-ContribAuthor ">Jin-Xuan  Li</span>, <span class="hlFld-ContribAuthor ">Yan-Fa  Yu</span>, <span class="hlFld-ContribAuthor ">Zhou  Qian</span>, <span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structure-based design, synthesis, and biological evaluation of novel pyrimidinone derivatives as PDE9 inhibitors. </span><span class="cited-content_cbyCitation_journal-name">Acta Pharmaceutica Sinica B</span><span> <strong>2018,</strong> <em>8 </em>
                                    (4)
                                     , 615-628. <a href="https://doi.org/10.1016/j.apsb.2017.12.007" title="DOI URL">https://doi.org/10.1016/j.apsb.2017.12.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.apsb.2017.12.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.apsb.2017.12.007%26sid%3Dliteratum%253Aachs%26jtitle%3DActa%2520Pharmaceutica%2520Sinica%2520B%26atitle%3DStructure-based%252Bdesign%25252C%252Bsynthesis%25252C%252Band%252Bbiological%252Bevaluation%252Bof%252Bnovel%252Bpyrimidinone%252Bderivatives%252Bas%252BPDE9%252Binhibitors%26aulast%3DWu%26aufirst%3DXu-Nian%26date%3D2018%26volume%3D8%26issue%3D4%26spage%3D615%26epage%3D628" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Chen  Zhang</span>, <span class="hlFld-ContribAuthor ">Qian  Zhou</span>, <span class="hlFld-ContribAuthor ">Xu-Nian  Wu</span>, <span class="hlFld-ContribAuthor ">Ya-Dan  Huang</span>, <span class="hlFld-ContribAuthor ">Jie  Zhou</span>, <span class="hlFld-ContribAuthor ">Zengwei  Lai</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel PDE9A inhibitors with antioxidant activities for treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Journal of Enzyme Inhibition and Medicinal Chemistry</span><span> <strong>2018,</strong> <em>33 </em>
                                    (1)
                                     , 260-270. <a href="https://doi.org/10.1080/14756366.2017.1412315" title="DOI URL">https://doi.org/10.1080/14756366.2017.1412315</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1080/14756366.2017.1412315&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1080%2F14756366.2017.1412315%26sid%3Dliteratum%253Aachs%26jtitle%3DJournal%2520of%2520Enzyme%2520Inhibition%2520and%2520Medicinal%2520Chemistry%26atitle%3DDiscovery%252Bof%252Bnovel%252BPDE9A%252Binhibitors%252Bwith%252Bantioxidant%252Bactivities%252Bfor%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DZhang%26aufirst%3DChen%26date%3D2018%26date%3D2017%26volume%3D33%26issue%3D1%26spage%3D260%26epage%3D270" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Kristen  Kokkonen</span>, <span class="hlFld-ContribAuthor ">David A.  Kass</span>. </span><span class="cited-content_cbyCitation_article-title">Nanodomain Regulation of Cardiac Cyclic Nucleotide Signaling by Phosphodiesterases. </span><span class="cited-content_cbyCitation_journal-name">Annual Review of Pharmacology and Toxicology</span><span> <strong>2017,</strong> <em>57 </em>
                                    (1)
                                     , 455-479. <a href="https://doi.org/10.1146/annurev-pharmtox-010716-104756" title="DOI URL">https://doi.org/10.1146/annurev-pharmtox-010716-104756</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1146/annurev-pharmtox-010716-104756&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1146%2Fannurev-pharmtox-010716-104756%26sid%3Dliteratum%253Aachs%26jtitle%3DAnnual%2520Review%2520of%2520Pharmacology%2520and%2520Toxicology%26atitle%3DNanodomain%252BRegulation%252Bof%252BCardiac%252BCyclic%252BNucleotide%252BSignaling%252Bby%252BPhosphodiesterases%26aulast%3DKokkonen%26aufirst%3DKristen%26date%3D2017%26volume%3D57%26issue%3D1%26spage%3D455%26epage%3D479" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">M S  Alexander</span>, <span class="hlFld-ContribAuthor ">M J  Gasperini</span>, <span class="hlFld-ContribAuthor ">P T  Tsai</span>, <span class="hlFld-ContribAuthor ">D E  Gibbs</span>, <span class="hlFld-ContribAuthor ">J M  Spinazzola</span>, <span class="hlFld-ContribAuthor ">J L  Marshall</span>, <span class="hlFld-ContribAuthor ">M J  Feyder</span>, <span class="hlFld-ContribAuthor ">M T  Pletcher</span>, <span class="hlFld-ContribAuthor ">E L P  Chekler</span>, <span class="hlFld-ContribAuthor ">C A  Morris</span>, <span class="hlFld-ContribAuthor ">M  Sahin</span>, <span class="hlFld-ContribAuthor ">J F  Harms</span>, <span class="hlFld-ContribAuthor ">C J  Schmidt</span>, <span class="hlFld-ContribAuthor ">R J  Kleiman</span>, <span class="hlFld-ContribAuthor ">L M  Kunkel</span>. </span><span class="cited-content_cbyCitation_article-title">Reversal of neurobehavioral social deficits in dystrophic mice using inhibitors of phosphodiesterases PDE5A and PDE9A. </span><span class="cited-content_cbyCitation_journal-name">Translational Psychiatry</span><span> <strong>2016,</strong> <em>6 </em>
                                    (9)
                                     , e901-e901. <a href="https://doi.org/10.1038/tp.2016.174" title="DOI URL">https://doi.org/10.1038/tp.2016.174</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/tp.2016.174&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Ftp.2016.174%26sid%3Dliteratum%253Aachs%26jtitle%3DTranslational%2520Psychiatry%26atitle%3DReversal%252Bof%252Bneurobehavioral%252Bsocial%252Bdeficits%252Bin%252Bdystrophic%252Bmice%252Busing%252Binhibitors%252Bof%252Bphosphodiesterases%252BPDE5A%252Band%252BPDE9A%26aulast%3DAlexander%26aufirst%3DM%2BS%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D9%26spage%3De901%26epage%3De901" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Su</span>, <span class="hlFld-ContribAuthor ">Tianhua  Zhang</span>, <span class="hlFld-ContribAuthor ">Shishun  Xie</span>, <span class="hlFld-ContribAuthor ">Jun  Yan</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Ling  Huang</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Discovery of novel PDE9 inhibitors capable of inhibiting Aβ aggregation as potential candidates for the treatment of Alzheimer’s disease. </span><span class="cited-content_cbyCitation_journal-name">Scientific Reports</span><span> <strong>2016,</strong> <em>6 </em>
                                    (1)
                                     <a href="https://doi.org/10.1038/srep21826" title="DOI URL">https://doi.org/10.1038/srep21826</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/srep21826&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fsrep21826%26sid%3Dliteratum%253Aachs%26jtitle%3DScientific%2520Reports%26atitle%3DDiscovery%252Bof%252Bnovel%252BPDE9%252Binhibitors%252Bcapable%252Bof%252Binhibiting%252BA%2525CE%2525B2%252Baggregation%252Bas%252Bpotential%252Bcandidates%252Bfor%252Bthe%252Btreatment%252Bof%252BAlzheimer%2525E2%252580%252599s%252Bdisease%26aulast%3DSu%26aufirst%3DTao%26date%3D2016%26date%3D2016%26volume%3D6%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Tao  Wang</span>, <span class="hlFld-ContribAuthor ">Mian-Bin  Wu</span>, <span class="hlFld-ContribAuthor ">Jian-Ping  Lin</span>, <span class="hlFld-ContribAuthor ">Li-Rong  Yang</span>. </span><span class="cited-content_cbyCitation_article-title">Quantitative structure–activity relationship: promising advances in drug discovery platforms. </span><span class="cited-content_cbyCitation_journal-name">Expert Opinion on Drug Discovery</span><span> <strong>2015,</strong> <em>10 </em>
                                    (12)
                                     , 1283-1300. <a href="https://doi.org/10.1517/17460441.2015.1083006" title="DOI URL">https://doi.org/10.1517/17460441.2015.1083006</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1517/17460441.2015.1083006&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1517%2F17460441.2015.1083006%26sid%3Dliteratum%253Aachs%26jtitle%3DExpert%2520Opinion%2520on%2520Drug%2520Discovery%26atitle%3DQuantitative%252Bstructure%2525E2%252580%252593activity%252Brelationship%25253A%252Bpromising%252Badvances%252Bin%252Bdrug%252Bdiscovery%252Bplatforms%26aulast%3DWang%26aufirst%3DTao%26date%3D2015%26date%3D2015%26volume%3D10%26issue%3D12%26spage%3D1283%26epage%3D1300" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Manna  Huang</span>, <span class="hlFld-ContribAuthor ">Yongxian  Shao</span>, <span class="hlFld-ContribAuthor ">Jianying  Hou</span>, <span class="hlFld-ContribAuthor ">Wenjun  Cui</span>, <span class="hlFld-ContribAuthor ">Beibei  Liang</span>, <span class="hlFld-ContribAuthor ">Yingchun  Huang</span>, <span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Xinhai  Zhu</span>, <span class="hlFld-ContribAuthor ">Peiqing  Liu</span>, <span class="hlFld-ContribAuthor ">Yiqian  Wan</span>, <span class="hlFld-ContribAuthor ">Hengming  Ke</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Structural Asymmetry of Phosphodiesterase-9A and a Unique Pocket for Selective Binding of a Potent Enantiomeric Inhibitor. </span><span class="cited-content_cbyCitation_journal-name">Molecular Pharmacology</span><span> <strong>2015,</strong> <em>88 </em>
                                    (5)
                                     , 836-845. <a href="https://doi.org/10.1124/mol.115.099747" title="DOI URL">https://doi.org/10.1124/mol.115.099747</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1124/mol.115.099747&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1124%2Fmol.115.099747%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520Pharmacology%26atitle%3DStructural%252BAsymmetry%252Bof%252BPhosphodiesterase-9A%252Band%252Ba%252BUnique%252BPocket%252Bfor%252BSelective%252BBinding%252Bof%252Ba%252BPotent%252BEnantiomeric%252BInhibitor%26aulast%3DHuang%26aufirst%3DManna%26date%3D2015%26date%3D2015%26volume%3D88%26issue%3D5%26spage%3D836%26epage%3D845" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">J. Richard  Morphy</span>. </span><span class="cited-content_cbyCitation_article-title">Medicinal Chemistry Strategies to Prevent Compound Attrition. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2015,</strong>,, 215-228. <a href="https://doi.org/10.1002/9781118819586.ch8" title="DOI URL">https://doi.org/10.1002/9781118819586.ch8</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9781118819586.ch8&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9781118819586.ch8%26sid%3Dliteratum%253Aachs%26atitle%3DMedicinal%252BChemistry%252BStrategies%252Bto%252BPrevent%252BCompound%252BAttrition%26aulast%3DMorphy%26aufirst%3DJ.%2BRichard%26date%3D2015%26date%3D2015%26spage%3D215%26epage%3D228%26pub%3DJohn%2520Wiley%2520%2526%2520Sons%252C%2520Inc%26atitle%3DAttrition%252Bin%252Bthe%252BPharmaceutical%252BIndustry%26aulast%3DAlex%26aufirst%3DAlexander%26date%3D2015" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Ana  Ugarte</span>, <span class="hlFld-ContribAuthor ">Francisco  Gil-Bea</span>, <span class="hlFld-ContribAuthor ">Carolina  García-Barroso</span>, <span class="hlFld-ContribAuthor ">Ángel  Cedazo-Minguez</span>, <span class="hlFld-ContribAuthor ">M. Javier  Ramírez</span>, <span class="hlFld-ContribAuthor ">Rafael  Franco</span>, <span class="hlFld-ContribAuthor ">Ana  García-Osta</span>, <span class="hlFld-ContribAuthor ">Julen  Oyarzabal</span>, <span class="hlFld-ContribAuthor ">Mar  Cuadrado-Tejedor</span>. </span><span class="cited-content_cbyCitation_article-title">Decreased levels of guanosine 3′, 5′-monophosphate (cGMP) in cerebrospinal fluid (CSF) are associated with cognitive decline and amyloid pathology in Alzheimer's disease. </span><span class="cited-content_cbyCitation_journal-name">Neuropathology and Applied Neurobiology</span><span> <strong>2015,</strong> <em>41 </em>
                                    (4)
                                     , 471-482. <a href="https://doi.org/10.1111/nan.12203" title="DOI URL">https://doi.org/10.1111/nan.12203</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/nan.12203&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fnan.12203%26sid%3Dliteratum%253Aachs%26jtitle%3DNeuropathology%2520and%2520Applied%2520Neurobiology%26atitle%3DDecreased%252Blevels%252Bof%252Bguanosine%252B3%2525E2%252580%2525B2%25252C%252B5%2525E2%252580%2525B2-monophosphate%252B%252528cGMP%252529%252Bin%252Bcerebrospinal%252Bfluid%252B%252528CSF%252529%252Bare%252Bassociated%252Bwith%252Bcognitive%252Bdecline%252Band%252Bamyloid%252Bpathology%252Bin%252BAlzheimer%252527s%252Bdisease%26aulast%3DUgarte%26aufirst%3DAna%26date%3D2015%26date%3D2015%26volume%3D41%26issue%3D4%26spage%3D471%26epage%3D482" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Zhe  Li</span>, <span class="hlFld-ContribAuthor ">Xiao  Lu</span>, <span class="hlFld-ContribAuthor ">Ling-Jun  Feng</span>, <span class="hlFld-ContribAuthor ">Ying  Gu</span>, <span class="hlFld-ContribAuthor ">Xingshu  Li</span>, <span class="hlFld-ContribAuthor ">Yinuo  Wu</span>, <span class="hlFld-ContribAuthor ">Hai-Bin  Luo</span>. </span><span class="cited-content_cbyCitation_article-title">Molecular dynamics-based discovery of novel phosphodiesterase-9A inhibitors with non-pyrazolopyrimidinone scaffolds. </span><span class="cited-content_cbyCitation_journal-name">Molecular BioSystems</span><span> <strong>2015,</strong> <em>11 </em>
                                    (1)
                                     , 115-125. <a href="https://doi.org/10.1039/C4MB00389F" title="DOI URL">https://doi.org/10.1039/C4MB00389F</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/C4MB00389F&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2FC4MB00389F%26sid%3Dliteratum%253Aachs%26jtitle%3DMolecular%2520BioSystems%26atitle%3DMolecular%252Bdynamics-based%252Bdiscovery%252Bof%252Bnovel%252Bphosphodiesterase-9A%252Binhibitors%252Bwith%252Bnon-pyrazolopyrimidinone%252Bscaffolds%26aulast%3DLi%26aufirst%3DZhe%26date%3D2015%26date%3D2015%26volume%3D11%26issue%3D1%26spage%3D115%26epage%3D125" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">F  Ahmad</span>, <span class="hlFld-ContribAuthor ">T  Murata</span>, <span class="hlFld-ContribAuthor ">K  Shimizu</span>, <span class="hlFld-ContribAuthor ">E  Degerman</span>, <span class="hlFld-ContribAuthor ">D  Maurice</span>, <span class="hlFld-ContribAuthor ">V  Manganiello</span>. </span><span class="cited-content_cbyCitation_article-title">Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets. </span><span class="cited-content_cbyCitation_journal-name">Oral Diseases</span><span> <strong>2015,</strong> <em>21 </em>
                                    (1)
                                     <a href="https://doi.org/10.1111/odi.12275" title="DOI URL">https://doi.org/10.1111/odi.12275</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1111/odi.12275&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1111%2Fodi.12275%26sid%3Dliteratum%253Aachs%26jtitle%3DOral%2520Diseases%26atitle%3DCyclic%252BNucleotide%252BPhosphodiesterases%25253A%252Bimportant%252Bsignaling%252Bmodulators%252Band%252Btherapeutic%252Btargets%26aulast%3DAhmad%26aufirst%3DF%26date%3D2015%26date%3D2014%26volume%3D21%26issue%3D1" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Meng  Li</span>, <span class="hlFld-ContribAuthor ">Bao-Xiang  Zhao</span>. </span><span class="cited-content_cbyCitation_article-title">Progress of the synthesis of condensed pyrazole derivatives (from 2010 to mid-2013). </span><span class="cited-content_cbyCitation_journal-name">European Journal of Medicinal Chemistry</span><span> <strong>2014,</strong> <em>85 </em>, 311-340. <a href="https://doi.org/10.1016/j.ejmech.2014.07.102" title="DOI URL">https://doi.org/10.1016/j.ejmech.2014.07.102</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.ejmech.2014.07.102&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.ejmech.2014.07.102%26sid%3Dliteratum%253Aachs%26jtitle%3DEuropean%2520Journal%2520of%2520Medicinal%2520Chemistry%26atitle%3DProgress%252Bof%252Bthe%252Bsynthesis%252Bof%252Bcondensed%252Bpyrazole%252Bderivatives%252B%252528from%252B2010%252Bto%252Bmid-2013%252529%26aulast%3DLi%26aufirst%3DMeng%26date%3D2014%26volume%3D85%26spage%3D311%26epage%3D340" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Nivedita  Singh</span>, <span class="hlFld-ContribAuthor ">Sanjukta  Patra</span>. </span><span class="cited-content_cbyCitation_article-title">Phosphodiesterase 9: Insights from protein structure and role in therapeutics. </span><span class="cited-content_cbyCitation_journal-name">Life Sciences</span><span> <strong>2014,</strong> <em>106 </em>
                                    (1-2)
                                     , 1-11. <a href="https://doi.org/10.1016/j.lfs.2014.04.007" title="DOI URL">https://doi.org/10.1016/j.lfs.2014.04.007</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/j.lfs.2014.04.007&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2Fj.lfs.2014.04.007%26sid%3Dliteratum%253Aachs%26jtitle%3DLife%2520Sciences%26atitle%3DPhosphodiesterase%252B9%25253A%252BInsights%252Bfrom%252Bprotein%252Bstructure%252Band%252Brole%252Bin%252Btherapeutics%26aulast%3DSingh%26aufirst%3DNivedita%26date%3D2014%26volume%3D106%26issue%3D1-2%26spage%3D1%26epage%3D11" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jayvardhan  Pandit</span>. </span><span class="cited-content_cbyCitation_article-title">PDE4: New Structural Insights into the Regulatory Mechanism and Implications for the Design of Selective Inhibitors. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 29-44. <a href="https://doi.org/10.1002/9783527682348.ch03" title="DOI URL">https://doi.org/10.1002/9783527682348.ch03</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527682348.ch03&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527682348.ch03%26sid%3Dliteratum%253Aachs%26atitle%3DPDE4%25253A%252BNew%252BStructural%252BInsights%252Binto%252Bthe%252BRegulatory%252BMechanism%252Band%252BImplications%252Bfor%252Bthe%252BDesign%252Bof%252BSelective%252BInhibitors%26aulast%3DPandit%26aufirst%3DJayvardhan%26date%3D2014%26date%3D2014%26spage%3D29%26epage%3D44%26pub%3DWiley%26atitle%3DPhosphodiesterases%252Band%252BTheir%252BInhibitors%26aulast%3DLiras%26aufirst%3DSpiros%26date%3D2014%26date%3D2014" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Michelle M.  Claffey</span>, <span class="hlFld-ContribAuthor ">Christopher J.  Helal</span>, <span class="hlFld-ContribAuthor ">Xinjun  Hou</span>. </span><span class="cited-content_cbyCitation_article-title">PDEs as CNS Targets: PDE9 Inhibitors for Cognitive Deficit Diseases. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 117-140. <a href="https://doi.org/10.1002/9783527682348.ch08" title="DOI URL">https://doi.org/10.1002/9783527682348.ch08</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1002/9783527682348.ch08&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1002%2F9783527682348.ch08%26sid%3Dliteratum%253Aachs%26atitle%3DPDEs%252Bas%252BCNS%252BTargets%25253A%252BPDE9%252BInhibitors%252Bfor%252BCognitive%252BDeficit%252BDiseases%26aulast%3DClaffey%26aufirst%3DMichelle%2BM.%26date%3D2014%26date%3D2014%26spage%3D117%26epage%3D140%26pub%3DWiley%26atitle%3DPhosphodiesterases%252Band%252BTheir%252BInhibitors%26aulast%3DLiras%26aufirst%3DSpiros%26date%3D2014%26date%3D2014%26volume%3D68" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Donald H.  Maurice</span>, <span class="hlFld-ContribAuthor ">Hengming  Ke</span>, <span class="hlFld-ContribAuthor ">Faiyaz  Ahmad</span>, <span class="hlFld-ContribAuthor ">Yousheng  Wang</span>, <span class="hlFld-ContribAuthor ">Jay  Chung</span>, <span class="hlFld-ContribAuthor ">Vincent C.  Manganiello</span>. </span><span class="cited-content_cbyCitation_article-title">Advances in targeting cyclic nucleotide phosphodiesterases. </span><span class="cited-content_cbyCitation_journal-name">Nature Reviews Drug Discovery</span><span> <strong>2014,</strong> <em>13 </em>
                                    (4)
                                     , 290-314. <a href="https://doi.org/10.1038/nrd4228" title="DOI URL">https://doi.org/10.1038/nrd4228</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1038/nrd4228&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1038%2Fnrd4228%26sid%3Dliteratum%253Aachs%26jtitle%3DNature%2520Reviews%2520Drug%2520Discovery%26atitle%3DAdvances%252Bin%252Btargeting%252Bcyclic%252Bnucleotide%252Bphosphodiesterases%26aulast%3DMaurice%26aufirst%3DDonald%2BH.%26date%3D2014%26date%3D2014%26volume%3D13%26issue%3D4%26spage%3D290%26epage%3D314" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jamison B.  Tuttle</span>, <span class="hlFld-ContribAuthor ">Bethany L.  Kormos</span>. </span><span class="cited-content_cbyCitation_article-title">The Use of PDE10A and PDE9 Inhibitors for Treating Schizophrenia. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2014,</strong>,, 255-316. <a href="https://doi.org/10.1007/7355_2014_54" title="DOI URL">https://doi.org/10.1007/7355_2014_54</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1007/7355_2014_54&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1007%2F7355_2014_54%26sid%3Dliteratum%253Aachs%26atitle%3DThe%252BUse%252Bof%252BPDE10A%252Band%252BPDE9%252BInhibitors%252Bfor%252BTreating%252BSchizophrenia%26aulast%3DTuttle%26aufirst%3DJamison%2BB.%26date%3D2014%26date%3D2014%26spage%3D255%26epage%3D316%26pub%3DSpringer%2520International%2520Publishing%26atitle%3DSmall%252BMolecule%252BTherapeutics%252Bfor%252BSchizophrenia%26aulast%3DCelanire%26aufirst%3DSylvain%26date%3D2015%26volume%3D13" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Benito  Alcaide</span>, <span class="hlFld-ContribAuthor ">Pedro  Almendros</span>. </span><span class="cited-content_cbyCitation_article-title">Four-Membered Ring Systems. </span><span class="cited-content_cbyCitation_journal-name"></span><span> <strong>2013,</strong>,, 71-96. <a href="https://doi.org/10.1016/B978-0-08-099406-2.00003-0" title="DOI URL">https://doi.org/10.1016/B978-0-08-099406-2.00003-0</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1016/B978-0-08-099406-2.00003-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1016%2FB978-0-08-099406-2.00003-0%26sid%3Dliteratum%253Aachs%26atitle%3DFour-Membered%252BRing%252BSystems%26aulast%3DAlcaide%26aufirst%3DBenito%26date%3D2013%26spage%3D71%26epage%3D96%26pub%3DElsevier%26date%3D2013%26volume%3D25" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li><li><span class="cited-content_cbyCitation_article-contributors"><span class="hlFld-ContribAuthor ">Jun-Hua  Li</span>, <span class="hlFld-ContribAuthor ">Da-Ming  Du</span>. </span><span class="cited-content_cbyCitation_article-title">Squaramide-catalysed enantioselective Michael addition of pyrazolin-5-ones to nitroalkenes. </span><span class="cited-content_cbyCitation_journal-name">Organic & Biomolecular Chemistry</span><span> <strong>2013,</strong> <em>11 </em>
                                    (36)
                                     , 6215. <a href="https://doi.org/10.1039/c3ob41045e" title="DOI URL">https://doi.org/10.1039/c3ob41045e</a></span><span class="deliverFormatsLinks"><a href="/servlet/linkout?suffix=&amp;dbid=16384&amp;doi=10.1039/c3ob41045e&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dcitedby%26id%3Ddoi%3A10.1039%2Fc3ob41045e%26sid%3Dliteratum%253Aachs%26jtitle%3DOrganic%2520%2526%2520Biomolecular%2520Chemistry%26atitle%3DSquaramide-catalysed%252Benantioselective%252BMichael%252Baddition%252Bof%252Bpyrazolin-5-ones%252Bto%252Bnitroalkenes%26aulast%3DLi%26aufirst%3DJun-Hua%26date%3D2013%26volume%3D11%26issue%3D36%26spage%3D6215" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></span></li></ol></div></div></div></div></div><div class="article_content-right" id="article_content-right" tabindex="0"><div class="tab tab--flex"><div class="tab__close"><i class="icon-close" tabindex="0" aria-label="close the sidebar."></i></div><ul role="tablist" class="rlist tab__nav"><li role="presentation" class="active"><a id="pane-m1con" href="#pane-m1" aria-controls="pane-m1" role="tab" data-toggle="tab" title="Figures" aria-selected="true" class="active empty" aria-label="Figures"><i class="icon-image"></i><span>Figures</span></a></li><li role="presentation"><a id="pane-m2con" href="#pane-m2" aria-controls="pane-m2" role="tab" data-toggle="tab" title="References" aria-selected="false" class="empty"><i class="icon-link"></i><span>References</span></a></li><li role="presentation"><a id="pane-m3con" href="#pane-m3" aria-controls="pane-m3" role="tab" data-toggle="tab" title="Support Info" aria-selected="false" class="empty tab__nav-suppInfo"><i class="icon-supporting-info"></i><span>Support Info</span></a></li></ul><div class="paneContainer"><ul class="rlist tab__content"><li id="pane-m1" aria-labelledby="pane-m1" class="tab__pane tab__pane-figures active empty"><figure data-id="f_tgr1" data-index="0" class="article__inlineFigure"><h2 class="fig-label">Abstract</h2><img class="rightTab-fig internalNav" src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0022.gif" alt="" id="tgr1" /></img><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0022.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=f_tgr1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig1" data-index="1" class="article__inlineFigure"><h2 class="fig-label">Figure 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0001.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0001.jpeg" id="rightTab-gr1" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 1. Structure and profile of starting PDE9A inhibitor <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0001.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig1"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig2" data-index="2" class="article__inlineFigure"><h2 class="fig-label">Figure 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0002.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0002.jpeg" id="rightTab-gr2" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 2. X-ray crystal structure of <b>1</b> bound to PDE9A (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JS1">3JS1</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0002.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig2"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig3" data-index="3" class="article__inlineFigure"><h2 class="fig-label">Figure 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0004.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0004.jpeg" id="rightTab-gr3" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 3. (top) Pyrrolidine PDE9 inhibitor PF-04447943 (<b>2</b>). (bottom) X-ray crystal structure of <b>2</b> bound to PDE9A with a water-mediated hydrogen bond to Tyr-424 via the pyrrolidine nitrogen (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW">3JSW</a>). Note an interaction with the N–CH<sub>2</sub> pyrimidine nitrogen in this case to the same bridging water.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0004.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig3"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig4" data-index="4" class="article__inlineFigure"><h2 class="fig-label">Figure 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0005.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0005.jpeg" id="rightTab-gr4" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 4. Design idea to address liabilities of hit <b>1</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0005.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch1" data-index="5" class="article__inlineFigure"><h2 class="fig-label">Scheme 1</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0006.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0006.jpeg" id="rightTab-gr13" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 1. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0006.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch1"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) R<sup>1</sup>-NHNH<sub>2</sub>, EtOH, NaOEt, rt to reflux; (b) H<sub>2</sub>O<sub>2</sub>, NH<sub>4</sub>OH, EtOH, rt or H<sub>2</sub>SO<sub>4</sub>, 0 °C to rt (60–65% over two steps); (c) (i) BrC(═O)CH(Me)Br, TEA, DMF; (ii) <i>p</i>-TsOH, toluene, reflux (22%); (d) HNRR′, K<sub>2</sub>CO<sub>3</sub>, CH<sub>3</sub>CN, reflux.</p></p></figure><figure data-id="fig5" data-index="6" class="article__inlineFigure"><h2 class="fig-label">Figure 5</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0009.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0009.jpeg" id="rightTab-gr5" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 5. Calculated and in vitro data for resynthesized library hit <b>3h</b> and the single enantiomer <b>3h</b>-(<i>R</i>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0009.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig5"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig6" data-index="7" class="article__inlineFigure"><h2 class="fig-label">Figure 6</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0010.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0010.jpeg" id="rightTab-gr6" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 6. X-ray structure of <b>3h</b>-(<i>R</i>) bound to PDE9A (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2J">4G2J</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0010.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig6"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig7" data-index="8" class="article__inlineFigure"><h2 class="fig-label">Figure 7</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0011.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0011.jpeg" id="rightTab-gr7" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 7. Merging SAR of <b>3h</b>-(<i>R</i>) and <b>2</b> yielded <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0011.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig7"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig8" data-index="9" class="article__inlineFigure"><h2 class="fig-label">Figure 8</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0012.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0012.jpeg" id="rightTab-gr8" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 8. In vivo increases in cGMP in rat CSF with increasing doses of <b>7</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0012.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig8"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch2" data-index="10" class="article__inlineFigure"><h2 class="fig-label">Scheme 2</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0013.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0013.jpeg" id="rightTab-gr14" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 2. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0013.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch2"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) amine, TEA, acetonitrile, 85–90 °C (54–70%); (b) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub> (67%); (c) R<sup>2</sup>-OH, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux, (33–85%); (d) R<sup>2</sup>-Cl or R<sup>2</sup>-Br, KO<i>t</i>-Bu, 70 °C (40–70%).</p></p></figure><figure data-id="sch3" data-index="11" class="article__inlineFigure"><h2 class="fig-label">Scheme 3</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0014.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0014.jpeg" id="rightTab-gr15" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Scheme 3. <sup>a</sup></p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0014.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch3"><span>Download MS PowerPoint Slide</span></a></div></div><p class="last"><p class="last"><span class="fn-label">Scheme a</span>(a) (<i>S</i>)-1-Chloro-1-oxopropan-2-yl acetate, dioxane, reflux; H<sub>2</sub>O, K<sub>2</sub>CO<sub>3</sub>, 45 °C (84–90%); (b) MsCl, triethylamine or <i>N</i>-methylmorpholine, 0 °C to rt (41–74%); (c) amine, TEA, acetonitrile, 85–90 °C (54–70%); (d) R<sup>2</sup>-Cl or R<sup>2</sup>-Br, KO<i>t</i>-Bu, 70 °C (40–70%); (e) MsCl, TEA, CH<sub>2</sub>Cl<sub>2</sub> (67%); (f) R<sup>2</sup>-OH, K<sub>2</sub>CO<sub>3</sub>, acetonitrile, reflux, (33–85%).</p></p></figure><figure data-id="fig9" data-index="12" class="article__inlineFigure"><h2 class="fig-label">Figure 9</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0017.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0017.jpeg" id="rightTab-gr9" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 9. Lead analogue <b>15</b> and less polar derivative <b>16</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0017.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig9"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="sch4" data-index="13" class="article__inlineFigure"><h2 class="fig-label">Scheme 4</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0018.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0018.jpeg" id="rightTab-gr16" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><div class="title2">Scheme 4. Proposed Mechanism for Rearrangement of <b>17</b> to <b>18</b></div></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0018.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=sch4"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig10" data-index="14" class="article__inlineFigure"><h2 class="fig-label">Figure 10</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0019.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0019.jpeg" id="rightTab-gr10" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 10. Calculated physicochemical properties and in vitro data for <b>19</b>.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0019.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig10"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig11" data-index="15" class="article__inlineFigure"><h2 class="fig-label">Figure 11</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0020.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0020.jpeg" id="rightTab-gr11" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 11. X-ray crystal structure of <b>19</b> bound to PDE9A (PDB <a href="https://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2L">4G2L</a>).</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0020.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig11"><span>Download MS PowerPoint Slide</span></a></div></div></figure><figure data-id="fig12" data-index="16" class="article__inlineFigure"><h2 class="fig-label">Figure 12</h2><img src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/medium/jm-2012-009635_0021.gif" alt="" data-lg-src="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0021.jpeg" id="rightTab-gr12" class="rightTab-fig internalNav" /></img><figcaption><div class="hlFld-FigureCaption caption"><p class="first last">Figure 12. CSF cGMP levels in rats treated with compound <b>19</b> as compared to vehicle.</p></div></figcaption><div class="figure-bottom-links"><div class="download-hi-res-img"><a title="High Resolution Image" href="/na101/home/literatum/publisher/achs/journals/content/jmcmar/2012/jmcmar.2012.55.issue-21/jm3009635/production/images/large/jm-2012-009635_0021.jpeg"><span>High Resolution Image</span></a></div><div class="download-ppt"><a title="Download MS PowerPoint Slide" href="/action/downloadFigures?doi=10.1021/jm3009635&amp;id=fig12"><span>Download MS PowerPoint Slide</span></a></div></div></figure></li><li id="pane-m2" aria-labelledby="pane-m2" class="tab__pane tab__pane-references empty"><div class="refs-header-label"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-_i57">References</h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a href="#" data-db-target-for="sectionsDB_25305" class="" data-db-switch="icon-angle-up"><span>Jump To</span><i class="icon-angle-down"></i></a><div data-db-target-of="sectionsDB_25305" class="dropBlock__holder"></div></div></div></div></div><hr /></hr></div><p class="rightTab-references-count">
            This article references 21 other publications.
        </p><ol id="rightTab-references" class="useLabel"><li id="rightTab-ref1"><div class="reference"><strong class="refLabel"><a href="#ref1" class="rightTabRefNumLink">1</a></strong><div class="NLM_citation" id="rightTab-cit1a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">O’Connor, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-LaFrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Suiciak, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Discovery of a Novel Class of Phosphodiesterase 10A Inhibitors and Identification of Clinical Candidate 2-[4-(1-Methyl-4-pyridin-4-yl-1<i>H</i>-pyrazol-3-yl)-phenoxymethyl]-quinoline (PF-2545920)(I) for the Treatment of Schizophrenia</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">5188</span><span class="NLM_x">–</span> <span class="NLM_lpage">5196</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm900521k" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=5188-5196&author=P.+R.+Verhoestauthor=D.+S.+Chapinauthor=M.+Cormanauthor=K.+Fonsecaauthor=J.+F.+Harmsauthor=X.+Houauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+O%E2%80%99Connorauthor=J.+Panditauthor=C.+Proulx-LaFranceauthor=A.+W.+Schmidtauthor=C.+J.+Schmidtauthor=J.+A.+Suiciakauthor=S.+Liras&title=Discovery+of+a+Novel+Class+of+Phosphodiesterase+10A+Inhibitors+and+Identification+of+Clinical+Candidate+2-%5B4-%281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%29-phenoxymethyl%5D-quinoline+%28PF-2545920%29%28I%29+for+the+Treatment+of+Schizophrenia"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1a&amp;dbid=16384&amp;doi=10.1021%2Fjm900521k&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm900521k%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DFonseca%26aufirst%3DK.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DO%25E2%2580%2599Connor%26aufirst%3DR.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DProulx-LaFrance%26aufirst%3DC.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DSuiciak%26aufirst%3DJ.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DDiscovery%2520of%2520a%2520Novel%2520Class%2520of%2520Phosphodiesterase%252010A%2520Inhibitors%2520and%2520Identification%2520of%2520Clinical%2520Candidate%25202-%255B4-%25281-Methyl-4-pyridin-4-yl-1H-pyrazol-3-yl%2529-phenoxymethyl%255D-quinoline%2520%2528PF-2545920%2529%2528I%2529%2520for%2520the%2520Treatment%2520of%2520Schizophrenia%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D5188%26epage%3D5196" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit1b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Chappie, T. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Humphrey, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Allen, M. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Estep, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fox, C. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lebel, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pandit, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tu, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Yang, F. V.</span><span> </span><span class="NLM_article-title">Discovery of a Series of 6,7-Dimethoxy-4-pyrrolidylquinazoline PDE10A Inhibitors</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">50</span><span class="NLM_x">, </span> <span class="NLM_fpage">182</span><span class="NLM_x">–</span> <span class="NLM_lpage">185</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm060653b" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=50&publication_year=2007&pages=182-185&author=T.+A.+Chappieauthor=J.+M.+Humphreyauthor=M.+P.+Allenauthor=K.+G.+Estepauthor=C.+B.+Foxauthor=L.+A.+Lebelauthor=S.+Lirasauthor=E.+S.+Marrauthor=F.+S.+Mennitiauthor=J.+Panditauthor=C.+J.+Schmidtauthor=M.+Tuauthor=R.+D.+Williamsauthor=F.+V.+Yang&title=Discovery+of+a+Series+of+6%2C7-Dimethoxy-4-pyrrolidylquinazoline+PDE10A+Inhibitors"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit1b&amp;dbid=16384&amp;doi=10.1021%2Fjm060653b&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm060653b%26sid%3Dliteratum%253Aachs%26aulast%3DChappie%26aufirst%3DT.%2BA.%26aulast%3DHumphrey%26aufirst%3DJ.%2BM.%26aulast%3DAllen%26aufirst%3DM.%2BP.%26aulast%3DEstep%26aufirst%3DK.%2BG.%26aulast%3DFox%26aufirst%3DC.%2BB.%26aulast%3DLebel%26aufirst%3DL.%2BA.%26aulast%3DLiras%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%2BS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DPandit%26aufirst%3DJ.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DTu%26aufirst%3DM.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DYang%26aufirst%3DF.%2BV.%26atitle%3DDiscovery%2520of%2520a%2520Series%2520of%25206%252C7-Dimethoxy-4-pyrrolidylquinazoline%2520PDE10A%2520Inhibitors%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2007%26volume%3D50%26spage%3D182%26epage%3D185" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref2"><div class="reference"><strong class="refLabel"><a href="#ref2" class="rightTabRefNumLink">2</a></strong><div class="NLM_citation" id="rightTab-cit2a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Andreeva, S. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Dikkes, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Epstein, P. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rosenberg, P. A.</span><span> </span><span class="NLM_article-title">Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain</span> <span class="citation_source-journal">J. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2001</span><span class="NLM_x">, </span> <span class="NLM_volume">21</span><span class="NLM_x">, </span> <span class="NLM_fpage">9068</span><span class="NLM_x">–</span> <span class="NLM_lpage">9076</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=11698617" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref2/cit2a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD3MXosleku7k%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=21&publication_year=2001&pages=9068-9076&author=S.+G.+Andreevaauthor=P.+Dikkesauthor=P.+M.+Epsteinauthor=P.+A.+Rosenberg&title=Expression+of+cGMP-specific+phosphodiesterase+9A+mRNA+in+the+rat+brain"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit2aR"><div class="casContent"><span class="casTitleNuber">2a</span><div class="casTitle"><span class="NLM_cas:atitle">Expression of cGMP-specific phosphodiesterase 9A mRNA in the rat brain</span></div><div class="casAuthors">Andreeva, Svetlana G.; Dikkes, Pieter; Epstein, Paul M.; Rosenberg, Paul A.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neuroscience</span>
        (<span class="NLM_cas:date">2001</span>),
    <span class="NLM_cas:volume">21</span>
        (<span class="NLM_cas:issue">22</span>),
    <span class="NLM_cas:pages">9068-9076</span>CODEN:
                <span class="NLM_cas:coden">JNRSDS</span>;
        ISSN:<span class="NLM_cas:issn">0270-6474</span>.
    
            (<span class="NLM_cas:orgname">Society for Neuroscience</span>)
        </div><div class="casAbstract">CGMP has been implicated in the regulation of many essential functions in the brain, such as synaptic plasticity, phototransduction, olfaction, and behavioral state.  Cyclic nucleotide phosphodiesterase (PDE) hydrolysis of cGMP is the major mechanism underlying the clearance of cGMP and is likely to be important in any process that depends on intracellular cGMP.  PDE9A has the highest affinity for cGMP of any PDE, and, here, we studied the localization of this enzyme in the rat brain using in situ hybridization.  PDE9A mRNA is widely distributed throughout the brain with varying regional expression.  The pattern of PDE9A mRNA expression closely resembles that of sol. guanylyl cyclase (sGC) in the rat brain, suggesting a possible functional assocn. or coupling of these two enzymes in the regulation of cGMP levels.  Most of the brain areas expressing PDE9A mRNA also contain neuronal nitric oxide synthase (NOS), the enzymic source of NO and the principal activator of sGC.  PDE9A is the only cGMP-specific PDE with significant expression in the forebrain, and, as such, is likely to play an important role in NO-cGMP signaling.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGoUKbKoOp02BrVg90H21EOLACvtfcHk0lit34HIGDx26Q"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXosleku7k%253D&md5=2f5e27e779e3494c89af02701c8e5745</span></div><a href="/servlet/linkout?suffix=cit2a&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DAndreeva%26aufirst%3DS.%2BG.%26aulast%3DDikkes%26aufirst%3DP.%26aulast%3DEpstein%26aufirst%3DP.%2BM.%26aulast%3DRosenberg%26aufirst%3DP.%2BA.%26atitle%3DExpression%2520of%2520cGMP-specific%2520phosphodiesterase%25209A%2520mRNA%2520in%2520the%2520rat%2520brain%26jtitle%3DJ.%2520Neurosci.%26date%3D2001%26volume%3D21%26spage%3D9068%26epage%3D9076" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit2b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Fisher, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Pillar, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">St. Denis, S. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Cheng, J. B.</span><span> </span><span class="NLM_article-title">Isolation and characterization of PDE9A, a novel human cGMP-specific phosphodiesterase</span> <span class="citation_source-journal">J. Biol. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1998</span><span class="NLM_x">, </span> <span class="NLM_volume">273</span><span class="NLM_x">, </span> <span class="NLM_fpage">15559</span><span class="NLM_x">–</span> <span class="NLM_lpage">15564</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=273&publication_year=1998&pages=15559-15564&author=D.+A.+Fisherauthor=J.+F.+Smithauthor=J.+S.+Pillarauthor=S.+H.+St.+Denisauthor=J.+B.+Cheng&title=Isolation+and+characterization+of+PDE9A%2C+a+novel+human+cGMP-specific+phosphodiesterase"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit2b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DFisher%26aufirst%3DD.%2BA.%26aulast%3DSmith%26aufirst%3DJ.%2BF.%26aulast%3DPillar%26aufirst%3DJ.%2BS.%26aulast%3DSt.%2BDenis%26aufirst%3DS.%2BH.%26aulast%3DCheng%26aufirst%3DJ.%2BB.%26atitle%3DIsolation%2520and%2520characterization%2520of%2520PDE9A%252C%2520a%2520novel%2520human%2520cGMP-specific%2520phosphodiesterase%26jtitle%3DJ.%2520Biol.%2520Chem.%26date%3D1998%26volume%3D273%26spage%3D15559%26epage%3D15564" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref3"><div class="reference"><strong class="refLabel"><a href="#ref3" class="rightTabRefNumLink">3</a></strong><div class="NLM_citation" id="rightTab-cit3a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Kleiman, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chapin, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freeman, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guanowsky, V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hajos, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Harms, J. F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hoffmann, W. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Majchrzak, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McGinnis, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">McLean, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Roof, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Seymour, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stephenson, D. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tingley, F. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo</span> <span class="citation_source-journal">J. Pharmacol. Exp. Ther.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">341</span><span class="NLM_x">, </span> <span class="NLM_fpage">396</span><span class="NLM_x">–</span> <span class="NLM_lpage">409</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1124%2Fjpet.111.191353" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=22328573" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC38Xmt1Kntb8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=341&publication_year=2012&pages=396-409&author=R.+J.+Kleimanauthor=D.+S.+Chapinauthor=C.+Christoffersenauthor=J.+Freemanauthor=K.+R.+Fonsecaauthor=K.+F.+Geogheganauthor=S.+Grimwoodauthor=V.+Guanowskyauthor=M.+Hajosauthor=J.+F.+Harmsauthor=C.+J.+Helalauthor=W.+E.+Hoffmannauthor=G.+P.+Kocanauthor=M.+J.+Majchrzakauthor=D.+McGinnisauthor=S.+McLeanauthor=F.+S.+Mennitiauthor=F.+Nelsonauthor=R.+Roofauthor=A.+W.+Schmidtauthor=P.+A.+Seymourauthor=D.+T.+Stephensonauthor=F.+D.+Tingleyauthor=M.+Vanase-Frawleyauthor=P.+R.+Verhoestauthor=C.+J.+Schmidt&title=Phosphodiesterase+9A+regulates+central+cGMP+and+modulates+responses+to+cholinergic+and+monoaminergic+perturbation+in+vivo"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3aR"><div class="casContent"><span class="casTitleNuber">3a</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase 9A regulates central cGMP and modulates responses to cholinergic and monoaminergic perturbation in vivo</span></div><div class="casAuthors">Kleiman, Robin J.; Chapin, Douglas S.; Christoffersen, Curt; Freeman, Jody; Fonseca, Kari R.; Geoghegan, Kieran F.; Grimwood, Sarah; Guanowsky, Victor; Hajos, Mihaly; Harms, John F.; Helal, Christopher J.; Hoffmann, William E.; Kocan, Geralyn P.; Majchrzak, Mark J.; McGinnis, Dina; McLean, Stafford; Menniti, Frank S.; Nelson, Fredrick; Roof, Robin; Schmidt, Anne W.; Seymour, Patricia A.; Stephenson, Diane T.; Tingley, Francis David; Vanase-Frawley, Michelle; Verhoest, Patrick R.; Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Pharmacology and Experimental Therapeutics</span>
        (<span class="NLM_cas:date">2012</span>),
    <span class="NLM_cas:volume">341</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">396-409</span>CODEN:
                <span class="NLM_cas:coden">JPETAB</span>;
        ISSN:<span class="NLM_cas:issn">1521-0103</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Cyclic nucleotides are crit. regulators of synaptic plasticity and participate in requisite signaling cascades implicated across multiple neurotransmitter systems.  Phosphodiesterase 9A (PDE9A) is a high-affinity, cGMP-specific enzyme widely expressed in the rodent central nervous system.  In the current study, we obsd. neuronal staining with antibodies raised against PDE9A protein in human cortex, cerebellum, and subiculum.  We have also developed several potent, selective, and brain-penetrant PDE9A inhibitors and used them to probe the function of PDE9A in vivo.  Administration of these compds. to animals led to dose-dependent accumulation of cGMP in brain tissue and cerebrospinal fluid, producing a range of biol. effects that implied functional significance for PDE9A-regulated cGMP in dopaminergic, cholinergic, and serotonergic neurotransmission and were consistent with the widespread distribution of PDE9A.  In vivo effects of PDE9A inhibition included reversal of the resp. disruptions of working memory by ketamine, episodic and spatial memory by scopolamine, and auditory gating by amphetamine, as well as potentiation of Risperidone-induced improvements in sensorimotor gating and reversal of the stereotypic scratching response to the hallucinogenic 5-hydroxytryptamine 2A agonist mescaline.  The results suggested a role for PDE9A in the regulation of monoaminergic circuitry assocd. with sensory processing and memory.  Thus, PDE9A activity regulates neuronal cGMP signaling downstream of multiple neurotransmitter systems, and inhibition of PDE9A may provide therapeutic benefits in psychiatric and neurodegenerative diseases promoted by the dysfunction of these diverse neurotransmitter systems.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGowRPHmE1fhCLVg90H21EOLACvtfcHk0ljlvJzO9A47uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC38Xmt1Kntb8%253D&md5=f4a217c7e731f7909557a1d493c9192d</span></div><a href="/servlet/linkout?suffix=cit3a&amp;dbid=16384&amp;doi=10.1124%2Fjpet.111.191353&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fjpet.111.191353%26sid%3Dliteratum%253Aachs%26aulast%3DKleiman%26aufirst%3DR.%2BJ.%26aulast%3DChapin%26aufirst%3DD.%2BS.%26aulast%3DChristoffersen%26aufirst%3DC.%26aulast%3DFreeman%26aufirst%3DJ.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DGeoghegan%26aufirst%3DK.%2BF.%26aulast%3DGrimwood%26aufirst%3DS.%26aulast%3DGuanowsky%26aufirst%3DV.%26aulast%3DHajos%26aufirst%3DM.%26aulast%3DHarms%26aufirst%3DJ.%2BF.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHoffmann%26aufirst%3DW.%2BE.%26aulast%3DKocan%26aufirst%3DG.%2BP.%26aulast%3DMajchrzak%26aufirst%3DM.%2BJ.%26aulast%3DMcGinnis%26aufirst%3DD.%26aulast%3DMcLean%26aufirst%3DS.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DNelson%26aufirst%3DF.%26aulast%3DRoof%26aufirst%3DR.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DSeymour%26aufirst%3DP.%2BA.%26aulast%3DStephenson%26aufirst%3DD.%2BT.%26aulast%3DTingley%26aufirst%3DF.%2BD.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%25209A%2520regulates%2520central%2520cGMP%2520and%2520modulates%2520responses%2520to%2520cholinergic%2520and%2520monoaminergic%2520perturbation%2520in%2520vivo%26jtitle%3DJ.%2520Pharmacol.%2520Exp.%2520Ther.%26date%3D2012%26volume%3D341%26spage%3D396%26epage%3D409" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Finger, E. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Magliaro, B. C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smith, S. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sanderson, P. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mullins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hyde, L. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eschle, B. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Turnbull, Z.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sloan, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Guzzi, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rindgen, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mazzola, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vivian, J. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Eddins, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bednar, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gambone, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le-Mair, W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marino, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sachs, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Xu, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Parmentier-Batteur, S.</span><span> </span><span class="NLM_article-title">The selective phosphodiesterase 9 (PDE9) inhibitor PF-04447943 (6-[(3<i>S</i>,4<i>S</i>)-4-methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one) enhances synaptic plasticity and cognitive function in rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">61</span><span class="NLM_x">, </span> <span class="NLM_fpage">665</span><span class="NLM_x">–</span> <span class="NLM_lpage">676</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=61&publication_year=2011&pages=665-676&author=P.+H.+Hutsonauthor=E.+N.+Fingerauthor=B.+C.+Magliaroauthor=S.+M.+Smithauthor=A.+Conversoauthor=P.+E.+Sandersonauthor=D.+Mullinsauthor=L.+A.+Hydeauthor=B.+K.+Eschleauthor=Z.+Turnbullauthor=H.+Sloanauthor=M.+Guzziauthor=X.+Zhangauthor=A.+Wangauthor=D.+Rindgenauthor=R.+Mazzolaauthor=J.+A.+Vivianauthor=D.+Eddinsauthor=J.+M.+Uslanerauthor=R.+Bednarauthor=C.+Gamboneauthor=W.+Le-Mairauthor=M.+J.+Marinoauthor=N.+Sachsauthor=G.+Xuauthor=S.+Parmentier-Batteur&title=The+selective+phosphodiesterase+9+%28PDE9%29+inhibitor+PF-04447943+%286-%5B%283S%2C4S%29-4-methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one%29+enhances+synaptic+plasticity+and+cognitive+function+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DFinger%26aufirst%3DE.%2BN.%26aulast%3DMagliaro%26aufirst%3DB.%2BC.%26aulast%3DSmith%26aufirst%3DS.%2BM.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DSanderson%26aufirst%3DP.%2BE.%26aulast%3DMullins%26aufirst%3DD.%26aulast%3DHyde%26aufirst%3DL.%2BA.%26aulast%3DEschle%26aufirst%3DB.%2BK.%26aulast%3DTurnbull%26aufirst%3DZ.%26aulast%3DSloan%26aufirst%3DH.%26aulast%3DGuzzi%26aufirst%3DM.%26aulast%3DZhang%26aufirst%3DX.%26aulast%3DWang%26aufirst%3DA.%26aulast%3DRindgen%26aufirst%3DD.%26aulast%3DMazzola%26aufirst%3DR.%26aulast%3DVivian%26aufirst%3DJ.%2BA.%26aulast%3DEddins%26aufirst%3DD.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26aulast%3DBednar%26aufirst%3DR.%26aulast%3DGambone%26aufirst%3DC.%26aulast%3DLe-Mair%26aufirst%3DW.%26aulast%3DMarino%26aufirst%3DM.%2BJ.%26aulast%3DSachs%26aufirst%3DN.%26aulast%3DXu%26aufirst%3DG.%26aulast%3DParmentier-Batteur%26aufirst%3DS.%26atitle%3DThe%2520selective%2520phosphodiesterase%25209%2520%2528PDE9%2529%2520inhibitor%2520PF-04447943%2520%25286-%255B%25283S%252C4S%2529-4-methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2529%2520enhances%2520synaptic%2520plasticity%2520and%2520cognitive%2520function%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2011%26volume%3D61%26spage%3D665%26epage%3D676" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3c"><span><span class="NLM_label">(c) </span><span class="NLM_contrib-group">Vardigan, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Converso, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hutson, P. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Uslaner, J. M.</span><span> </span><span class="NLM_article-title">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span> <span class="citation_source-journal">J. Neurogenet.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2011</span><span class="NLM_x">, </span> <span class="NLM_volume">25</span><span class="NLM_x">, </span> <span class="NLM_fpage">120</span><span class="NLM_x">–</span> <span class="NLM_lpage">126</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.3109%2F01677063.2011.630494" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=22070409" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3c&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=25&publication_year=2011&pages=120-126&author=J.+D.+Vardiganauthor=A.+Conversoauthor=P.+H.+Hutsonauthor=J.+M.+Uslaner&title=The+Selective+Phosphodiesterase+9+%28PDE9%29+Inhibitor+PF-04447943+Attenuates+a+Scopolamine-Induced+Deficit+in+a+Novel+Rodent+Attention+Task"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3cR"><div class="casContent"><span class="casTitleNuber">3c</span><div class="casTitle"><span class="NLM_cas:atitle">The Selective Phosphodiesterase 9 (PDE9) Inhibitor PF-04447943 Attenuates a Scopolamine-Induced Deficit in a Novel Rodent Attention Task</span></div><div class="casAuthors">Vardigan, Joshua D.; Converso, Antonella; Hutson, Pete H.; Uslaner, Jason M.</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Neurogenetics</span>
        (<span class="NLM_cas:date">2011</span>),
    <span class="NLM_cas:volume">25</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">120-126</span>CODEN:
                <span class="NLM_cas:coden">JLNEDK</span>;
        ISSN:<span class="NLM_cas:issn">0167-7063</span>.
    
            (<span class="NLM_cas:orgname">Informa Healthcare</span>)
        </div><div class="casAbstract">Numerous changes occur during aging and Alzheimer's disease (AD) progression, including a decline in cholinergic functioning and cognition, as well as alterations in gene expression and activity in the nitric oxide/cyclic guanosine monophosphate (NO/cGMP) pathway.  Donepezil, the current std. of care for Alzheimer's disease, improves cholinergic functioning and has demonstrated effects on multiple domains of cognition, including memory and attention in both preclin. species and patients.  We previously found that increasing activation of the NO/cGMP pathway via phosphodiesterase 9 (PDE9) inhibition also improves memory in rodents and suggested that PDE9 might be a promising target for novel treatments for AD.  Here we investigated whether PDE9 inhibition also enhances attention using a novel attention task in rats.  We validated this task using several pharmacol. manipulations and showed that the selective PDE9 inhibitor PF-04447943 produced effects similar to those of donepezil.  These data confirm and extend the hypothesis that PDE9 inhibition might serve as a novel treatment for AD and age-related cognitive decline.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqJa-1clww9LrVg90H21EOLACvtfcHk0ljlvJzO9A47uw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3MXhsV2hs7bF&md5=1d03e024134e690d1765bd4ee8576aad</span></div><a href="/servlet/linkout?suffix=cit3c&amp;dbid=16384&amp;doi=10.3109%2F01677063.2011.630494&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.3109%252F01677063.2011.630494%26sid%3Dliteratum%253Aachs%26aulast%3DVardigan%26aufirst%3DJ.%2BD.%26aulast%3DConverso%26aufirst%3DA.%26aulast%3DHutson%26aufirst%3DP.%2BH.%26aulast%3DUslaner%26aufirst%3DJ.%2BM.%26atitle%3DThe%2520Selective%2520Phosphodiesterase%25209%2520%2528PDE9%2529%2520Inhibitor%2520PF-04447943%2520Attenuates%2520a%2520Scopolamine-Induced%2520Deficit%2520in%2520a%2520Novel%2520Rodent%2520Attention%2520Task%26jtitle%3DJ.%2520Neurogenet.%26date%3D2011%26volume%3D25%26spage%3D120%26epage%3D126" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3d"><span><span class="NLM_label">(d) </span><span class="NLM_contrib-group">Halene, T. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Siegel, S. J.</span><span> </span><span class="NLM_article-title">PDE inhibitors in psychiatry—future options for dementia, depression and schizophrenia?</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">12</span><span class="NLM_x">, </span> <span class="NLM_fpage">870</span><span class="NLM_x">–</span> <span class="NLM_lpage">878</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=12&publication_year=2007&pages=870-878&author=T.+B.+Haleneauthor=S.+J.+Siegel&title=PDE+inhibitors+in+psychiatry%E2%80%94future+options+for+dementia%2C+depression+and+schizophrenia%3F"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3d&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHalene%26aufirst%3DT.%2BB.%26aulast%3DSiegel%26aufirst%3DS.%2BJ.%26atitle%3DPDE%2520inhibitors%2520in%2520psychiatry%25E2%2580%2594future%2520options%2520for%2520dementia%252C%2520depression%2520and%2520schizophrenia%253F%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2007%26volume%3D12%26spage%3D870%26epage%3D878" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3e"><span><span class="NLM_label">(e) </span><span class="NLM_contrib-group">Reneerkens, O. A. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steinbusch, H. W. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span> </span><span class="NLM_article-title">Selective phosphodiesterase inhibitors: a promising target for cognition enhancement</span> <span class="citation_source-journal">Psychopharmacology (Berlin, Ger.)</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">202</span><span class="NLM_x">, </span> <span class="NLM_fpage">419</span><span class="NLM_x">–</span> <span class="NLM_lpage">443</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1007%2Fs00213-008-1273-x" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=18709359" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3e&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXht1ehtLY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=202&publication_year=2009&pages=419-443&author=O.+A.+H.+Reneerkensauthor=K.+Ruttenauthor=H.+W.+M.+Steinbuschauthor=A.+Bloklandauthor=J.+Prickaerts&title=Selective+phosphodiesterase+inhibitors%3A+a+promising+target+for+cognition+enhancement"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3eR"><div class="casContent"><span class="casTitleNuber">3e</span><div class="casTitle"><span class="NLM_cas:atitle">Selective phosphodiesterase inhibitors: a promising target for cognition enhancement</span></div><div class="casAuthors">Reneerkens, Olga A. H.; Rutten, Kris; Steinbusch, Harry W. M.; Blokland, Arjan; Prickaerts, Jos</div><div class="citationInfo"><span class="NLM_cas:title">Psychopharmacology (Berlin, Germany)</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">202</span>
        (<span class="NLM_cas:issue">1-3</span>),
    <span class="NLM_cas:pages">419-443</span>CODEN:
                <span class="NLM_cas:coden">PSCHDL</span>;
        ISSN:<span class="NLM_cas:issn">0033-3158</span>.
    
            (<span class="NLM_cas:orgname">Springer GmbH</span>)
        </div><div class="casAbstract">A review.  Rationale: One of the major complaints most people face during aging is an impairment in cognitive functioning.  This has a neg. impact on the quality of daily life and is even more prominent in patients suffering from neurodegenerative and psychiatric disorders including Alzheimer's disease, schizophrenia, and depression.  So far, the majority of cognition enhancers are generally targeting one particular neurotransmitter system.  However, recently phosphodiesterases (PDEs) have gained increased attention as a potential new target for cognition enhancement.  Inhibition of PDEs increases the intracellular availability of the second messengers cGMP and/or cAMP.  Objective: The aim of this review was to provide an overview of the effects of phosphodiesterase inhibitors (PDE-Is) on cognition, the possible underlying mechanisms, and the relation to current theories about memory formation.  Materials and methods: Studies of the effects of inhibitors of different PDE families (2, 4, 5, 9, and 10) on cognition were reviewed.  In addn., studies related to PDE-Is and blood flow, emotional arousal, and long-term potentiation (LTP) were described.  Results: PDE-Is have a pos. effect on several aspects of cognition, including information processing, attention, memory, and executive functioning.  At present, these data are likely to be explained in terms of an LTP-related mechanism of action.  Conclusion: PDE-Is are a promising target for cognition enhancement; the most suitable candidates appear to be PDE2-Is or PDE9-Is.  The future for PDE-Is as cognition enhancers lies in the development of isoform-specific PDE-Is that have limited aversive side effects.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGplGdOOMyV-UrVg90H21EOLACvtfcHk0ljudLXJxDP9Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXht1ehtLY%253D&md5=77cb3c20950eff0d5590c704e74e4ba8</span></div><a href="/servlet/linkout?suffix=cit3e&amp;dbid=16384&amp;doi=10.1007%2Fs00213-008-1273-x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1007%252Fs00213-008-1273-x%26sid%3Dliteratum%253Aachs%26aulast%3DReneerkens%26aufirst%3DO.%2BA.%2BH.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DSteinbusch%26aufirst%3DH.%2BW.%2BM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26atitle%3DSelective%2520phosphodiesterase%2520inhibitors%253A%2520a%2520promising%2520target%2520for%2520cognition%2520enhancement%26jtitle%3DPsychopharmacology%2520%2528Berlin%252C%2520Ger.%2529%26date%3D2009%26volume%3D202%26spage%3D419%26epage%3D443" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3f"><span><span class="NLM_label">(f) </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span> </span><span class="NLM_article-title">Phosphodiesterase inhibitors as potential cognition enhancing agents</span> <span class="citation_source-journal">Curr. Top. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">222</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.2174%2F156802610790411009" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=20166957" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref3/cit3f&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2010&pages=222-230&author=C.+J.+Schmidt&title=Phosphodiesterase+inhibitors+as+potential+cognition+enhancing+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit3fR"><div class="casContent"><span class="casTitleNuber">3f</span><div class="casTitle"><span class="NLM_cas:atitle">Phosphodiesterase inhibitors as potential cognition enhancing agents</span></div><div class="casAuthors">Schmidt, Christopher J.</div><div class="citationInfo"><span class="NLM_cas:title">Current Topics in Medicinal Chemistry (Sharjah, United Arab Emirates)</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">10</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">222-230</span>CODEN:
                <span class="NLM_cas:coden">CTMCCL</span>;
        ISSN:<span class="NLM_cas:issn">1568-0266</span>.
    
            (<span class="NLM_cas:orgname">Bentham Science Publishers Ltd.</span>)
        </div><div class="casAbstract">A review.  As might be predicted for an organ designed for cell to cell communication, cyclic nucleotide signaling in the brain is highly organized and regulated.  Augmentation of cyclic nucleotide signaling by means of phosphodiesterase inhibition appears to be a viable and tractable means of enhancing neuronal communication.  Of the various CNS disorders that have been considered as target indications for phosphodiesterase inhibitors, no condition has received more attention than cognitive dysfunction.  This review provides a background for understanding the expanding literature in this field as well as a brief update on the rationale driving the search for selective inhibitors of targets such as PDE1B, PDE2, PDE5 and PDE9.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqBVYtnViej97Vg90H21EOLACvtfcHk0ljudLXJxDP9Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjtFajsrY%253D&md5=47e8397d9f69207c27940575411bbe12</span></div><a href="/servlet/linkout?suffix=cit3f&amp;dbid=16384&amp;doi=10.2174%2F156802610790411009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.2174%252F156802610790411009%26sid%3Dliteratum%253Aachs%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26atitle%3DPhosphodiesterase%2520inhibitors%2520as%2520potential%2520cognition%2520enhancing%2520agents%26jtitle%3DCurr.%2520Top.%2520Med.%2520Chem.%26date%3D2010%26volume%3D10%26spage%3D222%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3g"><span><span class="NLM_label">(g) </span><span class="NLM_contrib-group">Siuciak, J. A.</span><span> </span><span class="NLM_article-title">The role of phosphodiesterases in schizophrenia: therapeutic implications</span> <span class="citation_source-journal">CNS Drugs</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">22</span><span class="NLM_x">, </span> <span class="NLM_fpage">983</span><span class="NLM_x">–</span> <span class="NLM_lpage">993</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=22&publication_year=2008&pages=983-993&author=J.+A.+Siuciak&title=The+role+of+phosphodiesterases+in+schizophrenia%3A+therapeutic+implications"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3g&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DSiuciak%26aufirst%3DJ.%2BA.%26atitle%3DThe%2520role%2520of%2520phosphodiesterases%2520in%2520schizophrenia%253A%2520therapeutic%2520implications%26jtitle%3DCNS%2520Drugs%26date%3D2008%26volume%3D22%26spage%3D983%26epage%3D993" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit3h"><span><span class="NLM_label">(h) </span><span class="NLM_contrib-group">van der Staay, F. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rutten, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Baerfacker, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeVry, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Erb, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Heckroth, H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Karthaus, D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tersteegen, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">van Kampen, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blokland, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Prickaerts, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Reymann, K. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, U. H.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hendrix, M.</span><span> </span><span class="NLM_article-title">The novel selective PDE9 inhibitor BAY 73–6691 improves learning and memory in rodents</span> <span class="citation_source-journal">Neuropharmacology</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">908</span><span class="NLM_x">–</span> <span class="NLM_lpage">918</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2008&pages=908-918&author=F.+J.+van+der+Staayauthor=K.+Ruttenauthor=L.+Baerfackerauthor=J.+DeVryauthor=C.+Erbauthor=H.+Heckrothauthor=D.+Karthausauthor=A.+Tersteegenauthor=M.+van+Kampenauthor=A.+Bloklandauthor=J.+Prickaertsauthor=K.+G.+Reymannauthor=U.+H.+Schroederauthor=M.+Hendrix&title=The+novel+selective+PDE9+inhibitor+BAY+73%E2%80%936691+improves+learning+and+memory+in+rodents"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit3h&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3Dvan%2Bder%2BStaay%26aufirst%3DF.%2BJ.%26aulast%3DRutten%26aufirst%3DK.%26aulast%3DBaerfacker%26aufirst%3DL.%26aulast%3DDeVry%26aufirst%3DJ.%26aulast%3DErb%26aufirst%3DC.%26aulast%3DHeckroth%26aufirst%3DH.%26aulast%3DKarthaus%26aufirst%3DD.%26aulast%3DTersteegen%26aufirst%3DA.%26aulast%3Dvan%2BKampen%26aufirst%3DM.%26aulast%3DBlokland%26aufirst%3DA.%26aulast%3DPrickaerts%26aufirst%3DJ.%26aulast%3DReymann%26aufirst%3DK.%2BG.%26aulast%3DSchroeder%26aufirst%3DU.%2BH.%26aulast%3DHendrix%26aufirst%3DM.%26atitle%3DThe%2520novel%2520selective%2520PDE9%2520inhibitor%2520BAY%252073%25E2%2580%25936691%2520improves%2520learning%2520and%2520memory%2520in%2520rodents%26jtitle%3DNeuropharmacology%26date%3D2008%26volume%3D55%26spage%3D908%26epage%3D918" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref4"><div class="reference"><strong class="refLabel"><a href="#ref4" class="rightTabRefNumLink">4</a></strong><div class="NLM_citation" id="rightTab-cit4"><span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Proulx-Lafrance, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corman, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chenard, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Helal, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kleiman, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liu, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marr, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Menniti, F. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Vanase-Frawley, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schmidt, A. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Williams, R. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fonseca, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Liras, S.</span><span> </span><span class="NLM_article-title">Identification of a brain penetrant PDE9A inhibitor utilizing prospective design and chemical enablement as a rapid lead optimization strategy</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">52</span><span class="NLM_x">, </span> <span class="NLM_fpage">7946</span><span class="NLM_x">–</span> <span class="NLM_lpage">7949</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm9015334" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref4/cit4&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=52&publication_year=2009&pages=7946-7949&author=P.+R.+Verhoestauthor=C.+Proulx-Lafranceauthor=M.+Cormanauthor=L.+Chenardauthor=C.+J.+Helalauthor=X.+Houauthor=R.+Kleimanauthor=S.+Liuauthor=E.+Marrauthor=F.+S.+Mennitiauthor=C.+J.+Schmidtauthor=M.+Vanase-Frawleyauthor=A.+W.+Schmidtauthor=R.+D.+Williamsauthor=F.+R.+Nelsonauthor=K.+R.+Fonsecaauthor=S.+Liras&title=Identification+of+a+brain+penetrant+PDE9A+inhibitor+utilizing+prospective+design+and+chemical+enablement+as+a+rapid+lead+optimization+strategy"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit4R"><div class="casContent"><span class="casTitleNuber">4</span><div class="casTitle"><span class="NLM_cas:atitle">Identification of a Brain Penetrant PDE9A Inhibitor Utilizing Prospective Design and Chemical Enablement as a Rapid Lead Optimization Strategy</span></div><div class="casAuthors">Verhoest, Patrick R.; Proulx-Lafrance, Caroline; Corman, Michael; Chenard, Lois; Helal, Christopher J.; Hou, Xinjun; Kleiman, Robin; Liu, Shenping; Marr, Eric; Menniti, Frank S.; Schmidt, Christopher J.; Vanase-Frawley, Michelle; Schmidt, Anne W.; Williams, Robert D.; Nelson, Frederick R.; Fonseca, Kari R.; Liras, Spiros</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2009</span>),
    <span class="NLM_cas:volume">52</span>
        (<span class="NLM_cas:issue">24</span>),
    <span class="NLM_cas:pages">7946-7949</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A novel series of selective, brain penetrant PDE9A inhibitors I (R1 = i-Pr, i-Bu, cyclopentyl, R2 = Ph; R1 = cyclopentyl, R2 = 3-MeC6H4, 2-pyridyl, 6-quinoxalinyl, etc.) has been identified that are capable of producing in vivo elevations of brain cGMP.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGou_Q49qDJV3bVg90H21EOLACvtfcHk0ljudLXJxDP9Lg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1MXhsValtbzI&md5=4e1a67684031737596a83d1feb4bee08</span></div><a href="/servlet/linkout?suffix=cit4&amp;dbid=16384&amp;doi=10.1021%2Fjm9015334&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm9015334%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DProulx-Lafrance%26aufirst%3DC.%26aulast%3DCorman%26aufirst%3DM.%26aulast%3DChenard%26aufirst%3DL.%26aulast%3DHelal%26aufirst%3DC.%2BJ.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DKleiman%26aufirst%3DR.%26aulast%3DLiu%26aufirst%3DS.%26aulast%3DMarr%26aufirst%3DE.%26aulast%3DMenniti%26aufirst%3DF.%2BS.%26aulast%3DSchmidt%26aufirst%3DC.%2BJ.%26aulast%3DVanase-Frawley%26aufirst%3DM.%26aulast%3DSchmidt%26aufirst%3DA.%2BW.%26aulast%3DWilliams%26aufirst%3DR.%2BD.%26aulast%3DNelson%26aufirst%3DF.%2BR.%26aulast%3DFonseca%26aufirst%3DK.%2BR.%26aulast%3DLiras%26aufirst%3DS.%26atitle%3DIdentification%2520of%2520a%2520brain%2520penetrant%2520PDE9A%2520inhibitor%2520utilizing%2520prospective%2520design%2520and%2520chemical%2520enablement%2520as%2520a%2520rapid%2520lead%2520optimization%2520strategy%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2009%26volume%3D52%26spage%3D7946%26epage%3D7949" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref5"><div class="reference"><strong class="refLabel"><a href="#ref5" class="rightTabRefNumLink">5</a></strong><div class="NLM_citation" id="rightTab-cit5"><span><span class="NLM_contrib-group">Hopkins Andrew, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Groom Colin, R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Alex, A.</span><span> </span><span class="NLM_article-title">Ligand efficiency: a useful metric for lead selection</span> <span class="citation_source-journal">Drug Discovery Today</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">9</span><span class="NLM_x">, </span> <span class="NLM_fpage">430</span><span class="NLM_x">–</span> <span class="NLM_lpage">431</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=9&publication_year=2004&pages=430-431&author=L.+Hopkins+Andrewauthor=R.+Groom+Colinauthor=A.+Alex&title=Ligand+efficiency%3A+a+useful+metric+for+lead+selection"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit5&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DHopkins%2BAndrew%26aufirst%3DL.%26aulast%3DGroom%2BColin%26aufirst%3DR.%26aulast%3DAlex%26aufirst%3DA.%26atitle%3DLigand%2520efficiency%253A%2520a%2520useful%2520metric%2520for%2520lead%2520selection%26jtitle%3DDrug%2520Discovery%2520Today%26date%3D2004%26volume%3D9%26spage%3D430%26epage%3D431" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref6"><div class="reference"><strong class="refLabel"><a href="#ref6" class="rightTabRefNumLink">6</a></strong><div class="NLM_citation" id="rightTab-cit6a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Gleeson, M. P.</span><span> </span><span class="NLM_article-title">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">51</span><span class="NLM_x">, </span> <span class="NLM_fpage">817</span><span class="NLM_x">–</span> <span class="NLM_lpage">834</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm701122q" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref6/cit6a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=51&publication_year=2008&pages=817-834&author=M.+P.+Gleeson&title=Generation+of+a+Set+of+Simple%2C+Interpretable+ADMET+Rules+of+Thumb"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit6aR"><div class="casContent"><span class="casTitleNuber">6a</span><div class="casTitle"><span class="NLM_cas:atitle">Generation of a Set of Simple, Interpretable ADMET Rules of Thumb</span></div><div class="casAuthors">Gleeson, M. Paul</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Medicinal Chemistry</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">51</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">817-834</span>CODEN:
                <span class="NLM_cas:coden">JMCMAR</span>;
        ISSN:<span class="NLM_cas:issn">0022-2623</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">A set of simple, consistent structure-property guides have been detd. from an anal. of a no. of key ADMET assays run within GSK: soly., permeability, bioavailability, vol. of distribution, plasma protein binding, CNS penetration, brain tissue binding, P-gp efflux, hERG inhibition, and cytochrome P 450 1A2/2C9/2C19/2D6/3A4 inhibition.  The rules have been formulated using mol. properties that chemists intuitively know how to alter in a mol., namely, mol. wt., logP, and ionization state.  The rules supplement the more predictive black-box models available to us by clearly illustrating the key underlying trends, which are in line with reports in the literature.  It is clear from the analyses reported herein that almost all ADMET parameters deteriorate with either increasing mol. wt., logP, or both, with ionization state playing either a beneficial or detrimental affect depending on the parameter in question.  This study reemphasizes the need to focus on a lower mol. wt. and logP area of physicochem. property space to obtain improved ADMET parameters.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGo7PTdPHoD-c7Vg90H21EOLACvtfcHk0ljAyDgFBMKJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtl2msrk%253D&md5=42db5918ad8e9ea3ecf3a13846b3a434</span></div><a href="/servlet/linkout?suffix=cit6a&amp;dbid=16384&amp;doi=10.1021%2Fjm701122q&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm701122q%26sid%3Dliteratum%253Aachs%26aulast%3DGleeson%26aufirst%3DM.%2BP.%26atitle%3DGeneration%2520of%2520a%2520Set%2520of%2520Simple%252C%2520Interpretable%2520ADMET%2520Rules%2520of%2520Thumb%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2008%26volume%3D51%26spage%3D817%26epage%3D834" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit6b"><span><span class="NLM_label">(b) </span><span class="NLM_contrib-group">Hitchcock, S. A.</span><span> </span><span class="NLM_article-title">Structural Modifications that Alter the P-Glycoprotein Efflux Properties of Compounds</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span> <span class="NLM_volume">55</span><span class="NLM_x">, </span> <span class="NLM_fpage">4877</span><span class="NLM_x">–</span> <span class="NLM_lpage">4895</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm201136z" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=55&publication_year=2012&pages=4877-4895&author=S.+A.+Hitchcock&title=Structural+Modifications+that+Alter+the+P-Glycoprotein+Efflux+Properties+of+Compounds"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit6b&amp;dbid=16384&amp;doi=10.1021%2Fjm201136z&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm201136z%26sid%3Dliteratum%253Aachs%26aulast%3DHitchcock%26aufirst%3DS.%2BA.%26atitle%3DStructural%2520Modifications%2520that%2520Alter%2520the%2520P-Glycoprotein%2520Efflux%2520Properties%2520of%2520Compounds%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012%26volume%3D55%26spage%3D4877%26epage%3D4895" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref7"><div class="reference"><strong class="refLabel"><a href="#ref7" class="rightTabRefNumLink">7</a></strong><div class="NLM_citation" id="rightTab-cit7"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Chandrasekaran, R. Y.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Will, Y.</span><span> </span><span class="NLM_article-title">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">420</span><span class="NLM_x">–</span> <span class="NLM_lpage">434</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100007x" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref7/cit7&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=420-434&author=T.+T.+Wagerauthor=R.+Y.+Chandrasekaranauthor=X.+Houauthor=M.+D.+Troutmanauthor=P.+R.+Verhoestauthor=A.+Villalobosauthor=Y.+Will&title=Defining+Desirable+Central+Nervous+System+Drug+Space+through+the+Alignment+of+Molecular+Properties%2C+in+Vitro+ADME%2C+and+Safety+Attributes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit7R"><div class="casContent"><span class="casTitleNuber">7</span><div class="casTitle"><span class="NLM_cas:atitle">Defining Desirable Central Nervous System Drug Space through the Alignment of Molecular Properties, in Vitro ADME, and Safety Attributes</span></div><div class="casAuthors">Wager, Travis T.; Chandrasekaran, Ramalakshmi Y.; Hou, Xinjun; Troutman, Matthew D.; Verhoest, Patrick R.; Villalobos, Anabella; Will, Yvonne</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">420-434</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">As part of our effort to increase survival of drug candidates and to move our medicinal chem. design to higher probability space for success in the Neuroscience therapeutic area, we embarked on a detailed study of the property space for a collection of central nervous system (CNS) mols.  We carried out a thorough anal. of properties for 119 marketed CNS drugs and a set of 108 Pfizer CNS candidates.  In particular, we focused on understanding the relationships between physicochem. properties, in vitro ADME (absorption, distribution, metab., and elimination) attributes, primary pharmacol. binding efficiencies, and in vitro safety data for these two sets of compds.  This scholarship provides guidance for the design of CNS mols. in a property space with increased probability of success and may lead to the identification of druglike candidates with favorable safety profiles that can successfully test hypotheses in the clinic.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqvEMBo2f34BrVg90H21EOLACvtfcHk0ljAyDgFBMKJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVaqtbk%253D&md5=85716be86290fd85e93c6b8d5621683c</span></div><a href="/servlet/linkout?suffix=cit7&amp;dbid=16384&amp;doi=10.1021%2Fcn100007x&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100007x%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DChandrasekaran%26aufirst%3DR.%2BY.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26aulast%3DWill%26aufirst%3DY.%26atitle%3DDefining%2520Desirable%2520Central%2520Nervous%2520System%2520Drug%2520Space%2520through%2520the%2520Alignment%2520of%2520Molecular%2520Properties%252C%2520in%2520Vitro%2520ADME%252C%2520and%2520Safety%2520Attributes%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D420%26epage%3D434" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref8"><div class="reference"><strong class="refLabel"><a href="#ref8" class="rightTabRefNumLink">8</a></strong><div class="NLM_citation" id="rightTab-cit8"><span><span class="NLM_contrib-group">Hughes, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blagg, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Price, D. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bailey, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">DeCrescenzo, G. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Devraj, R. V.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fobian, Y. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gibbs, M. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gilles, R. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Greene, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huang, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Krieger-Burke, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Loesel, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wager, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Whiteley, L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhang, Y.</span><span> </span><span class="NLM_article-title">Physiochemical drug properties associated with in vivo toxicological outcomes</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">18</span><span class="NLM_x">, </span> <span class="NLM_fpage">4872</span><span class="NLM_x">–</span> <span class="NLM_lpage">4875</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1016%2Fj.bmcl.2008.07.071" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=18691886" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref8/cit8&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=18&publication_year=2008&pages=4872-4875&author=J.+D.+Hughesauthor=J.+Blaggauthor=D.+A.+Priceauthor=S.+Baileyauthor=G.+A.+DeCrescenzoauthor=R.+V.+Devrajauthor=E.+Ellsworthauthor=Y.+M.+Fobianauthor=M.+E.+Gibbsauthor=R.+W.+Gillesauthor=N.+Greeneauthor=E.+Huangauthor=T.+Krieger-Burkeauthor=J.+Loeselauthor=T.+Wagerauthor=L.+Whiteleyauthor=Y.+Zhang&title=Physiochemical+drug+properties+associated+with+in+vivo+toxicological+outcomes"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit8R"><div class="casContent"><span class="casTitleNuber">8</span><div class="casTitle"><span class="NLM_cas:atitle">Physiochemical drug properties associated with in vivo toxicological outcomes</span></div><div class="casAuthors">Hughes, Jason D.; Blagg, Julian; Price, David A.; Bailey, Simon; DeCrescenzo, Gary A.; Devraj, Rajesh V.; Ellsworth, Edmund; Fobian, Yvette M.; Gibbs, Michael E.; Gilles, Richard W.; Greene, Nigel; Huang, Enoch; Krieger-Burke, Teresa; Loesel, Jens; Wager, Travis; Whiteley, Larry; Zhang, Yao</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">18</span>
        (<span class="NLM_cas:issue">17</span>),
    <span class="NLM_cas:pages">4872-4875</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Relationships between physicochem. drug properties and toxicity were inferred from a data set consisting of animal in vivo toleration (IVT) studies on 245 preclin. Pfizer compds.; an increased likelihood of toxic events was found for less polar, more lipophilic compds.  This trend held across a wide range of types of toxicity and across a broad swath of chem. space.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrPMmGEpVF0mbVg90H21EOLACvtfcHk0ljAyDgFBMKJuw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXhtVOnsbjE&md5=80ea5ced359112a363f38b3545cd7646</span></div><a href="/servlet/linkout?suffix=cit8&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2008.07.071&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2008.07.071%26sid%3Dliteratum%253Aachs%26aulast%3DHughes%26aufirst%3DJ.%2BD.%26aulast%3DBlagg%26aufirst%3DJ.%26aulast%3DPrice%26aufirst%3DD.%2BA.%26aulast%3DBailey%26aufirst%3DS.%26aulast%3DDeCrescenzo%26aufirst%3DG.%2BA.%26aulast%3DDevraj%26aufirst%3DR.%2BV.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DFobian%26aufirst%3DY.%2BM.%26aulast%3DGibbs%26aufirst%3DM.%2BE.%26aulast%3DGilles%26aufirst%3DR.%2BW.%26aulast%3DGreene%26aufirst%3DN.%26aulast%3DHuang%26aufirst%3DE.%26aulast%3DKrieger-Burke%26aufirst%3DT.%26aulast%3DLoesel%26aufirst%3DJ.%26aulast%3DWager%26aufirst%3DT.%26aulast%3DWhiteley%26aufirst%3DL.%26aulast%3DZhang%26aufirst%3DY.%26atitle%3DPhysiochemical%2520drug%2520properties%2520associated%2520with%2520in%2520vivo%2520toxicological%2520outcomes%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2008%26volume%3D18%26spage%3D4872%26epage%3D4875" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref9"><div class="reference"><strong class="refLabel"><a href="#ref9" class="rightTabRefNumLink">9</a></strong><div class="NLM_citation" id="rightTab-cit9"><span><span class="NLM_contrib-group">Verhoest, P. R.; Fonseca, K. R.; Hou, X.; Proulx-LaFrance, C.; Corman, M.; Helal, C. J.; Claffey, M. M.; Tuttle, J.; Coffman, K. J.; Liu, S.; Nelson, F.; Kleiman, R. J.; Menniti, F. S.; Schmidt, C. J.; Vanase-Frawley, M.; Liras, S.</span><span> </span><span class="NLM_article-title">Design and Discovery of 6-[(3<i>S</i>,4<i>S</i>)-4-Methyl-1-(pyrimidin-2-ylmethyl)pyrrolidin-3-yl]-1-(tetrahydro-2<i>H</i>-pyran-4-yl)-1,5-dihydro-4<i>H</i>-pyrazolo[3,4-<i>d</i>]pyrimidin-4-one (PF-04447943), a Selective Brain Penetrant PDE9A Inhibitor for the Treatment of Cognitive Disorders</span>,  <span class="citation_source-journal">J. Med. Chem.</span>,<span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2012</span><span class="NLM_x">, </span>DOI <a href="http://pubs.acs.org/doi/abs/10.1021/jm3007799" class="extLink">http://pubs.acs.org/doi/abs/10.1021/jm3007799</a>.</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&publication_year=2012&author=P.+R.+Verhoest&author=K.+R.+Fonseca&author=X.+Hou&author=C.+Proulx-LaFrance&author=M.+Corman&author=C.+J.+Helal&author=M.+M.+Claffey&author=J.+Tuttle&author=K.+J.+Coffman&author=S.+Liu&author=F.+Nelson&author=R.+J.+Kleiman&author=F.+S.+Menniti&author=C.+J.+Schmidt&author=M.+Vanase-Frawley&author=S.+Liras&title=Design+and+Discovery+of+6-%5B%283S%2C4S%29-4-Methyl-1-%28pyrimidin-2-ylmethyl%29pyrrolidin-3-yl%5D-1-%28tetrahydro-2H-pyran-4-yl%29-1%2C5-dihydro-4H-pyrazolo%5B3%2C4-d%5Dpyrimidin-4-one+%28PF-04447943%29%2C+a+Selective+Brain+Penetrant+PDE9A+Inhibitor+for+the+Treatment+of+Cognitive+Disorders"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit9&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26atitle%3DDesign%2520and%2520Discovery%2520of%25206-%255B%25283S%252C4S%2529-4-Methyl-1-%2528pyrimidin-2-ylmethyl%2529pyrrolidin-3-yl%255D-1-%2528tetrahydro-2H-pyran-4-yl%2529-1%252C5-dihydro-4H-pyrazolo%255B3%252C4-d%255Dpyrimidin-4-one%2520%2528PF-04447943%2529%252C%2520a%2520Selective%2520Brain%2520Penetrant%2520PDE9A%2520Inhibitor%2520for%2520the%2520Treatment%2520of%2520Cognitive%2520Disorders%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2012" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref10"><div class="reference"><strong class="refLabel"><a href="#ref10" class="rightTabRefNumLink">10</a></strong><div class="NLM_citation" id="rightTab-cit10"><span><span class="NLM_contrib-group">Murphy, S. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Case, H. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellsworth, E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hagen, S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Huband, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Joannides, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Limberakis, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Marotti, K. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ottolini, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rauckhorst, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Starr, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Stier, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Taylor, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Zhu, T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Blaser, A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Denny, W. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Lu, G.-L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Smaill, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rivault, F.</span><span> </span><span class="NLM_article-title">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span> <span class="citation_source-journal">Bioorg. Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2007</span><span class="NLM_x">, </span> <span class="NLM_volume">17</span><span class="NLM_x">, </span> <span class="NLM_fpage">2150</span><span class="NLM_x">–</span> <span class="NLM_lpage">2155</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1016%2Fj.bmcl.2007.01.090" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=17303420" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref10/cit10&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=17&publication_year=2007&pages=2150-2155&author=S.+T.+Murphyauthor=H.+L.+Caseauthor=E.+Ellsworthauthor=S.+Hagenauthor=M.+Hubandauthor=T.+Joannidesauthor=C.+Limberakisauthor=K.+R.+Marottiauthor=A.+M.+Ottoliniauthor=M.+Rauckhorstauthor=J.+Starrauthor=M.+Stierauthor=C.+Taylorauthor=T.+Zhuauthor=A.+Blaserauthor=W.+A.+Dennyauthor=G.-L.+Luauthor=J.+B.+Smaillauthor=F.+Rivault&title=The+synthesis+and+biological+evaluation+of+novel+series+of+nitrile-containing+fluoroquinolones+as+antibacterial+agents"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit10R"><div class="casContent"><span class="casTitleNuber">10</span><div class="casTitle"><span class="NLM_cas:atitle">The synthesis and biological evaluation of novel series of nitrile-containing fluoroquinolones as antibacterial agents</span></div><div class="casAuthors">Murphy, Sean T.; Case, Heather L.; Ellsworth, Edmund; Hagen, Susan; Huband, Michael; Joannides, Themis; Limberakis, Chris; Marotti, Keith R.; Ottolini, Amy M.; Rauckhorst, Mark; Starr, Jeremy; Stier, Michael; Taylor, Clarke; Zhu, Tong; Blaser, Adrian; Denny, William A.; Lu, Guo-Liang; Smaill, Jeff B.; Rivault, Freddy</div><div class="citationInfo"><span class="NLM_cas:title">Bioorganic & Medicinal Chemistry Letters</span>
        (<span class="NLM_cas:date">2007</span>),
    <span class="NLM_cas:volume">17</span>
        (<span class="NLM_cas:issue">8</span>),
    <span class="NLM_cas:pages">2150-2155</span>CODEN:
                <span class="NLM_cas:coden">BMCLE8</span>;
        ISSN:<span class="NLM_cas:issn">0960-894X</span>.
    
            (<span class="NLM_cas:orgname">Elsevier Ltd.</span>)
        </div><div class="casAbstract">Several novel series of nitrile-contg. fluoroquinolones, e.g., I and II, with weakly basic amines are reported which have reduced potential for hERG (human ether-a-go-go gene) channel inhibition as measured by the dofetilide assay.  The new fluoroquinolones are potent against both Gram-pos. and fastidious Gram-neg. strains, including Methicillin resistant Staphylococcus aureus and fluoroquinolone-resistant Streptococcus pneumoniae.  Several analogs also showed low potential for human genotoxicity as measured by the clonogenicity test.  I and II (designated PF-00951966 and PF-02298732, resp.), which had good in vitro activity and in vitro safety profiles, also showed good pharmacokinetic properties in rats.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrhTahx73DqHrVg90H21EOLACvtfcHk0lh7rRpuXc-slg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD2sXjvVaisL4%253D&md5=708231abc3eafe5e302e9391d5ae58cc</span></div><a href="/servlet/linkout?suffix=cit10&amp;dbid=16384&amp;doi=10.1016%2Fj.bmcl.2007.01.090&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252Fj.bmcl.2007.01.090%26sid%3Dliteratum%253Aachs%26aulast%3DMurphy%26aufirst%3DS.%2BT.%26aulast%3DCase%26aufirst%3DH.%2BL.%26aulast%3DEllsworth%26aufirst%3DE.%26aulast%3DHagen%26aufirst%3DS.%26aulast%3DHuband%26aufirst%3DM.%26aulast%3DJoannides%26aufirst%3DT.%26aulast%3DLimberakis%26aufirst%3DC.%26aulast%3DMarotti%26aufirst%3DK.%2BR.%26aulast%3DOttolini%26aufirst%3DA.%2BM.%26aulast%3DRauckhorst%26aufirst%3DM.%26aulast%3DStarr%26aufirst%3DJ.%26aulast%3DStier%26aufirst%3DM.%26aulast%3DTaylor%26aufirst%3DC.%26aulast%3DZhu%26aufirst%3DT.%26aulast%3DBlaser%26aufirst%3DA.%26aulast%3DDenny%26aufirst%3DW.%2BA.%26aulast%3DLu%26aufirst%3DG.-L.%26aulast%3DSmaill%26aufirst%3DJ.%2BB.%26aulast%3DRivault%26aufirst%3DF.%26atitle%3DThe%2520synthesis%2520and%2520biological%2520evaluation%2520of%2520novel%2520series%2520of%2520nitrile-containing%2520fluoroquinolones%2520as%2520antibacterial%2520agents%26jtitle%3DBioorg.%2520Med.%2520Chem.%2520Lett.%26date%3D2007%26volume%3D17%26spage%3D2150%26epage%3D2155" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref11"><div class="reference"><strong class="refLabel"><a href="#ref11" class="rightTabRefNumLink">11</a></strong><div class="NLM_citation" id="rightTab-cit11"><span><span class="NLM_contrib-group">Hoffmann, R. W.</span><span> </span><span class="NLM_article-title">Allylic 1,3-strain as a controlling factor in stereoselective transformations</span> <span class="citation_source-journal">Chem. Rev.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1989</span><span class="NLM_x">, </span> <span class="NLM_volume">89</span><span class="NLM_x">, </span> <span class="NLM_fpage">1841</span><span class="NLM_x">–</span> <span class="NLM_lpage">1860</span></span><div class="citationLinks">[<a href="/doi/10.1021/cr00098a009" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=89&publication_year=1989&pages=1841-1860&author=R.+W.+Hoffmann&title=Allylic+1%2C3-strain+as+a+controlling+factor+in+stereoselective+transformations"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit11&amp;dbid=16384&amp;doi=10.1021%2Fcr00098a009&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcr00098a009%26sid%3Dliteratum%253Aachs%26aulast%3DHoffmann%26aufirst%3DR.%2BW.%26atitle%3DAllylic%25201%252C3-strain%2520as%2520a%2520controlling%2520factor%2520in%2520stereoselective%2520transformations%26jtitle%3DChem.%2520Rev.%26date%3D1989%26volume%3D89%26spage%3D1841%26epage%3D1860" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref12"><div class="reference"><strong class="refLabel"><a href="#ref12" class="rightTabRefNumLink">12</a></strong><div class="NLM_citation" id="rightTab-cit12a"><span><span class="NLM_label">(a) </span><span class="NLM_contrib-group">Sadowski, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Gasteiger, J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Klebe, G.</span><span> </span><span class="NLM_article-title">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-Ray Structures</span> <span class="citation_source-journal">J. Chem. Inf. Comput. Sci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1994</span><span class="NLM_x">, </span> <span class="NLM_volume">34</span><span class="NLM_x">, </span> <span class="NLM_fpage">1000</span><span class="NLM_x">–</span> <span class="NLM_lpage">1008</span></span><div class="citationLinks">[<a href="/doi/10.1021/ci00020a039" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref12/cit12a&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=34&publication_year=1994&pages=1000-1008&author=J.+Sadowskiauthor=J.+Gasteigerauthor=G.+Klebe&title=Comparison+of+Automatic+Three-Dimensional+Model+Builders+Using+639+X-Ray+Structures"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit12aR"><div class="casContent"><span class="casTitleNuber">12a</span><div class="casTitle"><span class="NLM_cas:atitle">Comparison of Automatic Three-Dimensional Model Builders Using 639 X-ray Structures</span></div><div class="casAuthors">Sadowski, Jens; Gasteiger, Johann; Klebe, Gerhard</div><div class="citationInfo"><span class="NLM_cas:title">Journal of Chemical Information and Computer Sciences</span>
        (<span class="NLM_cas:date">1994</span>),
    <span class="NLM_cas:volume">34</span>
        (<span class="NLM_cas:issue">4</span>),
    <span class="NLM_cas:pages">1000-8</span>CODEN:
                <span class="NLM_cas:coden">JCISD8</span>;
        ISSN:<span class="NLM_cas:issn">0095-2338</span>.
    </div><div class="casAbstract">Several criteria were defined to select a dataset of high-quality x-ray structures from the Cambridge file resulting in 639 mols.  Six currently available programs for automatic 3D structure generation were compared by converting the connectivity tables, including appropriate stereodescriptors from this dataset of 639 mol. structures into 3D geometries: CONCORD, ALCOGEN, Chem-X, MOLGEO, COBRA, and CORINA.  The geometries produced by the different programs were evaluated in terms of several quality criteria and discussed in detail.  These criteria measure how well the different programs reproduce the x-ray geometries of the 639 input structures.  Accordingly, the major strengths and weaknesses of the programs are indicated.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGr8vEtyDrrlq7Vg90H21EOLACvtfcHk0lh7rRpuXc-slg"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2cXkvVajsbY%253D&md5=246e4d66f11178a18daad2563c48331c</span></div><a href="/servlet/linkout?suffix=cit12a&amp;dbid=16384&amp;doi=10.1021%2Fci00020a039&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fci00020a039%26sid%3Dliteratum%253Aachs%26aulast%3DSadowski%26aufirst%3DJ.%26aulast%3DGasteiger%26aufirst%3DJ.%26aulast%3DKlebe%26aufirst%3DG.%26atitle%3DComparison%2520of%2520Automatic%2520Three-Dimensional%2520Model%2520Builders%2520Using%2520639%2520X-Ray%2520Structures%26jtitle%3DJ.%2520Chem.%2520Inf.%2520Comput.%2520Sci.%26date%3D1994%26volume%3D34%26spage%3D1000%26epage%3D1008" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div><div class="NLM_citation" id="rightTab-cit12b"><span><span class="NLM_label">(b) </span><span> </span><span class="NLM_article-title">The 3-D structure generator CORINA is available from Molecular Networks GmbH</span>, Erlangen, Germany (<a href="http://www.molecular-networks.com" class="extLink">http://www.molecular-networks.com</a>).</span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar?hl=en&q=+The+3-D+structure+generator+CORINA+is+available+from+Molecular+Networks+GmbH%2C+Erlangen%2C+Germany+%28http%3A%2F%2Fwww.molecular-networks.com%29."target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit12b&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Dweb%26sid%3Dliteratum%253Aachs%26atitle%3DThe%25203-D%2520structure%2520generator%2520CORINA%2520is%2520available%2520from%2520Molecular%2520Networks%2520GmbH" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref13"><div class="reference"><strong class="refLabel"><a href="#ref13" class="rightTabRefNumLink">13</a></strong><div class="NLM_citation" id="rightTab-cit13"><span><span class="NLM_contrib-group">Gehlhaar, D. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verkhivker, G. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rejto, P. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Sherman, C. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, D. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fogel, L. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Freer, S. T.</span><span> </span><span class="NLM_article-title">Molecular Recognition of the Inhibitor AG-1343 by HIV-1 Protease: Conformationally Flexible Docking by Evolutionary Programming</span> <span class="citation_source-journal">Chem. Biol.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">1995</span><span class="NLM_x">, </span> <span class="NLM_volume">2</span><span class="NLM_x">, </span> <span class="NLM_fpage">317</span><span class="NLM_x">–</span> <span class="NLM_lpage">324</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1016%2F1074-5521%2895%2990050-0" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=9383433" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref13/cit13&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=2&publication_year=1995&pages=317-324&author=D.+K.+Gehlhaarauthor=G.+M.+Verkhivkerauthor=P.+A.+Rejtoauthor=C.+J.+Shermanauthor=D.+B.+Fogelauthor=L.+J.+Fogelauthor=S.+T.+Freer&title=Molecular+Recognition+of+the+Inhibitor+AG-1343+by+HIV-1+Protease%3A+Conformationally+Flexible+Docking+by+Evolutionary+Programming"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit13R"><div class="casContent"><span class="casTitleNuber">13</span><div class="casTitle"><span class="NLM_cas:atitle">Molecular recognition of the inhibitor AG-1343 by HIV-1 protease: Conformationally flexible docking by evolutionary programming</span></div><div class="casAuthors">Gehlhaar, Daniel K.; Verkhivker, Gennady M.; Rejto, Paul A.; Sherman, Christopher J.; Fogel, David B.; Fogel, Lawrence J.; Freer, Stephan T.</div><div class="citationInfo"><span class="NLM_cas:title">Chemistry & Biology</span>
        (<span class="NLM_cas:date">1995</span>),
    <span class="NLM_cas:volume">2</span>
        (<span class="NLM_cas:issue">5</span>),
    <span class="NLM_cas:pages">317-24</span>CODEN:
                <span class="NLM_cas:coden">CBOLE2</span>;
        ISSN:<span class="NLM_cas:issn">1074-5521</span>.
    
            (<span class="NLM_cas:orgname">Current Biology</span>)
        </div><div class="casAbstract">An important prerequisite for computational structure-based drug design is prediction of the structures of ligand-protein complexes that have not yet been exptl. detd. by x-ray crystallog. or NMR.  For this task, docking of rigid ligands is inadequate because it assumes knowledge of the conformation of the bound ligand.  Docking of flexible ligands would be desirable, but requires one to search an enormous conformational space.  We set out to develop a strategy for flexible docking by combining a simple model of ligand-protein interactions for mol. recognition with an evolutionary programming search technique.  We have developed an intermol. energy function that incorporates steric and hydrogen-bonding terms.  The parameters in this function were obtained by docking in three different protein systems.  The effectiveness of this method was demonstrated by conformationally flexible docking of the inhibitor AG-1343, a potential new drug against AIDS, into HIV-1 protease.  For this mol., which has nine rotatable bonds, the crystal structure was reproduced within 1.5 Å rootmean-square deviation 34 times in 100 simulations, each requiring eight minutes on a Silicon Graphics R4400 workstation.  The energy function correctly evaluates the crystal structure as the global energy min.  We believe that a soln. of the docking problem may be achieved by matching a simple model of mol. recognition with an efficient search procedure.  The necessary ingredients of a mol. recognition model include only steric and hydrogen-bond interaction terms.  Although these terms are not necessarily sufficient to predict binding affinity, they describe ligand-protein interactions faithfully enough to enable a docking program to predict the structure of the bound ligand.  This docking strategy thus provides an important tool for the interdisciplinary field of rational drug design.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGrAErS8tcVx2bVg90H21EOLACvtfcHk0lgU1lYuUFEv7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADyaK2MXmvVClsbg%253D&md5=527cfc114545ea76b64b48d0aee21856</span></div><a href="/servlet/linkout?suffix=cit13&amp;dbid=16384&amp;doi=10.1016%2F1074-5521%2895%2990050-0&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1016%252F1074-5521%252895%252990050-0%26sid%3Dliteratum%253Aachs%26aulast%3DGehlhaar%26aufirst%3DD.%2BK.%26aulast%3DVerkhivker%26aufirst%3DG.%2BM.%26aulast%3DRejto%26aufirst%3DP.%2BA.%26aulast%3DSherman%26aufirst%3DC.%2BJ.%26aulast%3DFogel%26aufirst%3DD.%2BB.%26aulast%3DFogel%26aufirst%3DL.%2BJ.%26aulast%3DFreer%26aufirst%3DS.%2BT.%26atitle%3DMolecular%2520Recognition%2520of%2520the%2520Inhibitor%2520AG-1343%2520by%2520HIV-1%2520Protease%253A%2520Conformationally%2520Flexible%2520Docking%2520by%2520Evolutionary%2520Programming%26jtitle%3DChem.%2520Biol.%26date%3D1995%26volume%3D2%26spage%3D317%26epage%3D324" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref14"><div class="reference"><strong class="refLabel"><a href="#ref14" class="rightTabRefNumLink">14</a></strong><div class="NLM_citation" id="rightTab-cit14"><span><span class="NLM_contrib-group">Marrone, T. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Luty, B. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Rose, P. W.</span><span> </span><span class="NLM_article-title">Discovering High-Affinity Ligands from the Computationally Predicted Structures and Affinities of Small Molecules Bound to A Target: A Virtual Screening Approach</span> <span class="citation_source-journal">Perspect. Drug Discovery Des.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2000</span><span class="NLM_x">, </span> <span class="NLM_volume">20</span><span class="NLM_x">, </span> <span class="NLM_fpage">209</span><span class="NLM_x">–</span> <span class="NLM_lpage">230</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1023%2FA%3A1008741308684" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref14/cit14&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD3MXptFSg" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=20&publication_year=2000&pages=209-230&author=T.+J.+Marroneauthor=B.+A.+Lutyauthor=P.+W.+Rose&title=Discovering+High-Affinity+Ligands+from+the+Computationally+Predicted+Structures+and+Affinities+of+Small+Molecules+Bound+to+A+Target%3A+A+Virtual+Screening+Approach"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit14R"><div class="casContent"><span class="casTitleNuber">14</span><div class="casTitle"><span class="NLM_cas:atitle">Discovering high-affinity ligands from the computationally predicted structures and affinities of small molecules bound to a target: a virtual screening approach</span></div><div class="casAuthors">Marrone, Tami J.; Luty, Brock A.; Rose, Peter W.</div><div class="citationInfo"><span class="NLM_cas:title">Perspectives in Drug Discovery and Design</span>
        (<span class="NLM_cas:date">2000</span>),
    <span class="NLM_cas:volume">20</span>
        (<span class="NLM_cas:issue"></span>),
    <span class="NLM_cas:pages">209-230</span>CODEN:
                <span class="NLM_cas:coden">PDDDEC</span>;
        ISSN:<span class="NLM_cas:issn">0928-2866</span>.
    
            (<span class="NLM_cas:orgname">Kluwer Academic Publishers</span>)
        </div><div class="casAbstract">We describe a "virtual NMR screening" method to assist in the design of inhibitors that occupy different sites within a target.  We dock small mols. into the active site of an enzyme and score them.  Keeping the tightest-binding lead fixed in space, we dock and score other small mols. in its presence.  Using this approach, linker groups are used to join the compds. together to form a high-affinity inhibitor.  We present validation of our computational approach by reproducing exptl. results for FKBP and stromelysin.  Docking simulations are not subject to exptl. problems such as proteolysis, protein or compd. insoly., or enzyme size.  Because docking is fast and our scoring method can distinguish between high- and low-affinity inhibitors, this docking procedure shows promise as integral part of a drug-design strategy.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGql26ToXhh4jbVg90H21EOLACvtfcHk0lgU1lYuUFEv7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD3MXptFSg&md5=cea3010bea46c3636970ece8ee764ae2</span></div><a href="/servlet/linkout?suffix=cit14&amp;dbid=16384&amp;doi=10.1023%2FA%3A1008741308684&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1023%252FA%253A1008741308684%26sid%3Dliteratum%253Aachs%26aulast%3DMarrone%26aufirst%3DT.%2BJ.%26aulast%3DLuty%26aufirst%3DB.%2BA.%26aulast%3DRose%26aufirst%3DP.%2BW.%26atitle%3DDiscovering%2520High-Affinity%2520Ligands%2520from%2520the%2520Computationally%2520Predicted%2520Structures%2520and%2520Affinities%2520of%2520Small%2520Molecules%2520Bound%2520to%2520A%2520Target%253A%2520A%2520Virtual%2520Screening%2520Approach%26jtitle%3DPerspect.%2520Drug%2520Discovery%2520Des.%26date%3D2000%26volume%3D20%26spage%3D209%26epage%3D230" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref15"><div class="reference"><strong class="refLabel"><a href="#ref15" class="rightTabRefNumLink">15</a></strong><div class="NLM_citation" id="rightTab-cit15"><span><span class="NLM_contrib-group">Feng, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mills, J. B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Davidson, R. E.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Mireles, R. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janiszewski, J. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Troutman, M. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">de Morais, S. M.</span><span> </span><span class="NLM_article-title">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span> <span class="citation_source-journal">Drug Metab. Dispos.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2008</span><span class="NLM_x">, </span> <span class="NLM_volume">36</span><span class="NLM_x">, </span> <span class="NLM_fpage">268</span><span class="NLM_x">–</span> <span class="NLM_lpage">275</span></span><div class="citationLinks">[<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=16&amp;doi=10.1021%2Fjm3009635&amp;key=10.1124%2Fdmd.107.017434" title="">Crossref</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=8&amp;doi=10.1021%2Fjm3009635&amp;key=17962372" title="">PubMed</a>], [<a href="/servlet/linkout?suffix=ref15/cit15&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=36&publication_year=2008&pages=268-275&author=B.+Fengauthor=J.+B.+Millsauthor=R.+E.+Davidsonauthor=R.+J.+Mirelesauthor=J.+S.+Janiszewskiauthor=M.+D.+Troutmanauthor=S.+M.+de+Morais&title=In+vitro+P-glycoprotein+assays+to+predict+the+in+vivo+interactions+of+P-glycoprotein+with+drugs+in+the+central+nervous+system"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit15R"><div class="casContent"><span class="casTitleNuber">15</span><div class="casTitle"><span class="NLM_cas:atitle">In vitro P-glycoprotein assays to predict the in vivo interactions of P-glycoprotein with drugs in the central nervous system</span></div><div class="casAuthors">Feng, Bo; Mills, Jessica B.; Davidson, Ralph E.; Mireles, Rouchelle J.; Janiszewski, John S.; Troutman, Matthew D.; de Morais, Sonia M.</div><div class="citationInfo"><span class="NLM_cas:title">Drug Metabolism and Disposition</span>
        (<span class="NLM_cas:date">2008</span>),
    <span class="NLM_cas:volume">36</span>
        (<span class="NLM_cas:issue">2</span>),
    <span class="NLM_cas:pages">268-275</span>CODEN:
                <span class="NLM_cas:coden">DMDSAI</span>;
        ISSN:<span class="NLM_cas:issn">0090-9556</span>.
    
            (<span class="NLM_cas:orgname">American Society for Pharmacology and Experimental Therapeutics</span>)
        </div><div class="casAbstract">Thirty-one structurally diverse marketed central nervous system (CNS)-active drugs, one active metabolite, and seven non-CNS-active compds. were tested in three P-glycoprotein (P-gp) in vitro assays: transwell assays using MDCK, human MDR1-MDCK, and mouse Mdr1a-MDCK cells, ATPase, and calcein AM inhibition.  Addnl., the permeability for these compds. was measured in two in vitro models: parallel artificial membrane permeation assay and apical-to-basolateral apparent permeability in MDCK.  The exposure of the same set of compds. in brain and plasma was measured in P-gp knockout (KO) and wild-type (WT) mice after s.c. administration.  One drug and its metabolite, risperidone and 9-hydroxyrisperidone, of the 32 CNS compds., and 6 of the 7 non-CNS drugs were detd. to have pos. efflux using ratio of ratios in MDR1-MDCK vs. MDCK transwell assays.  Data from transwell studies correlated well with the brain-to-plasma area under the curve ratios between P-gp KO and WT mice for the 32 CNS compds.  In addn., 3300 Pfizer compds. were tested in MDR1-MDCK and Mdr1a-MDCK transwell assays, with a good correlation (R2 = 0.92) between the efflux ratios in human MDR1-MDCK and mouse Mdr1a-MDCK cells.  Permeability data showed that the majority of the 32 CNS compds. have moderate to high passive permeability.  This work has demonstrated that in vitro transporter assays help in understanding the role of P-gp-mediated efflux activity in detg. the disposition of CNS drugs in vivo, and the transwell assay is a valuable in vitro assay to evaluate human P-gp interaction with compds. for assessing brain penetration of new chem. entities to treat CNS disorders.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqsQyRSOySyGLVg90H21EOLACvtfcHk0lgU1lYuUFEv7w"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BD1cXht1yktbc%253D&md5=bbf8b6969bd6d6b3d741b6ef9e7853f3</span></div><a href="/servlet/linkout?suffix=cit15&amp;dbid=16384&amp;doi=10.1124%2Fdmd.107.017434&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1124%252Fdmd.107.017434%26sid%3Dliteratum%253Aachs%26aulast%3DFeng%26aufirst%3DB.%26aulast%3DMills%26aufirst%3DJ.%2BB.%26aulast%3DDavidson%26aufirst%3DR.%2BE.%26aulast%3DMireles%26aufirst%3DR.%2BJ.%26aulast%3DJaniszewski%26aufirst%3DJ.%2BS.%26aulast%3DTroutman%26aufirst%3DM.%2BD.%26aulast%3Dde%2BMorais%26aufirst%3DS.%2BM.%26atitle%3DIn%2520vitro%2520P-glycoprotein%2520assays%2520to%2520predict%2520the%2520in%2520vivo%2520interactions%2520of%2520P-glycoprotein%2520with%2520drugs%2520in%2520the%2520central%2520nervous%2520system%26jtitle%3DDrug%2520Metab.%2520Dispos.%26date%3D2008%26volume%3D36%26spage%3D268%26epage%3D275" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref16"><div class="reference"><strong class="refLabel"><a href="#ref16" class="rightTabRefNumLink">16</a></strong><div class="NLM_citation" id="rightTab-cit16"><span><span class="NLM_contrib-group">Wager, T. T.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hou, X.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Villalobos, A.</span><span> </span><span class="NLM_article-title">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span> <span class="citation_source-journal">ACS Chem. Neurosci.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">435</span><span class="NLM_x">–</span> <span class="NLM_lpage">449</span></span><div class="citationLinks">[<a href="/doi/10.1021/cn100008c" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], [<a href="/servlet/linkout?suffix=ref16/cit16&amp;dbid=32&amp;doi=10.1021%2Fjm3009635&amp;key=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D" title="">CAS</a></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=435-449&author=T.+T.+Wagerauthor=X.+Houauthor=P.+R.+Verhoestauthor=A.+Villalobos&title=Moving+beyond+Rules%3A+The+Development+of+a+Central+Nervous+System+Multiparameter+Optimization+%28CNS+MPO%29+Approach+To+Enable+Alignment+of+Druglike+Properties"target="_blank">Google Scholar</a><div class="casRecord" id="&#xA;                        rightTab-cas_cit16R"><div class="casContent"><span class="casTitleNuber">16</span><div class="casTitle"><span class="NLM_cas:atitle">Moving beyond Rules: The Development of a Central Nervous System Multiparameter Optimization (CNS MPO) Approach To Enable Alignment of Druglike Properties</span></div><div class="casAuthors">Wager, Travis T.; Hou, Xinjun; Verhoest, Patrick R.; Villalobos, Anabella</div><div class="citationInfo"><span class="NLM_cas:title">ACS Chemical Neuroscience</span>
        (<span class="NLM_cas:date">2010</span>),
    <span class="NLM_cas:volume">1</span>
        (<span class="NLM_cas:issue">6</span>),
    <span class="NLM_cas:pages">435-449</span>CODEN:
                <span class="NLM_cas:coden">ACNCDM</span>;
        ISSN:<span class="NLM_cas:issn">1948-7193</span>.
    
            (<span class="NLM_cas:orgname">American Chemical Society</span>)
        </div><div class="casAbstract">The interplay among commonly used physicochem. properties in drug design was examd. and utilized to create a prospective design tool focused on the alignment of key druglike attributes.  Using a set of six physicochem. parameters ((a) lipophilicity, calcd. partition coeff. (ClogP); (b) calcd. distribution coeff. at pH = 7.4 (ClogD); (c) mol. wt. (MW); (d) topol. polar surface area (TPSA); (e) no. of hydrogen bond donors (HBD); (f) most basic center (pKa)), a druglikeness central nervous system multiparameter optimization (CNS MPO) algorithm was built and applied to a set of marketed CNS drugs (N = 119) and Pfizer CNS candidates (N = 108), as well as to a large diversity set of Pfizer proprietary compds. (N = 11 303).  The novel CNS MPO algorithm showed that 74% of marketed CNS drugs displayed a high CNS MPO score (MPO desirability score ≥ 4, using a scale of 0-6), in comparison to 60% of the Pfizer CNS candidates.  This anal. suggests that this algorithm could potentially be used to identify compds. with a higher probability of successfully testing hypotheses in the clinic.  In addn., a relationship between an increasing CNS MPO score and alignment of key in vitro attributes of drug discovery (favorable permeability, P-glycoprotein (P-gp) efflux, metabolic stability, and safety) was seen in the marketed CNS drug set, the Pfizer candidate set, and the Pfizer proprietary diversity set.  The CNS MPO scoring function offers advantages over hard cutoffs or utilization of single parameters to optimize structure-activity relationships (SAR) by expanding medicinal chem. design space through a holistic assessment approach.  Based on six physicochem. properties commonly used by medicinal chemists, the CNS MPO function may be used prospectively at the design stage to accelerate the identification of compds. with increased probability of success.</div></div><div class="moreSciFi"><a title="Retrieve detailed record, substances, reactions and more for this article from SciFinder &#174;" href="https://scifinder.cas.org/scifinder/view/link_v1/reference.jsf?l=BmxxGlm8wGqB3Mvkgm_X5bVg90H21EOLACvtfcHk0liDW1gtscS3nw"> >> More from SciFinder <sup>®</sup></a></div><span class="casRefUrl">https://chemport.cas.org/services/resolver?origin=ACS&resolution=options&coi=1%3ACAS%3A528%3ADC%252BC3cXjvVejtr8%253D&md5=e94998f65a420be6ee4dec4a987cb983</span></div><a href="/servlet/linkout?suffix=cit16&amp;dbid=16384&amp;doi=10.1021%2Fcn100008c&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fcn100008c%26sid%3Dliteratum%253Aachs%26aulast%3DWager%26aufirst%3DT.%2BT.%26aulast%3DHou%26aufirst%3DX.%26aulast%3DVerhoest%26aufirst%3DP.%2BR.%26aulast%3DVillalobos%26aufirst%3DA.%26atitle%3DMoving%2520beyond%2520Rules%253A%2520The%2520Development%2520of%2520a%2520Central%2520Nervous%2520System%2520Multiparameter%2520Optimization%2520%2528CNS%2520MPO%2529%2520Approach%2520To%2520Enable%2520Alignment%2520of%2520Druglike%2520Properties%26jtitle%3DACS%2520Chem.%2520Neurosci.%26date%3D2010%26volume%3D1%26spage%3D435%26epage%3D449" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref17"><div class="reference"><strong class="refLabel"><a href="#ref17" class="rightTabRefNumLink">17</a></strong><div class="NLM_citation" id="rightTab-cit17"><span><div class="note"><p class="first last">For a recent review on methods used to pre-clinically evaluate brain penetration of compounds, see:</p></div><span class="NLM_contrib-group">Shaffer, C. L.</span><span> </span><span class="NLM_article-title">Defining neuropharmacokinetic parameters in CNS drug discovery to determine cross-species pharmacologic exposure–response relationships</span> <span class="citation_source-journal">Annu. Rep. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">45</span><span class="NLM_x">, </span> <span class="NLM_fpage">55</span><span class="NLM_x">–</span> <span class="NLM_lpage">70</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=45&publication_year=2010&pages=55-70&author=C.+L.+Shaffer&title=Defining+neuropharmacokinetic+parameters+in+CNS+drug+discovery+to+determine+cross-species+pharmacologic+exposure%E2%80%93response+relationships"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit17&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DShaffer%26aufirst%3DC.%2BL.%26atitle%3DDefining%2520neuropharmacokinetic%2520parameters%2520in%2520CNS%2520drug%2520discovery%2520to%2520determine%2520cross-species%2520pharmacologic%2520exposure%25E2%2580%2593response%2520relationships%26jtitle%3DAnnu.%2520Rep.%2520Med.%2520Chem.%26date%3D2010%26volume%3D45%26spage%3D55%26epage%3D70" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref18"><div class="reference"><strong class="refLabel"><a href="#ref18" class="rightTabRefNumLink">18</a></strong><div class="NLM_citation" id="rightTab-cit18"><span><span class="NLM_contrib-group">Choi, S.-W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Elmaleh, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Hanson, R. N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shoup, T. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Fischman, A. J.</span><span> </span><span class="NLM_article-title">Novel (bisarylmethoxy)butylpiperidine analogues as neurotransmitter transporter inhibitors with activity at dopamine receptor sites</span> <span class="citation_source-journal">Bioorg. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2002</span><span class="NLM_x">, </span> <span class="NLM_volume">10</span><span class="NLM_x">, </span> <span class="NLM_fpage">4091</span><span class="NLM_x">–</span> <span class="NLM_lpage">4102</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=10&publication_year=2002&pages=4091-4102&author=S.-W.+Choiauthor=D.+R.+Elmalehauthor=R.+N.+Hansonauthor=T.+M.+Shoupauthor=A.+J.+Fischman&title=Novel+%28bisarylmethoxy%29butylpiperidine+analogues+as+neurotransmitter+transporter+inhibitors+with+activity+at+dopamine+receptor+sites"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit18&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DChoi%26aufirst%3DS.-W.%26aulast%3DElmaleh%26aufirst%3DD.%2BR.%26aulast%3DHanson%26aufirst%3DR.%2BN.%26aulast%3DShoup%26aufirst%3DT.%2BM.%26aulast%3DFischman%26aufirst%3DA.%2BJ.%26atitle%3DNovel%2520%2528bisarylmethoxy%2529butylpiperidine%2520analogues%2520as%2520neurotransmitter%2520transporter%2520inhibitors%2520with%2520activity%2520at%2520dopamine%2520receptor%2520sites%26jtitle%3DBioorg.%2520Med.%2520Chem.%26date%3D2002%26volume%3D10%26spage%3D4091%26epage%3D4102" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref19"><div class="reference"><strong class="refLabel"><a href="#ref19" class="rightTabRefNumLink">19</a></strong><div class="NLM_citation" id="rightTab-cit19"><span><span class="NLM_contrib-group">Chang, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Steyn, S. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Umland, J. P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Scott, D. O.</span><span> </span><span class="NLM_article-title">Strategic Use of Plasma and Microsome Binding To Exploit in Vitro Clearance in Early Drug Discovery</span> <span class="citation_source-journal">ACS Med. Chem. Lett.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2010</span><span class="NLM_x">, </span> <span class="NLM_volume">1</span><span class="NLM_x">, </span> <span class="NLM_fpage">50</span><span class="NLM_x">–</span> <span class="NLM_lpage">53</span></span><div class="citationLinks">[<a href="/doi/10.1021/ml900012h" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=1&publication_year=2010&pages=50-53&author=G.+Changauthor=S.+J.+Steynauthor=J.+P.+Umlandauthor=D.+O.+Scott&title=Strategic+Use+of+Plasma+and+Microsome+Binding+To+Exploit+in+Vitro+Clearance+in+Early+Drug+Discovery"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit19&amp;dbid=16384&amp;doi=10.1021%2Fml900012h&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fml900012h%26sid%3Dliteratum%253Aachs%26aulast%3DChang%26aufirst%3DG.%26aulast%3DSteyn%26aufirst%3DS.%2BJ.%26aulast%3DUmland%26aufirst%3DJ.%2BP.%26aulast%3DScott%26aufirst%3DD.%2BO.%26atitle%3DStrategic%2520Use%2520of%2520Plasma%2520and%2520Microsome%2520Binding%2520To%2520Exploit%2520in%2520Vitro%2520Clearance%2520in%2520Early%2520Drug%2520Discovery%26jtitle%3DACS%2520Med.%2520Chem.%2520Lett.%26date%3D2010%26volume%3D1%26spage%3D50%26epage%3D53" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref20"><div class="reference"><strong class="refLabel"><a href="#ref20" class="rightTabRefNumLink">20</a></strong><div class="NLM_citation" id="rightTab-cit20"><span><span class="NLM_contrib-group">Nicholas, T</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Evans, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Styren, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Qui, R</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Wang, E. Q.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Nelson, F</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Le, V</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Grimwood, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Christoffersen, C</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Banerjee, S</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Corrigan, B.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Kocan, G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Geoghegan, K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Carrieri, C.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Raha, N.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Verhoest, P.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Soares, H.</span><span> </span><span class="NLM_article-title">(2009) PF-04447943, a novel PDE9A inhibitor, increases cGMP levels in cerebrospinal fluid: translation from non-clinical species to healthy human volunteers</span> <span class="citation_source-journal">Alzheimer’s Dementia</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2009</span><span class="NLM_x">, </span> <span class="NLM_volume">5</span><span class="NLM_x">, </span> <span class="NLM_fpage">P330</span></span><div class="citationLinks"><a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=5&publication_year=2009&pages=P330&author=T+Nicholasauthor=R+Evansauthor=S+Styrenauthor=R+Quiauthor=E.+Q.+Wangauthor=F+Nelsonauthor=V+Leauthor=S+Grimwoodauthor=C+Christoffersenauthor=S+Banerjeeauthor=B.+Corriganauthor=G.+Kocanauthor=K.+Geogheganauthor=C.+Carrieriauthor=N.+Rahaauthor=P.+Verhoestauthor=H.+Soares&title=%282009%29+PF-04447943%2C+a+novel+PDE9A+inhibitor%2C+increases+cGMP+levels+in+cerebrospinal+fluid%3A+translation+from+non-clinical+species+to+healthy+human+volunteers"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit20&amp;dbid=16384&amp;doi=&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26sid%3Dliteratum%253Aachs%26aulast%3DNicholas%26aufirst%3DT%26aulast%3DEvans%26aufirst%3DR%26aulast%3DStyren%26aufirst%3DS%26aulast%3DQui%26aufirst%3DR%26aulast%3DWang%26aufirst%3DE.%2BQ.%26aulast%3DNelson%26aufirst%3DF%26aulast%3DLe%26aufirst%3DV%26aulast%3DGrimwood%26aufirst%3DS%26aulast%3DChristoffersen%26aufirst%3DC%26aulast%3DBanerjee%26aufirst%3DS%26aulast%3DCorrigan%26aufirst%3DB.%26aulast%3DKocan%26aufirst%3DG.%26aulast%3DGeoghegan%26aufirst%3DK.%26aulast%3DCarrieri%26aufirst%3DC.%26aulast%3DRaha%26aufirst%3DN.%26aulast%3DVerhoest%26aufirst%3DP.%26aulast%3DSoares%26aufirst%3DH.%26atitle%3D%25282009%2529%2520PF-04447943%252C%2520a%2520novel%2520PDE9A%2520inhibitor%252C%2520increases%2520cGMP%2520levels%2520in%2520cerebrospinal%2520fluid%253A%2520translation%2520from%2520non-clinical%2520species%2520to%2520healthy%2520human%2520volunteers%26jtitle%3DAlzheimer%25E2%2580%2599s%2520Dementia%26date%3D2009%26volume%3D5%26spage%3DP330" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li><li id="rightTab-ref21"><div class="reference"><strong class="refLabel"><a href="#ref21" class="rightTabRefNumLink">21</a></strong><div class="NLM_citation" id="rightTab-cit21"><span><span class="NLM_contrib-group">Ranatunge, R. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Augustyniak, M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Bandarage, U. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Earl, R. A.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Ellis, J. L.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Garvey, D. S.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Janero, D. R.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Letts, L. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Martino, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Murty, M. G.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Richardson, S. K.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Schroeder, J. D.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Shumway, M. J.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Tam, S. W.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Trocha, A. M.</span><span class="NLM_x">; </span><span class="NLM_contrib-group">Young, D. V.</span><span> </span><span class="NLM_article-title">Synthesis and Selective Cyclooxygenase-2 Inhibitory Activity of a Series of Novel, Nitric Oxide Donor-Containing Pyrazoles</span> <span class="citation_source-journal">J. Med. Chem.</span><span class="NLM_x"> </span><span class="NLM_year" style="font-weight: bold;">2004</span><span class="NLM_x">, </span> <span class="NLM_volume">47</span><span class="NLM_x">, </span> <span class="NLM_fpage">2180</span><span class="NLM_x">–</span> <span class="NLM_lpage">2193</span></span><div class="citationLinks">[<a href="/doi/10.1021/jm030276s" title="">ACS Full Text <img src="/templates/jsp/_style2/_achs/images/acs-ref.gif" alt="ACS Full Text" /></img></a>], <a class="google-scholar" href="http://scholar.google.com/scholar_lookup?hl=en&volume=47&publication_year=2004&pages=2180-2193&author=R.+R.+Ranatungeauthor=M.+Augustyniakauthor=U.+K.+Bandarageauthor=R.+A.+Earlauthor=J.+L.+Ellisauthor=D.+S.+Garveyauthor=D.+R.+Janeroauthor=L.+G.+Lettsauthor=A.+M.+Martinoauthor=M.+G.+Murtyauthor=S.+K.+Richardsonauthor=J.+D.+Schroederauthor=M.+J.+Shumwayauthor=S.+W.+Tamauthor=A.+M.+Trochaauthor=D.+V.+Young&title=Synthesis+and+Selective+Cyclooxygenase-2+Inhibitory+Activity+of+a+Series+of+Novel%2C+Nitric+Oxide+Donor-Containing+Pyrazoles"target="_blank">Google Scholar</a><div class="casRecord empty" id="&#xA;                            rightTab-cas_R&#xA;                        "><div class="casContent">There is no corresponding record for this reference.</div></div><a href="/servlet/linkout?suffix=cit21&amp;dbid=16384&amp;doi=10.1021%2Fjm030276s&amp;type=refOpenUrl&amp;url=http%3A%2F%2Flbdiscover.ust.hk%2Furesolver%3Fgenre%3Darticle%26id%3Ddoi%3A10.1021%252Fjm030276s%26sid%3Dliteratum%253Aachs%26aulast%3DRanatunge%26aufirst%3DR.%2BR.%26aulast%3DAugustyniak%26aufirst%3DM.%26aulast%3DBandarage%26aufirst%3DU.%2BK.%26aulast%3DEarl%26aufirst%3DR.%2BA.%26aulast%3DEllis%26aufirst%3DJ.%2BL.%26aulast%3DGarvey%26aufirst%3DD.%2BS.%26aulast%3DJanero%26aufirst%3DD.%2BR.%26aulast%3DLetts%26aufirst%3DL.%2BG.%26aulast%3DMartino%26aufirst%3DA.%2BM.%26aulast%3DMurty%26aufirst%3DM.%2BG.%26aulast%3DRichardson%26aufirst%3DS.%2BK.%26aulast%3DSchroeder%26aufirst%3DJ.%2BD.%26aulast%3DShumway%26aufirst%3DM.%2BJ.%26aulast%3DTam%26aufirst%3DS.%2BW.%26aulast%3DTrocha%26aufirst%3DA.%2BM.%26aulast%3DYoung%26aufirst%3DD.%2BV.%26atitle%3DSynthesis%2520and%2520Selective%2520Cyclooxygenase-2%2520Inhibitory%2520Activity%2520of%2520a%2520Series%2520of%2520Novel%252C%2520Nitric%2520Oxide%2520Donor-Containing%2520Pyrazoles%26jtitle%3DJ.%2520Med.%2520Chem.%26date%3D2004%26volume%3D47%26spage%3D2180%26epage%3D2193" title="OpenURL HONG KONG UNIV SCIENCE TECHLGY" onclick="newWindow(this.href);return false" class="issue-item_open-url sfxLink"><img src="/userimages/4265000/sfxbutton" alt="OpenURL HONG KONG UNIV SCIENCE TECHLGY" /></img></a></div></div></div></li></ol></li><li id="pane-m3" aria-labelledby="pane-m3" class="tab__pane tab__pane-suppInfo empty"><div class="accessionCode mb-5"><div class="toolbar-section accession-codes"><ul><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JS1" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JS1','PDB','3JS1'); return false;">PDB: 3JS1</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=3JSW','PDB','3JSW'); return false;">PDB: 3JSW</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2J" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2J','PDB','4G2J'); return false;">PDB: 4G2J</a></li><li><a href="http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2L" onclick="trackOutboundLink('http://www.rcsb.org/pdb/search/structidSearch.do?structureId=4G2L','PDB','4G2L'); return false;">PDB: 4G2L</a></li></ul></div></div><h2 class="supp-info-label">Supporting Information</h2><div class="article_supporting-info" id="rightTab-notes-1"><div class="article_content-header"><div class="article_content-header-row"><div class="article_content-title"><h2 id="rightTab-rightTab-_i54"><a href="/doi/suppl/10.1021/jm3009635">Supporting Information</a></h2></div><div class="article_content-sections"><span>ARTICLE SECTIONS</span><div class="article_sections-dropBlock"><a class="" href="#"><span>Jump To</span><i class="icon-angle-down"></i></a><div class="dropBlock__holder" data-db-target-of="sectionsDB_72612"></div></div></div></div></div><hr /></hr><p class="last">Data table for PDE9 IC<sub>50</sub> values on key compound. LC/MS data for presence of α-chloro intermediate in amine displacement of <b>12b</b> when using the amine-HCl salt. This material is available free of charge via the Internet at <a class="extLink" href="http://pubs.acs.org">http://pubs.acs.org</a>.</p><div class="supInfoBoxOnFTP "><div class="sup-info-attachments"><ul><li><a class="suppl-anchor" href="/doi/suppl/10.1021/jm3009635/suppl_file/jm3009635_si_001.pdf">jm3009635_si_001.pdf (417.01 kb)</a></li></ul></div></div><div id="rightTab-figshare-widget"></div><br /></br><div class="TermsAndConditionsDropzoneRight" data-pb-dropzone="TermsAndConditionsDropzoneRight"><div data-widget-def="UX3HTMLWidget" data-widget-id="b84e6b6c-b4d0-4427-b286-3cf14d52d013" class="mb-4">
        



        
        <h2 style="font-size: 1rem;margin-bottom: 10px;">Terms & Conditions</h2>
<p>Most electronic Supporting Information files are available without a subscription to ACS Web Editions. Such files may be downloaded by article for research use (if there is a public use license linked to the relevant article, that license may permit other uses). Permission may be obtained from ACS for other uses through requests via the RightsLink permission system:
<a href="/page/copyright/permissions.html" title="RightsLink">http://pubs.acs.org/page/copyright/permissions.html</a>.</p>

        </div></div></div></li></ul><div class="recommendedDropzone7" data-pb-dropzone="recommendedDropzone7"><div data-ajaxurl="/pb/widgets/ux3/ux3-showRecommend?widgetId=b272b1fe-ab4e-454f-940c-a3deaf223d23&amp;doi=10.1021%2Fjm3009635&amp;pbContext=%3BrequestedJournal%3Ajournal%3Ajmcmar%3Bjournal%3Ajournal%3Ajmcmar%3Bpage%3Astring%3AArticle%2FChapter+View%3Bctype%3Astring%3AJournal+Content%3Bwgroup%3Astring%3AACHS+website+Group%3Bissue%3Aissue%3A10.1021%2Fjmcmar.2012.55.issue-21%3Bwebsite%3Awebsite%3Aacspubs%3BpageGroup%3Astring%3APublication+Pages%3Barticle%3Aarticle%3A10.1021%2Fjm3009635%3BsubPage%3Astring%3AFull+Text" class="show-recommended-placeholder"></div>




        
        <script>
$(document).ready(function() {
  setTimeout(function() {
    var myLink = $(".show-recommended").find("a").not("[href='http://acsmediakit.org']").not("[href='javascript:void(0);']");
    myLink.attr("href", function(i, href) {
        return href + '?ref=recommended';
    });
  }, 5000);
});
</script></div></div></div></div></div></div></div><div class="col-xs-12.clearfix"><div class="article_qv-xs-container"><div class="article_qv-xs"><ul><li><a href="#" title="In This Article"><span>In This Article</span></a></li><li><a href="#" title="Figures" data-slide-target=".tab__pane-figures" class="w-slide__btn slide-active"><i class="icon-image"></i><span>Figures</span></a></li><li><a href="#" title="References" data-slide-target=".tab__pane-references" class="w-slide__btn slide-active"><i class="icon-link"></i><span>References</span></a></li><li><a href="#" title="Supporting Information" data-slide-target=".tab__pane-suppInfo" class="w-slide__btn slide-active"><i class="icon-supporting-info"></i><span>Supporting Information</span></a></li><li><a href="#" title="Recommended Articles" data-slide-target=".recommendedDropzone7" class="show-recommended-qv w-slide__btn slide-active" target="_self"><i class="icon-newspaper-o"></i><span>Recommended Articles</span></a></li></ul><a title="PDF" href="/doi/pdf/10.1021/jm3009635" class="button_primary"><i class="icon-file-pdf-o"></i>PDF  <span class="filesize">[
                1MB]
            </span></a></div></div></div></div></div></div></article></main>




        
        <footer class="footer">



        
        <div class="footer_first-row" id="partners">
	<div class="container">
		<div class="row">
			<div class="col-xs-12">
				<div class="footer_first-row_title">
					<h2>
						Partners
					</h2>
				</div>
				<div class="footer_first-row_logos">
					<div>
						<a href="http://www.atypon.com/">
							<img src="/pb-assets/images/footer_logos/logo-atypon-1525376610217.png" alt="Atypon">
						</a>
					</div>
					<div>
						<a href="http://www.chorusaccess.org/">
							<img src="/pb-assets/images/footer_logos/logo-chorus-1525375622947.png" alt="Chorus">
						</a>
					</div>
					<div>
						<a href="http://publicationethics.org/">
							<img src="/pb-assets/images/footer_logos/logo-cope-1525375622977.png" alt="Cope publication ethics">
						</a>
					</div>
					<div>
						<a href="http://www.projectcounter.org/">
							<img src="/pb-assets/images/footer_logos/logo-counter-1523044519173.jpg" alt="Project Counter">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/">
							<img src="/pb-assets/images/footer_logos/logo-crossref-1525377362093.png" alt="Crossref">
						</a>
					</div>
					<div>
						<a href="http://www.crossref.org/crosscheck/index.html">
							<img src="/pb-assets/images/footer_logos/logo-crosscheck-1525375623000.png" alt="Crossref similarity check">
						</a>
					</div>
					<div>
						<a href="http://www.orcid.org/">
							<img src="/pb-assets/images/footer_logos/logo-orcid-1525375623187.png" alt="Orcid Connecting Research and Researchers">
						</a>
					</div>
					<div>
						<a href="http://www.portico.org/">
							<img src="/pb-assets/images/footer_logos/logo-portico-1525375623203.png" alt="Portico digital preservation service">
						</a>
					</div>
				</div>
			</div>
		</div>
	</div>
</div>





        
        <div class="footer_second-row col-xs-12 gutterless ">









        <div data-widget-def="ux3-layout-widget" data-widget-id="f963f9aa-5ade-4a09-8515-e6cd8e6364cf" class="row container">
        



        
        <div class="col-xs-12">



        
        <div class="footer_second-row_left col-md-2 gutterless ">



        
        <a href="/"><img src="/pb-assets/images/pubslogo-small-1444685090580.png" alt="ACS Publications"></a>
<div class="footer_menu">
	<ul>
		<li class="footer_menu_address">
			<span>
				1155 Sixteenth Street N.W.
			</span>
		</li>
		<li class="footer_menu_address">
			<span>
				Washington, DC 20036
			</span>
		</li>

		<li class="footer_menu_copyright">
			<a href="http://www.acs.org/content/acs/en/copyright.html">
				Copyright © 2021<br>
				American Chemical Society
			</a>
		</li>
	</ul>
</div>
</div><div class="footer_second-row_middle col-md-2 gutterless "></div><div class="footer_second-row_right col-md-8 gutterless ">



        
        <div class="footer_second-row_about col-xs-4">



        
        <h2>About</h2>
<ul>
    <li><a href="/page/about-us.html">About ACS Publications</a></li>
    <li><a href="http://acsopenscience.org">ACS & Open Access</a></li>
    <li><a href="https://www.acs.org/content/acs/en/membership/member-benefits/publications-discounts.html">ACS Membership</a></li>
</ul>
</div><div class="footer_second-row_resources col-xs-5">



        
        <h2>Resources and Information</h2>
<ul>
	<li><a href="/action/showPublications?pubType=journal">Journals A-Z</a></li>
	<li><a href="/action/showPublications?pubType=book">Books and Reference</a></li>
    <li><a href="http://acsmediakit.org/digital/acs-pubs/?utm_source=Footer&amp;utm_medium=Pubs&amp;utm_campaign=CEN">Advertising Media Kit</a></li>
    <li><a href="https://solutions.acs.org">Institutional Sales</a></li>
    <li><a href="https://publish.acs.org/publish/">ACS Publishing Center</a></li>
    <li><a href="http://www.acs.org/content/acs/en/privacy.html">Privacy Policy</a></li>
    <li><a href="https://www.acs.org/content/acs/en/terms.html">Terms of Use</a></li>
</ul>
</div><div class="footer_second-row_support col-xs-3">



        
        <h2>Support & Contact</h2>
<ul>
    <li><a href="https://acs.service-now.com/acs">Help</a></li>
    <li><a href="#" onclick="SnapEngage.startLink();return false;" class="help help-chat">Live Chat</a></li>
    <li><a href="https://acs.service-now.com/acs">FAQ</a></li>
</ul>
</div>
</div>




        
        <div class="footer_social_section col-xs-12">



        
        <div class="footer_social_header">
	<h2>Connect with ACS Publications</h2>
</div>
<div class="footer_social">
	<ul>
		<li>
			<a href="https://preferences.acspubs.org/journals" class="icon-envelope-o" aria-label="email">
			</a>
		</li>
		<li>
			<a href="https://www.facebook.com/ACSPublications/" class="icon-facebook" aria-label="facebook" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://twitter.com/ACSPublications" class="icon-twitter" aria-label="twitter" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="https://www.youtube.com/user/AmerChemSoc" class="icon-youtube-play" aria-label="youtube" target="_blank" rel="noreferrer">
			</a>
		</li>
		<li>
			<a href="/page/follow.html?widget=follow-pane-rss" class="icon-rss" aria-label="rss feed">
			</a>
		</li>
	</ul>
</div>

</div>
</div>

        </div>
    
</div>
</footer>




        
        <script>
(function(){
	
	/*Event Tracking for RIS menu dropdown - Article pages*/

	$('.cit-download-dropdown_button').on('click',function(e)
	{	
		e.preventDefault();
	    ga('send', 'event', 'Citation', 'Export', 'Main');
	});


	$('.cit-download-dropdown_content ul li').on('click',function(e)
	{	
	//	e.preventDefault();
	    var idx = $(this).index();
	    
	    var label = '';
	    if (idx === 0 ) {
	    	label = 'Citation';
	    } else if (idx === 1 ) {
	    	label = 'Abstract';
	    } else if (idx === 2 ) {
	    	label = 'Reference';
	    } else if (idx === 3 ) {
	    	label = 'More Options';
	    }
	   ga('send', 'event', 'Citation', 'Export', label);
	});

	$('.header_contnav-next a').on('click', function(e){
        e.preventDefault();
        ga('send', 'event', 'Article', 'Top', 'Right Arrow');
	}); 

 	$('.header_contnav-pre a').on('click', function(e){
	    e.preventDefault();
	     ga('send', 'event', 'Article', 'Top', 'Left Arrow');
	}); 

	$('.share_button').on('click', function(e){
		e.preventDefault();
		ga('send', 'event', 'Article', 'Top', 'Share');
	});

	$("#pane-m1con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Figures');
	});

	$("#pane-m2con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'References');
	});

	$("#pane-m3con").on('click', function(e) {
		e.preventDefault();
		ga('send', 'event', 'Article', 'Sidebar', 'Supporting Info');
	});

	$('.tab__close').on('click', function(){
		ga('send', 'event', 'Article', 'Sidebar', 'Close');
	}); 



})();

</script>






        
        <div aria-live="polite" aria-atomic="true" class="achs-mendeley"><input type="hidden" name="tokenEndpoint" value="https://sso.acs.org/mendeley/token" class="tokenEndpoint"/></input><input type="hidden" name="appID" value="literatum" class="appID"/></input><input type="hidden" name="reopen-mendeley-modal-after-reload" class="reopen-mendeley-modal-after-reload"/></input><input type="hidden" name="statusEndpoint" value="https://sso.acs.org/idp/status" class="statusEndpoint"/></input><input type="hidden" name="clientID" value="atypon-lives" class="clientID"/></input><div class="achs-mendeley_table"><div class="achs-mendeley_row"><div class="achs-mendeley_cell loop-trap"><div class="achs-mendeley_container"><a title="Close" aria-label="close" tabindex="0" class="achs-mendeley_close"><i aria-hidden="true" class="icon-close"></i></a><div class="achs-mendeley_dropzone1"><div class="achs-mendeley_dropzone1_state1">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state2">



        
        <p style="font-weight: bold;">Pair your accounts.</p>
<p>Export articles to Mendeley</p>
<p>Get article recommendations from ACS based on references in your Mendeley library.</p>
</div><div class="achs-mendeley_dropzone1_state3">



        
        <p style="font-weight: bold;">You’ve supercharged your research process with ACS and Mendeley!</p>
</div></div><div class="achs-mendeley_continue-header"><button class="achs-mendeley_continue-btn"><span class="achs-mendeley_buttonText">Continue</span></button></div><div class="achs-mendeley_steps"><div class="achs-mendeley_steps_row"><div class="achs-mendeley_steps_cell achs-mendeley_acsLogin"><h6>STEP 1:</h6><button class="button_primary achs-mendeley_acsLogin_button"><span class="achs-mendeley_buttonText">Login with ACS ID</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><span class="achs-mendeley_acsLogin_label">Click to create an ACS ID</span><i class="icon-if-arrow-right"></i></div><div class="achs-mendeley_steps_cell achs-mendeley_login"><h6>STEP 2:</h6><button class="button_primary achs-mendeley_login_button"><i class="icon-mendeley"></i><span class="achs-mendeley_buttonText">Login with Mendeley</span><span class="achs-mendeley_success_buttonText">Logged in Success</span></button><a href="https://id.elsevier.com/as/authorization.oauth2?state=c33c27125763433d4d32a15accaacc18&amp;prompt=login&amp;scope=openid%20email%20profile%20els_auth_info&amp;authType=SINGLE_SIGN_IN&amp;response_type=code&amp;platSite=MDY%2Fmendeley&amp;redirect_uri=https%3A%2F%2Fwww.mendeley.com%2Fcallback%2F&amp;client_id=MENDELEY" title="Create a Mendeley account">Create a Mendeley account</a></div></div></div><div class="achs-mendeley_dropzone2"><div class="achs-mendeley_dropzone2_state1">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state2">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div><div class="achs-mendeley_dropzone2_state3">



        
        <p style="font-weight: bold;font-style:italic;">Please note: If you switch to a different device, you may be asked to login again with only your ACS ID.
</p>
</div></div></div></div></div></div></div><div class="achs-mendeley_alert"><div class="achs-mendeley_alert_table"><div class="achs-mendeley_alert_row"><div class="achs-mendeley_alert_cell"><div class="achs-mendeley_alert_container"><a title="Close" aria-label="close" class="achs-mendeley_alert_close"><i aria-hidden="true" class="icon-close"></i></a><div role="alert" aria-live="polite" aria-atomic="true" class="achs-mendeley_alert_dropzone">



        
        <p>Please login with your ACS ID before connecting to your Mendeley account.</p><button class="button_tertiary achs-mendeley_acsLogin_button mendeley-acs-custom-login-btn" onclick="loginToAcsSso(event); return false;">Login with ACS ID</button>

<script>
 function loginToAcsSso(event){
 event.preventDefault();
 $('.achs-mendeley_acsLogin .achs-mendeley_acsLogin_button').trigger('click');
 }
</script>
</div><div class="achs-mendeley_alert_error-msg"></div></div></div></div></div><div class="pairing-expired-dialog-container"><div class="pairing-expired-dialog"><div class="pairing-expired-dialog_top-btns"><span class="pairing-expired-dialog_heading">MENDELEY PAIRING EXPIRED</span><button onClick="UX.achsMendeley.reconnectOnClickHandler();" class="pairing-expired-dialog_reconnect">Reconnect</button></div><div class="pairing-expired-dialog_content"><span>Your Mendeley pairing has expired. Please reconnect</span></div></div></div></div>




        
        <style type="text/css">
#gdpr-message-modal {
    display: none;
    /* Hidden by default */
    position: fixed;
    /* Stay in place */
    z-index: 2;
    /* Sit on top */
    /*padding-top: 100px;*/
    /* Location of the box */
    left: 0;
    bottom: 0;
    width: 100%;
    /* Full width */
    /*height: 100%;*/
    /* Full height */
    overflow: auto;
    /* Enable scroll if needed */
    /*background-color: rgb(0,0,0);*/
    /* Fallback color */
    /*background-color: rgba(0,0,0,0.4);*/
    /* Black w/ opacity */
}
#gdpr-message-content {
    font-family: Arial;
    background-color: #005083;
    color: #fff;
    margin: auto;
    padding: 5px 0 10px 0;
    /*border: 1px solid #888;*/
    box-shadow: 0 -1px 3px #666;
    width: 100%;
    display: block;
    bottom: 0;
}
#gdpr-message-container {
    /*width: 1130px;*/
    margin: 0 auto;
}
.gdpr-innerwrap {
    display: block;
    /*width: 1100px;*/
    margin: 0 auto;
    text-align: center;
}
#gdpr-message-content h1 {
    color: #0629b5;
    font-size: 26px;
    margin: 0.5em 0 0 0;
    border-bottom: solid 2px #4c7fb9;
    display: inline;
    padding-bottom: 10px;
}
#gdpr-message-content h4 {
    display: inline-block;
    margin-left: 0;
    margin-right: 14px;
    margin-top: 13px;
    /*width: 980px;*/
    font-size: 14px;
    font-weight: normal;
}
#gdpr-message-content p {
    font-size: 14px;
    margin: 2em 2em 0.5em 0em;
    text-align: left;
    font-weight: bold;
}
#gdpr-message-content a,
#gdpr-message-content a:hover {
    color: #9bcfff;
}
.gdpr-listwrap {
    display: block;
    margin-bottom: 10px;
    min-height: 100px;
    min-width: 200px;
}
#gdpr-message-content ul {
    margin-top: 20px;
    font-size: 13px;
}
#gdpr-ul1 {
    display: inline-block;
    float: left;
}
#gdpr-ul2 {
    display: inline-block;
    margin-left: 10px;
}
#gdpr-message-content ul li {
    margin-top: 4px;
}
a#gdpr-con-btn,
a#gdpr-con-btn:hover {
    width: 110px;
    height: 35px;
    background: #fec82a;
    background-image: none;
    background-image: -webkit-gradient(linear, 50% 0%, 50% 100%, color-stop(0%, #fec82a), color-stop(100%, #daa301));
    background-image: -webkit-linear-gradient(top, #fec82a, #daa301);
    background-image: -moz-linear-gradient(top, #fec82a, #daa301);
    background-image: -o-linear-gradient(top, #fec82a, #daa301);
    background-image: linear-gradient(top, #fec82a, #daa301);
    border-radius: 4px;
    color: #004a7b;
    display: inline-block;
    text-decoration: none;
    line-height: 35px;
    text-align: center;
    margin-top: 5px;
    /*margin-right: 14px;*/
    /*float: right;*/
    font-weight: bold;
}
#gdpr-message-btn {
    width: 60px;
    height: 38px;
    background: #4b8fc2;
    border-radius: 4px;
    color: white;
    display: inline-block;
    margin-top: -4px;
    font-size: 12px;
}
a#closebtn {
    float: right;
    color: #d4e5ef;
}
#gdpr-input {
    width: 200px;
    height: 30px;
    border-radius: 3px;
    border-width: 1px;
    box-shadow: none;
    margin-right: 10px;
    font-size: 14px;
    outline: none;
    padding-left: 2px;
    display: inline-block;
    float: left;
}
#gdpr-message-content p.gdpr_err {
    font-size: 15px;
    margin-top: 10px;
}
#gdpr-message-modal.mobile, #gdpr-message-modal.mobile .gdpr-message-content {
    height: 160px;
}
@media only screen and (min-width: 1026px) and (max-width: 1368px) {
	#gdpr-message-content h4 {
		width: 80%;
		text-align: left;
	}
}
</style>

<div id="gdpr-message-modal">
    <div id="gdpr-message-content">
        
	        <div class="gdpr-innerwrap container">
	            <h4>This website uses cookies to improve your user experience. By continuing to use the site, you are accepting our use of cookies. <a href="http://www.acs.org/content/acs/en/privacy.html">Read the ACS privacy policy</a>.</h4>
	            <a href="#" id="gdpr-con-btn">CONTINUE</a>
	        </div>
        
    </div>
</div>

<script type="text/javascript">
"use strict"
//Script checks gdpr cookie and submits form
	/* 
	Create an in-page pop-up message, only for the InfoCentral homepage, that will gather email registrants for the library marketing list.
	 
	Needs the end point
	*/

var infoCentralCapture = (function() {

    //Detect mobile device
    window.mobilecheck = function() {
        var check = false;
        (function(a){if(/(android|bb\d+|meego).+mobile|avantgo|bada\/|blackberry|blazer|compal|elaine|fennec|hiptop|iemobile|ip(hone|od)|iris|kindle|lge |maemo|midp|mmp|mobile.+firefox|netfront|opera m(ob|in)i|palm( os)?|phone|p(ixi|re)\/|plucker|pocket|psp|series(4|6)0|symbian|treo|up\.(browser|link)|vodafone|wap|windows ce|xda|xiino/i.test(a)||/1207|6310|6590|3gso|4thp|50[1-6]i|770s|802s|a wa|abac|ac(er|oo|s\-)|ai(ko|rn)|al(av|ca|co)|amoi|an(ex|ny|yw)|aptu|ar(ch|go)|as(te|us)|attw|au(di|\-m|r |s )|avan|be(ck|ll|nq)|bi(lb|rd)|bl(ac|az)|br(e|v)w|bumb|bw\-(n|u)|c55\/|capi|ccwa|cdm\-|cell|chtm|cldc|cmd\-|co(mp|nd)|craw|da(it|ll|ng)|dbte|dc\-s|devi|dica|dmob|do(c|p)o|ds(12|\-d)|el(49|ai)|em(l2|ul)|er(ic|k0)|esl8|ez([4-7]0|os|wa|ze)|fetc|fly(\-|_)|g1 u|g560|gene|gf\-5|g\-mo|go(\.w|od)|gr(ad|un)|haie|hcit|hd\-(m|p|t)|hei\-|hi(pt|ta)|hp( i|ip)|hs\-c|ht(c(\-| |_|a|g|p|s|t)|tp)|hu(aw|tc)|i\-(20|go|ma)|i230|iac( |\-|\/)|ibro|idea|ig01|ikom|im1k|inno|ipaq|iris|ja(t|v)a|jbro|jemu|jigs|kddi|keji|kgt( |\/)|klon|kpt |kwc\-|kyo(c|k)|le(no|xi)|lg( g|\/(k|l|u)|50|54|\-[a-w])|libw|lynx|m1\-w|m3ga|m50\/|ma(te|ui|xo)|mc(01|21|ca)|m\-cr|me(rc|ri)|mi(o8|oa|ts)|mmef|mo(01|02|bi|de|do|t(\-| |o|v)|zz)|mt(50|p1|v )|mwbp|mywa|n10[0-2]|n20[2-3]|n30(0|2)|n50(0|2|5)|n7(0(0|1)|10)|ne((c|m)\-|on|tf|wf|wg|wt)|nok(6|i)|nzph|o2im|op(ti|wv)|oran|owg1|p800|pan(a|d|t)|pdxg|pg(13|\-([1-8]|c))|phil|pire|pl(ay|uc)|pn\-2|po(ck|rt|se)|prox|psio|pt\-g|qa\-a|qc(07|12|21|32|60|\-[2-7]|i\-)|qtek|r380|r600|raks|rim9|ro(ve|zo)|s55\/|sa(ge|ma|mm|ms|ny|va)|sc(01|h\-|oo|p\-)|sdk\/|se(c(\-|0|1)|47|mc|nd|ri)|sgh\-|shar|sie(\-|m)|sk\-0|sl(45|id)|sm(al|ar|b3|it|t5)|so(ft|ny)|sp(01|h\-|v\-|v )|sy(01|mb)|t2(18|50)|t6(00|10|18)|ta(gt|lk)|tcl\-|tdg\-|tel(i|m)|tim\-|t\-mo|to(pl|sh)|ts(70|m\-|m3|m5)|tx\-9|up(\.b|g1|si)|utst|v400|v750|veri|vi(rg|te)|vk(40|5[0-3]|\-v)|vm40|voda|vulc|vx(52|53|60|61|70|80|81|83|85|98)|w3c(\-| )|webc|whit|wi(g |nc|nw)|wmlb|wonu|x700|yas\-|your|zeto|zte\-/i.test(a.substr(0,4))) check = true;})(navigator.userAgent||navigator.vendor||window.opera);
              return check;
        };

    var _isMobile = window.mobilecheck();
    if (_isMobile) {
        $('#gdpr-message-modal').addClass('mobile');
    }

    var emailValid = "",
        time = 3000,
        btnStatus = true,
        errorStatus = false,
        errormessage = "<p class='gdpr_err'><b>Please Enter a valid email address<b><p>";

    function init() {
        setTimeout(function() {
            var cookieExist = getCookie("gdpr");
            if (cookieExist) {
                //console.log("gdpr cookie exist");
                return false;
            } else {
                //console.log("gdpr cookie does not exist")
                gdprMessage();
            }
            //Events
            $('#closebtn').on("click", hideForm);

            //Handle submit
            $('#gdpr-message-btn').on("click", function(event) {
                handleClick();
            });

            // //Hide if clicked outside div - TO DO stop handling click after submit
            // $(document).click(function(event) {
            // 	event.stopPropagation();
            //   console.log(event.target);
            //   if (!$(event.target).closest("#gdpr-message-content").length) {
            //     $("body").find("#gdpr-message-modal").hide();
            //     $(this).off();
            //   }
            // });
            $('#gdpr-con-btn').click(function() {
                setCookie("gdpr", "true");
                hideForm();
            });
        }, time);
    }

    //Show the message
    function gdprMessage() {
        //console.log("Show GDPR Message");
        var tMessage, emailInput, messageButton, ewrap;

        $('#gdpr-message-modal').show();
    }

    function handleClick() {
        //console.log($("#gdpr-input").val());
        emailValid = validateEmail($("#gdpr-input").val());
        if (emailValid) {
            //Submit the form
            //Hide form
            if ($('.gdpr_err')) {
                $('.gdpr_err').hide();
            }

            $("#gdpr-message-content")
                //If successful then...
            setCookie("gdpr", "true");
            //console.log("emailValid " + emailValid + " submiting form");
        } else {
            //Show error message
            gdprErrorMessage();
            //console.log("emailValid " + emailValid);
        }
    }

    function gdprErrorMessage() {
        if (errorStatus) {
            return false;
        } else {
            errorStatus = true;
            $("#gdpr-message-content").append(errormessage);
        }
    }

    function validateEmail(email) {
        var re = /^(([^<>()\[\]\\.,;:\s@"]+(\.[^<>()\[\]\\.,;:\s@"]+)*)|(".+"))@((\[[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\.[0-9]{1,3}\])|(([a-zA-Z\-0-9]+\.)+[a-zA-Z]{2,}))$/;
        return re.test(String(email).toLowerCase());
    }

    function setCookie(name, value) {
        var expires = "";
        expires = "; expires=Fri, 31 Dec 9999 23:59:59 GMT";
        document.cookie = name + "=" + (value || "") + expires + "; path=/";
    }

    function getCookie(name) {
        var match = document.cookie.match(new RegExp(name + '=([^;]+)'));
        if (match) return match[1];
    }

    function hideForm() { //And set cookie
        $('#gdpr-message-modal').hide();
        setCookie("gdpr", "false");
        ga('send', 'event', 'Pubs GDPR', 'GDPR Modal', 'GDPR Dismissal');
    }

    return {
        init: init
    }
})();

$(document).ready(infoCentralCapture.init);
</script>





        
        <script>
    //Top nav tracking

    (function(){
        $('.header_my-activity a:first').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Activity')
            ga('send', 'event', 'Top Nav', 'Button', 'Activity');
        })


        $('.pubModal_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Publications')
            ga('send', 'event', 'Top Nav', 'Button', 'Publications');
        }) 

        $('.header_burger-menu_button').on('click', function(e){
            e.preventDefault();
            //console.log('Button , Hamburger');
            ga('send', 'event', 'Top Nav', 'Button', 'Hamburger');
        }) 

        // $('.header_burger-menu_content ul li').on('click', function(e){
        //     // e.preventDefault();
        //     var idx = $(this).index();
        //     console.log('Menu item' + idx)
        // })
    })();
    
    
</script>




        
        
<script type="text/javascript">
    adroll_adv_id = "3LBZJ4KXKBF2PJ46QCMT3X";
    adroll_pix_id = "6EITYRDI4FFGJPSZQ62UJJ";

    (function () {
        var _onload = function(){
            if (document.readyState && !/loaded|complete/.test(document.readyState)){setTimeout(_onload, 10);return}
            if (!window.__adroll_loaded){__adroll_loaded=true;setTimeout(_onload, 50);return}
            var scr = document.createElement("script");
            var host = (("https:" == document.location.protocol) ? "https://s.adroll.com" : "http://a.adroll.com");
            scr.setAttribute('async', 'true');
            scr.type = "text/javascript";
            scr.src = host + "/j/roundtrip.js";
            ((document.getElementsByTagName('head') || [null])[0] ||
                document.getElementsByTagName('script')[0].parentNode).appendChild(scr);
        };
        if (window.addEventListener) {window.addEventListener('load', _onload, false);}
        else {window.attachEvent('onload', _onload)}
    }());
</script>










        
        <div class="activity-container hidden-lg hidden-md"><div class="recentlyViewed" style="right: -100%;"><div class="activity_title_container"><span class="activity_title">Recently Viewed</span><a href="javascript:void(0)" class="activity_back"><i class="icon-angle-left"></i></a></div></div></div>




        
        <script>
$(document).ready(function(){
    var cookie = "";
    var uri = "/doi/full/10.1021/html_original_uri?id=123";
    console.log("ACSPubs2 start");
    $.getJSON('https://extreme-ip-lookup.com/json/', function(data, status) {
            if ( status == 'success' ) {
                $.each(data, function(i, field){
                    cookie=cookie.concat(i+' = '+field+" - ");
                });
                
            } else {
                    cookie=status;
            }

            cookie1 = cookie;
            cookie = cookie1 + "; path=/; domain=.acs.org";
            //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
            $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
            //TODO send cookie val to the controller for logging
            console.log("ACSPubs2 success");
    })
    .fail(function(xx, status, err){
        cookie="error: 127.0.0.1";
        //document.cookie = "ACSPubs2= "+ btoa(cookie) ;
        $.cookie("ACSPubs2", btoa(cookie), {path: '/'}); // Session cookie valid across the entire site.
        console.log("ACSPubs2 failed");
        //TODO send cookie val to the controller for logging
    });
});    
</script>





        
        



        
    

        </div>
    </div>





	

    <script>if (typeof define !== 'undefined')
    if (define.amd)
        define.amd = false</script><script src="/products/achs/releasedAssets/js/build.lazyload.bundle-191cb5c7d88ed9894acd.js"></script><script src="/products/achs/releasedAssets/js/main.bundle-524acd43b3dccf6df3df.js"></script>

<script type="text/javascript" src="/wro/kfa7~product.js"></script>































    












<script defer src="https://static.cloudflareinsights.com/beacon.min.js" data-cf-beacon='{"rayId":"67992a251c743d0c","token":"d4e766cffbf14806ad37e095398b9c5f","version":"2021.7.0","si":10}'></script>
</body>
</html>
